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Abstract 
 
A plethora of naturally-produced steroid hormones, or artificial 
homologues of them, are being introduced into the aquatic and terrestrial 
environments each year. Two examples of these are the natural oestrogen 
17-oestradiol (E2) and the oestrogen receptor antagonist, Bisphenol A (BPA), 
both of which target the ribonucleoprotein telomerase through upregulation of 
its telomerase reverse transcriptase component, TERT. The main objectives 
of this study were firstly to isolate and characterize the actual mRNA 
sequence for the telomerase catalytic subuninit, Tert, in rainbow trout 
(Oncorhynchus mykiss) (Walbaum, 1792) and European purple sea urchin 
(Paracentrotus lividus) (Lamarck, 1816), with the aim of developing qPCR 
assays for the amplification and quantification of Tert. Further objectives were 
to use these assays in controlled exposure studies to establish whether and to 
what extent the aforementioned chemicals regulate Tert transcription and by 
doing so further understand the mechanism of Telomerase gene expression 
and the extent to which environmental oestrogen can interfere. The initial step 
of sequence characterization and assay devlopment was successful in the 
case of rainbow trout where two possible splice variants of Tert mRNA are 
identified, omTertShort and omTertLong. Two qPCR assays were developed 
for the relative quantification of both of these splice variants in rainbow trout 
samples, the latter of these successfully amplifying its target in test samples. 
In order to demonstrate in vitro and in vivo modulation of telomerase activity 
and mRNA expression, early life-stages of rainbow trout and purple sea 
urchin, as well as rainbow trout hepatocytes, were exposed to a range of 
concentrations of E2 and BPA. Purple sea urchin embryos were exposed to 
200, 20 and 2 ng E2/ml for 28 hours until they had reached the stage of 
pluteus larvaes. Rainbow trout embryos were exposed to 500, 20 and 0.1 ng 
E2/ml and 600 and 150 ng BPA/ml for 167 days from immediately after 
fertilization. Rainbow trout hepatocytes were exposed to 20 and 2 ng E2/ml for 
48 hours. The results from this study show that telomerase activity as well as 
TERT mRNA expression can be significantly modulated by exposure to 
oestrogens and other oestrogenic chemicals. E2 concentrations as low as 20 
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ng/ml lead to an increase in telomerase activity early-life stages of purple sea 
urchin and upregulation in the transcription of Tert mRNA in unhatched 
rainbow trout embryos. BPA induced similar response (600 ng/ml) in hatched 
rainbow trout alevins larvae. Very high exposures to E2 (500 ng/ml) do 
however lead to downregulation of Tert mRNA in hatched alevins larvae. 
Differential regulatory response can be observed between different tissue 
types of 167 day old fry, with an upregulatory response observed at 0.1 ng 
E2/ml in liver and muscle tissues, but not in brain. Similarly, brain tissues were 
observed expressing significantly less mRNA than liver and muscle samples 
when exposed to BPA (150 ng/ml). It is evident that the previously observed 
link between environmental oestrogens and telomerase is also present in the 
two test species examined; purple sea urchin and rainbow trout.   
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1.1.  Telomeres and telomerase 
 
1.1.1 The Eukaryotic telomeres 
 
In all eukaryotic cells, the chromosomal ends are capped with 
telomeres (Muller, 1938; McClintock, 1941) that protect the chromosomes 
from degradation, end-to-end fusion and recombination (Blackburn, 1991). 
These telomeres play a vital role in the functional organization of 
chromosomes within the nucleus and the regulation of gene expression, and 
their presence is necessary for the chromosomes to be replicated completely 
(Cong et al., 2002). In most eukaryotic somatic cell types these telomeres 
shorten as the cells age (Harley et al., 1990; Hastie et al., 1990) by about 65 
base pairs per generation (Counter et al., 1992). A process that triggers 
cellular senescence once telomeres become critically short has been 
observed in these cells (Campisi et al., 2001). It has been suggested that their 
shortening acts as a molecular clock that monitors the replicative history and 
capacity of normal human cells (Harley et al., 1992; Wright and Shay, 1992; 
Cong et al., 2002). In rapidly dividing human cells like germline cells and stem 
cells this telomere shortening is bypassed by a unique ribonucleoprotein 
enzyme called telomerase, which attaches to the ends of the telomeres and 
adds DNA repeats onto the ends of the telomeres on the chromosomes 
(Greider and Blackburn, 1989). An alternative recombinational mechanism 
(ALT) also exists for the lengthening of telomeres in certain cell types, where 
telomere length is maintained in the absence of significant telomerase activity 
through of homologous recombination and inter-telomeric copying, where 
single- stranded DNA from one telomere uses another telomere as a copy 
template (Henson et al, 2002, Nittis et al, 2009). The two mechanisms can co-
exist, although research suggests that a factor acting as a repressor of the 
ALT mechanism, exists within telomerase-positive cells (Perrem et al, 2001). 
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1.1.2 Telomeres in evolution 
 
The telomere DNA sequence at the end of chromosomes is highly 
conserved. Some of the distinguishing features of telomeres are their 
composition; they are rich in Guanine and Thymine and their ends is a 3’ 
single-stranded DNA overhang.  In humans, the DNA sequence of telomeres 
consists of tandem (TTAGGG)n repeats comprising 0.01-0.2% of the genome 
(Moyzis, et al., 1988). The same sequence seems to be present in most 
eukaryotes, excluding some insects, which highlights a high degree of 
conservation throughout evolution (Lejnine et al., 1995; Podlevsky et al., 
2007).  Examples are numerous amongst other vertebrates including from 
reptiles (e.g. Cnemidophorus sexlineatus), amphibians (e.g. Xenopus laevis), 
birds (e.g. Gallus gallus) and mammals (e.g. Mus musculus) (Meyne et al, 
1989, Lejnine et al., 1995, Makarov et al., 1997, Wright et al., 1997). The 
same also applies to bony fish like the rainbow trout (Onchorhynchus mykiss) 
(Albuín et al., 1996) and even in some invertebrates like the bay scallop 
(Argopecten irradians) (Sinclair et al, 2007) and the American purple sea 
urchin (Strongylocentrotus purpuratus) (Lejnine et al., 1995). Despite the 
highly conserved telomere sequence, the average telomere lengths vary 
significantly between chromosomes, various cell types and species. It may 
also vary depending on the age of the cell itself (Blasco et al., 1999). One 
example of such variance between species is when telomere lengths of mice 
and humans are compared; the sequences of telomeric DNA repeats are 
many times larger in mice than in humans (Kipling and Cooke, 1990). Another 
example of the variability of the telomere sequence is in humans where 
telomere length is different between cell types, with germline cells having far 
longer telomeres than somatic cells (Allshire et al., 1989; Cooke et al., 1989; 
Cross et al., 1989; de Lange et al., 1990; Hastie et al., 1990). It is worth noting 
that telomeric-like repeats can also be found at internal sites in human, as 
well as other vertebrates like chimpanzee, mouse and rat. It has been 
proposed that these are remnants of double-strand breakage repair 
performed sometime in early vertebrate evolution (Garagna et al, 1997, Ruiz-
Herrera et al, 2008, Bolzán, 2012).  
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1.1.3 Telomerase reverse transcriptase 
 
Telomerase is a eukaryotic ribonucleoprotein (RNP) complex (Morin, G.B., 
1989) which plays an important role in stabilising telomere length and 
maintaining genomic stability in eukaryotic cells and the long-term viability of 
high-renewal organ systems (Greider and Blackburn, 1985; Lee at al., 1998; 
van Steensel et al., 1998; Smogorzewska et al., 2000; Campisi et al., 2001; 
Feldser et al., 2003). Telomerase does this by attaching itself to the telomeric 
DNA strand at the end of the chromosomes, and then proceeding to copy its 
own intrinsic template of the telomeric DNA repeats and then synthesize it 
(figure 1). Telomerase is typically repressed in human somatic cells, with 
telomerase activity early in embryogenesis but reducing as cellular 
differentiation and embryogenesis progresses (Wright et al., 1996; Ulaner and 
Giudice, 1997). Telomerase activity is also present in rapidly dividing cells, 
such as stem cells, reproductive cells (Wright et al., 1996) and cancer cells 
(Kim et al., 1994, Shay and Bacchetti, 1997). There are some normal human 
diploid cells that have been shown to express telomerase activity in vivo. 
These include bone marrow hematopoietic cells (Chiu et al., 1996) and blood 
leukocytes; T lymphocytes, B cells and monocytes (Kim et al., 1994; Broccoli 
et al., 1995; Counter et al., 1995). The ectopic expression of telomerase in 
normal human cells has been shown to extend their replicative life span 
(Bodnar et al., 1998), but does not seem to induce changes associated with a 
malignant phenotype (Jiang et al., 1999; Morales et al., 1999). Telomerase 
repression during early development has also been observed in large 
mammals, as well as some avian species (Fitzgerald et al. 1996; Forsyth et 
al. 2002; Argyle et al. 2003), whereas many vertebrates as well as 
invertebrates express telomerase in somatic tissues throughout their lifespan. 
These include some aquatic species like like sponges, lobsters, fish and sea 
urchins (Koziol et al., 1998; Klapper at al., 1998; McChesney et al., 2004; 
Francis et al., 2006).  
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Figure 1. Schematic diagram of the process of the human telomerase 
reaction (adapted from: Chen and Greider, 2003), showing the main 
steps in telomerase action. Telomerase binds to the 3’ single-stranded 
DNA overhang at the end of the chromosomes, copies its own intrinsic 
template of the telomeric DNA repeats and synthesizes it. 
 
Klapper and co-workers (1998) who observed telomerase activity in the 
adult tissues of the lobster species Homarus americanus concluded that 
telomerase activity is maintained in adult somatic tissues in organisms that 
grow indeterminately as means of preserving long-term cell proliferation 
capacity. A recent study by Francis and co-workers (2006) focused on 
establishing whether a difference could be seen between the telomerase 
activity and telomere length in the adult tissues of long- and short-lived sea 
urchins (American red sea urchin, Strongylocentrotus franciscanus, and 
variegated sea urchin, Lytechinus variegatus, respectively). By using the 
telomeric repeat amplification protocol (TRAP) assay to determine the 
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telomerase activity (Kim et al., 1994) and the terminal restriction fragment 
(TRF) length analysis to determine the telomere length, they observed no 
difference between the two species. This indicates that sea urchins, whether 
long- or short lived, do not use telomerase repression to suppress neoplastic 
transformation but use an alternative mechanism to avoid developing 
tumours. Seeing as both long-lived and short-lived aquatic species express 
somatic telomerase activity, one might conclude that telomerase does not 
play as big a role, if any, in longevity as was previously believed. Elmore and 
colleagues (2008) suggested that this ubiquitous level of telomerase 
expression was more likely related to these animals potential for tissue repair 
and regeneration. 
 
1.1.4 Telomerase structure and accessory proteins 
 
Telomerase is a highly conserved enzyme with many structural and 
catalytic subunits (Harrington at al., 1997). In deuterostome animals, fungi, 
ciliates and other protists as well as some plants, the two core components of 
human telomerase, making up the core enzyme, are the catalytic subunit 
TERT (telomerase reverse transcriptase) and TR, telomerase’s intrinsic RNA 
(telomere RNA). TERT seems to play a regulatory role with regards to 
telomerase activity for it has been shown to be the only telomerase subunit to 
limit the biological and biochemical rate of telomerase activity (Chang et al., 
2002). In human cells TERT expression changes proportionally with the level 
of telomerase activity (Chang et al., 2002) and is generally repressed in 
normal human telomerase-negative cells (Meyerson et al., 1997; Nakamura et 
al., 1997). TR which is used as a template for reverse transcription (Feng et 
al., 1995; Nugent and Lundblad, 1998) is, however, expressed in human 
tissues irrespective of the telomerase activity detected (Avantaggiati et al., 
1997), although the rate of which it is transcribed is considerably higher in 
those cell types which also express TERT (Yi et al., 1999). In vitro studies 
have detected telomerase activity with only hTR and hTERT present (Feng et 
al.,, 1995; Nakamura et al., 1997). These subunits do, however, seem to be 
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assisted by a range of other telomerase subunits, telomerase associated 
proteins and telomere-binding proteins in vivo. The composition of these 
does, however, vary signficantly between groups and species.  
In yeast (Saccharomyces cerevisiae) the two main telomerase 
components are homologues of those in humans; a catalytic subunit (Est2p) 
and the telomerase RNA template (TLC1). In addition, in yeast there are also 
two additional subunits to the telomerase complex required for in vivo activity, 
these are Est1p and Est3p (Hughes et al, 2000). It is interesting to note that 
three Est1 orthologs are found in the human genome, two of which play a role 
in the regulation of telomerase (Snow et al, 2003, Reichenback et al, 2003, 
Redon et al, 2007). 
Two molecular chaperones have been identified as being necessary for 
the assembly of active human telomerase in vivo, p23 and Hsp90 (Holt et al., 
1999; Keppler et al., 2006). TEP1 (telomerase-associated protein 1) has also 
been shown to be associated with telomerase activity and studies have shown 
that it binds specifically with the telomerase RNA (TR) (Harrington et al., 
1997; Nakayama et al., 1997) and interacts with TERT (Beattie et al., 2000). 
However, evidence suggests that TEP1 binding with the telomerase does not 
affect its catalytic activity (Beattie et al., 2000) and it is not essential for 
telomerase activity or telomere length maintenance (Liu et al., 2000), so its 
exact role in telomerase metabolism has yet to be established.  
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Table 1. The roles of the two main human telomerase subunits, hTERT 
and hTR and of the known human telomerase subunits. 
Protein Function References  
hTERT 
The catalytic subunit of 
telomerase (contains reverse 
Harrington at al., 1997; Linger et 
al., 1997; Meyerson et al., 1997; 
 
  transcriptase motifs). Nakamura et al., 1997  
     
hTR The telomerase’s intrinsic RNA Feng et al., 1995; Nugent  
    and Lundblad, 1998  
Hsp90-
p23 
Conformation, stabilization of 
telomerase complex 
Holt et al., 1999; Keppler et al., 
2006 
 
TEP1 Unknown Beattie et al., 2000  
 
Various human telomere-binding proteins have been identified in 
recent years, proteins that bind to the telomeres themselves. These include 
the telomeric repeat binding factors 1 and 2 (TRF1 and TRF2). TRF1 seems 
to be an in cis negative regulator of telomere length (van Steensel and de 
Lange, 1997) and forms shelterin (a protein complex important in telomere 
protection and telomere length maintenance) with TRF2 and four other 
proteins, POT1 (protection of telomeres 1), TIN2 (TRF-1 interacting protein 2), 
TPP1, and Rap1 (de Lange, 2005). The role of this protein complex is to 
protect the chromosome ends, preventing them from being recognised by 
DNA damage repair mechanisms. It is also believed to recruit/regulate 
telomerase access to the telomeres (Abreu et al, 2010), for when vital 
components to the protein complex are missing, telomerase fails to be 
recruited at the telomere ends (Aritonovska, 2011). Shelterin has only been 
found to accumulate at the ends of the chromosomes and has no other known 
function than to protect the telomeres (de Lange, 2005). 
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There are also numerous human telomerase associated proteins that 
seem to play a part in telomere maintenance, including a few poly(ADP-
ribose) polymerases (PARPs). TERT possesses poly (ADP-ribose) binding 
sequences and has the potential to interact with PARPs (Pleschke et al., 
2000). PARP-1 is a nuclear enzyme periodically found at normal telomeres, 
but is mainly found at damaged telomeres in mammalian cells (Gomez et al., 
2006) and suggested by Bouchard and associates in 2003 to be a DNA 
damage-signaling enzyme (Bouchard et al., 2003). Conflicting evidence has 
been published in the recent years concerning how PARP-1 deficiency affects 
telomere maintenance (d’Adda di Fagagna et al., 1999; Samper et al., 2001), 
but the bulk of the studies showed no apparent effect of PARP-1 deficiency on 
telomere length or telomere capping (Samper et al., 2001; Bailey et al., 2004; 
Bailey and Goodwin, 2004; Espejel et al., 2004). It has, however, been 
established that PARP-1 affects telomerase activity in human cells by 
changing the poly(ADP-ribosyl)ation of TERT and/or the expression of TEP1 
(Ghosh et al., 2007). Gomez and co-workers (2006) furthermore 
demonstrated that PARP-1 can interact with telomere repeat binding factor 2 
(TRF2). They suggested that PARP1 aids in the protection of eroded ends of 
the chromosomes through regulation of TRF2.  
VPARP (Vault poly(ADP-ribose) polymerase), or PARP-4 as it is also 
known, has been shown to be associated with telomerase activity in vivo and 
to interact with TEP1 in human cells, but researchers have been unable to 
demonstrate a direct association between VPARP and TERT in mammals. It 
has, however, been suggested, but not proven, that TEP1 or VPARP 
association with telomerase may not play a role unless the cells are exposed 
to stress (Liu et al., 2004). 
TNKS 1 (Tankyrase 1) is yet another PARP that is associated with 
telomerase. It positively regulates telomere length by ADP-ribosylating the 
telomere repeat binding factor 1 (TRF1), which is a telomeric DNA-binding 
protein, and preventing it from binding to telomeric DNA (Smith et al., 1998; 
Cook et al., 2002). It has been suggested that by doing this, TNKS allows 
telomerase access to the telomeres it also regulates access of telomerase to 
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the telomeric complex (Smith and de Lange, 2000). Tankyrase 2 displays 
properties similar to those of tankyrase (Cook et al., 2002). 
VPARP (Vault poly(ADP-ribose) polymerase), or PARP-4 as it is also 
known, has been shown to be associated with telomerase activity in vivo and 
to interact with TEP1 in human cells, but researchers have been unable to 
demonstrate a direct association between VPARP and TERT in other 
mammals. It has, however, been suggested, but not proven, that TEP1 or 
VPARP association with telomerase may not play a role unless the cells are 
exposed to stress (Liu et al., 2004). 
 
1.1.5  Telomerase in evolution  
 
The composition of the telomerase protein seems to differ considerably 
between the various groups of eukaryotes whereas the telomerase reverse 
transcriptase component of the telomerase protein complex (TERT) is highly 
conserved across the animal kingdom, with great homology especially 
amongst vertebrates, but also to a lesser extent amongst invertebrates. The 
sequence of telomerase’s intrinsic RNA component (TR) does, however, vary 
greatly between different groups of fauna, except for the RNA template itself 
as well as a few conserved motifs that bind TERT and other proteins 
(Podlevsky et al., 2008). In addition to that, the TERT gene sequences have 
been found across a far more varied range of species than TR which has only 
been identified in one invertebrate species, the American purple sea urchin (Li 
et al., 2013) and has yet to be identified in several other groups of organisms 
(Podlevsky et al., 2008). Such a high level of conservation is suggestive of the 
importance of TERT in the function of the telomerase protein function. As has 
been previously noted, a great number of telomerase-associated proteins 
have been identified from human cells. Their interaction with telomerase does, 
however, seem to be species specific, as some proteins have been identified 
to be telomerase-associating in mammalian cells, but not ciliate or yeasts (an 
example: Dez et al., 2001). 
30 
 
The sequence encoding for TERT contains three main structural elements, 
containing several well conserved domains; including the N-terminus, a 
catalytic RT domain and the C-terminus (figure 2). The N-terminus contains 
two conserved DNA and RNA-binding domains: the TEN domain and 
telomerase RNA-binding domain (TRBD) wherein lie several TERT specific 
motifs, completely separate from the RT-motifs, required for the binding of 
TERT and TR (Friedman and Cech, 1999, Jinquiang et al, 2000, Bachand and 
Autexier, 2001, Lai et al, 2001, Xia et al, 2000). The RT domain contains 
seven RT-like motifs as well as a telomerase-specific (T/motif 3) motif, all of 
which are well conserved across phyla and are required for an active form of 
telomerase to be synthesised (Weinrich et al, 1997, Lingner et al, 1997, 
Harrington et al, 1997, Counter et al, 1997). Finally the C-terminus is also 
required for telomerase activity but is weakly conserved. However, it has been 
suggested that the C-terminus has some species-specific functions (Lai et al, 
2001, Wyatt et al, 2010). 
 
 
 
Figure 2. The different regions of the hTERT sequence: N-terminus, RT-
Domain and C-Terminus, showing the locations of the various motifs 
within the sequence (Adapted from: Wyatt et al., 2010). 
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The second main component of telomerase, TR the telomerase RNA 
subunit, is much less conserved than TERT, but it does still have several 
conserved regions with ten helical regions of the RNA which are universally 
conserved. It has three conserved domains: firstly a pseudoknot/template 
core domain containing the RNA template for telomere elongation and thus 
essential for the functionality of the telomerase protein. Secondly there is a 
CR4/CR5 domain, and at last a box H/ACA domain (Chen et al, 2000, Wyatt 
et al, 2010).  
 
1.1.6 Telomerase and Cancer 
 
The link between telomerase and cancer has been widely discussed in 
scientific articles published in recent years. It has been suggested that 
telomere shortening acts as a molecular clock, monitoring the replicative 
capacity of normal human cells (Harley et al., 1992; Wright and Shay, 1992; 
Cong et al., 2002), forcing cells to enter the state of cellular senescence once 
the telomeres have become critically short (Campisi et al., 2001). It has been 
suggested that telomerase inactivation during development has come to exist 
as a ‘tumour-protection mechanism’ in humans as well as other long-lived 
mammals and birds (Wright and Shay, 2001). It is widely believed that the 
main function of cellular senescence is to restrict tumorigenesis. Avoiding 
entering a state of cellular senescence is believed to be one of the critical 
steps in the formation of most malignancies. For a malignant tumour to 
develop, cells needs to acquire several mutations, each requiring minimally 
20–30 cell divisions. But by limiting the dividing potential of cell down to less 
than a hundred divisions, cells that have begun accumulating mutations are 
denied the opportunity to become tumorigenic, minimizing the risk of genetic 
instability (Shay and Roninson, 2004; Campisi, 2003). In most human cancers 
(50-100%) the mutated cells avoid cellular senescence by activating 
telomerase (Kim et al., 1994; Bacchetti and Counter, 1995) and by doing so 
they preserve genomic stability, by being able to maintain structural integrity 
of the chromosome ends. Telomerase is, therefore, one of the focuses in 
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cancer research and development of anti-cancer therapeutic agents (Shay et 
al, 2001). In some cancers an alternative mechanism is used to maintain 
telomeres, ALT, which also exists in some non-cancerous cells (Bryan et al., 
1995; Bryan et al., 1997; Dunham et al., 2000; Bechter et al., 2004a). This 
mechanism has been induced in human cancer cells by telomerase inhibition, 
which suggests the possibility for cancer cells to develop an anti-telomerase 
therapy resistance (Bechter et al., 2004b). 
 
1.1.7 Telomerase and the cell cycle 
 
The eukaryotic cell cycle consists of a series of events in a cell that leads 
to the duplication of that specific cell. Through this process the cell completes 
its growth and DNA replication before dividing into two daughter cells. The 
growth and reproduction of all eukaryotes depends on the proper function of 
the cell cycle, which is why its control is vital (Nurse, 1997, Nurse et al., 
1998). The cell cycle consists of two phases, the interphase, where cell 
growth and DNA replication occurs, and M phase, which is the process by 
which a cell separates its duplicated genome into two identical halves 
(mitosis) and subsequently where the cytoplasm and the cell membrane is 
divided into two (cytokinesis). The interphase can further be divided into three 
phases, two growth phases (G1 and G2) that are separated by the S phase in 
which DNA replication takes place (figure 3). 
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Figure 3. The Eukaryotic Cell Cycle which consists of two phases; 
interphase, where cell growth and DNA replication occurs, and M-phase, 
which is the process by which a cell separates its duplicated genome 
into two identical halves (mitosis) and subsequently where the 
cytoplasm and the cell membrane is divided into two (cytokinesis). The 
interphase can further be divided into three phases, two growth phases 
(G1 and G2) that are separated by the S phase in which DNA replication 
takes place. 
 
The replication and elongation of the telomeres takes place throughout 
most of the S phase, but not during other phases of the cell cycle (Ten Hagen 
et al., 1990; Wright et al., 1999). Some research performed in the last couple 
of decades has indicated that telomerase activity is regulated in a cell cycle-
dependent manner in human cells, although others have indicated that it is 
not (Zhu et al., 1996; Buchkovich and Greider, 1996; Beata et al., 2005; Holt 
et al., 1996; Holt et al., 1997). A relationship between telomerase activity and 
cell cycle regulation has been suggested in other mammals as well (Kruk et 
al., 1997). Through studies on human leukocytes, telomerase activity was 
shown to be regulated in G1 phase as the cells entered the cell cycle 
(Buchkovich and Greider, 1996). In a study on various human tumour cell 
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lines it was shown that if the cell’s progress through the cell-cycle was halted, 
the telomerase activity was not inhibited (Zhu et al., 1996). This study 
furthermore showed that the greatest telomerase activity was found to be in 
the S phase, whereas levels observed at the G2/M phase were extremely low. 
More recent studies have, however, suggested that the variability in 
telomerase activity observed between various stages of the cell cycle is 
merely drug induced. In immortal cell lines where cells were sorted on the 
basis of DNA content, such differences were only seen when toxic cell cycle 
inhibitors were used. Without drug treatment, telomerase activity did not vary 
significantly between the different stages of the cell cycle (Holt et al., 1996; 
Holt et al., 1997). These studies furthermore showed that telomerase activity 
generally correlates with growth rate and is repressed in cells that exit the cell 
cycle and become quiescent. This repression can be reversed upon re-entry 
into the cell cycle. Telomerase activity has, in fact, been shown to increase 
10-fold as quiescent cells entered the cell cycle (Buchkovich and Greider, 
1996). A more recent study by Fleisig and Wong (2012) confirms the 
relationship between cell-cycle controls, cell growth and telomerase, where in 
human cancer cell-lines telomerase causes cell-cycle phase dependent 
induction of cell-growth (Fleisig and Wong, 2012). 
Studies have shown that many cell culture types repress telomerase 
during differentiation (Holt et al., 1996; Albannell et al., 1996; Bestilni et al., 
1996). This repression could merely result from the same down-regulation 
mechanism of telomerase in quiescent cells, or be a part of the differentiation 
process itself (Holt et al., 1997). A recent study, by Tomlinson and co-workers 
(2006), suggested that in human cell lines the intra-nuclear trafficking of hTR 
and hTERT, the main components of telomerase, may regulate its activity. 
These were recruited to subsets of telomeres during S phase (peaking at mid 
S phase), whereas throughout the other stages of the cell cycle, they 
accumulated at intra-nuclear sites away from telomeres. The hTR and hTERT 
components were furthermore shown to be associated with nucleoli and Cajal 
bodies during S phase, suggesting that both have a role to play in the 
trafficking and even biogenesis of telomerase. A publication by Cristofari and 
co-workers (2007) furthermore supports the importance of subnuclear 
35 
 
localization as a regulatory mechanism of human telomere length, as does 
work produced by Gallardo and colleagues (2011). In this study, single 
telomerase particles were tracked in live yeast cells through-out the cell-cycle, 
revealing that telomerase forms transient association with telomeres in G1 
and G2 phases of the cell cycle, but does not form a subset of telomerase 
enzyme clusters and subsequently form a stable form with the telomeres, until 
the S-phase. Similar evidence has been found in another study on yeast 
where the composition of telomerase varies throughout the cell cycle. In the 
two yeast species, Saccharomyces cerevisiae and Candida albicans, 
telomerase contains one catalytic protein subunit, Est2p/TERT, and at least 
two non-catalytic subunits, Est1p and Est3p, which are all required for 
telomerase to be fully active in vitro (Hsu et al, 2007). Est1p only attaches 
when telomere lengthening takes place, which is in late S/G2 phase of the cell 
cycle, and is therefore believed to play a regulatory role where it interacts with 
yet another telomerase associated protein Cdc13p in order to bind to and 
activate Est2p (TERT), which remains telomerase associated throughout most 
of the cell cycle (Taggart et al, 2002, Osterhage et al, 2006, Chan et al., 
2008). 
 
 
1.2 Environmental pollution 
 
1.2.1 Endocrine disruption 
 
Many substances, of both natural and anthropogenic origin, are being 
introduced into the aquatic and terrestrial environments every year at an 
increasing rate (EEA, 2005, Roy et al., 1996). Some of these substances 
have the ability to disrupt the normal function of the hormonal systems of both 
vertebrates and invertebrates. A common term for these substances is 
“endocrine disrupters” (EDs) (DEFRA, 2002). In recent years numerous 
publications have shown that EDs adversely affect the endocrine system by 
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various mechanisms; they have been shown to disturb the homeostatic 
balance of the body, disrupting normal development and initiate physiological 
processes at abnormal times in the life cycle (EU, 1999). Within the scientific 
community, proposals have been made that the aforementioned effects are 
the results of endocrine disrupting chemical’s ability to: 
a) Mimic or antagonise the effects of natural hormones 
b) Alter the pattern of synthesis and metabolism of hormones 
c) Modify hormone receptor levels (Soto et al., 1995).  
Certain EDs have also been shown to cause cellular and genomic instability 
through structural and functional changes at the cellular levels. Furthermore 
they have been shown to alter cell cycle kinetics, induce DNA damage, and 
produce telomeric associations and chromosomal aberrations (Roy et al., 
1998).  
Many definitions for environmental endocrine disrupters have been 
proposed, but one way to define them is as follows: 
 
An endocrine disrupter is an exogenous substance that interferes with 
the synthesis, secretion, transportation, binding, action, or elimination 
of natural hormones in the body of an intact organism or its progeny, 
these being responsible for the maintenance of homeostasis, 
reproduction, development, and/or behaviour (adapted from EC, 1997; 
Crisp et al., 1998). 
 
It is complicated to compile an exclusive list of endocrine disrupters 
due to the difficulty of identifying the substances that belong to this group 
owing to the lack of internationally accepted tests for said disrupters. Today, 
scientific authorities are investing substantial amounts of research time and 
effort into the development of such tests (DEFRA, 2002; FWR, 2002). 
However, many groups of chemicals have been suggested as possible 
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endocrine disrupters, including various insecticides (e.g. chlordane), 
herbicides (e.g. 2,4-D), fungicides (e.g. hexachlorobenzene), dioxins, and 
polychlorinated biphenyls (PCBs) (FWR, 2002). 
Steroid hormones are crucial substances that greatly affect endocrine, 
neuroendocrine and behavioural functions, by regulating protein synthesis via 
binding to intracellular receptors (Silver, 1985). Sex steroids - such as 
oestrogen - are key hormones in various biological processes including 
reproduction and somatic cell function, sexual differentiation and the 
development of secondary sex characteristics (Fairbrother, 2000). They are 
small, lipophilic hormones that are able to diffuse through a cell membrane 
and bind with intracellular receptors to induce transcription of specific genes. 
There exist three main classes of sex steroid hormones; these are androgens, 
oestrogens and progestagens.  
 
1.2.2 Endocrine disruption and telomerase 
 
Recent studies in human cells have indicated that sex steroid 
hormones regulate telomerase in target tissues. Oestrogens have been 
shown to be able to activate telomerase in some human cell lines through the 
trans-activation of the telomerase catalytic subunit, hTERT (Kyo et al., 1999). 
The oestrogen 17β-oestradiol (E2) has also been shown to induce the hTERT 
mRNA production and telomerase activity in various human normal and 
cancerous cell lines in a dose-dependent manner (Nanni et al., 2002; Gao et 
al., 2003). 
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Figure 4. Structure of the natural steroid hormone 17β-oestradiol (E2). 
 
The mechanism by which E2 affects telomerase may be closely 
associated with modulation of cell cycle phases in humans, since 
simultaneous to the induced telomerase activity, the cell cycle phases have 
been shown to change in MCF-7 cells, which are E2 responsive human cells, 
the length of the quiescent phase (G0) as well as the Gap1 growth phase (G1 
within Interphase) was reduced whereas the length of the Synthesis phase (S) 
where DNA replication takes place significantly increased (Gao et al., 2003). 
A study performed by Wang and his associates (2000) showed that 
progesterone affected human TERT mRNA expression in a time-dependent 
manner - it induced human TERT mRNA to begin with, but exposures past 48 
hours resulted in inhibited oestrogen-induced activation. Furthermore, the 
long- and short-term effects of progesterone were shown to be mediated by 
the mitogen-activated protein kinase signaling pathway. For an oestrogenic 
endocrine disruptor (OEDs) to exert a direct oestrogenic effect in a cell, the 
cell must have oestrogen receptors (ERs). The receptors could be found in 
the nucleus, cytoplasm or cell membrane. Hormonal disruption caused by 
oestrogens or OEDs is initiated by binding to this receptor, interrupting the 
normal metabolism and specific gene regulation by oestrogen (Welshons et 
al., 2003). At least two nuclear hormone receptors have been identified in 
humans as the mediators of physiological reactions to oestrogen; these are 
the human oestrogen receptor 1, esr1 or ERα (encoded by the gene ESR1) 
and human oestrogen receptor 2, esr2 or ER (encoded by the gene ESR2), 
and they interact with the oestrogen response elements (EREs) which are a 
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hormone-receptor complex with a set of specific DNA sequences (Beato and 
Sanchez-Pacheco, 1996). Mistiti and associates (2000) identified a 
degenerate ERE capable of binding esr1 in vitro, located within the human 
TERT promoter and noted that E2 exposure in esr1-positive cells leads to a 
specific modification of this region (ERE). This ERE has been shown to be 
responsive to oestrogen-bound ER, with binding of the two inducing 
transcriptional activation of TERT (Kyo, Takakura et al, 1999). This suggests 
that oestrogen-dependent chromatin remodelling takes place. E2 activated 
human TERT transcription is ER dependent since ER-negative cells show no 
response (Kyo et al., 1999). Another means by which oestrogen effects TERT 
transcription is indirectly through c-Myc, a regulatory protein that codes for a 
transcription factor, which binds to E-boxes in the promoter region of TERT 
(Greenberg et al., 1999). Oestrogen-bound ER is a known inducer of c-Myc. 
Furthermore, hTERT also contains a sp1/ER motif that weakly functions as an 
ERE site, with much less binding between oestrogen activated ER and the 
site, but none the less leading to some transcriptional induction albeit less 
than that of the degenerate ERE (Kyo, Takakura et al, 1999). 
The synthetic compound, Bisphenol A (BPA), mainly used as an 
additive in the manufacturing of plastics and epoxy resins, is a well known 
endocrine disrupting chemical. Its mechanisms of action are not fully 
explained, but it has been shown to be weakly oestrogenic in human cell lines 
(Li et al., 2012). It is worth noting that BPA has been shown to act as an 
agonist of oestrogen in some tissues and antagonist in others (Wetherill et al., 
2007). Due to this variability in its mechanism of action, BPA it is defined as a 
selective ER modulator. BPA seems to bind weakly to human ERs esr1 and 
esr2 with significantly less binding affinity and transcription activation capacity 
than E2 (Lemmen at al., 2004). It has however been shown to bind strongly to 
the human oestrogen-related receptor γ (ERRγ) (Takayanagi et al., 2006; 
Matsushima et al., 2008), a receptor found to be highly expressed in the the 
prostate, placenta and fetal brain (Takeda et al., 2009). 
BPA’s mode of action does not only differ between tissues, it displays 
variability in action between the subtypes of the human ERs. It works as both 
agonist and antagonist of oestrogen in some human cell types via ER subtype 
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esr1, but only as an agonist of oestrogen via the other subtype, esr2 
(Kurosawa et al., 2002). Further studies have shown this may be due to 
difference in exposure dose in human cell lines, with BPA acting as antagonist 
at lower concentrations (Li et al., 2012). It is also worth noting that BPA has 
been shown to up-regulate TERT transcription in human cell lines (Takahashi 
et al, 2004). 
 
1.2.3 Sex steroids and deuterostome animals 
 
Coelomate animals can be divided into the two superphylums, 
protostomia and deuterostomia, based on their developmental pattern. 
Echinoderms belong to the superphylum deuterostomia, along with 
hemichordates, xenoturbellites and chordates (which includes vertebrates). 
Protostomes can, however, be divided into ecdysozoa, lophotrochozoa and 
platyzoa. Sex steroid receptor-like proteins have been identified in some 
Protostomes. Functional sex steroid receptors have been found in 
lophotrochozoans, in at least three classes of molluscs, bivalvia (Gagné et al., 
2001; Stefano et al., 2003; Canesi et al., 2004), gastropoda (Bettin et al., 
1996; Thornton et al., 2003) and cephalopoda (Di Cosmo et al., 1998). There 
also exists some evidence of sex steroid-responding system in ecdysozoans 
(Baldwin and LeBlanc, 1994a, b; Schirling et al., 2006; Köhler et al., 2007) 
although there does not exist an agreement on the physiological effects sex 
steroids may have in these animals. 
In teleost fish, almost all of the nuclear receptor (NR) types that exist in 
mammals, have been identified. This includes the sex steroid receptors such 
as ERs. In fact, many teleost species have three separate ERs (Hawkins et al, 
2000) that are differentially expressed throughout different tissue types and 
also show varied responses to exposures to oestrogenic chemicals (Filby and 
Tyler, 2005). An example of oestrogenic response mediated through ERs in 
fish species such as the zebrafish (Danio rerio) and the rainbow trout is the 
induction of vitellogenin production in adult males during controlled oestrogen 
41 
 
exposures (Rose et al, 2002, Van der Belt et al, 2003, Van den Belt et al, 
2004).  
There is little information on the existence and relevance of sex 
steroids in invertebrates. Among the invertebrates that belong to the 
deuterostomia clade, a true ER has been identified within the acrania clade 
(acrania, cephalochordata, Branchiostoma belcheri) (Fang et al., 2001; Fang 
et al., 2003) and oestrogen response has been documented among 
echinoderms, although it has yet to be shown what type of receptor is 
involved in the mechanism of response; a NR, a membrane-associated 
receptor, or a different way of signalling (Roepke et al. 2005). A study 
published in 2006 (Lutz et al.) provided evidence for the existence of specific 
cytosolic androgen and oestrogen binding sites, resembling androgen 
receptors and ERs in vertebrates, in the purple sea urchin (echinoidea), which 
is one of the test species for this study, and the feather-star (crinoidea) 
Antedon mediterranea. 
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1.3 Animal test models for telomerase studies 
 
1.3.1 The European purple sea urchin as a model 
 
The sea urchin is frequently used in ecotoxicological studies, mainly 
due to it being one of the key models used in developmental research. It has 
been one of the favourite tools of developmental biologists to gain 
understanding of the various developmental processes; including fertilization, 
egg activation, cleavage, gastrulation and gene regulation in early 
development (Davidson et al., 1998: Davidson et al., 2003). It is therefore a 
key model for studying the effect of pollution on reproduction and 
development. Echinoderms have furthermore recently been showed to have a 
greater importance in research into the molecular pathways of toxicity and 
development in vertebrates, due to their genetic proximity to the vertebrate 
lineage. The Sea Urchin Genome project, the results of which were published 
in 2006 (SUGSC, 2006), revealed that the American purple sea urchin, 
otherwise known as the American purple sea urchin, has about 23,300 genes, 
a similar estimate to that of vertebrates, representing nearly all vertebrate 
gene families. Many genes that were previously believed to be vertebrate-
specific, were found to be present in this species. 
Paracentrotus lividus (Echinodermata : Echinoidea : Echinidae), the 
sea urchin which is normally referred to as the purple sea urchin in Europe, or 
the common European sea urchin, is an echinoid that occurs along the 
European coasts of the North Atlantic and throughout the Mediterranean Sea 
(Spirlet et al., 2001; Grosjean, 2001). It is a regular sea urchin, deep violet in 
colour, and in the British Isles they are predominantly found on the western 
coasts of Ireland. It is therefore an environmentally relevant species to use in 
the UK, Western and South Europe. The urchin’s predominant habitats are 
limestone rock pools although they are occasionally found in shallower water 
beneath large stones and rocks, but rarely in water in excess of 30 metres 
deep (Picton and Morrow, 2005). The roe of this urchin is edible and are 
prized as a delicacy in many Mediterranean countries. 
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Considerable research has been performed into the cell cycle of early 
developmental stages of sea urchin embryos. It starts with fertilization, 
followed by the first replication process (the first cell cycle) which has a 
lengthy and noticeable G1 phase. The next few subsequent cycles have very 
short G1 and G2 phases, until the embryo reaches the mid-blastula stage (12 
hours after). The same can be seen in other marine invertebrates (Whitaker 
and Patel, 1990). The meiotic and mitotic cell cycles in frog and marine 
invertebrate oocytes and zygotes progress without requirements for cell 
growth and external nutrients. Furthermore, the genetic activities are not 
turned on in the zygote until it reaches the stage of mid-blastula. As applies to 
the early embryos of sea urchins, other marine invertebrate zygotes lack G1 
and G2 phases and checkpoints, until they reach mid-blastula. Once the cells 
differentiate, the cell cycles become more complex and the cell needs many 
sensitive checkpoint mechanisms to be able to regulate it (Nurse et al., 1998). 
Although the cell cycle of the early sea urchin embryo is simple, it possesses 
control points similar to those of yeast and mammalian cell lines (start, mitosis 
entry and mitosis exit). These control points are triggered by an increase in 
intracellular free calcium (Steinhardt et al., 1977; Poenie et al. 1985), the first 
one at fertilization also leads to an increase in intracellular pH (Shen and 
Steinhardt, 1978; Johnson et al. 1976; Johnson and Epel, 1981). 
Limited research has been performed on telomerase expression in sea 
urchins, but telomerase activity has been detected in adult tissues in two sea 
urchin species American red sea urchin and Lytechinus variegates. 
Telomerase activity has also been mapped in all stages of early embryonic 
development in L. variegates (gastrula, prism, and pluteus), as well as egg 
cells (Francis et al., 2006). 
The early life stages of sea urchins have been thoroughly studied, with 
several species of urchins frequently used for embryo toxicity testing. The 
American purple sea urchin, the purple-spined sea urchin (Arbacia 
punctulata), variegated sea urchin (Lytechinus pictus), eccentric sand dollar 
(Dendraster excentricus), and the European purple sea urchin are a few 
examples. The last of these was the species chosen for this study due to its 
availability in the UK. Sea urchin sexual development is gonochoristic and 
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fertilization is external. The spawning is synchronized and comes in response 
to an external, environmental signal like a change in temperature or 
disturbance (Spirlet et al, 1998; Spirlet, 1999). Although sea urchins are 
invertebrates, their early embryonic development is different from that of most 
other invertebrates because they are deuterostomes. As such their early 
embryonic development is largely the same as that of vertebrates. The initial 
cleavage is radial, their development is indeterminate and the blastopore 
becomes the anus (Raven and Johnson, 2002). Most embryonic exposures of 
sea urchins last until the embryos reach the larval stage of pluteus or 
echinopluteus, which are planktotrophic larvae (Strathmann, 1978). In the 
European purple sea urchin it takes 48 hours from fertilization for the embryos 
to reach this stage, when incubated at 15ºC. After 2 hours the embryo 
reaches multi-cell stage, after 12 hours a ciliated blastula hatches, and at 24 
hours the embryo has gone through gastrulation and a fully developed 
gastrula has formed, after 36 hours it reaches the intermediate prism stage 
and by 48 hours a fully developed pluteus larvae with fragile arms formed by 
lobes of ciliated bands and supported by fragile rods of calcite, the skeletal 
material, has formed. Echinoderms are bilaterally symmetrical as larvae but 
metamorphose to radially symmetrical adults (Raven and Johnson, 2002). 
When the larvae become competent, they seek a solid substrate to settle and 
metamorphose, a process that is completed within one hour. These post-
larvae are endotrophic and resemble small adults. It takes these postlarvae 
several days to completely finish their transformation into a juvenile that feeds 
exotrophically (Strathmann, 1978). 
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Figure 5. Embryonic development of European purple sea urchin 
incubated at 15ºC with a photoperiod of 16h light and 8h dark 
photoperiod. 
 
1.3.2 Rainbow trout as a model 
 
Various fish species have been used as experimental models for 
environmental toxicity. One of the main reasons for this is that they have a 
very informative comparative status as non-mammalian vertebrates with many 
biological mechanisms similar to those of mammalian vertebrates. 
Furthermore, the limitations of in vitro human tissue culturing call for model 
organisms suitable for in vivo research of various biological processes. For 
this, fish are ideally suited. They have also been used as indicator species for 
ecological contamination, but can also be used as indicators of possible 
human exposure to contaminants found in water. As non-mammalian 
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vertebrates, these have also been used to further understand the 
mechanisms of pollutant toxicity in humans and other species.  
Rainbow trout are amongst the most sensitive species of fish in relation to 
environmental pollution and water quality (Sinnhuber et al., 1977). They are a 
practical species to use due to their low rearing costs and a wide-ranging 
body size which allows for harvesting of target tissues for direct analyses or 
cell culturing. As they are sensitive to many types and forms of contaminants 
and their embryonic development is well-described, they feature as a 
sensitive early life-stage bioassay. Despite being native to North-America, 
they are readily available worldwide as they are one of the most widely 
introduced fishes. They have been introduced to all continents, excluding 
Antarctica, and are in many places considered a pest. They are therefore a 
globally relevant test species. 
Studies have shown that the vast majority of tissues from rainbow trout 
have functional telomerase activity. Klapper and Heidorn et al. (1998) found 
activity in all the tissues in their study, including the kidney, liver, skin, heart, 
muscle and brain. Telomerase activity has also been detected in eyed 
embryos of rainbow trout (Yoda et al., 2002). Klapper and colleagues 
suggested that this high somatic telomerase activity goes hand in hand with 
indeterminate growth in fish as well as slow occurrence of senescence, and 
should be restricted to indeterminately growing tissues. Furthermore, studies 
have established that the telomere DNA sequence at the end of 
chromosomes is made up of the same tandem repeats as those in humans, 
(TTAGGG)n (Abuín et al., 1996).  
Many of the common biomarker endpoints used to study endocrine 
disruption have been used in rainbow trout, with responses to endocrine 
disrupting chemicals recorded both in apical endpoints such as growth 
(Norbeck and Sheridan, 2011; Hanson et al., 2014) as well as typical EDC 
biomarkers like vitellogenin and vitelline envelope protein, as well as 
molecular biomarkers (biomarker genes) such as cytochrome p4501A and 
UDP-glucuronosyl transferase (Finne et al., 2007; Nagler et al., 2010).  
Immunotoxicological effects have also been recorded in response to common 
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endocrine disruptors such as Atrazine and nonylphenol (Shelley et al., 2012) 
as well as E2 (Shelley et al., 2013). It is, however, worth noting that the 
interaction between endocrine disruptors and some steroid receptors in 
teleost fish is quantitatively different from that observed in humans and other 
mammals. An example is the failure of endosulfan, dieldrin, and methoxychlor 
to bind to esr1 in various vertebrates, including humans, whereas it binds to 
the receptor of trout (Matthews et al., 2000). This could be partly explained by 
the fact that although esr1 is homologous across vertebrates, the other two 
described subtypes in teleost fish have some  homology with mammalian esr2 
(Hawkins and Thomas, 2004; Hawkins et al., 2000). It must also be noted that 
a second form of esr1 has been detected in rainbow trout (Nagler at al., 
2007). Furthermore, teleost ERs seem to bind oestrogens like E2 with 3-5 
times less affinity than mammal ERs, with temperatures greatly affecting the 
affinity of fish ERs and not those of mammals (Petit et al., 1995). This may 
clearly result in some variability in response between teleost fish and 
mammals. As for rainbow trout, it has been established that their ERs are 
responsive to E2. Both E2 and 17α-ethynyloestradiol (EE2) have been shown 
to elevate ER mRNA transcription both in vivo and in vitro, although differing 
response was observed between the ER subtypes (Boyce-Derricott, et al., 
2009). It is important to note that one study showed that in embryonic rainbow 
trout, only one of the esr1 isoforms (ERα1) is responsive to E2 (Boyce-
Derricott et al., 2010). 
Taking all of the above into consideration, rainbow trout are excellent for 
use as environmental indicator species for aquatic environmental pollution 
and well suited for the study of the role of telomerase in environmental 
toxicity, but in order to completely map the range of environmental disruption 
of endocrine disrupting chemicals a selection of test species from a wide 
range of phyla native to each ecosystem would need to be applied.  
The development of the early life stages of rainbow trout has been 
extensively studied. In Northern and Central Europe and North-America, 
spawning takes place between December to late February (Vernier, 1969). In 
nature, fertilization takes place immediately after the release of the eggs and 
milt for within 30 seconds of entering the water, the outer membrane of the 
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egg begins to toughen. Within one hour the egg has completed this process. 
Immediately after fertilization the zygote begins cell division and becomes an 
embryo. The embryo goes through three main stages of development; 1) 
cleavage, which begins with fertilization and is completed with the appearance 
of terminal node (4 days post fertilization, or dpf, at 10ºC), 2) gastrulation, 
which is completed when the blastopore closes (9 dpf 10ºC), and 3) caudal 
bud stage which lasts until embryo hatches (31 days at 10ºC) (Vernier, 1969). 
At 10ºC hatching occurs after an average of 31 days, at 12.8ºC it takes the 
embryos on average 24 days to reach this point (Barton, 1996) although it 
should be noted that there is considerable variability in hatchin times as 
hatching usually takes place over a few days. Once hatched the larvae are 
called alevins. The main observed transformations in early rainbow trout larval 
development are: hatching, first feeding, early respiration, and swim-up. After 
hatching the larvae are called Alevins and in the earliest stages their gas 
exchange is cutaneous and their nourishment comes from the yolk-sac only. 
Secondary lamellae occur on the gills 8 days after hatching allowing for gas 
exchange across the gills (Rombough, 1999). Once the yolk has been almost 
completely absorbed the alevins become ‘swim-up fry’ and begin exogenous 
feeding, this process is also sometimes called emergence and in nature this is 
when the fry emerge from the gravel. At this point the fry swim immediately to 
the surface to take in air to inflate the swim bladder (Blaxter, 1988; Barton, 
1996, Groot, 1996). When rainbow trout embryos are used for exposure, the 
stage at which her young are at each sampling time must be observed and 
imaged.  
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Figure 6. Embryonic development of rainbow trout incubated at 10ºC 
with a photoperiod of 16h light and 8h dark. Time measured in days post 
fertilization (dpf). Figure adapted from Vernier (1969). 
 
 
1.4 Thesis Aims and Objectives  
 
The objectives of this project is to identify and characterize the main 
catalytic subunit of telomerase reverse transcriptase, TERT, in two model 
species, the teleost fish species rainbow trout and the deuterostome 
invertebrate purple sea urchin. This will be done by cloning and 
characterization of TERT genes from the aforementioned species. Secondly 
the aim is to develop a qPCR assay for this gene, allowing for quantitative 
analysis of the TERT RNA expression. Thirdly the aim is to explore and define 
any links between the expression of TERT, cell-cycle controls, embryonic 
development and environmental oestrogens in the embryonic stages of these 
two animal models by utilizing controlled exposure studies to two known 
environmental oestrogenic chemicals; E2 and BPA (figure 5). In order to 
accomplish the latter, the following hypotheses were addressed: 
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A. The natural steroid hormone E2 can disrupt the embryonic 
development of the purple sea urchin. 
B. The natural steroid hormone E2 and the ER agonist BPA inhibit 
growth and reduce survival of early life-stages of rainbow trout.  
C. The natural steroid hormone E2 and the ER agonist BPA induce 
telomerase activity in early life-stages of purple sea urchin and 
rainbow trout, as well as in hepatocyte cell cultures of rainbow trout. 
D. The natural steroid hormone E2 and the ER agonist BPA induce the 
mRNA expression of the main catalytic subunit of telomerase, 
TERT, in early life-stages of purple sea urchin and rainbow trout. 
E. The two model species are affected by exposures to the two 
oestrogenic chemicals, E2 and the ER agonist BPA, reflected both 
in their developmental success as well as transcriptional efficiency. 
 
The means by which these aims are addressed is by, firstly, isolating 
and characterising the mRNA sequence for the telomerase catalytic subunit, 
TERT, in the rainbow trout, as well as the purple sea urchin, which so far have 
not been identified. Secondly, to design species-specific quantitative PCR 
assays for the amplification of TERT. The effects of oestrogenic pollutants on 
both telomerase mRNA expresson as well as telomerase activity in the 
embryonic stages of the purple sea urchin and the rainbow trout will be 
examined by utilizing the newly designed qPCR assay as well a modified 
version of the TRAP assay (Kim et al., 1994). These will be accompanied by 
an observation of embryonic developmental success. 
Our first focus will be the oestrogen E2, of which high concentrations 
have been shown to induce teratogenic effects in various organisms (Henry et 
al., 2005). E2 also has an environmental relevance due to it being one of the 
principal components responsible for oestrogenic activity in sewage treatment 
works’ effluents. It has been found in sewage effluents up to 50 ng/L and has 
been widely used to study the mechanisms of environmental oestrogen action 
(Desbrow et al., 1998). E2 has been shown to induce telomerase activity as 
well as TERT mRNA expression in human cancer cells as well as the fish 
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species Japanese medaka (Misiti et al., 2000; Kyo et al., 2008; Piu, 2011). 
We will also focus on BPA, a monomer which is mainly used in the 
manufacture of polycarbonate plastics and epoxy resins which line many food 
and beverage cans. It is furthermore used as a composite in some dental 
sealants. BPA is known to be an endocrine disruptive chemical, it antagonizes 
androgen and thyroid hormone action and mimics the oestrogen hormone E2 
(Lee et al., 2003; Moriyama et al., 2002). BPA has been shown to up-regulate 
TERT transcription in human cell lines (Takahashi et al., 2004). 
 
A.            B.    
        
Figure 7. Chemical structures of; A) E2, B) BPA. 
 
Hopefully this research may further advance research into the molecular 
processes involving telomerase and its function during the cell cycle, as well 
as expand the global knowledge of the common mode of action of pollutants 
in invertebrates and vertebrates. Limited information exists on the action and 
function of sex steroids in invertebrates, but these results will hopefully further 
the understanding of their function by providing an example of oestrogens 
acting in a model invertebrate, as well as further explain the mechanisms of 
the relationship between steroid hormones and telomerase in deuterostome 
vertebrates. We will furthermore examine the effects of known anti-oestrogen, 
tamoxifen (TAM), in order to determine whether the effect we have observed 
is an effect mediated through the ER or in some other way. By using both a 
vertebrate and an invertebrate model, light might be thrown on any similarities 
and/or differences that may exist between the action of these pollutants in 
vertebrates and invertebrates, and their effect on telomerase activity, telomere 
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length and cell cycle controls. This may also provide a better understanding of 
the basic molecular processes involved in telomere maintenance and 
telomerase activation in deuterostome vertebrates. 
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2 Materials and Methods 
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2.1 Biological research models 
 
Three research models were used for this study. Firstly the sea urchin 
bioassay, as first proposed by Kobayashi (1971) (Pagano, G. et al., 1985; 
Pagano et al., 1986) is a method to observe developmental effects. Its use is 
necessary in order to be able to establish whether our contaminant induces 
any developmental disturbance as well as effects on telomerase activity and 
telomere length. For this study a modified version of the assay was utilised to 
allow for, and compliment, the species and experimental conditions. The 
second model chosen was primary cultures of rainbow trout hepatocytes 
which have been repeatedly used as a model cell system and a multi-
endpoint bioassay for toxicity testing, this includes both acute toxicity as well 
as sub-lethal effects, for various chemicals including many endocrine 
disruptors (Berry and Friend, 1969; Sumpter and Jobling, 1995; Tollefsen et 
al., 2006). The liver is an important organ that plays a vital role in many of the 
main metabolic processes, including the metabolism of xenobiotics and 
important reproductive processes such as the synthesis of the egg yolk 
protein vitellogenin. Vitellogenin gene expression is controlled by several 
hormones, but predominantly by oestrogens, particularly E2 which induces the 
synthesis of the egg yolk protein vitellogenin in fish liver (Anderson and 
Hinton, 1995; Campbell et al., 1994; Rabelo and Tata, 1993). During fish 
sexual maturation, the concentrations of vitellogenin and E2 in the plasma 
rise, reaching to tens of milligrams per millilitres in species like the rainbow 
trout (Scott and Sumpter, 1983; Bon et al., 1997). The liver has a high 
concentration of ERs (Pottinger, 1986) but the vitellogenic response to 
oestrogens can also be observed in isolated hepatocytes which synthesize 
these steroid receptors as well as vitellogenin. This is one of the reasons why 
hepatocytes are suitable for use as a cellular model in toxicological testing, 
particularly involving oestrogenic chemicals where they are a sensitive assay 
(Guguen-Guillouzo, 2002). The third model is yet again in rainbow trout, but 
this time early-life stages of this species. Rainbow trout is a globally 
distributed teleost fish which is widely available, relatively inexpensive to 
maintain and has early-life sensitivity to various environmentally relevant 
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chemicals. For this reason it has been widely used as a model research 
species for toxicity testing in early-life. The embryonic development of this 
species has been extensively studied (chapter 2.1.3 below) which makes it a 
good choice for embryonic exposure studies. 
 
2.1.1 Sea urchin developmental assay and toxicity testing 
 
Four to five adult purple sea urchins (4.9-5.4 cm test diameter) were 
induced to spawn by the injection of 2-5 ml of 0.53 M KCl under the 
peristomial membrane into the coelom. The animals were then left and 
observed for three minutes (Figure 8). If a lack of gonadal response was 
recorded, the urchins were injected for a second time. Gametes were 
collected on release from the gonophores and examined under a microscope 
to check their viability; eggs being uniformly circular and intact, and sperm 
actively motile. Fertilization was performed by diluting 5 ml of a concentrated 
egg solution in 1000 ml of filtered sea water and adding three drops of a 
diluted sperm solution (2:10). This results in an approximate sperm to egg 
ratio of 1:2000. This is the desired ratio to avoid polyspermy (Dale and 
DeFelice, 2011). The resulting suspension was deposited on a stirring plate 
for one hour to allow fertilisation to occur. Successful fertilisation was 
determined by studying a sample of embryo suspension under a light 
microscope, to determine the appearance of the fertilization membranes 
which are clearly elevated above the egg surface. 
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Figure 8. A) A spawning male purple sea urchin, white sperm being 
released from the gonophores can be observed on its surface. B) A 
spawning female purple sea urchin, orange eggs can be seen collecting 
at the bottom of the container. 
 
Once it had been established that fertilization had taken place, the 
embryos were exposed to the testing chemical throughout their development 
up to the larval stage of pluteus. By doing this the exposure is continuous 
during important developmental stages (cleavage, blastula, gastrula, prism 
and pluteus for example). Samples were taken throughout the developmental 
process, as well as on the last day of exposure when embryos had reached 
the larval stage of pluteus at 48 hours (see Roepke et al., 2005), and fixed in 
4% formaldehyde so that observation of developmental defects (DDs) could 
be performed using a light microscope. The DDs were then scored out of at 
least 200 embryos for each sample, and classified as follows (Pagano et al., 
1985; Hamdoun et al., 2002): 
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A) Normal (N), when no morphological divergence from the control 
embryos can be observed.  
B) Inhibited (I), when the physical growth is inhibited and physical size 
of the control pluteus larvae is more than twice the size of the 
observed larvae. 
C) Pathologic (P) when larval malformations were observed. 
 
After adult sea urchins have been induced to spawn, the resulting 
embryos can be used for exposure studies. For this study sea water was 
collected near Dawlish Warren in South Devon, UK (Figure 9) and filtered 
though a 0.22μm membrane. The sea water pH was 8.2, the salinity at 33.7 
and O2 at sufficient levels of above 7.8 mg/l (69% saturation) (Davis, 1975; 
DFO, 1983).  It was kept aerated and cooled to the correct temperature of 
15ºC until exposures took place. The embryos were cultured in the exposure 
medium for 48 hours, at 15º with a 16 hour light and 8 hour dark photoperiod, 
in two set-ups: 500 ml exposure solutions in solvent washed pyrex glass 
containers for sample extraction, and in 96-well plates for observation of 
survival rates and developmental success. The embryos were exposed to 2, 
20 and 200ng E2/ml from immediately after fertilization, until they reached the 
larval stage of pluteus. When exposing to E2, ethanol (EtOH) was used as a 
solvent. The solvent concentrations never exceeded that of 0.05%, which was 
then used as the concentration for the solvent controls. The embryos were 
sampled at the following time points: 1) 2 hours – multi-cell stage, 2) 12 hours 
– early to late blastula, 3) 24 hours – early to mid gastrula, 4) 36 hours – 
prism or pluteus, 5) 48 hours – pluteus. At these time points development and 
embryo survival were also recorded. 
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Figure 9. The Map of the sea water sampling site by Dawlish Warren. 
Image from Google Maps. 
 
 
2.1.2 Using primary cultures of rainbow trout hepatocytes for toxicity 
testing 
 
The method of rainbow trout hepatocyte extraction was as follows: the 
fish was placed in a bucket with a benzocaine solution (100 mg/l) until it was 
almost motionless, at which moment it was immediately removed from the 
bucket in order to ensure the heart was still pumping, injected with heparin 
(200 l) and placed in benzocaine again until breathing ceased. The next step 
was to weigh the fish and measure its length, and then destroy the brain in 
order to confirm death. To be able to gain access to the peritoneum, one side 
of the fish was opened revealing the hepatic artery into which a needle was 
pushed. The perfusion process began as follows: A) 50-100 ml (depending on 
the size of the fish) pre-perfusion solution was pumped through the liver until 
the liver changed from pink to yellowish due to the blood being pumped out of 
the liver. B) 50-100 ml perfusion solution (with 12 mg collagenase D and Ca2+) 
was pumped through the liver, decreasing the livers elasticity. C) 50-100 ml 
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post-perfusion solution containing EDTA was pumped through the liver, 
deactivating the collagenase. The next step was to tear apart the liver tissue 
and place in calcium-magnesium-free (CMF) medium where it was chopped 
up and disintegrated further. The CMF with the liver cells was poured through 
250 m, 100 m and then 50 m mesh and the filtered cell suspension 
centrifuged at about 700 rpm for 5 min (4C). Then the cell pellet was washed 
with CMF and centrifuged again 1-3 times and finally resuspended in M199 
culture medium. Viability of the cells as well as their concentration was 
examined with a haemocytometer. The volume of M199 culture medium to be 
added to reach the correct cell concentration was calculated as follows: 
((Number of cells in a grid x 104) x total volume of cell suspension (ml)) / 1.5 x 
106. The chemical make up of the above mentioned cell isolation solutions 
can be seen in Table 2, except the M199 culture medium was made up from a 
ready-made powder; Medium 199 with Hanks’ salts and L-Glutamine (M0393) 
(Sigma-Aldrich, 3050 Spruce St, St. Louis, Missouri 63103, United States). 
This was made up to 1 litre volume as per manufacturers instructions, sterile 
filtered with a 0.22 m membrane, after which Penicillin and Streptomycin was 
added to the solution to a final concentration of 100 units/ml and 10 g/ml 
respectively. 
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Table 2. Cell isolation solution used for rainbow trout hepatocyte 
isolation. 
Chemical Pre-perfusion Perfusion Post-perfusion CMF 
g/l g/l g/l g/l 
NaCl 4.150 4.000 4.150 4.150 
KCl 0.200 0.200 0.200 0.200 
CaCl2 x 2H2O - 0.179 - - 
Na2HPO4 0.036 0.036 0.036 0.036 
KH2PO4 0.030 0.030 0.030 0.030 
NaHCO3 0.018 0.018 0.018 0.018 
HEPES 1.785 1.785 1.785 1.785 
Na2-EDTA x 
2H2O 
1.0995 - 0.440 - 
 
Once the cells have been isolated and placed in the M199 culture 
medium they were moved to culture flasks with loosened caps in order to 
allow for sufficient gas exchange and grown at a temperature of 12ºC in a 
humid environment.  
Once rainbow trout liver hepatocytes have been isolated and cultured 
for 24 hours, they can be used for exposure studies. Exposure mediums were 
made up of M199 culture medium, infused with 10% Foetal Bovine Serum 
(FBS), 100 units/ml Penicillin and 10 g/ml Streptomycin, as well as the 
exposure chemicals of choice. The hepatocytes were exposed at a cell 
concentration of 0.41 million cells/ml in a total volume of 4 ml exposure 
solutions in glass vials for 48 hours during which time they were kept in an 
incubator throughout the exposure at a constant temperature of 12 ºC. The 
cell cultures were exposed to 2 and 20 E2/ml, using EtOH as chemical 
solvent. The solvent concentration was kept at 0.05%, which was then used 
as the concentration for the solvent controls. The hepatocytes were sampled 
at the following time points: 1) 4 hours, 2) 6.5 hours, 3) 12 hours, 4) 24 hours, 
5) 36 hours, and 6) 48 hours. 
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2.1.3 Rainbow trout embryos – early life-stages chemical exposures 
 
In preparation for rainbow trout embryonic exposure to the two oestrogenic 
chemicals, E2 and BPA, female and male gametes were collected from adult 
rainbow trout from a trout farm1 in Dorset, South West England. These were 
fertilized and then rinsed and allowed to harden in clean freshwater until 2 hpf 
(hours post fertilization) when they were transferred to ten different 
experimental exposure vessels, 130 embryos in each. These vessels 
contained the following experimental chemicals: the sex steroid E2, the major 
oestrogen in humans; the antioestrogen TAM, an antagonist of the ER; BPA, 
an oestrogen mimic; and 3'-azido-3'-deoxy-thymidine (AZT), an inhibitor of 
retroviral reverse transcriptase. The exposure concentrations were made up 
in dechlorinated, filtered freshwater and were as follows: 0.1 ng, 20 ng and 
500 ng E2 / ml; a combination exposure of 500 ng E2 and 0.019 ng TAM / ml; 
150 ng and 600 ng BPA / ml; and 100 M AZT. The E2, TAM and BPA stock 
solutions were made up with dimethyl sulfoxide (DMSO) for a final solvent 
concentration in exposure wells of 0.05%. The AZT stock solution was made 
up with ethanol (EtOH) for a final solvent concentration in exposure wells of 
0.01%. The controls were as follows: a freshwater control; a 0.01% EtOH 
control; and a 0.05% DMSO control. 
Throughout the exposure, water changes were performed every other day, 
with the same exposure concentrations. The fish were kept under a constant 
photo-period of 16 hours light/8 hours dark and once the larvae become 
swim-up fry and begin exogenous feeding they were fed to satiation twice a 
day firstly with powdered feed, Liquifry No. 1 (Interpet, Dorking, U.K.) and live 
Artemia (ZM Ltd., Hampshire, U.K.), and then later with live and frozen 
Daphnia (Tropical Marine Center, Chorleywood, U.K.). The animals were 
monitored for mortalities twice daily. The water quality was examined at 
regular intervals, testing for both nitrite (NO2
-) and nitrate (NO3
-). In 
                                                             
1 Hooke Springs Trout Farm, Hooke, Beaminster, Dorset, DT8 3NZ 
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preparation for the detection of the mRNA expression of the telomerase 
catalytic subunit TERT, whole embryos and larvae were sampled at several 
time points throughout their development (n=4): 12, 14, and 37 days post 
fertilization (dpf) by immediate immersion in liquid nitrogen. At 167 dpf fry 
were killed by terminal anesthesia using benzocaine (Sigma, Missouri, USA) 
at a 0.5g/l concentration (ethyl-p-aminobenzoate, C9H11NO2). Once killed 
whole body weight was measured and tissue samples taken from brain, 
muscle and liver (n=4). All protocols involving animal use were carried out 
ethically in accordance with U.K. Home Office guidelines. 
The fish in the control exposures were imaged throughout their 
development and the physical growth (fork length) of fish in all exposures was 
measured at 49 dpf with the use of photo-imaging and then fork length at 
point of death was measured at 167 dpf. The development of the trout 
embryos was plotted and their growth and mortality rate evaluated during the 
167 day exposure. 
 
2.2 Telomeric Repeat Amplification Protocol (TRAP) Assay 
 
The TRAP assay (Kim et al., 1994) is an assay used to examine 
telomerase activity. In this study the TRAPEZE
 XL Telomerase Detection kit 
from Chemicon International (Billerica, Massachusetts, USA) was used. This 
method works by the use of amplifluor primers. At the primers 3’end there is a 
sequence complimentary to that of the target sequence, and at the 5’end, a 
hairpin structure with both the fluorophore and a fluorescence quencher (4-
(dimethylamine)azo benzene sulfonic acid). The primers are designed to be 
incorporated into the PCR product. When incorporated into a PCR product the 
hairpin structure is unfolded, no quenching occur and they emit fluorescence, 
but whereas if they are not, the hairpin structure is present, the fluorophore 
and the quencher are close to each other and so no fluorescence is emitted 
(Nazarenko et al., 1997). During the procedure, if telomerase is present in the 
samples used, it adds telomeric repeats onto a substrate oligonucleotide 
provided with the kit. These TRAP products are subsequently amplified using 
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the amplifluor primers. The emission from the primers incorporated into the 
PCR product is directly proportional to the amount of extended TRAP product 
produced by the telomerase in the first step, and the amount of TRAP 
products is directly proportional to the amount of telomerase in the samples 
used (Chemicon International, 2005). 
 
2.2.1 Sea urchin embryo and hepatocyte cell extract preparation for 
TRAPEZE telomerase assay 
 
Sea urchin embryo samples were collected by pelleting 10 ml of 
embryo solution with gentle centrifugation (2000 rpm). These samples were 
then rinsed with Mg2+ and Ca2+ free PBS (pH 7,37), repelleted, and the PBS 
removed. The pellets were then re-suspended in 200 μl CHAPS lysis buffer 
provided in the TRAPEZE XL telomerase assay kit [10 mM Tris-HCl pH 7.5, 1 
mM MgCl2, 1 mM EGTA, 0.1 mM benzamidine, 5 mM β-mercaptoethanol, 
0.5% CHAPS, 10% glycerol, 150 units ml-1 of RNAase inhibitor] and 
homogenized with a motorized pestle. This suspension was incubated on ice 
for 30 minutes before being spun at 12,000 x g for 20 minutes at 4°C. The 
supernatant was then aliquoted into fresh tubes, for both TRAPEZE analysis as 
well as protein concentration determination, and stored at -75°C to -85°C. All 
plastics and reagents used in this stage were PCR grade and certified 
RNase/DNase free. 
The rainbow trout hepatocyte samples were collected by pelleting the 
exposed cell cultures with gentle centrifugation of 600 rpm. These were then 
re-suspended in 200 μl CHAPS lysis buffer as with the sea urchin embryos, 
and incubated on ice for 30 minutes before being spun at 12,000 x g for 20 
minutes at 4°C. The supernatant was then stored at -75°C to -85°C. 
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2.2.2 TRAPEZE assay procedure 
 
The assay was performed in a 96-well RT-PCR plate and the following 
reagents were used for each assay reaction. 1) 10 l TRAPEZE XL reaction 
mix [TS primer, RP Amplifluor primer, K2 Amplifluor primer, TSK2 template, 
dA, dC, dG, dTTP – diluted in: 100 mM Tris-HCl (pH 8,3), 7.5 mM MgCl2, 315 
mM KCl, 0.25% Tween 20, 5 mM EGTA, 0.5 mg/ml BSA], 2) 0.4 l taq 
polymerase, 3) 37.6µl PCR grade H2O, and 4) 2µl sample extract. 
The plate was then placed in the Quantitative PCR machine, the 
Quantica Real Time qPCR Thermal Cycler from Techne (Bibby Scientific Ltd., 
Beacon Road, Stone, Staffordshire, UK), incubated for 30 minutes at 30°C 
and then 36 cycles of a 4-step PCR cycle were performed: 94°C for 30 sec, 
59°C for 30 sec, 72°C for 1 minute. Then at last a 3 minutes extension step at 
72°C and then 25 minutes at 55°C, ending with incubation at 4°C. The 
fluorescein and sulforhodamine emission in sample extracts were measured 
at the end of the cycling.  
 
2.3 Protein determination 
 
In order to be able to quantify the telomerase activity in the extracts, 
their protein concentration was determined through the Bio-Rad protein assay 
from Bio-Rad Laboratories (Hercules, California, USA). The BioRad dye 
reagent was diluted 1:5 and protein standards prepared using bovine serum 
albumin from Fermentas International (Thermo Fisher Scientific, Waltham, 
Massachussetts, USA) in distilled water [DH2O] at protein concentrations of 0, 
0.1, 0.2, 0.4, 0.6, 0.8 and 1.0 mg ml-1. The following dilution series was then 
prepared for each of the sample extracts using CHAPS lysis buffer; 2:17, 1:5, 
1:3 and 1:2. In a 96-well plate, 200µl of 1:5 BioRad dye reagent was added to 
10µl of each of the sample dilutions and standards. The standards were 
analysed in triplicate and the sample dilutions in duplicate. The plates were 
then incubated at room temperature for 15 minutes and then placed into a 
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plate reader. The absorbance of each well was read at 550nm, and the mean 
absorbance calculated and the protein concentration determined.  
 
2.4 RNA extraction and purification 
 
Extract preparation from purple sea urchin embryos was performed by 
pelleting 10 ml of embryo solution with gentle centrifugation (2000 rpm) in a 
refrigerated centrifuge. Adult sea urchin samples were gathered from a 
selection of tissues by cutting open the shell of the animals, the tests, 
horizontally and gently removing the upper half of the test. Whole rainbow 
trout embryos and larvae were sampled by immediate immersion in liquid 
nitrogen. When 167 day old fry were sampled, they were killed by terminal 
anesthesia using benzocaine (Sigma, Missouri, USA) at a 0.5g/l concentration 
(ethyl-p-aminobenzoate, C9H11NO2), and tissue samples taken from brain, 
muscle and liver. All protocols involving animal use were carried out ethically 
in accordance with U.K. Home Office guidelines. 
Total RNA was extracted by resuspending and homogenizing the 
embryos and tissues in 900 l Tri reagent (Sigma-Aldrich; Missouri, USA), 
following manufacturer’s instructions. After homogenization the samples were 
allowed to rest for five minutes at 4ºC. Afterwards the homogenate was 
centrifuged for 5 minutes at >10 000 rpm at 4ºC. The pellet was then disposed 
of and 0.1 ml chloroform added to the supernatant. This was shaken 
vigorously by hand for 15 seconds, allowed to stand for 15 minutes at room 
temperature and then centrifuged for 15 minutes at 12 000 rpm at 4ºC. 
Immediately after centrifugation the clear layer at the top, containing RNA, 
was removed and placed in a clear tube, to which 0.25 ml isopropanol and 1 
µl LPA (linear polyacrylamide) was added. This was allowed to stand for ten 
minutes at room temperature or over night at -20ºC, afterwhich it was 
centrifuged at 13 000 rpm for 30 minutes at 4ºC. A mark was made on the 
outside of the tube where the now visible pellet was placed after which the 
isopropanol was decanted. The pellet was washed twice with 1 ml 70% 
ethanol, vortexed, centrifuged for 10 minutes at 13 000 rpm at 4ºC and the 
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ethanol decanted. After two ethanol-washes the pellet was allowed to dry and 
then resuspended with 8-40µl H2O, transferred to a clean tube and frozen at 
at -80ºC. 
To further clean the RNA samples from polymucosaccharides, the 
samples were purified using RNeasy Mini kit RNA extraction columns from 
Qiagen (Crawley, West Sussex, UK) which incorporate a DNase step. The 
column purification was performed as per manufacturer’s guidelines. The first 
step was to add 350 µl buffer RLT to the RNA sample, mix this and then spin 
at full speed for 3 minutes, afterwhich the supernatant was decanted to a new 
microcentrifuge tube. To this, an equivalent volume of ethanol was added 
(approximatelt 360 µl) and the two thoroughly mixed by pipetting. The entire 
contents of the tube are subsequently transferred to a RNeasy Mini column 
placed in a 2 ml collection tube and centrifuged for 15 seconds at 10 000 rpm. 
The next step was to add 350 µl buffer RW1 to the column and centrifuge 
again for 15 seconds at 10 000 rpm. Before continuing, 10 µl DNase I stock 
solution was diluted in 70 µl RDD buffer and gently mixed by inverting the 
tube. For a large number of samples, 130 µl DNase I stock solution was 
diluted in 910 µl RDD buffer. 80 µl of this DNase mixture was then added to 
each column membrane and allowed to stand at 20-30ºC for 15 minutes, after 
which 350 µl of buffer RW1 was added to the column and it centrifuged at >10 
000 rpm for 15 seconds. This was repeated with 500 µl buffer RPE and then 
500 µl 80% ethanol except that after the ethanol was added the column was 
centrifuged for 2 minutes. The column was next placed in a new collection 
tube and centrifuged at full speed for 5 minutes after which 14 µl RNase-free 
water were added directly to the column membrane and the column 
centrifuged in a clean microcentrifuge tube and centrifuged at full speed for 1 
minute. The resulting eluate was then stored at -80ºC. 
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2.5 Reverse transcription of total RNA 
 
 Before reverse transcription, the quality of DNase treated and purified 
RNA extracts as well as the total RNA concentration were established. This 
was done with the use of NanoDrop-1000 Spectrophotometer (NanoDrop 
Technologies, Wilmington, USA) and the accompanying software ND-1000. 
The quality of the samples was established by examining the ratio of sample 
absorbance at 260 and 280 nm (260:280 ratios) as well as the ratio of sample 
absorbance at 260 and 230 nm (260:230 ratios). The 260:280 ratios should 
be ~1.8 and ~2.0 for RNA. A different ratio indicates contamination of a 
sample potentially by DNA or phenol. The 260:230 ratios for nucleic acids 
should be between 1.8 and 2.2 and if it is significantly lower, it indicates the 
presence of contamination of co-purified contaminants, including salts, 
ethanol or proteins. The next step was to reverse transcribe 2 μg RNA, with 
the use of M-MLV reverse transcriptase (Promega, Fitchburg, Winsconsin), 
product number M1701. Reverse transcription was conducted as per 
manufacturers instructions yielding a product of cDNA which can be stored at 
-20ºC. 
 
2.6 Identification of target sequences in public databases 
 
Gene and protein databases of the National Center for Biotechnology 
Information (NCBI; http://www.ncbi.nlm.nih.gov/) were screened for the 
presence of homologues for the sequences of interest, and sequences 
showing high percentage homology were chosen for further study. Multiple 
sequence alignments between these potential nucleotide and protein 
sequences and those from other vertebrate as well as invertebrate species 
were created using ClustalW, a widely-used progressive multiple sequence 
alignment program (Higgins et al, 1996) embedded within the BioEdit software 
package (http://www.mbio.ncsu.edu/bioedit/bioedit.html). Sequence identities 
were further confirmed using BLAST (Altschul et al, 1990). 
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After having identified potential target and aligned them with 
sequences from other vertebrate species, highly homologous areas were 
used as a focus for the oligonucleotide PCR primer design (chapter 2.7 
below). 
 
2.7 Oligonucleotide primer design 
 
When desiring to amplify a specific DNA sequence, synthetic 
oligonucleotide primers need to be designed specific for the DNA sequence in 
question. In order to bind to the DNA, the primer sequence needs to be 
designed as the reverse compliment of the DNA sequence. When mRNA is 
the target of study, complementary DNA (cDNA) is first produced which is far 
more stable than RNA itself, but the known mRNA sequence is used as a 
template for oligonucleotide design. The forward primer is the exact copy of a 
sequence on the target RNA and the reverse primer the reverse compliment 
of a sequence closer to the 3’end of that same RNA sequence. 
Oligonucleotide primers can be designed by eye, by studying the mRNA 
sequence itself and choosing primers that are specific to that sequence and 
are unlikely to form hairpin structures or primer-dimers. Alternatively, a 
specific primer-design program can be used, such as the online computer 
program Primer3Plus (Primer3Plus.com, Untergasser et al, 2012), to generate 
suitable primers. In this study Primer3Plus was used to design most of the 
primers, except for the degenerate primers that were designed by eye. When 
designing primers the known target mRNA sequence is retrieved from the 
NCBI GenBank database and used as a template for primer design. All the 
primers designed for this study were synthesized by Eurofins MWG Operon 
(Acton, London). 
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2.7.1 Degenerate primers  
 
Degenerate primers are a pool of similar primers with some variability 
in nucleotide composition. These are used as a pool when the target 
sequence is not fully known, in hope of finding the target sequence 
irrespectively of the non-specificity of the primers. Within the pool of primers 
there might be a sequence that matches the target DNA, allowing for it to be 
amplified. The mixed bases in the sequence are called wobble bases, and 
when degenerate primers are designed, a standard mix-base nomenclature is 
used (Table 3). 
 
Table 3. The wobble base nomenclature used for designs of degenerate 
primers. 
Wobble 
name 
M R W S Y K 
Nucleotides AC AG AT GC CT GT 
Wobble 
name 
V H D B N  
Nucleotides AGC ACT AGT GCT AGCT  
 
In order to increase the efficiency of degenerate primers one can 
increase their length and as such, annealing temperatures, by adding a tail to 
the 5´ of the primers. An EcoRI tail (GCGCGGAATTC) is attached to the 5´ of 
the forward primer and a HindIII tail (GCGCGCAAGCTT) to the 5´ end of the 
reverse primer. These also benefit from known restriction sites which can be 
used later should any amplified fragment need to be cloned.  
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2.7.2 Quantitative PCR primer design 
  
For relative quantification by qPCR the quality and specificity of the 
primers needs to be far higher than in standard PCR, which is why the 
Beacon Designer 3.0 Software was used for the design of these primers. All 
primers in this study were synthesized by Eurofins MWG Operon (Acton, 
London). These were then used to identify, isolate, clone and sequence the 
actual TERT sequence in rainbow trout which could then be used as a 
template for the design of quantitative PCR (qPCR) primers using the primer 
design program Beacon Designer 3.0 Software (Premier Biosoft International, 
Palo Alto, CA, USA).  
 
 
2.8 cDNA amplification with Polymerase chain reaction, PCR 
 
Amplification of TERT cDNA sequences was performed with the use of 
GoTaq Green master mix (Promega, Fitchburg, Winsconsin) and a Peltier 
thermal cycler (PCT-200; MJ Research, USA). Sample cDNA was amplified in 
a total PCR reaction volume of 12.5 μl made up of the following: 6.3 μl 
GoTaq Green master mix, 1 μl forward primer, 1 μl reverse primer, 1 μl 
cDNA, and 3.2 μl water. Details on the specific primers used for amplification 
of the various genes are given in the chapters where their use is detailed. The 
PCR reaction conditions were as follows: 1) denaturation at 95ºC for 2 
minutes, 2) amplification through 35 cycles of a) 95ºC for 30 seconds, b) 
annealing at 55ºC for 30 seconds, c) extension at 72ºC for 1 minute, 3) final 
extension at 72ºC for 5 minutes. The PCR products were then stored at -20ºC 
until required for further analysis (such as agarose gel electrophoresis). 
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2.8.1 Touchdown PCR using degenerate oligonucleotide primers 
 
Touchdown polymerase chain reaction, or touchdown PCR, is a 
variation of the standard PCR procedure designed to specifically avoid non-
specific amplification. The amplification begins at an annealing temperature 
above or equal to that of the estimated melting temperature (Tm) of the 
primers, then cycle by cycle the annealing temperature decreases in a 
declining gradient, with the last few cycles at an annealing temperature well 
below the melting temperature. When choosing the annealing temperatures 
for primer-template combinations with suspected mismatches, the usual 
annealing temperatures should be reduced by 5-20 degrees. The theory 
behind this procedure is that just below the melting temperature of the 
primers, the most specific amplification will take place. The primers that pair 
best with the target sequence will begin amplification at this stage. As the 
temperature drops other less specific hybridizations will take place but as 
these will be amplified through a lesser number of cycles should yield lesser 
amount of product. When the primers used for this procedure are degenerate, 
the method needs to be altered slightly, raising the annealing temperatures of 
the last few cycles to a relatively high level. This will benefit the newly formed 
amplicons that are now fully complimentary to the primers available and as 
such have a higher Tm and do not benefit from excessively low annealing 
temperatures. Due to the fact that the exact mRNA sequence for TERT of 
European purple sea urchin was not known, this approach would enhance the 
chances of amplification of this gene sequence. The designated degenerate 
primers used would have a good chance of having several mismatches so the 
annealing temperatures chosen for the gradient were 15ºC lower than the 
melting temperature, Tm, in order to allow for this. Touchdown PCR reactions 
were prepared in the same way as those for the standard PCRs. The PCR 
reaction conditions used were as follows: 
 
1) Denaturation at 95ºC for 4 minutes 
2) Amplification through 30 cycles of 
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a) 94ºC for 1 minute 
b) annealing over a temperature gradient for 2 minutes at each 
temperature, with one cycle at each different temperature 
c) extension at 74ºC for 3 minutes 
3) Amplification through 10 cycles of 
a) 94ºC for 1 minute 
b) annealing at a high temperature for 2 minutes 
c) extension at 74ºC for 3 minutes 
4) Final extension at 74ºC for 7 minutes. 
 
The PCR products were then stored at -20ºC until required for further 
analysis. 
 
 
2.8.2 Quantitative PCR 
 
The standard method of qPCR  performed for this study was as 
follows: The quantitative PCR reaction was performed in the Quantica Real 
Time qPCR Thermal Cycler from Techne (Bibby Scientific Ltd., Beacon Road, 
Stone, Staffordshire, UK), with each test sample amplified in triplicate. The 
PCR reactions were performed using the Absolute qPCR Master Mix 
(Thermo-Scientific, Waltham, Massachusetts, USA) which includes a ROX 
passive reference dye. Before beginning the procedure the ROX dye was 
diluted to 1.25% concentration. The total PCR reaction for each sample was 
20 μl  made up of the following: 10 μl absolute blue reaction mix, 0.08 μl ROX 
dilution, 6.92 μl H2O, 0.5 μl forward primer, 0.5 μl reverse primer and 2 μl 
cDNA template dilution. Details on the specific primers used for amplification 
of the various genes are stated in results chapters 4.4 and 5.4.  
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The PCR reaction was performed at the following assay conditions: 1) 
denaturation at 95ºC for 15 minutes, 2) amplification through 50 cycles of a) 
95ºC for 15 seconds, b) annealing at varied temperatures, depending on the 
primers used, for 60 seconds, c) extension at 72ºC for 30 seconds, 3) 
followed by a dissociation curve analysis. The sequences were then stored at 
-20°C until required for further analysis (e.g. visualization by gel 
electrophoresis as per methodology chapter 2.9). 
 
2.8.3 Quantitative PCR optimization 
 
In order to be able to use a qPCR assay for relative quantification, it 
firstly needs to be optimized. This process ensures that the amplification in 
each one of the samples has equal efficiency, and by calculating the assays 
PCR efficiency (E) allows for the adaptation of any following upregulation 
calculations. The Quantica thermal cycler uses a PMT (photomultiplier tube) 
detector mechanism which allows for the simultaneous use of SYBR Green 
fluorescent dye as well as the passive reference dye (PRD) ROX. This 
corrects for any pipetting differences and also any non-PCR related variations 
in fluorescence detection. 
 The process of optimization requires the following steps: a) Perform a 
temperature gradient, b) run a standard curve at the optimal temperature, 
chosen where Ct was minimal in the temperature gradient run, this will 
provide information on the amplification efficiency of the reaction (E = 10-
1/slope), c) run a dissociation curve to establish whether any non-specific 
amplification has taken place. 
 The first step in qPCR optimization is to perform a temperature 
gradient for the oligonucleotide primers in question, in order to establish what 
their optimal annealing temperature is. Annealing temperatures are varied 
over a gradient of 7 different temperatures over a 7ºC range. The Gradient 
calculator software (Bibby Scientific, UK) provided with the Quantica thermal 
cycler is used for this purpose. The temperature range is centered around the 
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estimated calculated annealing temperatures for each of the primer pairs in 
question. The reagent for each reaction is as described in the previous 
chapter (chapter 5.3.4). The PCR reaction was performed as follows: 1) 
denaturation at 95ºC for 15 minutes, 2) amplification through 50 cycles of a) 
95ºC for 15 seconds, b) annealing at a gradient for 60 seconds, c) extension 
at 72ºC for 30 seconds, 3) followed by a dissociation curve analysis. The 
optimal annealing temperature is that which yields the greatest amplification 
(lowest Ct) with good replicates and no non-specific amplification. 
 The second step in qPCR optimization is to generate a standard curve 
for the oligonucleotide primers in question. With the optimal annealing 
temperature established in the previous step, a standard dilution of a rainbow 
trout cDNA pool is created. The reagents for each reaction are as described in 
chapter chapter 5.3.4 and the PCR reaction was as follows: 1) denaturation at 
95ºC for 15 minutes, 2) amplification through 50 cycles of; a) 95ºC for 15 
seconds, b) annealing at the optimized annealing temperature for each primer 
pair for 60 seconds, c) extension at 72ºC for 30 seconds, 3) followed by a 
dissociation curve analysis. When the dissociation curve shows no non-
specific amplification and the standard curve yields a PCR efficiency of 
between 80-120%, the qPCR assay is considered optimized. If the efficiency 
is too high it indicated non-specific binding or primer-dimers being formed, an 
increase of the annealing temperature of the reaction can reduce this effect. If 
the efficiency is to low the annealing temperature may be too high for the 
primers used and may need to be decreased. 
 
2.9 Separation and visualisation of amplified cDNA products 
 
Gel electrophoresis is a method widely used for the separation of 
nucleotide fragments, such as amplified PCR products, based on size. An 
agarose gel is prepared at an agarose concentration of between 0.5% and 2% 
depending on the size of the fragments. The larger the fragment the lower the 
concentration of agarose needs to be. For fragments of a size between 300 
and 1000 bp as are used in this study a 1.5% agarose gel is appropriate. The 
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gel is prepared by dissolving agar in 1% TBE buffer by heating it. The liquid 
solution is then allowed to cool slightly before ethidium bromide is added; 6-7 
μl per 100 ml of solution. The gel is then allowed to set in a gel tray. Once set 
the gel is placed into the gel electrophoresis tank which has been filled with 
the same buffer that was used to make the gel, and 5 μl of PCR products and 
DNA ladders, either a 100 bp or a 1kb DNA ladder (Promega, Fitchburg, 
Winsconsin) are loaded onto the gel. The electrophoresis is run at about 130 
volts for approximately 30 minutes, or until the marker dye has moved more 
than half way down the gel. Gel imaging takes place in an ultraviolet imaging 
cabinet (Uvi-tech gel documenting system; Jencons-PLS, Leighton Buzzard, 
UK), specifically designed for the purpose. 
 
2.10 Rapid amplification of cDNA (3’ race) 
 
Rapid amplification of cDNA ends (RACE) is a combination of 
procedures used to obtain the sequence for the full length of RNA transcripts 
found in samples, a major step in that process is 3´race where the focus is on 
obtaining the transcript for the 3´ tail of the sequence in question. 
Complimentary DNA (cDNA) is produced through reverse transcription (RT), 
whilst priming for the poly(A) tail existent at the very tail end (3´ end) of all 
eucaryotic mRNA sequences. This is done by using a special oligo-dT anchor 
primer which includes an added priming site sequence for the poly(A)tail (3R-
Anchor). The target sequence is then amplified through PCR using a 
sequence specific forward primer and an adapter primer which recognises the 
poly(A) tail (3R-Outer). In order to re-amplify the 3’race products a second 
nested PCR is then performed with a sequence specific forward primer which 
is nested within the original one and a reverse primer which is nested within 
the previous one (3R-Inner). This increases the specificity of the procedure 
and minimizes the risk of non-target sequences being amplified. These nested 
sequences are then cloned and sequenced. The poly(A) tail specific RT and 
PCR primers used in this procedure are displayed in Table 4.  
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Table 4. The poly(A) tail specific RT and PCR primers. 3R-Anchor is the 
oligo-dT anchor primer used for reverse transcriotion. 3R-Outer is an 
anti-sense adapter primer which recognises the poly(A) tail. 3R-Inner is 
an anti-sense adapter primer nested within 3R-Outer. 
Primer 
name 
Sequence  
3R-Anchor 5´-GCGAGCACAGAATTAATACGACTCACTATAGGTTTTTTTTTTTTVN-3´ 
3R-Outer 5´-GCGAGCACAGAATTAATACGACT-3´ 
3R-Inner 5´-GAATTAATACGACTCACTATAGG-3´ 
 
For this study, both outer 3´race and nested inner 3´race PCR 
reactions were performed in a Peltier thermal cycler (PCT-200; MJ Research. 
USA). The total reaction volume was 25µl using GoTaq Green master mix 
(Promega, Fitchburg, Winsconsin), combining reagents as follows: 12.6 μl 
GoTaq Green master mix, 2 μl forward primer, 2 μl reverse primer, 6.4 μl 
water, and finally 2 μl cDNA for the outer PCR reactions and 2 ul PCR product 
for the nested inner PCR reactions. 
 
The assay conditions for the 3´race outer PCR reactions were as follows: 
1) Initial cycle of a) 94°C for 5 min, b) 55°C for 5 min and then c) 72°C 
for 40 min 
2)  Amplification for 40 cycles: a) 94°C for 30 seconds, b) annealing at 
55°C for 30 seconds, c) 72ºC for 90 seconds 
3) A final cycle of a) 94°C for 30 sec, b) 55°C for 30 seconds and then 
c) 72°C for 15 minutes. 
The assay conditions for the 3´race nested inner PCR reactions were as 
follows: 
1) Denaturation at 94°C for 2 min 
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2) Amplification for 45 cycles: a) 94°C for 30 seconds, b) annealing at 
54°C for 30 seconds, c) extension at 72ºC for 90 seconds 
3) Final extension at 72ºC for 10 minutes. 
 
2.11 Cloning of sequences 
 
In order to clone a target sequence, it must firstly be amplified via PCR 
using primers designed from a predicted sequence or sequence homologues 
of other species found in public databases. It can then be visualized on an 
agarose gel using gel electrophoresis, and finally ligated into pCR®2.1-TOPO® 
plasmids using the TOPO TA cloning procedure (Invitrogen, Carlsbad, 
California, USA). This procedure directly inserts taq polymerase-amplified 
PCR products into a plasmid vector which includes priming sites for M13 
sense and anti-sense primers (Table 5) provided in the kit. The two priming 
sites bracket the ligation site allowing for the cloned product to be amplified 
(Figure 10). The TOPO TA cloning procedure was performed following 
manufacturer’s instructions, using 0.5 and 1 μl of PCR product for each 
ligation reaction. 
 
Table 5. The M13 qPCR oligonucleotide primers provided with the 
Invitrogen TOPO TA cloning kit, for amplification of the PCR product 
within the pCR®2.1-TOPO® plasmid. 
Position Primer Sequence 
Sense M13 forward (-20) 5´-GTAAAACGACGGCCAG-3´ 
Anti-sense M13 reverse 5´-CAGGAAACAGCTATGAC-3´ 
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Figure 10. The locations of the primer binding sites for the M13 forward 
and reverse primers on the pCR®2.1-TOPO® plasmid and the size of the 
area between the two primer sites. 
 
The cultured transformants acquired were analysed with PCR; several 
bacterial colonies were pricked with a sterilized toothpick, re-suspended in 
100 μl of H2O and vortexed, and then used for the PCR reaction. A PCR was 
performed with a total reaction volume of 12.5 μl using the GoTaq Green 
master mix (Promega, Fitchburg, Winsconsin) and M13 forward and reverse 
primers provided with the cloning kit. For each PCR reaction the reagents 
were assembled as follows: 6.25 μl GoTaq Green master mix, 3.25 μl H2O, 1 
μl forward primer, 1 μl reverse primer, and 1 μl colony suspension. The assay 
conditions were: 1) denaturation at 94ºC for 10 minutes, 2) amplification 
through 30 cycles of a) 95ºC for 30 seconds, b) annealing at 58ºC for 30 
seconds, c) extension at 72ºC for 2 minutes, 3) final extension at 72ºC for 10 
minutes. 
The PCR products were then visualized with the use of gel electrophoresis 
in order to establish whether the bands visualized on the gel were of the 
expected size. When amplifying a sequence incorporated into the plasmid, 
using the M13 primer pair, the size of the amplified products produced should 
be 201 bp plus the size of the PCR product incorporated into the plasmid 
(Figure 10 and Figure 11). The bacterial cultures containing the clones were 
then centrifuged for 10 min at 6000 rpm after which the plasmid including the 
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clone was purified from the pelleted bacterial cells using the QIAPrep 
Miniprep Plasmid purification kit from Quiagen and sequenced by Eurofins 
MWG Operon (Acton, London). The column purification was performed at 
room temperature as per manufacturer’s guidelines. The previously pelleted 
bacterial cells were resuspended in 250 µl buffer P1, which includes RNase, 
by vortexing or repeated pipetting. The resuspension was transferred to a 
microcentrifuge tube to which 250 µl buffer P2 was added. Once this had 
been thoroughly mixed by inverting the tube, 350 µl buffer N1 was added and 
its contents mixed completely by inverting the tube. The tube was 
subsequently centrifuged for 10 min at 13 000 rpm and the supernatant 
moved to a QIAprep spin column which was centrifuged for 30-60 seconds. 
The spin column was washed firstly with 0.5 ml buffer PB and centrifuged for 
30-60 seconds, and secondly with 0.75 ml buffer PE and centrifuged for 30-60 
seconds. The flow-through was discarded and the column centrifuged again 
at full speed for 1 minute. Lastly the spin column was placed in a clean 1.5 ml 
microcentrifuge tube and the DNA eluted by placing 50 µl of water to the 
column, this allowed to stand and centrifuged for 1 minute. 
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Figure 11. The sequence surrounding the TOPO cloning site in the 
pCR®2.1-TOPO® plasmids. Displayed are the binding sites for the M13 
forward and reverse primers as well as the cloning site for the PCR 
product. The size of the amplified products produced whilst using the 
M13 forward and reverse primers should be 201 basepairs plus the size 
of the PCR product incorporated into the plasmid. 
 
 
2.12 Quantitative PCR analysis of target sequence mRNA 
expression 
 
Once quantitative PCR assays had been designed for the specific 
amplification of a target sequence, they could be used for quantitative 
analysis of sequence expression. An optimized assay for a housekeeping 
gene must also be run in parallel for normalization purposes. In preparation 
for quantitative analysis, total RNA was extracted using Tri reagent (Sigma-
Aldrich, Missouri, USA) following manufacturer’s instructions.  
Target mRNA was amplified in the Quantica Real Time qPCR Thermal 
Cycler, with a triplicate amplification for each of the sample biological 
replicates. Before beginning the procedure the ROX dye is diluted to 1.25% 
concentration. The total PCR reaction for each replicate was 15 μl using the 
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Absolute qPCR master mix (Thermo-Scientific, Waltham, Massachusetts, 
USA) which includes a ROX passive reference dye. Each PCR reaction was 
made up of the following: 7.5 μl Absolute blue reaction mix, 0.06 μl Rox dye 
dilution, 5.94 μl H20, 0.375 μl forward primer, 0.375 μl reverse primer, 0.75 μl 
sample cDNA. For each plate two negative controls were included, without a 
cDNA template and the other without reverse transcriptase. 
The PCR reaction was as follows: 1) denaturation at 95ºC for 15 
minutes, 2) amplification through 40 cycles of a) 95ºC for 15 seconds, b) 
annealing at 59ºC (60 ºC for rpl8) for 60 seconds, c) extension at 72ºC for 30 
seconds, 3) followed by a dissociation curve analysis.  
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3 Telomerase and oestrogenic pollution in 
purple sea urchins – telomerase activity and 
isolation of the telomerase catalytic subunit, 
TERT 
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3.1 Introduction 
 
3.1.1 Endocrine disruption and invertebrates 
 
Steroid hormones are lipid chemical messengers that play an important 
role in various physiological processes, such as metabolic control, immune 
functions and sexual development. They regulate the synthesis of proteins by 
interacting with intracellular receptors and thus influence endocrine, 
neuroendocrine and even behavioural functions (Silver, 1985). Sex steroids 
such as E2, the most potent natural oestrogen in humans, are vital to various 
biological processes involving the sexual development and reproduction of 
animals. Many substances, of both natural and anthropogenic origin, are 
being introduced into the aquatic and terrestrial environments every year at an 
increasing rate (EEA, 2005, Roy et al., 1996). Some of these are naturally-
produced steroid hormones or artificial homologues of them. When introduced 
to the environment, they can be absorbed by the vertebrate and invertebrate 
organisms inhabiting the exposed habitats where they often disrupt their 
normal hormonal functions. These environmentally relevant steroid hormones 
and their mimics are commonly known as “endocrine disruptors” (EDs) 
(DEFRA, 2002). E2 is one of many endocrine disruptors causing 
environmentally hazardous oestrogenic activity in sewage treatment works 
effluents. It is therefore a popular target for the study of the mechanisms of 
environmental oestrogen action (Desbrow et al., 1998). 
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Figure 12. Structure of 17β-oestradiol (E2). 
  
Invertebrates are commonly used as a research model for endocrine 
disruption. They represent a significant proportion of the planet’s biodiversity, 
making up about 95% of all animal species, and are therefore important for 
the proper function of each and every ecosystem they inhabit. Using these as 
focus species of pollution studies gives an excellent indication of ecosystem 
health. Invertebrates have been used in a range of environmental biomarker 
studies with a range of detrimental effects of endocrine disruptors reported 
(Roast and Benstead, 2007). One of the most notable examples will be that of 
the widely reported and established effect of tributyltin (TBT) on marine 
gastropods. TBT compounds are organotin compounds once widely used as a 
biocide in anti-fauling paints used for ship hulls, as well as agricultural 
fungicides and disinfecting agents. TBT leachates from anti-fouling paints are 
highly toxic and have been shown to induce imposex in gastropod species 
(Boyer, 1989; Fent, 1996; Horiguchi et al., 1997; Matthiessen and Gibbs, 
1998). The mechanism by which this happens has long been unclear, with 
some having suggested the inhibition of cytochrome P450 function, leading to 
prevention of oestrogen conversion from androgen in gastropods (Bettin et al., 
1996), whereas other studies have shown that in human cancer cells these 
compounds induce E2 biosynthesis by functioning as an agonist for NRs as 
opposed to aromatase inhibitor (Nakanishi et al., 2002; Nakanishi et al., 2005; 
Nakanishi, 2008). The most recent studies have linked imposex with the 
retinoid X receptor (RXR) and androgen signalling pathways (Lima et al., 
2011; Stange et al., 2012). TBT has been shown to alter RXR gene 
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expression with a positive correlation between female penis length and RXR 
gene transcription (Abidli et al., 2013). The use of TBT compounds has been 
banned by the International Convention on the control of harmful anti-fauling 
systems on ships (AFS Convention, Oct 5th 2001), a treaty by the International 
Maritime Organization.  
 Although such well established examples of endocrine disruption exist 
within the invertebrate phyla, the mechanisms of invertebrate’s susceptibility 
to endocrine disruptors are not fully explained due to a lack of unserstanding 
of their endocrine system as well as characterization of their NRs. As far as 
we understand, observed endocrine disruption in vertebrates is in many cases 
due to NR modulation (Castro and Santos, 2014). The nature of NRs does 
however vary between invertebrates and vertebrates. It was previously 
believed that NRs first came about in evolution with the emergence of 
vertebrates, and was this based on the observed absence of NRs in some of 
the most widely used invertebrate test species, like Daphnia magna and 
Drosophila melanogaster. But these have gone through severe gene loss 
through evolution and therefore poorly represent invertebrates as a phylum 
(Bridgham et al., 2010). The emergence of NRs is now believed to have 
occurred early in metazoan evolution (Escriva et al., 2000; Bertrand et al., 
2004; Bridgham et al., 2010). The current consensus is that a selection of 
NRs was lost in some invertebrates like nematodes and insects, as opposed 
to having not come to be until the emergence of vertebrates (Bertrand et al., 
2004). Sex-steroid receptor-like proteins have been identified in protostome 
invertebrates. Receptors closely similar to the human ER and oestrogen-
related receptor (ERR) have been cloned from the gastropod California sea 
hare (Aplysia californica) (Thornton et al., 2003) as well as octopus (Octopus 
vulgaris) (Keay et al., 2006), a freshwater snail (Marisa cornuarietis) 
(Bannister et al., 2007) and the Pacific oyster (Crassostrea gigas) (Matsumoto 
et al., 2007) to name a few, although none of these bind oestrogen. In 
octopus the ligand-binding site is too small to bind to oestrogen. These do, 
however, seem to influence gene transcription without steroid involvement, 
much like human ERRs (Thornton et al., 2003; Keay et al., 2006; Greschik et 
al., 2002; Bannister et al., 2007; Matsumoto et al., 2007; Baker and 
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Chandsawangbhuwana, 2007). NRs that do seem to show transcriptional 
response to oestrogen have been found in annelids, although it is not clear 
whether this is a ligand-activated response or not (Keay and Thornton, 2009).   
An ERR has been cloned from a deuterostome invertebrate, the 
American purple sea urchin (Sodergren et al., 2006) which has been shown to 
respond to both oestrogens and androgens. A study by Roepke and 
colleagues (2005) showed that oestrogenic chemicals such as E2 and 
selective oestrogen-receptor modulators (SERMs) like BPA are teratogenic to 
exposed sea urchin embryos and larvae, inhibiting normal embryonic 
development. The sensitivities of the exposed embryos were however 
significantly decreased with simultanious exposure to both E2 and the partial 
ER agonist TAM, suggesting a mode of action involving an ERR. The 
sensitivity of early life stages of sea urchins to oestrogenic pollution seems 
similar to that of molluscs, but significantly greater than that of many other 
invertebrates (Roepke et al., 2005). A later study by Roepke and co-workers 
(2006) showed that the above mentioned embryonic sensitivity is greatly 
reduced following maternal exposure to oestrogenic chemicals like E2, 
suggesting desensitisation. The above study also established that expression 
of the orphan steroid receptor SpSHR2 in eggs from mothers exposed to 
these chemicals was greatly increased. Oestrogenic response has also been 
recorded in the sea urchin species chosen for the present study, the 
European purple sea urchin. The two known groups of oestrogen mimics, 
nonylphenols and octylphenols, have been shown to be greatly teratogenic to 
the embryonic and larval stages of this urchin, limiting growth and inducing 
larval malformations as well as reducing the mitotic indexes with increasing 
exposure concentrations (Arslan et al., 2007). Adult European purple sea 
urchins exposed to the environmental oestrogen E2 do, however, show no 
effect on the maturation of gonads or development of gametes, with slight 
effect was observed on gonad index and lipid content. This may suggests that 
E2 functions differently in urchins than it does in vertebrates (Sugni et al., 
2012).  
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3.1.2 Telomerase in invertebrates 
 
The ribonucleoprotein (RNP) complex (Morin, G.B., 1989) telomerase 
is typically present in rapidly dividing cells, such as stem cells, reproductive 
cells (Wright et al., 1996) and cancer cells (Kim et al., 1994, Shay and 
Bacchetti, 1997) but inactivated in most somatic cells in humans and other 
long-lived mammals and birds. This process is believed to be a part of 
processes that inhibit tumour development and advancement (Wright and 
Shay, 2001). Telomerase inactivation does, however, not happen universally 
in the somatic cells of the life-forms on this planet. Many vertebrates as well 
as invertebrates express telomerase in somatic tissues throughout their 
lifespan. These include some aquatic species like sponges, lobsters, fish and 
sea urchins (Koziol et al., 1998; Klapper at al., 1998; McChesney et al., 2004; 
Francis et al., 2006). Telomerase activity has been detected in various adult 
tissues as well as the embryonic development of two sea urchin species, 
variegated sea urchin and American red sea urchin. The adult tissues 
analysed were Aritotle lantern muscle, esophagus, intestine, ampullae and 
gonad, all of which exhibited telomerase activity. High activity was also 
detected in eggs, gastrula, prism and pluteus larvae, but not in sperm (Francis 
et al., 2006). Despite such high somatic telomerase expression, the sea 
urchin species American red sea urchin has an extremely long lifespan, over 
100 years, during which it exhibits indeterminate growth (Ebert and Southon, 
2003; Rogers-Bennett et al., 2003) and yet very few incidences of neoplasm 
have been documented in sea urchins, including S. franciscaus (Sparks, 
1985). This suggests that these animals use an alternative means of tumour 
avoidance. For this reason it might be suggested that this ‘tumour-protection 
mechanism’ in most long-lived mammals and birds is a relatively recent 
evolutionary step, perhaps arising due to an increased mutation load due to 
longer life-spans, larger bodies and more complex physiological 
developmental processes.  
When comparing vertebrates and invertebrates, considerable 
difference exists in the sequences coding for this protein, with great variability 
in the telomerase intrinsic RNA component (TR or TERC). To date TR has 
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only been identified in one invertebrate species, the American purple sea 
urchin (Li et al., 2013; Sodergren et al., 2006) although it has been identified 
in several species of fungi (Qi et al., 2013; Kuprys et al., 2013). The sequence 
for the telomerase reverse transcriptase (TERT) is, however, highly 
conserved (Podlevsky et al., 2008) with four domains: a) TEN domain or 
TERT-Essential N-terminal, b) TRBD or TERT RNA binding domain, c) RT 
domain or the reverse transcriptase domain, and lastly d) the C-terminal 
extension (CTE) (Mason et al., 2011). Sea squirts are invertebrate chordates 
and therefore very closely related to the vertebrate lineage. TERT has been 
identified and characterized in the sea squirt species Ciona intestinalis and 
shown to contain 17 exons which are similar to those in vertebrates. It has 
also been shown to contain all of the reverse transcriptase motifs usually 
present in vertebrate telomerase, these being; motifs 1, 2, 3, A, B, C, D and E 
(Li et al., 2007). As has been previously stated the TERT sequence has also 
been cloned from the American purple sea urchin (Sodergren et al., 2006).  
Studies on the telomerase catalytic subunit, TERT, in sea urchins have 
revealed that a significant amount of hypervariability exists in its gene 
sequence in these animals. Two paralogues of the gene sequence have been 
identified from their genome, sequences that are differentially expressed 
throughour embryogenesis, as well as several novel domains. Hypervariability 
between individuals furthermore suggests great fluidity in the genetic 
sequence of sea urchin species, and possibly other deuterostome 
invertebrates. Sea urchins do therefore propose a novel and interesting model 
for telomerase research, its genomic fluidity and novel domains allowing for 
research into telomerase evolution, the possibility for alternative roles of the 
enzyme, which might throw a light on the origin and conservation of the 
sequence in humans, as well as possibly furthering research into human 
pathological conditions, such as glandular dysplasia in Barrett’s oesophagus 
(Going et al, 2004). 
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3.2 Aims and objectives 
 
The primary objectives of this study were firstly to examine the effect of 
oestrogenic exposure on telomerase activity in the European purple sea 
urchin and secondly to isolate and characterize the mRNA sequence for 
TERT in the European purple sea urchin which could then be used to design 
an optimized qPCR assay intended to quantify the expression of purple sea 
urchin tert mRNA in embryonic as well as adult samples exposed to a range 
of endocrine disrupting chemicals. 
The first objective of this project was to examine the effects of an 
environmental oestrogen, E2, on telomerase activity in the embryonic stages 
of the purple sea urchin, and to see whether it correlates with a disruption of 
embryo development. E2, of which excessive quantities have been shown to 
induce teratogenic effects in various organisms (Henry et al., 2005), has great 
environmental relevance due to it being one of the principal components 
responsible for oestrogenic activity in sewage treatment works effluents. It has 
been detected in sewage effluents at concentrations up to 50 ng/l and has 
been widely used to study the mechanisms of environmental oestrogen action 
(Desbrow et al., 1998). We furthermore examined the effects of a known 
telomerase inhibitor, AZT, in order to determine whether the effect observed 
from oestrogen exposure was an effect on telomerase expression itself or on 
the regulation of the expressed enzyme. By using an invertebrate model we 
hope to gain knowledge of the nature of telomerase activity and determine 
any links between telomerase activity, and cell cycle controls in a model 
invertebrate. In order to accomplish the latter, the following hypotheses were 
addressed: 
 
A. The natural steroid hormone E2 can disrupt the embryonic 
development of the purple sea urchin. 
B. The natural steroid hormone E2 induces telomerase activity in early life-
stages of purple sea urchin. 
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C. The telomerase inhibitor, AZT, reverses the induction of telomerase 
activity by E2. 
D. The natural steroid hormone E2 induces the mRNA expression of the 
main catalytic subunit of telomerase, TERT, in early life-stages of 
purple sea urchin. 
E. Purple sea urchins are affected by exposures to the oestrogenic 
chemical, E2, reflected both in their developmental success as well as 
transcriptional efficiency. 
 
Whereas considerable information exists on the action and function of 
sex steroids in vertebrates such information is limited when it comes to 
invertebrates, but these results might hopefully further the understanding of 
their function by providing an example of oestrogens acting in a model 
invertebrate.  
The second main objective of this study was to isolate and characterize 
the mRNA sequence for TERT in the European purple sea urchin, which so 
far had not been identified. This would be done by identifying any potential 
TERT sequences in public databases, and to compare them to known TERT 
sequences from other invertebrate and vertebrate species. From these, 
oligonucleotide primers could be designed to detect TERT in purple sea 
urchin samples, which once detected would be cloned and sequenced. This 
would be a step in mapping the alteration or conservation of the generally 
highly conserved telomerase throughout the invertebrate and vertebrate 
evolution. Once identified, this sequence could be used to develop a 
quantitative qPCR assay for this gene to be used for oestrogenic exposure 
studies, mainly focused on establishing whether oestrogenic chemicals can 
modulate the RNA expression of TERT. This would allow for further 
understanding the mechanism of telomerase modulation, and with a parallel 
study of tert mRNA in the rainbow trout, it would allow for examination of any 
similarities and/or differences that may exist between the action of these 
pollutants in vertebrates and invertebrates, and their effect on telomerase 
modulation. Designing a comparative deuterostome invertebrate model for 
telomere maintenance and telomerase activation may help us further 
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understand how these processes work in vertebrates. It is our hope that this 
research might further advance knowledge of the molecular processes 
involving telomerase and its function during the cell cycle. It may also give us 
a better understanding of the links between telomeres and longevity. By using 
environmental pollutants we hope to expand the global knowledge of the 
mode of action of pollutants in invertebrates and vertebrates. 
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3.3 Materials and Methods 
 
3.3.1 Validation of the fluorescence readings of the Quantica qPCR 
Thermal Cycler 
 
The TRAPEZE
 XL Telomerase Detection kit from Chemicon 
International uses an Amplifluor Primer system for the fluorometric detection 
of telomerase activity in test samples. The use of this is described in chapter 
2.2 in the Materials and Methods chapter. In order to validate the functionality 
of this kit with the Quantica qPCR thermal cycler, as opposed to a 
fluorescence plate reader as is recommended in the manufacturers manual, 
the ability of the excitation and emission filters provided with the machine to 
detect the fluorescence the two amplifluor primers provided in the kits, needed 
to be established. The primers themselves were labelled with fluorescein and 
sulforhodamine and the machine used two cartridges that contain the 
excitation and emission reading filters, SYBR and ROX (Table 6).  
 
Table 6. Middle wavelength () excitation and emission bandwidths for 
Quantica qPCR Thermal Cycler cartridges, and the ideal middle 
wavelength for detection of fluorescein and sulforhodamine used in the 
The TRAPEZE
 XL Telomerase Detection kit as recommended by the 
manufacturers manual. 
    Excitation 
wavelength 
Emission 
wavelength 
Real-time-PCR 
cartridges 
SYBR 485 nm 520 nm 
ROX 580 nm 615 nm 
Recommended 
wavelengths of 
filters 
Fluorescein  485 nm  535 nm 
Sulforhodamine  585 nm  620 nm 
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In order to establish whether these wavelengths were still adequate for 
use in this assay, several samples of purple sea urchin embryo extracts were 
prepared and amplified using the kit and the Quantica qPCR machine. These 
were then retrospectively analysed with a fluorimeter, using the FL winlab 
software in order to be able to plot the excitation and emission spectrums for 
fluorescein and sulforhodamine to see whether the RT-PCR cartridges were 
compatible. 
 
3.3.2 Plotting the normal embryonic development in purple sea urchin 
 
Before performing an extensive purple sea urchin embryo exposure, it 
is important to first plot the normal embryonic development of purple sea 
urchin embryos as well as the telomerase activity present in the various 
stages of development. This helps establish whether there are any time 
related patterns in the purple sea urchin embryonic development, and also 
allows us to establish the TRAPEZE
 assay’s ability to measure quantitative 
differences at low level concentrations. Adult purple sea urchins were induced 
to spawn and fertilization of sea urchin eggs performed. The resulting 
embryos were observed and imaged regularly for a period of 48 hours until 
they reached pluteus larval stage (methods described in chapter 2.1.1). 
 
3.3.3 Plotting the normal telomerase activity in purple sea urchin 
embryos and larvae 
 
A preliminary study of the telomerase expression in purple sea urchin 
larval extracts was performed, using extracts from various time points the 
embryonic development. Five pools of approximately 500 embryos at each 
developmental stage were sampled at A) 2-cell stage, B) gastrula stage, C) 
half-way between gastrula and intermediate ‘prism’ stage, and D) having 
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reached an intermediate ‘prism’ stage. The embryos were gently centrifuged 
at a speed of 2000 rpm in a refrigerated centrifuge, rinsed with a PBS buffer 
(pH 7.34) and lysed and homogenized in CHAPS lysis buffer provided with 
the TRAPEZE
 kit. After that the telomerase activity in the sample extracts 
(protein concentration 0.05 mg/ml) was analysed by qPCR amplification in the 
Quantica qPCR thermal cycler as per manufacture’rs guidelines (see chapter 
2.2). The significance of differences in telomerase activity was tested by one-
way ANOVA and Duncan’s multiple range tests using Minitab® Statistical 
Software (Minitab Inc). 
 
3.3.4 Validation of the accuracy of the TRAPEZE
® kit used with the 
Quantica qPCR Thermal Cycler 
 
In order to establish whether the telomerase activity measured by the 
qPCR machine is consistent across a range of sample dilutions, purple sea 
urchin embryo samples extracts from various embryonic developmental 
stages (samples A, B and C) were used to perform a dilution series. The 
telomerase activity was measured in the dilution series (see section 2.2 in 
Materials and Methods chapter) and the logarithm of one thousand part of the 
concentration of 8 telomeric repeats AG(GGTTAG)7) extensions on the TS 
primers was plotted against the fluorescence index: log(TPG Units) agains 
log(FL/R) respectively.  
 
3.3.5 Examination of the use of different rinsing buffers for extract 
preparation – effect on telomerase activity 
 
 When purple sea urchin embryos were sampled for this study, they 
were rinsed in a PBS buffer before being lysed in the CHAPS lysis buffer 
provided with the TRAPEZE
 kit. In order to establish whether PBS is indeed 
the best buffer available for this procedure, a comparison study between four 
different rinsing buffers was performed. Five pools of approximately 500 
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purple sea urchin pluteus larvae were gently centrifuged at 2000 rpm and then 
rinsed with the following buffers: A) TE-buffer, pH 7.7 (10 mM Tris-HCl and 1 
mM EDTA in 1 litre distilled water), B) physiosaline, pH 8.14 (29.2 g NaCl, 
4.257 g Na2SO4, 0.7457 g KCl and 1.4 g HEPES (acid) in 1 litre distilled 
water), C) physiosaline, pH 7.7, and D) Mg2+ and Ca2+ free PBS, pH 7.34. The 
telomerase activity in these was then measured usin the TRAPEZE
® kit. After 
that the telomerase activity in the sample extracts (protein concentration 0.05 
mg/ml) was analysed by qPCR amplification in the Quantica qPCR thermal 
cycler as per manufacture’rs guidelines (see chapter 2.2). The significance of 
differences in telomerase activity was tested by one-way ANOVA and 
Duncan’s multiple range tests using Minitab® Statistical Software (Minitab 
Inc). 
 
3.3.6 Exposure of purple sea urchin embryos to E2 
 
In order to perform a embryonic exposure study, adult purple sea 
urchins were induced to spawn and their embryos and larvae were exposed to 
the sex hormone E2 (see section 2.1.1 in Materials and Methods chapter 
above). The embryos and larvae were exposed for 48 hours at 15ºC. The 
chemical was dissolved in sea water with ethanol as a solvent, at a 
concentration of 0.05%. The solvent control for this study was 0.05% ethanol. 
All statistical analyses were performed using the statistical program Minitab® 
Statistical Software (Minitab Inc). 
 
3.3.6.1 Preliminary E2 exposure – establishing that exposure 
concentrations are sub-lethal 
 
A preliminary embryonic survival study at the highest chosen exposure 
concentrations of E2 was performed in order to establish that the exposure 
concentrations chosen for this study were sub-lethal and therefore appropriate 
for the examination on the effect of the chemical on telomerase activity. Adult 
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individuals of the purple sea urchin were induced to spawn and the resulting 
eggs fertilized and incubated in 500 ml pyrex glass containers. After 48 hours 
the larvae were moved to 96-well plate, with more than 100 larvae exposed in 
13 replicates of each exposure. These were exposed to a high concentration 
of E2; 200 ng/ml, for observation of survival rates. The total exposure solution 
volume was 200 μl. The significance of differences in survival was tested by 
two-way ANOVA and Duncan’s multiple range tests. 
 
3.3.6.2 Preliminary E2  exposure - analysis of telomerase activity 
 
In order to establish how much telomerase activity can be modified by 
the steroid hormone E2 during the embryonic development of purple sea 
urchins, another exposure study was performed. Four adult purple sea 
urchins were induced to spawn: a) female with 5.2 cm test diameter, b) female 
with 5.1 cm test diameter, c) male with 4.9 cm test diameter, d) male with a 
5.4 cm test diameter (see section 2.1.1 in Materials and Methods chapter). 
Once spawned, fertilization was performed and the resulting embryos 
exposed to two concentrations of E2; 200 and 20 ng E2/ml. The exposure 
lasted from immediately after fertilization until the embryos had reached the 
larval stage of pluteus. The embryos were monitored throughout the entire 
study, their survival rates observed as well signs of teratogenicity, or the 
presence of any developmental defects (section 2.1.1 in Materials and 
Methods chapter). The exposures were performed in 500 ml exposure 
solutions with four replicates for each exposure, in solvent washed pyrex 
glass containers. Samples were taken at several time points from pools of 
approximately 500 embryos (3 replicates). A) 2 h - multi-cell stage, B) 12 h - 
blastula, C) 24 h - gastrulation, D) 28 h - half-way between gastrula and an 
intermediate ‘prism’ stage, E) 34 h - intermediate ‘prism’ stage - early, F) 38 h 
- intermediate ‘prism’ stage – late, G) 44 h - nearly fully developed pluteus, H) 
48 h - fully developed pluteus. These were then analysed for telomerase 
activity using a variation of the TRAP assay (section 2.2 in Materials and 
Methods chapter). The significance of differences of telomerase activity 
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sampled at several timeponts was tested by two-way ANOVA and Tukey HSD 
post-hoc tests.  
  
3.3.6.3 Secondary E2 exposure - analysis of telomerase activity 
 
A secondary exposure study was performed, exposing purple sea 
urchin embryos to lower concentrations of E2; 20 and 2 ng E2/ml. 
Furthermore, an exposure to a nucleoside reverse transcriptase inhibitor, 
AZT, at a concentration of 100 μM was included in order to establish whether 
these effects would be reversed. Embryonic samples were taken at several 
time points from three replicate pools of approximately 500 embryos, these 
were: A) 2 hours – multi-cell stage, B) 6 hours – pre-hatching, C) 12 hours – 
early to late blastula, D) 24 hours – early to mid gastrula, E) 36 hours – 
intermediate ‘prism’ stage, F) 48 hours – pluteus larvae. These were then 
analysed for telomerase activity using a variation of the TRAP assay, the 
TRAPEZE
 XL telomerase detection kit and the Quantica qPCR thermal cycler. 
One-way ANOVA and Duncan’s multiple range tests were used to analyse the 
difference between different exposures at each point in time. Only one of the 
TRAPEZE
® analyses was successful, these were of samples taken at gatrula 
stage (24 h). For the rest of the samples either the Quantica Thermal Cycler 
or the TRAPEZE
® kit itself failed. The significance of differences of telomerase 
activity sampled at several timeponts was tested by two-way ANOVA and 
Tukey HSD post-hoc tests. The significance of differences of developmental 
defects and telomerase activity sampled at only one timepoint were tested by 
one-way ANOVA with a Fishers LSD post-hoc tests. 
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3.3.7 Identification and characterisation of potential sea urchin TERT, -
actin and Hsp90 gene sequences  
 
3.3.7.1 Initial identification of potential TERT, -actin and Hsp90 gene 
sequences for sea urchin in public databases 
 
In preparation for examination of the RNA expression of the main 
telomerase subcomponent, TERT, predicted sea urchin sequences 
homologous to TERT, Hsp90 and β-actin sequences in other species were 
found. The GenBank accession numbers for these were XM_001181282.1, 
XM_001188258.1 and XM_001188812.1 respectively. The accession 
numbers for the corresponding protein sequences were XP001181282.1, 
XP_001188258.1 and XP001188812.1 respectively. The reason why 
sequences from the American urple sea urchin genome were used was that 
the genome for the European purple sea urchin genome had not been fully 
sequenced and published. Multiple sequence alignments between these 
potential nucleotide and protein urchin sequences, and those from other 
vertebrate as well as invertebrate species, were created (chapter 2.6 above). 
The other nucleotide sequences used for alignment with sea urchin TERT 
were; zebrafish (NM_001083866.1), Japanese medaka (Oryzias latipes) 
(NM_001104816.1), chicken (Gallus gallus) (NM_001031007.1), brown rat 
(Rattus norvegicus) (NM_053423.1), and human (Homo sapiens) transcript 
variant 1 (NM_198253.2). The protein sequences used for alignment with sea 
urchin TERT were; zebrafish (NP_001077335.1), Japanese medaka 
(NP_001098286.1), chicken (NP_001026178.1), brown rat (NP_445875.1), 
and human isoform 1 (NP_937983.2). The nucleotide sequences used for 
alignment with sea urchin Hsp90 were; zebrafish (NM_131328.1), laboratory 
mouse (Mus musculus) (NM_010480.5), and human Hsp90 β 
(NM_007355.2). The protein sequences used for alignment with sea urchin 
Hsp90 were; zebrafish (NP_571403.1), laboratory mouse (NP_034610.1), and 
human Hsp90 β (NP_031381.2). The nucleotide sequences used for 
alignment with sea urchin β-actin were;  zebrafish (NM_131031.1), grey wolf 
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(Canis lupus) (NM_001003349.1) and rainbow trout (NM_001124235.1). The 
protein sequences used for alignment with sea urchin β-actin were;  zebrafish 
(NP_571106.1), grey wolf (NP001003349.1) and rainbow trout 
(NP_001117707.1). 
 
3.3.7.2 Oligonucleotide primer design – using predicted American sea 
urchin sequences – primer set 1 
 
The online computer program Primer3Plus was used to design 
oligonucleotide primers (chapter 2.7 above) intended to find and amplify the 
mRNA for the main telomerase subcomponent, TERT, -actin and Hsp90 in 
purple sea urchin, using the three predicted sequences from American purple 
sea urchin: TERT (XM_001181282.1), -actin (XM_001188812.1) and Hsp90 
(XM_001188258.1) (chapter 3.3.7.1 above and 3.4.7.1 below). The designed 
primers were expected to result in products ranging in size from 151 bp to 733 
bp (Table 7). 
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Table 7. Oligonucleotide primers designed to detect purple sea urchin 
TERT, -actin and Hsp90, based on published American purple sea 
urchin mRNA sequences with the accession numbers XM_001181282.1, 
001188812.1 and XM_001188258.1 respectively. 
Position Name of 
primer 
Sequence Product 
size 
Melting 
temperature, 
°C (TM) 
Sense TERT 1fp1 5´- TGGAGGGTTATTCACCGAAG -
3´ 
240 bp 57.3 
Anti-
sense 
TERT 1rp1 5´- CATCTGCAGTGGAGCTGGTA -
3´ 
 59.4 
Anti-
sense 
TERT 2fp2 5´- CCATCCCAAGAGGAATGAGA -
3´ 
151 bp 57.3 
Sense TERT 2rp2 5´- GACCTGCCATGGATCTGTCT -3´  59.4 
Anti-
sense 
Hsp90 1fp1 5´- ACCATGTCGACTGACACCAA -3´ 523 bp 57.3 
Sense Hsp90 1rp1 5´- TGTGGACAGTGAAGGAACCA -
3´ 
 57.3 
Anti-
sense 
Hsp90 2fp23 5´- ACCGGTGAAGATTGTCGAAC -
3´ 
733 bp 57.3 
Sense Hsp90 2rp24 5´- ATGGGGTAGCCAATGAACTG -
3´ 
 57.3 
Anti-
sense 
-actin fp1 5´- AAGGCAATCATTCCAAATGC -3´ 367 bp 59.4 
Sense -actin rp1 5´- CTGGATTGGCCACGTAAAAT -3´  61.4 
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3.3.7.3 Secondary identification of potential TERT, -actin and Hsp90 
gene sequences for sea urchin in public databases 
 
The primers designed to detect sea urchin TERT and Hsp90 from 
predicted sequences found in NCBI nucleotide databases (chapter 3.3.7.2 
above) were blasted against the database (method in chapter 2.6 above). No 
sequences of high homology were found, but this search revealed that the 
actual American purple sea urchin sequence had now been published 
(accession number NM_001129816). This sequence was aligned with the 
previous predicted American purple sea urchin sequence (XM_001181282) 
and furthermore, in order to establish what areas are most conserved in the 
TERT mRNA, the actual American purple sea urchin nucleotide and protein 
sequences were aligned with a selection of other invertebrate and vertebrate 
species. The vertebrate protein sequences used for alignment with sea urchin 
TERT were; zebrafish (NP_001077335.1), Japanese medaka 
(NP_001098286.1), chicken (NP_001026178.1), brown rat (NP_445875.1), 
and human isoform 1 (NP_937983.2) and isoform 2 (NP_937986.1). The 
vertebrate nucleotide sequences used for alignment with sea urchin TERT 
were; the zebrafish (Nm_001083866.1), Japanese medaka 
(NM_001104816.1), chicken (NM_001031007.1), brown rat (NM_053423.1), 
and human isoform 1 (NM_198253.2) and isoform 2 (NM_198255.2). 
 
3.3.7.4 Degenerate primer design – using the actual American sea 
urchin TERT sequence – primer set 2 
 
 A number of degenerate primers were designed to specifically identify 
and amplify European purple sea urchin TERT and Hsp90 (method in chapter 
0 above), and secondly for the creation of an optimized qPCR intended for 
quantitative analysis of TERT mRNA expression. The areas on the sequence 
chosen for the primers were those showing at least 60-70% similarity in the 
alignments created below (Figure 34 to Figure 36). The degenerate primers 
designed (Table 8) are marked on the previously created alignments for 
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visualization of where they are located on the American purple sea urchin 
sequence (Figure 34 to Figure 36). 
Of these forward primers two could be mixed with different reverse 
primers. FP3 and RP1 would be expected to yield a 726 bp product (+23 bp 
with tails). FP1 and RP2 would be expected to yield a 972 bp product (+23 bp 
with tails). These expected product sizes are based on the actual American 
purple sea urchin mRNA sequence (NM_001129816.1) and may be slightly 
different in the European purple sea urchin. 
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Table 8. Degenerate oligonucleotide primers designed to amplify 
European purple sea urchin TERT mRNA based on an alignment 
between the published American purple sea urchin mRNA sequence 
(NM_001129816.1) and a selection of vertebrates; zebrafish 
(NM_001083866.1), Japanese medaka (NM_001104816.1), chicken 
(NM_001031007.1), brown rat (NM_053423.1), and human isoform 1 
(NM_198253.2) and isoform 2 (NM_198255.2). The forward primers have 
an EcoRI tail was attached to their 5´ end (GCGCGGAATTC) and the 
reverse primers have a HindIII tail attached to the 5´ end 
(GCGCGCAAGCTT). The expected product size is based on the actual 
American purple sea urchin mRNA sequence (NM_001129816.1). 
Position Title Sequence Computed 
degeneracy 
Expected 
product 
size (+23 
bp w. tails) 
Melting 
temp., 
°C (TM) 
Sense Urchin 
TERT2 – 
FP1 
5´- EcoRI - 
GV'HTS'CGC'TTY'RTY'CCY'AA -3´ 
288  70.9 
Anti-
sense 
Urchin 
TERT2 – 
RP1 
5´- HindIII - 
RTC'HVY'CTT'NAC'AAA'GTA -3´ 
144 263 67.4 
Sense Urchin 
TERT2 – 
FP2 
5´- EcoRI - 
D'GGV'ATC'MSN'CAG'GGC'TC -3´ 
144  73.7 
Anti-
sense 
Urchin 
TERT2 – 
RP2 
5´- HindIII - 
HAD'RCC'RCA'CCA'BGG'RAA -3´ 
216 298 72.0 
Sense Urchin 
TERT2 – 
FP3 
5´- EcoRI - 
G'HTS'TAC'TTT'GTN'AAG'RBD'GA -3´ 
144  68.6 
Anti-
sense 
Urchin 
TERT2 – 
RP3 
5´- HindIII - 
CCA'GAC'ANN'TTB'CCG'RTA'GAA -3´ 
96 318 72.2 
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3.3.8 Search for purple sea urchin TERT and Hsp90 mRNA sequences 
using PCR 
 
Based on previous evidence of telomerase activity found in adult 
tissues of two other species of sea urchins, the Lytechinus variegates and the 
American red sea urchin (Francis et al., 2006), several tissue types from 
adults of the European purple sea urchin were sampled and total RNA 
extracted from them (chapter 2.4 above). These were intestinal walls, 
stomach, oesophagus, ampullae and female gonads. Adult sea urchins were 
also induced to spawn, with the resulting eggs fertilized and the embryos 
incubated for 48 hours until reaching the stage of pluteus larvae when 
samples were taken (chapter 2.1.1 above). The extracts were then used to 
make cDNA (chapter 0 above). 
Gene fragments were amplified by PCR in two phases, firstly using the 
following primer sets from Table 7: TERT 1fp1 and 1rp1, Hsp90 1fp1 and 
1rp1, and finally -actin fp1 and rp1 (chapter 2.8 above) and in the second 
phase using several different primer combinations (Table 9) whilst loading 8μl 
of PCR product on to the agarose gel for the gel electrophoresis in an attempt 
to increase the chances of visualization of any successfully amplified 
sequences, as opposed to the 5μl from the previous run. The PCR products 
were visualized as previously described (chapter 2.9 above) but failing to 
detect both TERT and Hsp90 from European purple sea urchin in several 
PCR runs. 
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Table 9. The oligonucleotide primer combinations used for the second 
phase of PCR in attempt to detect the sequences for TERT and Hsp90 
mRNA from the purple sea urchin. 
 Primer combination Sense Anti-Sense 
Purple sea urchin 
TERT 
T1 TERT 1fp1 TERT 1rp1 
 T2 TERT 1fp1 TERT 2rp2 
 T3 TERT 2fp2 TERT 1rp1 
 T4 TERT 2fp2 TERT 2rp2 
Purple sea urchin 
Hsp90 
H1 Hsp90 1fp1 Hsp90 1rp1 
 H2 Hsp90 1fp1 Hsp90 2rp24 
 H3 Hsp90 2fp23 Hsp90 1rp1 
 H4 Hsp90 2fp23 Hsp90 2rp24 
 
 
3.3.9 Search for purple sea urchin TERT and Hsp90 sequences – using 
touchdown PCR and degenerate primers 
 
A series of touchdown PCR procedures were used in an attempt to find 
and identify the actual TERT sequence from European purple sea urchin. The 
methodology is described in chapter 0 with annealing temperature gradient of 
the final touchdown PCR run  from 62ºC to 44.5ºC, with the final 10 cycles at 
60ºC. The primer combinations used were: a) urchin TERT2–FP1 and 
TERT2–RP1, b) urchin TERT2–FP2 and TERT2–RP2, c) urchin TERT2–FP3 
and TERT2–RP3 (Table 8). Four adult purple sea urchin tissue samples were 
used, from intestine, oesophagus and a female gonad, as well as pluteus 
larve cDNA. 
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A couple of the touchdown PCR runs resulted in the detection of a 
band of the approximate correct size but when these were repeated with the 
intent of producing a large enough quantity of PCR product in order to isolate 
the band and sequence it, none of the subsequent PCR runs performed 
resulted in a band of the correct size when visualised on an agarose gel. 
Attempts to match the primers previously used in a different manner in order 
to search for a larger PCR product were also performed. Primers TERT2 FP1 
and RP2 (Table 8) were matched which should yield a 972 bp product (+23 bp 
with tails) when based on the actual American purple sea urchin mRNA 
sequence (NM_001129816.1), although this may be slightly different in the 
European purple sea urchin. This procedure was, however, also 
unsuccessful, failing to yield a band during visualisation on agarose gel. At 
this stage the attempt to detect and isolate European purple sea urchin TERT 
mRNA sequence was abandoned.  
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3.4 Results 
 
3.4.1 Validation of the fluorescence readings of the Quantica qPCR 
Thermal Cycler 
 
In order to validate the functionality of this kit with the Quantica qPCR 
thermal cycler, as opposed to a fluorescence plate reader as is recommended 
in the manufacturers manual, several samples of purple sea urchin embryo 
extracts were amplified using the kit and the Quantica qPCR machine (see 
Materials and Methods chapter 3.3.1). As can be observed from Table 1 
(chapter 3.3.1) the fluorescence wavelengths detected by the qPCR Thermal 
Cycler cartridges are not identical to those recommended for the TRAPEZE
 
XL Telomerase Detection kit. In order to establish whether these wavelengths 
were still adequate for use in this assay, several samples of purple sea urchin 
embryo extracts were prepared and amplified as per chapter 3.3.1. The 
results are displayed in Figure 13 and Figure 14). 
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Figure 13. The excitation and emission spectrums of fluorescein. The 
vertical lines at 485 nm excitation and 520 nm emission display where 
the Quantica qPCR cartridge (SYBR) reads the fluorescence. 
 
 
Figure 14. The excitation and emission spectrums of sulforhodamine. 
The vertical lines at 580 nm excitation and 615 nm emission display 
where the Quantica qPCR cartridge (ROX) reads the fluorescence,. 
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When the excitation and emission spectrums of fluorescein and 
sulforhodamine are examined (Figure 13 and Figure 14) one can observe that 
the excitation and emission reading of the Quantica qPCR catridges is close 
to the peak of the excitation and emission spectrum of the two fluorescent 
labels used in this assay, fluorescein and sulforhodamine, without entering 
into the spectrum of the other label. From this it is clear that the fluorescence 
reading capability of the Quantica qPCR cartridges should be adequate for 
detection of the two fluorescent dyes used in the TRAPEZE
 XL Telomerase 
Detection kit from Chemicon International.  
 
 
3.4.2 Normal embryonic development of the purple sea urchin 
 
The normal development of purple sea urchin embryos was observed 
and imaged at regular intervals throughout their embryonic development. In 
the image series below, the purple sea urchins can be seen from the recently 
fertilized egg stage, with a raised fertilization membrane to a fully developed 
pluteus larvae (chapter 3.3.2 in Materials and Methods chapter) (Figure 15). 
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Figure 15. Normal embryonic development of European purple sea urchin in a 
freshwater control exposure, incubated at 15ºC. A) A newly fertilized egg with a 
raised ferilization membrane, B) embryo going through first division, C) 
embryo at a 2-cell stage, D) embryo at a 2-cell stage, E) embryo at a 4-cell 
stage, F) embryo at a 16-cell stage, G) embryo going through blastulation, H) 
embryo at a blastula stage, I) embryo going through gastrulation, J) embryo 
gradually reaching an intermediate prism stage, K) embryo at an intermediate 
prism stage, L) embryo at an intermediate prism stage, M) larval stage of 
pluteus, N) larval stage of pluteus. Images captured by light microscopy. 
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3.4.3 Telomerase activity in healthy purple sea urchin embryos 
 
Embryonic telomerase activity was examined using the TRAPEZE
® kit as 
described in chapter 3.3.3. These were plotted against a timescale (Figure 16) and 
tested for statistical significance.  
 
 
Figure 16. Telomerase activity (concentration of telomeric repeats 
AG(GGTTAG)7) extensions) in purple sea urchin embryo extracts from 5 pools 
of approximately 500 embryos, collected at various developmental stages: A) 
2-cell stage, B) gastrula, C) half way between gastrula and an intermediate 
‘prism’ stage, D) intermediate ‘prism’ stage. The animals were cultured in 
collected sea water with pH at 8.2 and salinity at 33.7, and incubated at 15ºC. 
Sample extract protein concentration was 0.05 mg protein/ml. Statistically 
significant differences are denoted by stars (*), p<0.05. 
 
 Telomerase activity gradually increases throughout the embryonic 
development, until it peaks somewhere between the stage of gastrula and that of the 
intermediate ‘prism’ stage, after which it declines (Figure 16). The telomerase activity 
is significantly low in the earliest stage tested, the two-cell stage, compared to the 
latter stages. The peak observed at gastrulation and the subsequent drop once 
‘prism’ stage has been reached is also significant (one-way ANOVA; F=4.10, 38 d.f., 
p<0.05). 
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3.4.4 Validation of the accuracy of the TRAPEZE
® kit used with the Quantica 
qPCR Thermal Cycler 
 
Telomerase activity in a dilution series of purple sea urchin embryo extracts 
was measured and the logarithm of one thousand part of the concentration of 8 
telomeric repeats AG(GGTTAG)7) extensions on the TS primers was plotted against 
the fluorescence index (see chapter 3.3.4 in Materials and Methods section).  
 
 
Figure 17. A dilution series plotting the logarithm of one thousand part of the 
concentration of 8 telomeric repeats AG(GGTTAG)7) extensions on the TS 
primers against the fluorescence index of the dilution series of various purple 
sea urchin embryonic developmental stages: A) 2-cell stage, B) gastrula, C) 
half way between gastrula and an intermediate ‘prism’ stage, D) intermediate 
‘prism’ stage. The animals were cultured in collected sea water with pH at 8.2 
and salinity at 33.7, and incubated at 15ºC. Trend line equation y = 1.2455x + 
2.2669. 
 
It is clear that the dilution series form a linear correlation (Figure 17), which 
means the telomerase activity detected is directly proportional to the concentration of 
telomeric repeats in our sample assay. This means that the TRAPEZE
 assay yields 
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quantitative results when used on purple sea urchin embryo extracts using the 
Quantica qPCR Thermal Cycler.  
 
3.4.5 The effect of different rinsing buffers on the telomerase activity in 
extracts from healthy purple sea urchin embryos 
 
In order to establish the best rinsing buffer used during sample extraction of 
sea urchin embryo, telomerase activity was measured in sample extracts where four 
different buffers were used (chapter 3.3.5 in Materials and Methods section). Mg2+ 
and Ca2+ free PBS PBS buffer (buffer D) was found to yield by far the greatest 
telomerase activity from these larval extracts (Figure 31) and buffer B the least. 
These differences were statistically significant (one-way ANOVA; F=4.13, 34 d.f., 
p<0.05). It is, however, worth noting that one cannot be entirely sure whether this is 
merely due to the difference in pH or the buffer compositions, further research would 
be needed in order to establish this.  
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Figure 18. Telomerase activity (concentration of 8 telomeric repeats 
AG(GGTTAG)7 extensions on the TS primers) in purple sea urchin pluteus 
larvae extracts made from pools of about 500 larvae and rinsed prior to lysis in 
the following buffers: A) TE-buffer, pH 7.7, B) physiosaline, pH 8.14, C) 
physiosaline, pH 7.7, and D) PBS, pH 7.34. Sample extract protein 
concentration was 4mg protein/ml. Statistically significant differences are 
denoted by stars (*), p<0.05. 
 
 
3.4.6 Purple sea urchin embryos exposed to E2 
 
3.4.6.1 E2 preliminary exposure – survival rates 
 
A preliminary exposure of purple sea urchin larvae to E2 was performed 
(chapter 3.3.6.1) where larval survival was observed in order to establish that the 
concentrations chosen for further exposures was sublethal. The concentration of the 
exposure chemical, E2, used for this survival study was 200 ng/ml. When the results 
are examined (Table 10) it is clear that neither the solvent control, nor the E2 
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exposure, causes a significant increase in mortality during the early stages of 
development of purple sea urchins (two-way ANOVA; Finteraction=0.133, 4 d.f., 
P=0.97). This E2 concentration is therefore appropriate for the study of sub-lethal 
effects of this chemical, such as the possible effect on telomerase activity. 
 
Table 10. Observed mortality, or survival rates, of purple sea urchin pluteus 
larvae exposed to 200 ng/L E2 and a 0.05 % EtOH solvent control, for 48 hours. 
Average density of larvae was 35 larvae/ mL, n = 13. 
 Control  0,05 % EtOH 200ng/L E2 
Time 
(Hours) 
Number 
of 
embryos 
Standard 
deviation 
Number 
of 
embryos 
Standard 
deviation 
Number 
of 
embryos 
Standard 
deviation 
0 110 2,588689 112 4,064949 129 4,645097 
24 109 2,711527 108 4,178175 123 4,254711 
46 106 2,685056 104 4,109223 122 4,646476 
 
 
3.4.6.2 E2 preliminary exposure 
 
In order to establish how much telomerase activity can be modified by the 
steroid hormone E2 during the embryonic development of purple sea urchins, 
embryos were exposed to two concentrations of E2; 200 and 20 ng E2/ml (see 
section 3.3.6.2). The results show that no significant difference is observed in 
telomerase activity between the two controls; sea water control and 0.05% EtOH 
control (two-way ANOVA; F=3.81, 48 d.f., P>0.05) (Figure 19). Exposing the 
embryos to E2 at the concentration of both 20 and 200 ng/ml, did however yield a 
significant increase in telomerase activity (two-way ANOVA for 200 ng E2/ml; 
F=423.35, 48 d.f., p<0.05; two-way ANOVA for 20 ng E2/ml; F=264.07, 48 d.f., 
p<0.05) at several timepoints. These were timepoints A (2 h), a multi-cell stage, D 
(28 h), half-way between gastrula and an intermediate ‘prism’ stage, E, (34 h), 
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intermediate ‘prism’ stage - early, H (48 h), fully developed pluteus. No dilution 
difference could, however, be detected between the two E2 concentrations (two-way 
ANOVA; F=0.13, 48 d.f., p>0.05) which suggests that even below lethal 
concentration a capping of effects exhibits itself beyond a certain concentration, 
perhaps due to saturation. These results show that telomerase activity can be 
modulated in purple sea urchin embryos by the steroid hormone E2. 
 
 
Figure 19. Telomerase activity (concentration of 8 telomeric repeats 
AG(GGTTAG)7 extensions on the TS primers) in purple sea urchin pluteus 
embryos exposed to two concentrations of E2 (200 and 20 ng E2/ml). Pools of 
approximately 500 embryos were sampled at various time points throughout 
their embryonic development, from a multi-cell stage to pluteus larvae, The 
analysis was performed at a protein concentration 0.034 mg protein/ml. The 
sampling points were A) multi-cell stage, B) blastula, C) gastrulation, D) half-
way between gastrula and an intermediate ‘prism’ stage, E) intermediate 
‘prism’ stage - early, F) intermediate ‘prism’ stage – late, G) nearly fully 
developed pluteus, H) fully developed pluteus. Statistically significant 
differences are denoted by stars (*), p<0.05. 
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3.4.6.3 E2 secondary exposure 
 
A secondary exposure study was performed exposing purple sea urchin 
embryos to lower concentrations of E2; 20 and 2 ng E2/ml. When the results are 
examined, it is clear that the higher of the two E2 concentrations, 20 ng E2/ml, is 
significantly teratogenic (Figure 20). The number of larvae exhibiting inhibited or 
pathological development rose from less than 10% in the controls to approximately 
20% in the 20 ng E2/ml exposure (one-way ANOVA: F=4.10, 39 d.f., p<0.05). No 
significant teratogenicity was observed in the 2 ng E2/ml exposure. Considerable 
number of larvae from the AZT exposure exhibited inhibited and pathological 
development, but the variability between replicates was too great for this to be 
significant. 
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Figure 20. Differential counts of sea urchin embryos exposed to two 
concentrations of E2; 20 and 2 ng/ml, and a telomerase inhibitor, AZT at 100 μM 
concentraion. 0.05% EtOH was used as solvent control. The dotted bar 
represents the percentage of larvae that exhibit normal development. The 
white bar represents the percentage of larvae that exhibit inhibited 
development. The striped bar represets the percentage of larvae that exhipit 
pathological development; the presence of developmental defects. Each bar 
represents average counts from 5 replicates. Statistically significant 
differences are denoted by stars (*), p<0.05 
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Figure 21. Two examples of fixed pluteus larvae displaying pathological 
development of the arms. 
 
During the analysis of the sample extracts with the TRAPEZE
® kit, several of 
the analysis runs failed. The only successful runs were those sampled at time point 
24h, at the gastrula embryonic developmental stage. The results from these runs 
show that the higher concentration of E2, 20 ng/ml, seems to significantly increase 
telomerase activity in the exposed embryos, whereas the lower concentration of 2 
ng/ml E2 seems to have no effect (Figure 22) (one-way ANOVA; F=4.30, 23 d.f., 
p<0.05). The telomerase inhibitor, AZT, seems to reverse the effect to a level apar to 
that of the control, which suggests that the telomerase activity in the controls is well 
below the detection level of this assay. Furthermore, when the following results are 
examined, it is clear that the concentration of telomeric repeats AG(GGTTAG)7) 
extensions (amole/Rx), is extremely low compared to that in the preliminary 
exposure (Figure 19). From this one might conclude that there is hardly any 
telomerase activity detected in any of these samples. Taking that into account as 
well as the analysis runs for the other sample times failed, the efficacy and 
reproducibility of this assay must be called into question. 
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Figure 22. The concentration of telomeric repeats AG(GGTTAG)7) extensions 
in purple sea urchin embryos after 24 hours of exposure to two concentrations 
of E2, 2 and 20 ng E2/ml, and a telomerase inhibitor AZT at 100 M. Statistically 
significant differences are denoted by stars (*), p<0.05. 
 
Several attempts at troubleshooting the TRAPEZE procedure were performed. 
Different TRAPezeXL kits were ordered and different types and batches of Taq 
polymerase were used. A complete overhaul, calibration and sterilization of all work 
surfaces and equipment was performed, and different thermal cyclers and 
fluorescent readers used. It was clear that this procedure was not functioning, 
seemingly because of failure of PCR to initiate. A decision was therefore made to 
abandon this procedure and move on with different telomerase detection methods. 
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3.4.7 Identification and characterisation of P. lividus TERT mRNA 
 
3.4.7.1 Initial identification of potential TERT, -actin and Hsp90 gene 
sequences for sea urchin in public databases 
 
In preparation for examination of the RNA expression of the main telomerase 
subcomponent, TERT, a search for American purple sea urchin TERT, Hsp90 and β-
actin sequences was conducted (chapter 3.3.7.1 above). At the time when the work 
for this part of the thesis began, only predicted sequences for the American purple 
sea urchin TERT, Hsp90 and -actin had been published (Figure 23 to Figure 24). 
These aligned well with published sequences of other deuterostomes. The overall 
percentage homology for the nucleotide aligments for TERT, Hsp90 and -actin were 
58.21%, 73.52%, and 72.6% respectively (Figure 26, Figure 30 and Figure 28).  
Analysis for the corresponding protein sequences (Figure 27, Figure 31 and Figure 
29) showed an overall percentage homology of 35.55%, 80.26% and 71.70% 
respectively.   
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Figure 23. Predicted American purple sea urchin mRNA sequence for TERT 
(GenBank accession number XM_001181282.1).  
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Figure 24. Predicted American purple sea urchin mRNA sequence for Hsp90 
(GenBank accession number XM_001188258.1).  
 
 
Figure 25. Predicted American purple sea urchin mRNA sequence for -actin 
(GenBank accession number XM_001188812.1).  
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Figure 26. Nucleotide sequence aligment between the predicted American 
purple sea urchin TERT nucleotide sequence (XM_001181282.1) and those of 
other deuterostome species: zebrafish (NM_001083866.1), Japanese medaka 
(NM_001104816.1), chicken (NM_001031007.1), brown rat (NM_053423.1), and 
human transcript variant 1 (NM_198253.2). The black shading represent 100% 
similarity. For the full length alignment, see figure A.4.4 in the Appendix. 
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Figure 27. An alignment of the predicted protein sequences for American 
purple sea urchin TERT (XP001181282.1) and those of other deuterostome 
species: zebrafish (NP_001077335.1),  Japanese medaka (NP_001098286.1), 
chicken (NP_001026178.1), brown rat (NP_445875.1), and human isoform 1 
(NP_937983.2). The black shading represent 100% similarity. For the full length 
alignment, see figure A.4.5 in the Appendix. 
 
 126 
 
 
Figure 28. A nucleotide alignment between the predicted American purple sea 
urchin Hsp90 nucleotide sequence (XM_001188258.1) and those of other 
deuterostome species: zebrafish (NM_131328.1), laboratory mouse 
(NM_010480.5), and human Hsp90 β (NM_007355.2). The black shading 
represent 100% similarity. For the full length alignment, see figure A.4.8 in the 
Appendix. 
 
 
 127 
 
Figure 29. An alignment of the predicted American purple sea urchin Hsp90 
protein sequence (XP_001188258.1) and those of other deuterostome species: 
zebrafish (NP_571403.1), laboratory mouse (NP_034610.1), and human Hsp90 β 
(NP_031381.2). The black shading represent 100% similarity. For the full length 
alignment, see figure A.4.9 in the Appendix. 
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Figure 30. Nucleotide sequence aligment between the predicted American 
purple sea urchin -actin nucleotide sequence (XM_001188812.1) and those of 
other deuterostome species: zebrafish (NM_131031.1), grey wolf 
(NM_001003349.1) and rainbow trout (NM_001124235.1). The black shading 
represent 100% similarity. For the full length alignment, see figure A.4.6 in the 
Appendix. 
 
 
 
Figure 31. An alignment of the predicted American purple sea urchin -actin 
protein sequence (XP001188812.1) and those of other deuterostome species: 
zebrafish (NP_571106.1), grey wolf (NP001003349.1) and rainbow trout 
(NP_001117707.1). The black shading represent 100% similarity. For the full 
length alignment, see figure A.4.7 in the Appendix. 
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3.4.7.2 Secondary identification of potential TERT, -actin and Hsp90 gene 
sequences for sea urchin in public databases 
 
 With the actual TERT sequence for American purple sea urchin published 
(GeneBank accession number NM_001129816), this was aligned with the previous 
predicted sequence (accession number XM_001181282.1) (chapters 2.6 and 3.4.7.1 
above). It is clear from the alignment that the two sequences are somewhat different 
(Figure 32), with 93.73% homology and base-pair differences occurring in some of 
the primer locations. When the alignment is examined it is clear that the previously 
designed primers (Table 7)  were a poor fit for the actual American purple sea urchin 
TERT sequence and as such likely to be a poor fit for the European purple sea 
urchin TERT sequence. And the primer combination TERT 2fp2 and 1rp1 would 
clearly not work as the reverse primer is located in front of the forward primer on the 
sequence. 
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Figure 32. Nucleotide alignment between the two American purple sea urchin 
TERT sequences, the new TERT sequence (NM_001129816) and the previous 
‘predicted’ sequence (XM_001181282.1). The oligonucleotide primers marked 
by the red and blue lines represent the primers designed from the ‘predicted’ 
sequence (Table 7) that failed to detect TERT in purple sea urchin tissue 
samples. The black shading represent 100% similarity. 
 
 In order to establish what areas are most conserved in the TERT mRNA, 
another set of alignments was performed, this time between the protein sequence of 
the American purple sea urchin TERT and those of a selection of other invertebrate 
and vertebrate species (chapters 2.6 and 0 above). The urchin sequence aligned far 
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better with the vertebrate sequences than it did with invertebrate sequences, which 
is perhaps not unsurprising as sea urchins belong to the superphylum of 
deuterostomia just like vertebrates (Figure 33). The overall homology of the 
alignment is only 40% but there are several highly conserved regions. These regions 
were further examined by looking at an alignment of the corresponding nucleotide 
sequences. Three highly conserved regions of this alignment (Figure 34, Figure 35 
and Figure 36) were used to design degenerate primers (Table 8).  
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Figure 33. A highly conserved section of the TERT protein visualized in an 
alignment between the American purple sea urchin (NP_001123288.1) and a 
selection of vertebrates; the zebrafish (NP_001077335.1), Japanese medaka 
(NP_001098286.1), chicken (NP_001026178.1), brown rat (NP_445875.1), and 
human isoform 1 (NP_937983.2) and isoform 2 (NP_937986.1). The blue, green 
and red lines mark the degenerate oligonucleotide primers designed in chapter 
3.3.7.4 to detect purple sea urchin tert (blue: urchin TERT2 – FP3 and RP3, 
green: urchin TERT2 – FP1 and RP1, red: urchin TERT2 - FP2 and RP2). The 
black shading represents 100% similarity. 
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Figure 34. A highly conserved section of the TERT mRNA visualized in an 
alignment between the American purple sea urchin (NM_001129816.1) and a 
selection of vertebrates; zebrafish (Nm_001083866.1), Japanese medaka 
(NM_001104816.1), chicken (NM_001031007.1), brown rat (NM_053423.1), and 
human isoform 1 (NM_198253.2) and isoform 2 (NM_198255.2). The blue lines 
mark the degenerate oligonucleotide primer pair urchin TERT2 – FP3 and RP3 
designed in chapter 3.3.7.4. The black shading represents 100% similarity. 
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Figure 35. A highly conserved section of the TERT mRNA visualized in an 
alignment between the American purple sea urchin (NM_001129816.1) and a 
selection of vertebrates; zebrafish (Nm_001083866.1), Japanese medaka 
(NM_001104816.1), chicken (NM_001031007.1), brown rat (NM_053423.1), and 
human isoform 1 (NM_198253.2) and isoform 2 (NM_198255.2). The green lines 
mark the degenerate oligonucleotide primer pair urchin TERT2 – FP1 and RP1 
designed in chapter 3.3.7.4. The black shading represents 100% similarity.  
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Figure 36. A highly conserved section of the TERT mRNA visualized in an 
alignment between the American purple sea urchin (NM_001129816.1) and a 
selection of vertebrates; zebrafish (Nm_001083866.1), Japanese medaka 
(NM_001104816.1), chicken (NM_001031007.1), brown rat (NM_053423.1), and 
human isoform 1 (NM_198253.2) and isoform 2 (NM_198255.2). The green lines 
mark the degenerate oligonucleotide primer pair urchin TERT2 - FP2 and RP2 
designed in chapter 3.3.7.4. The black shading represents 100% similarity.  
 
3.4.8 Search for purple sea urchin TERT, β-actin and Hsp90 mRNA sequences 
using PCR 
 
In an attempt to isolate TERT, β-actin and Hsp90 mRNA sequences from 
European purple sea urchin samples, several PCR runs were performed (chapter 
3.3.8 above) using primer set 1 (Table 7). When the PCR products were visualized 
on an agarose gel, no bands were detected for either the purple sea urchin TERT or 
purple sea urchin Hsp90. The -actin mRNA was, however, easily found (Figure 37) 
indicating that the mRNA had been successfully extracted and converted to cDNA. 
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Figure 37. The results from the agarose gel electrophoresis of the PCR 
products derived from using oligonucleotide primers designed to amplify 
TERT, -actin and Hsp90 mRNA from adult purple sea urchin tissue samples.  
Five microlitres of each sample and ladder were loaded on the gel. 
 
 
3.4.9 Search for purple sea urchin TERT and Hsp90 mRNA sequences using 
touchdown PCR and degenerate primers 
 
 A variation of the standard PCR procedure, touchdown PCR, was used in an 
attempt to detect TERT in European purple sea urchin samples (chapter 3.3.9 
above). A series of PCR runs was performed using adult purple sea urchin intestinal 
samples, oesophagus samples and female gonad samles as well as 48 h pluteus 
larvae samples, and primer combination no 2, TERT2 – FW/RV2 (Table 9).  
Visualization of the PCR products on agarose gel resulted in the detection of one 
smeared band in two adult intestinal samples at approximately 300 bp (sample D in 
Figure 38). This band was of the correct size, for the expected product size of this 
primer combination is 321 bp (298 bp product + 23 bp with EcoRI and HindIII tails). 
All subsequent touchdown PCR replications intended for band extraction and 
sequence isolation did however fail to reproduce this band. 
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Figure 38. The results from the agarose gel electrophoresis of the Touchdown 
PCR products derived from using degenerate oligonucleotide primers 
designed to detect tert mRNA from adult purple sea urchin samples. 5μl of 
each sample and 5μl of a 100 bp ladder were loaded on the gel. A) Adult purple 
sea urchin female gonad. B) Adult purple sea urchin oesophagus sample C) 
Adult purple sea urchin intestinal sample no 1. D) Adult purple sea urchin 
intestine sample no 2. The degenerate primer combination used was TERT 2 - 
FW/RV2. 
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3.5 Discussion 
 
The scientific community is greatly concerned with the high occurrence of 
endocrine disruptors in the environment, as well as the effects these are known to 
have on the exposed ecosystems as well as humans that come into close contact 
with these, and the possible unknown effects these chemicals might have. The study 
detailed in this chapter was intended as means to further examine the effects 
oestrogenic pollutants may have on telomerase activity specifically, and the 
consequences this might have on embryonic development, by using deuterostome 
invertebrate model (European purple sea urchin). It is important not to forget the 
invertebrates when examining environmental pollution for they make up 
approximately 95% of the known species in the animal kingdom (Oehlmann and 
Schulte-Oehlmann, 2003) and are therefore essential to global bio-diversity as well 
as ecosystem structure and function. Had this study succeeded it would have 
allowed us to examine any similarities and or differences that might exist between 
the action of these pollutants in vertebrates and invertebrates as well as detailed 
whether the concentrations found in the environment are capable of leading to 
drastic developmental interruption. We had hoped we might have been able to 
provide a better understanding of the basic molecular processes involved in telomere 
maintenance and telomerase activation in both vertebrates and invertebrates. 
Another issue to be noted is that telomerase plays a vital role in carcinogenesis 
(Bryan et al., 1995), and the fact that it is sensitive to oestrogens may suggest a vital 
role in oestrogen-responsive cancers. 
The first objective of this study was to examine the effects of an 
environmental oestrogen, E2, on telomerase activity in the embryonic stages of the 
purple sea urchin, and to see whether it correlates with a disruption of embryo 
development. The results show that telomerase activity can clearly be modulated by 
E2 at high exposure concentrations (Desbrow et al., 1998), which could potentially 
have serious consequences on embryonic development, leading to a cascade 
effects on an organizational level. This corresponds with that observed in human cell 
lines, such as ovary epithelium cells where both telomerase activity and TERT 
expression is induced by E2 (Misiti et al., 2000). The same has been described in 
other cell lines, such as endometrial cancer cells, where the process has been 
shown to be ER-dependent (Boggess et al., 2006). When the results from the 
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preliminary purple sea urchin exposure are examined (Figure 19) one can see that 
telomerase activity is present throughout the embryonic development of purple sea 
urchins, but it peaks at two time-points; firstly at gastrulation and then secondly when 
the embryos are developing from the intermediate ‘prism’ stage to that of pluteus 
larvae. These are developmental stages where great amount of cell differentiation 
and division takes place. This is different from what is observed in Xenopus 
embryogenesis, where telomerase activity is present throughout embryonic 
development but is lowest in late-stage gastrula (Mantell and Greider, 1994). The 
aforementioned peak in telomerase activity in sea urchin embryos is slightly 
hastened when exposed to E2, suggesting a possible induction in cellular 
proliferation allowing for hastening of the developmental process. E2 is known to 
induce cellular proliferation in several cell types, e.g. granulosa cells in the rat ovary 
and in breast cancer cells (Mrinalini et al., 1978; Pattarozzi et al., 2008). It is 
therefore possible that cellular proliferation is induced in these sea urchin embryos, 
but further research would need to be performed in order to establish whether this is 
indeed the case. The main findings of this work is that throughout the embryonic 
development, the telomerase activity is significantly increased in the presence of E2 
and that early life-stages of sea urchins are sensitive to oestrogens, exhibiting similar 
transcriptional relationship between telomerase and oestrogenic chemials as have 
been demonstrated in humans (Li et al., 2010). An ERR has been cloned from the 
American purple sea urchin  (Sodergren et al., 2006) which has been shown to 
respond to both oestrogens and androgens. It is possible that the telomerase 
induction observed in this study is mediated via such a receptor. The results from 
secondary embryo exposure were limited. A clear morphological response to E2 is 
observed with pluteus larvae exposed to 20 ng E2/ml displaying significant increase 
in developmental defects. This corresponds to previous findings in another species 
of sea urchin, the white sea urchin (Lytechinus anamesus), where E2 induced 
developmental defects at similar concentrations. The study, conducted by Roepke 
and colleagues (2005), established that the blastula stage was most sensitive to 
exposure to E2, pluteus most sensitive to DDD (dichlorodiphenyldichloroethane) 
exposure and that pluteus and blastula were equally sensitive to TBT. In the 
experiments performed for this thesis the urchin embryos were exposed to E2 
throughout this most sensitive stage, blastulation. E2 is highly genotoxic at high 
concentrations (Miller et al., 2003), which may explain the increased telomerase 
activity observed in the exposed animals, for telomerase has a function in DNA 
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repair (Chico et al., 2011). Studies on molluscs and sea urchins have shown that 
marine invertebrates express similar types of chemical-induced damage as is 
observed in various vertebrates. These include DNA strand breaks and chromosome 
aberrations (Dixon et al., 2002). The TERT promoter region in humans has been 
shown to contain a degenerate ERE which specifically binds to the ER. Studies have 
shown that when oestrogen-activated ER binds to this element it leads directly to 
transcriptional activation (Kyo, Takakura et al, 1999). With a similar response evident 
in sea urchins it is clear that they are suitable deuterostome invertebrate 
comparative model for telomerase modulation.  
The TRAPEZE kit used for the detection of telomerase activity ceased to work 
at a critical stage in this study. It would be interesting to map the time-dependent 
effects of E2 to more detail, by focusing on more frequent sampling in the first 48 
hours where a lot of differentiation occurs. Another avenue of research would be to 
explore responses to other oestrogenic chemicals to see whether telomerase activity 
responds in a similar way. This might further our understanding into the mechanisms 
by which oestrogen modulates telomerase in sea urchins.  
 The second objective of this study was to identify and characterize the 
TERT mRNA sequence from European purple sea urchins and subsequently to 
design an optimized qPCR assay intended for the quantification of purple sea urchin 
TERT mRNA for use in exposure studies. This study did however fail to yield any 
results due to lack of success of identifying the actual TERT mRNA sequence. 
Working with the sequenced genome of another sea urchin, the American purple sea 
urchin, failed to provide us with sufficient information to be able to design primers 
appropriate for the task. This work was therefore suspended, with the hope that 
more information might become available at a later date. Should the purple sea 
urchin genome sequence become available, this task should prove far easier. Since 
having abandoned this line of research, a yet another sequence for American purple 
sea urchin tert mRNA has been published and identified as a long splice variant, 
coding for a short isoform of the TERT mRNA sequence (NCBI accession number 
NM_001172051) whereas the previously published sequence is now identified as a 
short splice variant coding for a short isoform of telomerase reverse transcriptase 
(NM_001129816.1). Furthermore, in the years since this work was performed, 
significant improvements in sequencing technology have taken place, with high-
throughput sequencing more available and affordable than a few years ago. 
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Acquiring the entire transcriptome for a species is now a viable option, which would 
make this work far more plausible and likely to succeed. What must also be noted is 
that since the work for his study was performed, further information on the gene 
sequences of sea urchin TERT has become available. A recent publication by Wells 
and colleagues (2009) showed that a significant amount of hypervariability exists in 
its gene sequence in these animals. Two paralogues of the gene sequence exist 
within its genome, sequences that are differentially expressed throughout 
embryogenesis, as well as several novel domains. There exists an extremely high 
hypervariability between individuals as well which suggests that sea urchins may be 
in a state of evolutionary diversity generation. These two paralogues differ by 
approximately 90 amino acids (a.a.), most of which occurred in the region of exon 11 
which includes the RT motifs. Small changes were also present in the TEN domain. 
Despite this, the shorter variant remained active, if slightly less so than the full length 
one. When such variability exists within one species, one might expect even greater 
variability to exist between sea urchin species. It is highly likely that the two species 
differ significantly in their gene sequences, despite homology with other 
deuterostomes. This indicates that using oligonucleotide primers designed using 
gene sequences from a related species, is highly unlikely to successfully amplify 
sequences from another species for TERT. 
 
   
Conclusion 
 
 The work in this study failed to identify and characterize the TERT mRNA 
sequence from the European purple sea urchin and as such was unable to provide 
an optimized qPCR assay for the specific amplification of these in test samples. With 
sequencing technology having greatly progressed in the years since this work was 
conducted, this task might prove far easier and could be repeated, provided the 
initial step would be the mapping of the complete transcriptome from purple sea 
urchin. It would provide an interesting model for telomerase study, a deuterostome 
invertebrate animal model readily accessible to researchers in Europe, and suitable 
for comparative work with the rapidly progressing field of vertebrate telomerase 
research. 
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4 Isolation and characterization of the telomerase 
catalytic subunit, TERT, in rainbow trout 
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4.1 Introduction 
 
4.1.1 Telomerase in teleost fish: Rainbow trout 
 
The teleost salmonid rainbow trout is a freshwater species or in some cases 
anadromous (Steelhead), native to Asia and North America. It has been widely 
introduced across the world due to its popularity in sport fishing and aquaculture and 
does therefore now have a global distribution stretching across all the continents 
except Antarctica. Due to its global distribution and use in aquaculture it is widely 
available to the international research community. It is also relatively inexpensive to 
maintain, and has early-life sensitivity to various chemicals, including many high-
profile carcinogens (Bailey et al., 1987, Bailey et al., 1996). It has furthermore been 
shown to have a high level of similarity to mammals in many metabolic processes 
(Bailey et al., 1987, Bailey et al., 1996). It is a low-cost model, allowing for low-dose 
response queries, yielding results comparable to that of mammals, and has therefore 
been used as a research model for various biological processes such as 
carcinogenesis and toxicity responsiveness for many years.    
The TERT genes have been found and identified in a number of fish species, 
including the teleost fish species Japanese pufferfish (Fugu rubripes) (Yap et al, 
2005), Japanese medaka and zebrafish (Lau et al, 2008), but it has yet to be 
identified and fully sequenced in rainbow trout. However, at the time of this study, 
sequences homologous with the TERT sequences of other vertebrates had been 
published. In addition studies have established that the telomere DNA sequence at 
the end of chromosomes is made up of the same tandem repeats as those in 
humans, (TTAGGG)n (Abuín et al., 1996). Some research has been performed on 
telomerase expression in rainbow trout; telomerase activity has been detected in 
eyed embryos of rainbow trout (Yoda et al., 2002) as well as several adult tissues; 
kidney, liver, skin, heart, muscle and brain (Klapper et al., 1998). Somatic expression 
of telomerase is well documented in aquatic vertebrates, excluding mammals. In 
Japanese medaka, telomerase activity is detectable at high levels in adult gill, liver 
and gut tissues as well as 10-day old fry and juveniles (Elmore et al., 2008) and in 
zebrafish telomerase activity has been detected in adult retina (Lau et al, 2007). 
Ubiquitous telomerase activity has furthermore been detected in the tissues of little 
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skate (Raja erinacea), dogfish shark (Squalus acanthias), mackerel (Scomber 
scombrus), and killifish (Fundulus heteroclitus) (Elmore et al., 2008). The presence 
of detectable telomerase activity in adult somatic tissues in these animals indicates 
that telomerase may play a role in mechanisms other than those directly affecting 
telomere maintenance. It has been suggested that the lack of telomerase 
suppression in the adult tissues of many aquatic species is related to longevity 
(Klapper et al., 1998), however, others have shown that somatic telomerase 
expression exists in both long-lived and short-lived animals and have suggested that 
the reason for somatic expression may instead be related to their great capacity for 
tissue regeneration. Elmore and colleagues (2008) examined telomerase activity in 
caudal fin tissues removed from three species of fish; killifish, Japanese medaka, 
and zebrafish. Telomerase activity was increased as these tissues were allowed to 
regenerate whilst telomeres were maintained in most of the fish examined. At the 
same time, the expression of the molecular chaperone, Hsp90, known to regulate 
telomerase function, was also elevated. This indicates that telomerase plays a role in 
tissue regeneration by maintaining the telomeres during rapid cellular proliferation 
and preventing early senescence. Further studies support the theory that telomerase 
plays such a role. When TERT expression is induced in human somatic progenitor 
cells, telomerase activity is subsequently induced and the regenerative activity of the 
cells enhanced, leading to a delay in senescence (Murasawa et al., 2002). 
One of the main animal models used for comparative study is the laboratory 
mouse, but the telomeres in inbred mice used for molecular research are much 
longer than those in humans, whereas in many fish the telomeres are of a similar 
length. Studies have suggested that the function and regulation of the mouse 
telomere system is extremely complex (Prowse and Greider, 1995; Blasco et al., 
1997; Lee et al., 1998; Kishi et al., 2002). A development of an alternative animal 
models for the study of telomerase and its function, would allow for a wider range of 
study and greater animal replacement potential, which would fit in with the current 
accepted principles of humane experimental technique (Flecknell, 2002).  
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4.1.2 TERT and alternative splicing 
 
Alternative splicing is a process which plays a vital role in gene expression, 
allowing for a single gene to code for many proteins (isoforms) and therefore greatly 
increasing the proteomic biodiversity (Stamm et al., 2005; Kelemen et al., 2013). 
Johnson and coworkers (2002) performed microarray experiments and concluded 
that up to 74% of all human genes are alternatively spliced. Several isoforms of the 
telomerase reverse transcriptase, TERT, have been identified; a few examples are in 
human where eight isoforms have been identified (Ulaner et al., 1998; Hrdlickova et 
al., 2012b), six in chicken (Hrdlickova et al., 2012b) and five in the Japanese medaka 
(Pfennig et al, 2008, Rao et al., 2011). There is an indication that alternative splicing 
plays a vital role in the regulation of telomerase activity, some have suggested that 
telomerase is modulated post-transcriptionally with alternative splicing with full length 
tert transcripts necessary for telomerase to be active (Krams et al, 2001). Alternative 
splicing in human tert produces mRNA sequences lacking some vital reverse 
transcriptase motifs (Ulaner et al, 2000). This seems to occur in both normal and 
neoplastic cells, which suggests that this posttranscriptional control may often be lost 
in malignancy. In chicken, normal T cells have high proportion of in-frame splice 
variants resulting in non-functional tert isoforms. But in lymphomagenesis in chicken 
telomerase is upregulated by changing the pattern of posttranscriptional splicing; the 
proportion of constitutively spliced tert variants is increased and in-frame variants are 
replaced with nonsense mediated decay-targeted variants (Amor et al, 2010). 
Another animal model where alternative splicing has been identified, is the dog 
(Canis familiaris), where varied combinations of two insertions and two deletions 
result in the formation of five different transcripts. The two deletions, occurring on 
Exon 8, were due to alternative splicing. All of the five variants resulted in truncated, 
nonfunctional proteins that lacked reverse transcriptase motifs (Angelopoulou et al., 
2008). There are therefore many indications that alternative splicing plays an 
important role in telomerase modulation across various phyla. In Japanese medaka, 
five isoforms have been identified, four of which are truncated versions of the full 
length one and are differentially expressed through cell differentiation. Medaka 
variant TERTa is ubiquitously expressed in adult tissues and throughout embryo 
development. Splice variants TERTc and TERTd are only expressed during cell 
differentiation. Variant TERTb is only expressed in testis in adults and in embryos it 
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is not expressed until gastrulation, TERTe, however, is only expressed in embryos 
(Rao et al, 2011). This apparent variability in medaka telomerase system and the low 
expression of the truncated variants suggess that alternative splicing plays a role in 
cellular potency. This furthermore suggests that teleost fish may be a good model for 
the exploration of telomerase modulation and any potential alternative functions.  
 
 
4.2 Aims and objectives 
 
The main objective of this study was to firstly isolate and characterize the 
mRNA sequence for the telomerase catalytic subunit, TERT, in the rainbow trout, 
which so far had not been identified. Once accomplished, the second objective was 
to develop a quantitative qPCR assay for this gene to be used for oestrogenic 
exposure studies, mainly focused on establishing whether oestrogenic chemicals 
can modulate the RNA expression of TERT. 
The first step was to identify any potential TERT sequences in public 
databases, and to compare them to known TERT sequences from other vertebrate 
species, mainly other fish. With oligonucleotide primers designed based on these 
sequences, the rainbow trout sequence could be isolated, and sequenced. This 
would be an important step in the universal mapping of telomerase conservation and 
expression amongst the vertebrate phyla.  
The second step was to design and optimize a qPCR assay for the relative 
quantification of TERT expression in embryonic, larval and fry samples exposed to 
oestogenic compounds. In order to do that oligonucleotide quantitative PCR primers 
needed to be designed to be used for a series of qPCR optimization steps. Once 
finished, this can be used as a tool for the exploration of how TERT specifically, and 
telomerase as a whole, is modulated in a model teleost fish species under exposure 
conditions. It may also further our understanding of how telomerase is modulated in 
vertebrates in general, including humans, and possibly provide a useable bioassay 
for the examination of oestrogenic environmental disturbance. It is our hope that this 
research might throw a light on the workings of the molecular processes involving 
telomerase and its function in vertebrates. 
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4.3 Materials and Methods 
 
4.3.1 Isolation and characterization of rainbow trout TERT 
 
4.3.1.1 Identification of potential TERT gene sequences for rainbow trout in 
public databases 
 
In preparation for examination of the RNA expression of the main telomerase 
subcomponent, TERT, in rainbow trout embryos, the NCBI gene and protein 
databases were screened for the presence of rainbow trout sequences, homologous 
to TERT sequences in other species. The TERT nucleotide sequences from other fish 
species was used to identify a homologous trout sequence from the NCBI GenBank 
database. These were the TERT nucleotide sequences from zebrafish (NCBI 
GenBank accession number NM_001083866.1) and Japanese medaka 
(NM_001104816.1). Two homologous trout sequences were found, CX246542.1 and 
CA 353864.1. 
The TERT nucleotide sequences from various fish species was used to 
identify homologous trout sequences from another genomic database, cGRASP, 
these were amongst others the TERT protein sequences from zebrafish 
(NP_001077335.1), and Japanese medaka (NP_001098286.1). Ten further 
homologous sequences of rainbow trout TERT were found; Their accession numbers 
were: BX889962.3, CA380121.1, BX088059.3, BX315053.3, BX882610.3, 
BX886589.3, BX315052.3, CU074054.1, BX088058.3 and CX246541.1.  
Multiple sequence alignments were created, between the potential rainbow 
trout sequences and between these and those of two other fish species; zebrafish 
(NCBI GenBank accession number NM_001083866.1) and Japanese medaka 
(NM_001104816.1). 
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4.3.1.2 Search for the mRNA sequences for the two possible splice variants 
of rainbow trout TERT – Phase 1 
 
Specific primers were designed (Table 11) with the aim to amplify the two 
possible splice variants of rainbow trout TERT (methodology in chapter 2.7 above). 
The two sequences from the NCBI GenBank database, CX246542.1 and 
CA363864.1, were used as templates for this purpose. The primers in the table 
below were expected to result in a 248-378 bp products for the longer sequence and 
a 133-263 bp products for the shorter sequence.  
 
Table 11. Oligonucleotide primers designed to amplify two possible rainbow 
trout TERT splice vatiants, a long and a short one, based on published 
rainbow trout mRNA sequences with accession numbers CX246542.1 and 
CA363864.1 respectively. 
Position Name of primer Sequence Melting 
temperature, °C 
(TM) 
Sense omISOTERT F1 5´-CGAGGAGGGTGTCTGATGA -3´ 58.8 
Sense omISOTERT F2 5´-TGACGATTTCCTCCTCATCA -3´ 61.4 
Sense omISOTERT F3 5´- GGCACAGACCTTCCTCAAGA-3´ 55.3 
Sense omISOTERT F4 5´-CCTCCTCATCACTCCTGACC -3´ 57.3 
Anti-
sense 
omISOTERT R2 5´-GGCGTGGCACTTGAATCTAA -3´ 59.4 
Anti-
sense 
omISOTERT R3 5´-AGCCTAGCGTCAGGCTGTAG -3´ 61.4 
 
In an effort to amplify the two possible splice variants rainbow trout TERT 
mRNA, gene fragments were amplified by PCR, using a trout embryo cDNA pool as 
template and the primer sets displayed in Table 11 and Table 12. The methodology 
used was according to that outlined in chapter 2.8 with a small modification: the 
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increase of number of amplification cycles to 45. The three primer combinations 
used (Table 12) were all designed to be able to detect both possible rainbow trout 
splice variants and should therefore show two bands of different sizes, representing 
the two possible splice variants. 
 
 
Table 12. Oligonucleotide primer combinations used to amplify the sequences 
of the two rainbow trout TERT splice variants, omTertLong and omTertShort. 
 Oligonucleotide primers (sense + 
anti-sense) 
Expected product size 
Isoform primer 
combination 1 
omISOTERT – F1 + 
omISOTERT – R1 
Long: 310 bp 
Short: 195 bp 
Isoform primer 
combination 2 
omISOTERT – F3 + 
omISOTERT – R1 
Long: 248 bp 
Short: 133 bp 
Isoform primer 
combination 3 
omISOTERT – F4 + 
omISOTERT – R1 
Long: 274 bp 
Short: 159 bp 
 
 
4.3.1.3 Search for the potential splice variant mRNA sequences for rainbow 
trout TERT – Phase 2 
 
To be able to further establish that these products do indeed represent the 
two splice variants, a nested PCR was performed where the PCR product from the 
previous PCR run using primer combination 3 (primary) were used as template for a 
secondary (nested) PCR run with oligonucleotide primers which were designed to be 
nested within the primers used in the primary PCR run. Primer combinations 2 and 3 
are nested within primer combination 1. In addition primer combination 2 is nested 
within primer combination 3 (Table 12). 
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4.3.1.4 Search for the full length mRNA sequences for the two possible 
splice variants of rainbow trout TERT  
 
Specific primers were designed (Table 13 and Table 14) with the aim to find the 
full length of the two possible splice variants of rainbow trout TERT, estimated to be 
approximately 667 amino acids long, or 2001 bp. Several sets of primers were 
designed; two sets of primers designed to amplify sequences of length of 
approximately 1000 bp that should overlap by approximately 150 basepairs, and 
then a set of primers designed to amplify most of the whole length of the rainbow 
trout TERT sequence, 2001 basepairs. The primers were designed in such a manner 
that some were nested within others (Figure 39), in order to be able to proceed with 
rapid amplification of cDNA ends of the resulting PCR products, or 3´race. 
Sequences BX889962, CX246542.1 and BX315053 from NCBI database were used 
to design these. 
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Table 13. Oligonucleotide primers designed to amplify the full length of the two 
possible rainbow trout TERT splice variants based on published rainbow trout 
mRNA sequences with accession numbers BX889962, CX246542.1 and 
BX315053. 
Position Name of primer Sequence Melting 
temperature, °C 
(TM) 
Sense omFUTERT F1 5´-CTGTCCGCAGTCAGGAACTT -3´ 59.4 
Sense omFUTERT F2 5´-CACAGAGAGCATGGGACAGA -3´ 59.4 
Sense omFUTERT F3 5´-AGAGAGGGCAAAGTTCACGA -3´ 57.3 
Anti-
sense 
omFUTERT R1 5´-CCATCAGGGTCTTGAGGAAG -3´ 59.4 
Anti-
sense 
omFUTERT R2 5´-AGAGGTGACAAGGCGCAGA -3´ 58.8 
Anti-
sense 
omFUTERT R3 5´-TGACACCGGGACAATTTACA -3´ 55.3 
Anti-
sense 
omFUTERT R4 5´- GACCTACAACCTCGGTCTGC-3´ 61.4 
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Table 14. Oligonucleotide primer combinations used in the aim of amplifying 
the full length rainbow trout TERT sequence. 
Sequence searched for Oligonucleotide primers 
(sense + anti-sense) 
Full length sequence omFuTERT – F1 + 
omFuTERT – R2 
 omFuTERT – F2 + 
omFuTERT – R4 
First 1000 bp sequence omFuTERT – F1 + 
omFuTERT – R1 
 omFuTERT – F2 + 
omISOTERT – R1 
Second 1000 bp sequence omISOTERT – F3 + 
omFuTERT – R2 
 omISOTERT – F3 + 
omFuTERT – R4 
 
 
Figure 39. The positions of the oligonucleotide primers designed to amplify the 
full rainbow trout TERT sequence when compared to sequences BX889962, 
CX246542.1 and BX315053 from NCBI database. 
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In an effort to amplify the full length of rainbow trout TERT mRNA, gene 
fragments were amplified by PCR, using a trout embryo cDNA pool as and the 
primer combinations displayed in Table 14 and following the methodology outlined in 
chapter 2.8 above with a small modification: the increase of number of amplification 
cycles to 45 and the length of the extension step was increased to approximately 
1min/kb, 2 minutes for the full length 2000 bp sequence and 1 minute for the 1000 
bp sequences. 
 
4.3.1.5 Cloning and sequencing of of cDNA’s of the two distinct rainbow 
trout TERT splice variants 
 
The sequences for the potential TERT splice variants that were previously 
amplified (chapters 0 and 4.4.1.2) were cloned into pCR®2.1-TOPO® plasmids 
(methods chapter 2.11 above). The transformants were then analysed via PCR using 
M13 forward and reverse primers provided with the cloning kit (chapter 2.11 above), 
of which sequences can be found in Table 5. The PCR products were then 
visualized on an agarose gel (chapter 2.9 above) in order to establish whether the 
PCR products were of the correct size expected for the two splice variants of 
rainbow trout TERT (360 bp for omTertShort and 475 bp for omTertLong). 
These amplified sequences were purified and then sequenced by Eurofins 
MWG Operon (chapter 2.11). The sequenced clones were then aligned with two of 
the previously published TERT sequences in order to establish the level of homology 
between them. 
 
4.3.1.6 Search for complete sequences for short and long splice variants of 
rainbow trout TERT - 3´ race 
 
 Rapid amplification of cDNA ends, or 3´race is a method used to obtain the 
sequence for the full length of RNA transcripts found in samples. In an attempt to 
obtain the full sequence of the two TERT splice variants, a 3´race was performed 
using cDNA from total RNA extracts from rainbow trout embryo samples. The 
samples used for this were five trout embryo tissue samples where either short or 
 154 
long TERT sequence, omTertShort or omTertLong, had previously been amplified. 
These were two brain tissue samples and two liver tissue samples from 161 dpf old 
rainbow trout fry, and a whole embryo sample from a 14 dpf old embryo. 
 Before pursuing this step, size-specific oligonucleotide sense primers were 
designed in order to be able to search for the short and long TERT sequences, 
omTertShort and omTertLong; (Figure 40 and Table 15). The forward primers 
specific to the long isoform sequence were located in the 115bp sequence that is 
missing from the short isoform sequence. The forward primers specific to the 
sequence for the short splice variant were located where the 115bp sequence is 
missing, bordering the gap on either side (Figure 40). The primers used for this 
process are displayed in Table 15, Table 16, and Table 17.  
 
 
Figure 40. The position of the size-specific oligonucleotide sense primers were 
designed in order to be able to search for the short and long TERT sequences, 
omTertShort and omTertLong, in reference to the two sequenced sequences. 
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Table 15. Size-specific oligonucleotide sense primers were designed in order 
to be able to search for the long and short splice variants of rainbow trout 
TERT, omTertLong and omTertShort. 
Primer 
name 
Short 
name 
Specific to 
isoform 
sequence 
Sequence Melting 
temperature, 
°C (TM) 
Om3RacL-
F1 
LF1 Long 5´-
ACTGTCTGTTCCCCTGGTGT -
3´ 
59.4 
Om3RacL-
F2 
LF2 Long 5´-
TTCCCCTGGTGTGGACTACT -
3´ 
59.4 
Om3RacS-
F1 
SF1 Short 5´- 
TAACTTCCCTTTGGCTACGC-
3´ 
57.3 
Om3RacS-
F2 
SF2 Short 5´-
TTAACTTCCCTTTGGCTACG -
3´ 
55.3 
Om3RacIN-
F1 
3RacIn Inner 
primer for 
both 
5´-
GCCTATCCCTGCGCTACAG -
3´ 
61.0 
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Table 16. The oligonucleotide primers used for the first phase of rapid 
amplification of cDNA ends, or 3´race, in attempt to obtain the full length 
sequence of the long and short splice variants of rainbow trout TERT, 
omTertLong and omTertShort. 
Phase 1 Outer PCR 
Name Outer A Outer B 
Sense omISOFW1  omISOFW4 
Anti-
sense 
Outer reverse anchor primer 
 Inner PCR Inner PCR 
Name Inner A Inner B 
Sense omISO-FW4 omQSHORT-FW3 
Anti-
sense 
Inner reverse anchor primer 
 Inner PCR Inner PCR 
Name iA - 
Long F1 
iA - 
Long F2 
iA - 
Short F1 
iA - 
Short F2 
iB - 
Long F1 
iB – 
Long F2 
iB - 
Short F1 
iB -  
Short F2 
Sense LF1 LF2 SF1 SF2 LF1 LF2 SF1 SF2 
Anti-
sense 
Inner reverse anchor primer Inner reverse anchor primer 
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Table 17. The oligonucleotide primers used for the second phase of rapid 
amplification of cDNA ends, or 3´race, in attempt to obtain the full length 
sequence of the long and short splice variants of rainbow trout TERT, 
omTertLong and omTertShort. 
Phase 2 Outer PCR 
Name Outer Long A Outer Long B Outer Short A Outer Short B 
Sense LF1 LF2 SF1 SF2 
Anti-
sense 
Outer reverse anchor primer 
 Inner PCR – Long Inner PCR – Short 
Name iLong F1 iLong F2 iShort F1 iShort F2 
Sense 3RacIn 
Anti-
sense 
Inner reverse anchor primer 
 
 
4.3.1.7 Cloning and sequencing of the PCR products obtained from the rapid 
amplification of cDNA ends, or 3´race. 
 
Several of the sequences that were successfully amplified in the 3’race detailed 
in the previous chapter (4.3.1.6), were cloned into pCR®2.1-TOPO® plasmids 
(method in chapter 2.11 above). These were the amplified products from the 
following 3’races: Inner A, Inner B, iLong F1, iLong F2 and iB – Long F1.  The 
transformants deemed to contain the target sequences were selected, amplified, 
purified and then sequenced by Eurofins MWG Operon (method in chapter 2.11). 
These were subsequently aligned with TERT sequences from other deuterostomes 
and phylogenetic tree built using the online computer program Phylogeny.fr 
(Dereeper et al., 2008; Dereeper et al., 2010). The sequences used were: zebrafish 
(NM_001083866.1), Japanese medaka (NM_001104816.1), two rainbow trout 
sequences representing the two splice variants (Long: CX246542 and Short: 
CA353864), two human splice variants 1 and 2 (NM_198253.2 and NM_198255.2 
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respectively), rat (NM_053423.1), chicken (NM_001031007.1), Japanese quail 
(DQ681294.1), American purple sea urchin (XM_001181282.1), sea squirt 
(NM_001100135.1), honey bee (NM_001040681.1) and frog (NM_001085633.1). 
 
4.3.2 Design and optimization of a qPCR assay for TERT expression in 
rainbow trout 
 
One of the main objectives of this study was to design and optimize a qPCR 
assay for the relative quantification of TERT expression in rainbow trout samples. In 
order to do that, qPCR primers needed to be designed, and the assay optimized by 
firstly performing a temperature gradient, and secondly by running a standard curve 
at the optimal temperature (method in chapter 2.8.3). 
 
4.3.2.1 qPCR primer design for rainbow trout TERT – two splice variants 
 
Quantitative PCR oligonucleotide primers were designed (method in chapter 0) to 
amplify rainbow trout TERT, using Beacon Designer 3.0 Software according to the 
manufacturer’s guidelines (Table 18). The cloned sequences from the previous 
chapter were used for this purpose (chapter 4.3.1.7). 
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Table 18. Quantitative PCR primers designed to amplify the two splice variants 
of rainbow trout TERT, omTertLong and omTertShort. The primers designed 
were rated ‘BEST’ which indicates that their rating is > 70%; likelihood of self-
dimers nil; likelihood of cross-dimers minimal; Tm similar in matching primers 
and close to 55ºC; likelihood of hairpin nil; and proportion of GC similar in 
both primers. 
Position Name of primer Sequence Melting 
temperature. 
°C (TM) 
Sense omQLONG-FW1 5´- CGGGTGTGTGGTGAAC-3´ 54.3 
Anti-
sense 
omQLONG-RV1 5´-GGCGTAGTTGTTGTAGAC -3´ 53.7 
Sense omQLONG-FW3 5´-CCTCCTCATCACTCCTG -3´ 55.2 
Anti-
sense 
omQLONG-RV3 5´-CCCACTCACCCAAAGG -3´ 54.3 
Sense omQSHORT-FW3 5´-GCACAGACCTTCCTCAAG -3´ 56.0 
Anti-
sense 
omQSHORT-RV3 5´-GCCAGCGTAGCCAAAG -3´ 54.3 
 
The above primers were expected to result in a 101 bp product for the 
omQSHORT-FW/RV3 primer pair and 160 bp and 128 bp products for primer pairs 
omQLONG-FW/RV1 and omQLONG-FW/RV3 respectively. 
 
4.3.2.2 Temperature gradient for qPCR primer pairs designed to amplify the 
omTertLong sequence 
 
The first step in qPCR optimization is to perform a temperature gradient for 
the oligonucleotide primers in question, in order to establish what their optimal 
annealing temperature is. A series of temperature gradients were produced, the first 
of which, TempGradL1, was performed using both of the two primer pairs 
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omQLONG-FW/RV1 and omQLONG-FW/RV3 (Table 18) designed for amplification 
of the longer rainbow trout TERT sequence, omTertLong. This was perfomed as 
previously described (2.8.3), with primers at a 10 pmol/ul dilution. A large 
temperature range was chosen in order to get an approximate idea of the ideal 
annealing temperatures. The temperature range was based on the calculated 
melting temperatures (TM) provided by BeaconDesigner 3.0; between 53ºC and 
60ºC. A pool of trout embryo total RNA extracts were used as a source for cDNA, 
diluted 1:4 with H2O. 
After the initial temperature gradient quantitative PCR had given an estimated 
ideal annealing temperatures for primer pairs omQLONG-FW/RV1 and omQLONG-
FW/RV3, a second temperature gradient was performed, TempGradL2, with a much 
narrower temperature range in order to better establish the ideal annealing 
temperatures; between 58ºC and 60ºC. These did however yield exceedingly poor 
results, with much non-specific binding. 
With the second temperature gradient quantitative PCR for trout primer pairs 
omQLONG-FW/RV1 and omQLONG-FW/RV3 having produced inadequate results, 
a third temperature gradient, TempGradL3, was performed using only omQLONG-
FW/RV3 with cDNA pools believed to have a higher TERT activity present, and 
diluted to 1:2 with water. The cDNA sample pools chosen were from rainbow trout 
embryo and liver extracs as well as brain tissue extracts exposed to 150 ng/ml BPA. 
These did however yield poor results, with inconsistent results, poor replication, and 
non-specific binding. 
 Two more temperature gradients were performed, TempGradL4 and 
TempGradL5, using only omQLONG-FW/RV1 with the same cDNA pools as were 
used in TempGradL3. For TempGradL4 the temperatures ranged from 53ºC to 60ºC 
but for TempGradL5 they ranged from 58.5ºC to 60ºC.  
 
4.3.2.3 Standard curve for rainbow trout primer pair omQLONG-FW1/RV1 
 
 The second step in qPCR optimization is to amplify a standard dilution of 
cDNA in order to produce a standard curve. With the above optimal annealing 
temperature established for omQLONG-FW/RV1, a series of standard dilutions were 
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performed with this primer pair. In the first of these, StCurveL1, the same cDNA 
pools as were used in temperature gradient qPCR runs TempGradL3-5 (chapter 
4.3.2.2 above). The volume of cDNA used was 2µl per 20µl reaction. The sample 
dilutions were as follows: 1:1, 1:2, 1:5, 1:7, and 1:10. The standard curve was 
performed at previously established ideal annealing temperature of T=59ºC, but with 
poor results as only two standard dilutions were successful, providing insufficient 
data to draw a standard curve and with an extremely low PCR efficiency at 35.7%. 
With the previous standard curve having provided inadequate results with 
primer pair omQLONG-FW/RV1, a second standard dilution, StCurveL2, was 
performed. Fresh cDNA pools were used from rainbow trout liver extracts as well as 
embryo extracts and a narrower dilution series. The sample dilutions were as 
follows: 1:2, 1:3, 1:4, 1:5, and 1:6 cDNA diluted with water. This yielded poor results 
with the slope a positive figure whereas it should be a negative figure, resulting in an 
amplification efficiency of -77%. 
Seeing as both the previous standard curves required narrow cDNA dilution 
series and still failed to yield an acceptable result it was clear that the long TERT 
mRNA, omTertLong, had very low expression in embryonic samples and it might be 
necessary to create an RNA probe using the previously cloned plasmids in order to 
optimize this assay. A third standard dilution was performed, StCurveL3, with a 
plasmid containing the omTertLong sequence. The plasmid dilutions were as follows: 
1:10, 1:100, 1:1000, 1:10 000, 1:100 000, 1:1 000 000 plasmid diluted with water. 
A fourth standard dilution was performed, StCurveL4, with much lower 
plasmid concentrations in order to yield similar Ct values as that of real samples. The 
plasmid dilutions were as follows: 1:100, 1:1000, 1:10 000, 1:100 000, 1:1 000 000, 
1:10 000 000, 1:100 000 000 plasmid diluted with water. 
 
4.3.2.4 Temperature gradient for qPCR primer pairs designed to amplify the 
omTertShort sequence: omQSHORT-FW/RV3 
 
In order to establish what the optimal annealing temperature of the qPCR 
primers designed to detect the short TERT sequence, omTertShort, a temperature 
gradient quantitative PCR was performed for trout primer pair omQSHORT-FW/RV3 
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(Table 18) at a 10 pmol/ul dilution. The temperature range was chosen based on the 
calculated melting temperatures (TM) provided by Beacon Designer 3.0 Software; 
between 53ºC and 60ºC. Plasmids containing the short TERT sequence from 
rainbow trout, omTertShort, were used as a template and diluted 1:10 000 000 with 
H2O. 
 
4.3.2.5 Standard curve for rainbow trout primer pair omQSHORT-FW/RV3 
 
 With the above optimal annealing temperature established for omQSHORT-
FW/RV3, a standard dilution, StCurveS1, was performed with this pair and with a 
plasmid containing the omTertShort sequence. A 10-fold dilution series of the 
plasmid was used, ranging between 1:10 000 and 1:10 000 000 000 plasmid diluted 
with water. The volume of plasmid dilution used was 1µl per 20µl reaction. The 
standard curve was performed at annealing temperature T=59ºC with poor results, 
poor replication and a low PCR efficiency at 73.7%. 
A second standard dilution was performed, StCurveS2, with the primer pair 
omQSHORT-FW/RV3 and with a plasmid containing the omTertShort sequence. A 
10-fold dilution series of the plasmid was used, ranging between 1:10 000 and 1:10 
000 000 000 plasmid diluted with water. The volume of plasmid dilution used was 1µl 
per 20µl reaction. Seeing as the previous standard curve yielded unacceptable 
results due to too low a PCR efficiency, the annealing temperature was dropped by 
one degree to T=58ºC. 
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4.4 Results 
 
4.4.1 Isolation and characterization of rainbow trout TERT 
 
4.4.1.1 Identification of potential TERT gene sequences for rainbow trout in 
public databases 
 
Multiple sequence alignments between the two potential rainbow trout TERT 
nucleotide sequences found in the NCBI database (CX246542.1 and CA 353864.1) 
and those from other fish species were created using ClustalW (chapters 4.3.1 and 
2.6 above), revealing a 115 bp gap in one of the sequences (CA 353864.1) not 
appearing in the other sequence (Figure 41). This creates a clear difference in length 
between the two sequences which could lead one to conclude that they might 
possibly be two separate splice variants of rainbow trout TERT, a short and a long 
one (omTertShort and omTertLong respectively). 
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Figure 41. Nucleotide sequence aligment of the two published rainbow trout 
EST sequences that are possibly TERT, CX246542.1 and CA353864.1, showing 
a 115 bp gap indicating that these may possibly be two separate splice 
variants. The black shading represent 100% similarity. For complete alignment 
see figure A.5.4 in Appendix. 
 
A search into another genomic database, cGRASP, found ten further rainbow 
trout sequences homologous to TERT in other fish species. When compared to each 
other and the aforementioned sequences retrieved from the NCBI database, it is 
clear that these can be grouped into three separate groups: Group 1, 2 and 3. The 
way these groups are placed in the overall TERT sequence is: Group 1 is placed 
closest to the 5’ of the TERT sequence and Group 3 closest to the 3’ of the 
sequence, with Group 2 in the middle, overlapping with Group 3. The two sequences 
from the NCBI database, CX246542.1 and CA363864.1, fall into group 2, with overall 
52.98% Homology. Group 2 brackets the 115 basepair gap which distinguishes the 
two possible isoforms. The other sequences have the following NCBI GenBank 
accession numbers: Group 1: BX889962.3, CA380121.1, BX088059.3, with overall 
79.5% Homology (Figure 42); Group 3: BX315053.3, BX882610.3, BX886589.3, 
BX315052.3, CU074054.1, BX088058.3 and CX246541.1, with overall 76.63% 
homology (Figure 43). The possible TERT nucleotide sequences in groups 1 and 3 
were aligned with each other using the computer program BioEdit (Figure 42 and 
Figure 43). 
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Figure 42. Nucleotide sequence aligment of Group 1 of the newly published 
rainbow trout TERT sequences: BX889962.3, CA380121.1 and BX088059.3. The 
black shading represent 100% similarity. For complete alignment see figure 
A.5.3 in Appendix. 
 
Figure 43. Nucleotide sequence aligment of Group 3 of the newly published 
rainbow trout TERT sequences: BX315053.3, BX882610.3, BX886589.3, 
BX315052.3, CU074054.1, BX088058.3 and CX246541.1. The black shading 
represent 100% similarity. For complete alignment see figure A.5.4 in 
Appendix. 
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These twelve sequences were furthermore aligned with TERT sequences from 
other fish species, Japanese medaka (NM_001104816.1) and zebrafish 
(NM_001083866.1) (figure A.5.5.A in Appendix). Overall percentage homology for 
this alignment was 68.29%. And the same was done for the translation of 
corresponding protein sequences of the aforementioned sequence (Figure 44). 
Overall percentage homology for this alignment was 71.3%. For this alignment 
composite protein translations were created for Groups 1, 2 and 3 and these were 
then aligned with TERT of two other fish species; Japanese medaka 
(NP_001098286.1), and zebrafish (NP_001077335.1). For the purpose of clarity the 
shorter sequence from Group 2 which contains a 115 bp gap (CA 363864.1) was left 
out for this alignment.  
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Figure 44. Alignment of composite translations of the twelve possible rainbow 
trout TERT sequences with TERT from two other fish species, Japanese 
medaka (NP_001098286.1) and zebrafish (NP_001077335.1). The rainbow trout 
sequences translated are; Group 1: BX889962.3, CA380121.1, BX088059.3, 
Group 2: CX246542.1, Group 3: BX315053.3, BX882610.3, BX886589.3, 
BX315052.3, CU074054.1, BX088058.3 and CX246541.1. The black shading 
represent 100% similarity. 
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4.4.1.2 Search for the mRNA sequences for the two possible splice variants 
of rainbow trout TERT – Phase 1 
 
In an effort to amplify the two possible splice variants rainbow trout TERT mRNA, 
gene fragments were amplified by PCR (method in chapter 2.8 above). The three 
primer combinations used (Table 12) were all designed to be able to detect both 
possible rainbow trout splice variants and as is clear when analysing the results from 
the electrophoresis of the PCR products (Figure 45) bands are amplified in all lanes 
tested, indicating that the mRNA had been successfully extracted and converted to 
cDNA. But only the larger band of the two is amplified and visualised where primer 
combinations 1 and 2 were used. It is only primer combination 3 that yields two 
bands of the expected sizes (274 and 159 bp), representing the two possible splice 
variants.  
 
 
Figure 45. The results from the agarose gel electrophoresis of the PCR 
products derived from using oligonucleotide primers designed to detect the 
two rainbow trout TERT splice variants, omTertLong and omTertShort. Five 
microliters of product and ladder were loaded onto the gel. 
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4.4.1.3 Search for the mRNA sequences for the two possible splice variants 
of rainbow trout TERT – Phase 1 
 
 To be able to further establish that these products do indeed represent the 
two splice variants, a nested PCR was performed (method in chapter 4.3.1.3 above). 
When examining the results from this nested PCR (Figure 46) clear bands were 
visualised on the agarose gel, indicating successful reverse transcription and 
amplification of the target sequences. Most noticeable is that when a nested PCR is 
performed using primer combination 2 on the previous PCR product from primary 
PCR run using primer combination 3, that yet again two bands appear of the correct 
expected size. In the primary run the two bands found in the same well using primer 
combination 3 (Table 12) should be 274 basepairs and 159 basepairs in length. In 
the secondary run, primer combination 2 was used which should yield products 
smaller or 248 basepairs and 133 basepairs.  
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Figure 46. The results from the agarose gel electrophoresis of the products 
from a nested PCR where the products from the primary PCR run were used as 
template for the secondary nested PCR. Five microliters of product and ladder 
were loaded onto the gel (1000 bp ladder for the primary run and 100 bp for the 
nested PCR run). 
 
 
4.4.1.4 Cloning and sequencing of of cDNA’s of the two distinct rainbow 
trout TERT splice variants 
 
The sequences that were amplified in the previous chapter (4.4.1.2) were cloned 
and visualized on an agarose gel (methods chapter 4.3.1.5 above). When amplifying 
a sequence incorporated into a plasmid with the M13 primer pair, the size of the 
amplified products produced should be 201 bp plus the size of the PCR product 
incorporated into the plasmid (Figure 10). This would yield a 360 bp-sized product for 
the smaller variant sequence (omTertShort) and a 475 bp-sized product for the 
larger variant sequence (omTertLong). When the results were examined (Figure 47) 
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several bands of the correct size were detected for both the short and the long 
sequence. 
 
 
Figure 47.  The results from the agarose gel electrophoresis of the PCR 
products amplified after the two different TERT splice variants were 
incorporated into a pCR
®
2.1-TOPO
®
 plasmid and amplified using PCR and the 
M13 primer pair. Five microliters of product and ladder were loaded onto the 
gel. 
 
These amplified sequences were purified and sequenced (method in chapter 
2.11) and the sequenced clones aligned with two of the previously published TERT 
sequences, with overall percentage homology of 99.4% (Figure 48). As was 
predicted, sequences of different lengths were found, the shorter one with a 115 bp 
deletion gap, corresponding to the two possible Trout TERT splice variants, 
omTertShort and omTertLong. 
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Figure 48. Nucleotide sequence aligment of the cloned rainbow trout cDNA 
encoding the two rainbow trout TERT splice variant sequences, omTertLong 
and omTertShort, with the two published TERT sequences: The longer 
sequence CX246542.1 and the shorter sequence CA353864. The black shading 
represents 100% similarity. For complete alignment see figure A.5.10 in 
Appendix. 
 
Sequencing analysis showed the first two clones, samples 02 and 09, contain 
the same open reading frame and align with the longer of the two published 
sequences (CX246542.1). Whereas the latter four clones, samples 10, 13, 04 and 
05, all have the nucleotide gap previously identified in the shorter of the two 
published sequences (CA353864). 
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4.4.1.5 Search for complete sequences for short and long splice variants of 
rainbow trout TERT - 3´ race 
 
In order to find the full length of the two possible splice variants of rainbow 
trout TERT, the process of rapid amplification of cDNA ends, or 3’race, was used 
(method in chapter 2.10). The PCR products yielded from the second phase of 
3’race were visualized on an agarose gel via agarose gel electrophoresis (Figure 
49). What is clearly noticeable from the results, is that there are two distinct bands 
detected from 3’race runs  iB – Long F1 and iB – Long F2, one about 1000 bp and 
another just over 500 bp. They seem to be of very similar size between the two runs, 
but that is to be expected seeing as they are located very near each other on the 
longer TERT sequence. 
 
 
Figure 49. The results from the agarose gel electrophoresis of the PCR 
products amplified in 3’race. A) 3’race iB - Long F1. B) 3’race iB – Long F2. 
Five microliters of product and ladder were loaded onto the gel. 
 
 Furthermore, a possible long sequence was detected in several of the 3´races 
(Figure 50). The difference between the band furthest on the left and the two ones in 
the middle should be 217bp. And the difference between the band furthest on the 
right and the two bands in the middle should be 75 bp. The difference between the 
band furthest on the right and the band furthest on the left should be 142bp. An 
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alignment of the cDNA clones displays the position of the respective primers used on 
the rainbow trout TERT sequences (Figure 51). It appears that the 3’race procedure 
successfully managed to amplify omTertLong. In order to establish whether this was 
the case, and whether omTertShort was also successfully amplified, the 3’race PCR 
products were cloned and sequenced. 
 
 
Figure 50. The results from the agarose gel electrophoresis of the PCR 
products amplified in the following 3’race reactions:  inner B, iLong F1, iLong 
F2 and iB – Long F1. The bands visualized are of the corrected sizes expected 
for the long TERT splice variant omTertLong. The difference between the inner 
B band and the, iLong F1, iLong F2 bands should be 217bp. And the difference 
between the iB – Long F1 band and the iLong F1, iLong F2 bands in the middle 
should be 75 bp. The difference between the inner B band and the iB – Long F1 
band should be 142bp. 
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Figure 51: Nucleotide sequence aligment of the cloned rainbow trout cDNA 
encoding the two rainbow trout TERT splice variant sequences, omTertLong 
and omTertShort, with the two published TERT sequences: The longer 
sequence CX246542.1 and the shorter sequence CA353864. The black shading 
represents 100% similarity. The image furthermore shows the position of the 
primers used to obtain the bands in figure 5.13, displayed in relation to the 
cloned rainbow trout TERT sequences. 
 
4.4.1.6 Cloning and sequencing of the PCR products obtained from the rapid 
amplification of cDNA ends, or 3´race. 
 
Several of the PCR products amplified in the 3’race (chapter) were cloned and 
twelve of these were sequenced (method in chapter 4.3.1.7), resulting in high quality 
sequences at the length between 822bp and 1080bp. Sequencing analysis shows 
that 8 of the clones contain the same open reading frame and align with the 
published sequence of the long form of rainbow trout TERT, CX246542.1, as well as 
the previously cloned long sequences of omTertLong (clones: Samples 2 and 9), 
with an overall percentage homology of 97.6%. These were clones D1-3, H2, G5, 
F5, F7 and E6 (Figure 52). The 3´race seemingly failed to find the short sequence in 
samples where it was indicated they might be found for none of the cloned 
sequences contain the same open reading frame as the shorter of the two published 
sequences, CA353864. 
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Figure 52. Nucleotide sequence aligment of the cloned rainbow trout cDNA 
encoding the rainbow trout TERT splice variant sequences, omTertLong and 
omTertShort, with the two published TERT sequences: the longer sequence 
CX246542.1 and the shorter sequence CA353864. The black shading 
represents 100% similarity. 
 
A selection of the above sequences as well as those previously sequenced 
(chapter 4.4.3) were published in the NCBI GenBank database and received the 
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following accession numbers: KC204729, KC204730 and KC204731 for sample 9, 
Clone B5 and Clone D2 respectively, all of which encode the longer TERT splice 
variant omTertLong, and then KC204732 for Sample 10 encoding the shorter TERT 
splice variant omTertShort. The phylogenetic relationship of these sequences to 
those of other deuterosomes were plotted revealing that the above mentioned clones 
are phylogenetically closest to previously published sequences of rainbow trout, and 
then to other teleost fish. These then show higher phylogenetic association to sea 
squirt than the mammalian and avian species (Figure 53).  
 
 
Figure 53. Phylogenetic relationship of cloned omTertLong and omTertShort 
sequences with sequences from selected deuterostome animals. 
 
 
4.4.2 qPCR optimization for rainbow trout TERT assay 
 
4.4.2.1 Temperature gradient for qPCR primer pairs designed to amplify the 
omTertLong sequence: omQLONG-FW/RV1 and omQLONG-FW/RV3 
 
A series of temperature gradient quantitative PCR’s were performed in order 
to produce an optimized qPCR assay for the relative quatification of omTertLong 
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expression in rainbow trout (method in chapter 4.3.2.2). The first, TempGradL1, was 
performed with the two qPCR primer pairs omQLONG-FW/RV1 and omQLONG-
FW/RV3 (Table 18). Judging by the results from this temperature gradient, the 
estimated ideal annealing temperatures for these primers were 58º and 59ºC for 
omQLONG-FW/RV1 and omQLONG-FW/RV3 respectively (Table 19). Because the 
temperature range used in this temperature gradient was very wide, ranging from 
53ºC to 60ºC, these results are insufficient in order to establish the optimal annealing 
temperature for these primer pairs. 
 
Table 19. The estimated ideal annealing temperatures for the amplification of 
rainbow trout sequence omTertLong using omQLONG-FW/RV1 and 
omQLONG-FW/RV3. 
Primer pair Lowest Ct value (no. 
cycles) 
Estimated ideal annealing 
temperature (ºC) 
omQLONG-FW/RV1 33.6 58 
omQLONG-FW/RV3 34.5 59 
 
With a series of temperature gradient qPCR’s failing to yield acceptable 
results, another temperature gradient was performed, TempGradL4, using only 
omQLONG-FW/RV1. These did however yield poor results, with non-specific binding 
found exhibited in all temperatures, except at 59ºC. At this temperature no non-
specific binding was present and Ct value was at 34 (Figure 54).  
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Figure 54. Dissociation curve for a temperature gradient performed using 
primer pair omQLONG-FW/RV1 at temperatures ranging from 53ºC to 60ºC, 
using rainbow trout embryo, liver and brain cDNA diluted to 1:2 with water. 
 
With the results from TempGradL4 havingindicated that 59ºC might be an ideal 
annealing temperature for primer pair omQLONG-FW/RV1, yet another temperature 
gradient qPCR was performed, TempGradL5, using only the above mentioned 
primer pair and a much narrower temperature range; 58.5ºC to 60ºC. These did yield 
acceptable results, with no non-specific binding at temperatures equalling or 
exceeding 59ºC (Figure 55 and Table 20). With an ideal annealing temperature 
established for primer pair omQLONG-FW/RV1 and not for omQLONG-FW/RV3, 
attempts to use the latter were abandoned. 
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Figure 55. Dissociation curve for a temperature gradient performed using 
primer pair omQLONG-FW/RV1 at temperatures ranging from 58.5ºC to 60ºC, 
using rainbow trout embryo, liver and brain cDNA diluted to 1:2 with water. 
 
Table 20. Ideal annealing temperatures for the amplification of rainbow trout 
sequence omTertLong using trout primer pair omQLONG-FW/RV1. 
Primer pair Lowest Ct value (no. 
cycles) 
Estimated ideal annealing 
temperature (ºC) 
omQLONG-FW/RV1 34.3 59 
 
 
4.4.2.2 Standard curve for rainbow trout primer pair omQLONG-FW1/RV1 
 
The second step in qPCR optimization is to amplify a standard dilution of 
cDNA in order to produce a standard curve. A standard dilution was performed with 
a plasmid containing the omTertLong sequence (method in chapter 4.3.2.3). This 
yielded excellent results (Figure 56) with PCR efficiency at 95.9%. 
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Figure 56. Standard curve for the amplification of rainbow trout sequence 
omTertLong, using primer pair omQLONG-FW/RV1 and a plasmid as template, 
at T=59ºC, a 10 pmol/ul primer dilution, a 60 second annealing step, plasmid 
dilutions from 1:10 to 1:1 000 000, and 1µl plasmid dilution per 20µl reaction. 
 
With the previous standard curve having provided good results, another 
standard dilution was performed, StCurveL4, with much lower plasmid 
concentrations. This yielded excellent results (Figure 57) with PCR efficiency at 
88.5%, which is a little lower than that at higher concentrations (Figure 56). This 
assay was now optimized using primer pair omQLONG-FW/RV1 at 88.5% PCR 
efficiency appropriate for the lower expression range of actual rainbow trout embryo 
samples. 
 
 
 
 
 184 
 
Figure 57. Standard curve for the amplification of rainbow trout sequence 
omTertLong, using primer pair omQLONG-FW/RV1 and a plasmid as template, 
at T=59ºC, a 10 pmol/ul primer dilution, a 60 second annealing step, plasmid 
dilutions from 1:100 to 1:100 000 000,  and 1µl plasmid dilution per 20µl 
reaction. 
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4.4.2.3 Temperature gradient for qPCR primer pairs designed to amplify the 
omTertShort sequence: omQSHORT-FW/RV3 
 
In order to establish what the optimal annealing temperature of the qPCR 
primers designed to detect the short TERT sequence, omTertShort, a temperature 
gradient quantitative PCR was performed (method in chapter 4.3.2.4 above). The 
amplification acquired from primer pair omQSHORT-FW/RV3 yielded good results 
from which the ideal annealing temperature for these primers was estimated; 58.9ºC 
(Table 21 and Figure 58). 
 
Table 21. Ideal annealing temperatures for the amplification of the rainbow 
trout sequence omTertShort using Trout primer pair omQSHORT-FW/RV1. 
Primer pair Lowest Ct value (no. 
cycles) 
Estimated ideal annealing 
temperature (ºC) 
omQLONG-FW/RV3 24.82 58.9 
 
 
Figure 58. Dissociation curve for a temperature gradient performed using 
primer pair omQSHORT-FW/RV3 at temperatures ranging from 53.5ºC to 60ºC, 
using plasmids diluted to 1:10 000 000 with H2O. 
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4.4.2.4 Standard curve for rainbow trout primer pair omQSHORT-FW/RV3 
 
 With the above optimal annealing temperature established for omQSHORT-
FW/RV3, a standard dilution was performed, StCurveS2 (method in chapter 4.3.2.5). 
This yielded excellent results (Figure 59) with PCR efficiency at 94.1%. This assay is 
now optimized using primer pair omQSHORT-FW/RV3 at 94.1% PCR efficiency 
appropriate for the lower expression range of actual rainbow trout embryo samples. 
 
 
Figure 59. Standard curve for the amplification rainbow trout sequence 
omTertShort, using primer pair omQSHORT-FW/RV3 and a plasmid as 
template, at T=58ºC, a 10 pmol/ul primer dilution, a 60 second annealing step, 
plasmid dilutions from 1:10 000 to 1:10 000 000 000,  and 1µl plasmid dilution 
per 20µl reaction. 
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4.5 Discussion  
 
Prior to this study the genes encoding the telomerase catalytic subunit TERT 
had been identified in a number of fish species, including the teleost fish species 
pufferfish (Yap et al, 2005), Japanese medaka and zebrafish (Lau et al, 2008), but it 
had yet to be identified and fully sequenced in rainbow trout. Sequences 
homologous with the TERT sequences of other vertebrates had, however, been 
published. This study successfully identified two different splice variants of rainbow 
trout telomerase reverse transcriptase subunit, TERT; which were named 
omTertLong and omTertShort. Both variants were successfully amplified and cloned 
with their sequences subsequently published in public databases. The second 
objective of this study was to design and optimize two specific quantitative PCR 
assays intended for the exclusive amplification of omTertLong and omTertShort. 
Analysis of the two rainbow trout sequences, omTertLong and omTertShort, 
revealed that the latter contained a 115 bp gap not present in the other, indicating 
that alternative splicing might play a role in TERT regulation in rainbow trout. As has 
been previously detailed, several different splice variants of TERT exist in many 
species. A few examples are humans (Ulaner et al., 1998), platypus 
(Ornithorhynchus anatinus) (Hrdličková et al., 2012a) and one fish species, the 
Japanese medaka (Pfennig et al, 2008, Rao et al., 2011). Alternative splicing is 
believed to play a vital role in the regulation of telomerase activity, some have 
suggested that telomerase is modulated post-transcriptionally with alternative 
splicing with full length TERT transcripts necessary for telomerase to be active 
(Krams et al, 2001). Alternative splicing in human TERT produces truncated mRNA 
sequences which lack vital reverse transcriptase motifs (Ulaner et al, 2000) and 
interestingly telomerase is upregulated in human lymphomagenesis via alternative 
splicing, where truncated variants are replaced with full length variants 
posttranscriptionally (Amor et al, 2010). Alternative splicing also seems to play a 
regulatory role in chicken, where in-frame splice variants translate into non-functional 
TERT isoforms. Chicken variants are of two types, the first that contain the original 
open reading frame and the latter that code for a premature stop codon, resulting in 
mRNA which fails to be translated into a protein (Nilson and Gravely, 2010; Nehyba 
et al., 2012). In Japanese medaka, five different variants have been identified from 
embryonic stem cells and adult somatic cells, the longest of which is ubiquitous in 
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embryos and adult tissues (variant A), all the other were considerably truncated (Rao 
et al., 2011). 
When the two rainbow trout splice variants characterized in this study were 
translated to a protein sequence, it became apparent that the 115 bp deletion gap 
existing in omTertShort caused a frameshift with a termination codon a bit further 
down the sequence. This is similar to what happens in human TERT splice variant 
hTERTβ where a deletion causes premature translation termination, with the 
resulting TERT isoform failing to reconstitute telomerase activity in vitro (Yi et al, 
2000). It is therefore highly likely that the deletion in rainbow trout variant 
omTertShort yields a non-functional isoform as well. Interestingly, this human splice 
variant hTERTβ is highly expressed in stem and cancer cells. The deletion causes a 
frame-shift which leads to translation of a protein which lacks most of the reverse 
transcriptase domain but retains the known RNA binding motifs (Listerman et al., 
2013). When this variant is overexpressed in human breast cancer cells it competes 
for binding to hTR RNA, and by doing so inhibits telomerase activity. It seems that 
overexpression of this variant increases the cancer cells growth potential by 
protecting them from cisplatin-induced apoptosis, meaning that the hTERT RT 
domain and C-terminus are not necessary for TERT to protect the cell from 
apoptosis  (Listerman et al., 2013). It is clear that telomerase activity plays a vital 
role in cells that retain great potency for cell differentiation and regeneration, by 
preventing telomere shortening during high levels of cell proliferation. This is also 
evident in aquatic organisms such as teleost fish, where somatic telomerase 
expression has been linked with the animals capacity for tissue regeneration, with 
telomerase activity is increased whilst tissue regenerates (Elmore et al., 2008). 
Teleost fish have a remarkable capacity for tissue regeneration being able to 
regenerate severed appendages, which involves the regeneration of a host of 
differentiated tissues derived from both dermal and cartilaginous origin (Morgan, 
1900; Akimenko et al., 2002). As a teleost fish, this ability is also present in rainbow 
trout (Alonso et al., 2000). The mechanisms of tissue regeneration are not fully 
understood, but is well known that in zebrafish fibroblast growth factor (FGF) 
signalling is vital for this process, or specifically for the formation of the blastema 
(Poss et al., 2000a). FGF signalling has on the other hand been shown to influence 
TERT transcription in coronary microvascular endothelial cells (Donnini et al.¸2009). 
The Wnt signalling pathway also plays a role in the regenerative process in fish, with 
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transcriptional regulators lef1 and wnt5 expressed in presumptive basal epithelial 
cells during regeneration of a wound (Poss et al., 2000b). Telomerase has been 
shown to act as a cofactor and modulate Wnt/β-catenin signalling, with the TERT 
activating Wnt-dependent reporters in cultured epidermal stem cells (Park et al., 
2009). There is therefore considerable potential for further study of telomerase and 
its role in tissue regeneration, notably the potential interaction of telomerase, 
alternative splicing and the two above mentioned signalling pathways, FGF and Wnt 
signalling pathways. 
When the omTertShort and omTertLong nucleotide sequences were aligned with 
full length TERT sequences from other species and phylogenetically analysed it was 
revealed that rainbow trout TERT, as well as those of other teleost fish, shows 
greater phylogenetic association with sea squirt than with mammalian and avian 
species (Figure 53). This was suprising seeing as sea squirts are deuterostome 
invertebrates and not deuterostome vertebrates like rainbow trout. Teleost fish do, 
however, express telomerase in somatic tissues, and have indeterminate growth and 
high capacity for tissue regeneration. This is also the case for sea urchins, which are 
also deauterostome invertebrates like sea squirts (Ebert and Southon, 2003; Rogers-
Bennett et al., 2003; Francis et al., 2006). It is therefore not surprising that a 
sequence coding for an enzyme that plays a role in cell differention, is more similar 
to those expressed in mechanistically similar animals. Furthermore it was clear that 
the clones sequenced in this study span across two of the most highly conserved 
motifs that exist within vertebrate TERT sequences, motifs C and E (figure 84).  
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Figure 60. A. The different regions of the hTERT sequence: N-terminus, RT-
Domain and C-Terminus, showing the locations of the various motifs within 
the sequence (Adapted from: Wyatt et al., 2010). B. Visualising the area of the 
TERT sequence where the cloned sequences derive from: Sequence clones 
clone D1-3, H2, G5, F5, F7 and E6 as well as samples 2, 4, 5, 9, 10, and 13. The 
115 bp gap found in samples 4, 5, 10 and 13 is also shown.  
 
In another teleost fish, the marine medaka, motif E contains signature residues 
that are essential for telomerase activity and which also distinguish telomerase 
reverse transcriptase from other reverse transcriptases (RTs). The 115 bp deletion 
gap present in the shorter of the two splice variants, omTertShort, spans right across 
the area of sequence where these signature residues are placed within the E motif, 
(tryptophan-X-glycine-X-serine/leucine residues) (Yu et al., 2006). This further 
suggests that omTertShort encodes a non-functional isoform of TERT. Furthermore, 
four truncated splice variants of the full length sequence have been identified in 
Medaka, and most curiously these are differentially expressed through cell 
differentiation (Rao et al, 2011). One of these has a deletion in medaka exon 11, in 
RT motif EIII, and it also lacks E-IV (Lau et al, 2009), which is very close to where 
the deletion is occuring in rainbow trout. Alternative splicing has also been observed 
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in zebrafish, where a deletion occurs out of frame (Lau et al, 2009). There does 
seem to be considerable species-specific variability in the location and mode of 
action of alternative splicing, but it may well be that it plays a significant role in 
telomerase regulation in rainbow trout. 
 
Conclusion 
 
This study successfully achieved both of its main two objectives; to identify 
and characterize rainbow trout TERT and to design two optimized, specific 
quantitative PCR assays intended for the exclusive amplification of omTertLong and 
omTertShort. During the examination and characterization of the mRNA sequence 
for the telomerase catalytic subunit, TERT, in rainbow trout, two possible splice 
variants were identified. There are many indications that alternative splicing plays an 
important role in telomerase modulation across various phyla, and it may well do so 
in rainbow trout. The samples from where omTertShort was isolated were whole 
embryo samples. It is therefore quite possible that alternative splicing plays a role in 
the regulation of telomerase in cell proliferation and/or differentiation in 
embryogenesis. Rainbow trout, like many other aquatic animals, express telomerase 
activity in somatic tissues (Klapper and Heidorn et al, 1998), so it may well be that 
alternative splicing plays a role in the regulation of telomerase throughout their life-
span, perhaps as a part of tumour-protection mechanism or as a protection against 
senescence via telomere preservation. Two quantitative PCR assays designed to 
amplify omTertShort and omTertShort were optimized. These could facilitate studies 
on telomerase regulation in this fish species, and could be used for ecotoxicological 
as well as embryogenesis studies, as well as studies into the relationship between 
telomerase and cell longevity. 
 Further research is required in order to sequence characterize the full length 
of the shorter splice variant omTertShort and in order to examine the role the two 
splice variants play in telomerase regulation. It would be curious to examine whether 
these are differentially expressed through embryonic development or perhaps across 
tissue types. It would further our understanding of the modes of action of telomerase 
regulation.  
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5 Oestrogenic pollution and TERT: The effect of 
endocrine disrupting chemicals on TERT mRNA 
expression in rainbow trout 
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5.1 Introduction 
 
2.1.1 Sewage and industrial waste effluents 
 
Discharges from sewage as well as industrial outfalls have the potential to 
cause environmental impacts to surrounding aquatic ecosystems. In the United 
Kingdom, approximately 347,000 kilometres of sewers collect over 11 billion litres of 
waste water each day. This is subsequently treated at around 9,000 sewage 
treatment works across the UK before the effluents are discharged into inland 
waters, estuaries and the sea (DEFRA, 2002). The United Kingdom is obligated to 
meet its commitments for the treatment of sewage under the Urban Waste Water 
Treatment Directive (CEC, 1991). A host of chemicals including pharmaceutical 
compounds such as EE2 which is a synthetic hormone (Verlicchi et al., 2012), natural 
and other synthetic oestrogens, degradation products of alkylphenol ethoxylate 
surfactants, and plasticisers are frequently present in these effluents across the 
world (Metcalfe et al., 2009). Most sewage treatment works are not equipped to treat 
complex pharmaceuticals (Onesios et al., 2009) and shifts in biodiversity at sewage 
effluent discharge sites have been widely documented at both freshwater and marine 
sites (Manning, 1979; Brown et al., 1990; Adams et al., 2008). The natural oestrogen 
E2 is frequently detected in considerably high concentrations in sewage effluents, 
measuring from between 5 and 50 ng/l (Desbrow et al., 1998; Lee and Peart, 1998), 
and when E2 is present, its metabolites estrone (E1) and estriol (E3) are usually also 
present (Lee and Peart, 1998). These three oestrogenic hormones, along with EE2 
are the main chemicals behind detectable oestrogenicity of sewage effluents (Hamid 
and Eskicioglu, 2012).  Full-scale engineered wastewater treatment plants (WWTPs) 
and those utilizing activated sludge system with nutrient removal are highly efficient 
in removing oestrogens. The complete removal of such micropollutanst is, however, 
not a criterion such treatment plants are required to fulfil, resulting in incomplete 
removal (Hamid and Eskicioglu, 2012). Rainbow trout has been shown to be highly 
responsive to oestrogenic sewage effluents (Purdom et al., 1994). This corresponds 
to other published data showing that rainbow trout is highly sensitive to oestrogens, 
more so than many other teleosts (Van den Belt et al., 2003). In the wild, animals are 
more likely to come into contact with a host of chemicals, which may lead to 
synergistic response. Combination exposures in rainbow trout have reported 
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synergism where a combined exposure to a range of oestrogens induces a 
significantly greater response than single oestrogen at identical concentrations 
(Routledge et al., 1998). Two types of ERs have been described from rainbow trout; 
esr1 and esr2, each of which has two isoform versions. E2 induces only of of the 
esr1 isoforms (ERα1) mRNA expression, but not that of the other isoforms (Boyce-
Derricott et al., 2008).  
 
 
2.1.2 Telomerase regulation and oestrogen 
 
Telomerase, also called telomere terminal transferase, is a ribonucleoprotein 
enzyme whose main function is to counteract the end-replication problem, the 
gradual erosion of telomere ends in Eukaryotic cells. Telomerase reactivation, and 
thus telomere stabilization, is a major step in the development of most cancers (Shay 
and Bacchetti, 1997), indicating that telomerase seems to be a reliable marker of 
malignancy in many tumours. TERT upregulation seems to be a vital step in the 
development of ovarian cancer (Kyo, Kanaya et al, 1999) as well as many other 
cancers (Miura, et al, 2010, Pacini et al, 2011). Telomerase activity, as well as the 
expression of the telomerase catalytic subunit TERT, has been suggested to be 
good for use as biomarkers for malignant tumors in humans (Mantripragada et al., 
2008). The regulation of telomerase is not fully understood but seems to happen at 
many levels; via transcription and post-transcriptional splicing, also by maturation 
and modification of the two main telomerase components, TR and TERT. The 
subsellular localization of each of these components is also vital in telomerase 
regulation, as well as the process of protein assembly and its ability to access the 
telomeres (Cong et al., 2002). Oestrogens have been shown to activate telomerase 
in esr1-positive human cell lines through the trans-activation of the telomerase 
catalytic subunit, hTERT (Kyo, Takakura et al., 1999, Misiti et al, 2000). E2 has also 
been shown to induce the hTERT mRNA production and telomerase activity in 
various human normal and cancerous cell lines in a dose-dependent manner (Nanni 
et al., 2002; Gao et al., 2003, Benvenuti et al, 2005). The hTERT promoter region 
contains a degenerate ERE which specifically binds to the ER, and studies have 
shown that oestrogen-activated ER binding to this element leads directly to 
transcriptional activation (Kyo, Takakura et al, 1999). Oestrogen activated ER 
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furthermore induces the expression of c-Myc, a regulatory protein that codes for a 
transcription factor, which then binds to E-boxes in the promoter region of hTERT, 
resulting in indirect upregulation by activated ER. Human TERT furthermore contains 
a sp1/ER motif that weakly functions as an ERE site, with much less binding 
between oestrogen-activated ER and the site, leading to much less transcriptional 
induction (Kyo, Takakura et al, 1999). These findings are most significant and help to 
explain the roles and interaction of oestrogen and telomerase, and suggest that 
oestrogen regulates telomerase transcription and activity in many physiological 
processes involving ER-positive cells. The main mediators seem to be ER, ERE, c-
Myc and Activation protein 1 (AP1) (reviewed in Bayne and Liu, 2005). Research 
does in fact suggest that the presence of oestrogen is necessary for telomerase 
activation in some tissues. Bayne and colleagues (2008) artificially disrupted 
oestrogen expression in mice, resulting in oestrogen deficiency, which directly lead 
to inhibition of telomerase activity in their adrenal glands. Another example of 
oestrogenic regulation of telomerase is the human endometrium. Telomerase activity 
is present in many human reproductive organs like the ovaries and testis (Wright et 
al, 1996), as well as the endometrium (Tanaka et al, 1998). In the endometrium, 
telomerase activity, as well as c-Myc expression, does however remain very low 
throughout menstruation when circulatory oestrogen remains low, but increases 
greatly once the endometrium begins to regenerate and oestrogen is increased 
(Tanaka et al, 1998). 
Oestrogen plays a pivotal role in differentiation and regeneration in many cell 
types and tissues, often inducing growth (Diel, 2002, O’Donnell et al, 2001, 
Nicholson et al, 1999, Razandi, 2003), an example of this is angiogenesis in the 
human placenta (Albrecht and Pepe, 2010). It is worth noting that oestrogen plays a 
direct role in tumorigenesis and tumour pogression in several different cancers, 
including endometrial cancer, by stimulating cell proliferation (Sutton, 1990) whilst 
the anti-oestrogen TAM significantly reduces the risk of developing oestrogen-
responsive cancer (Fisher et al, 1998). The mechanism by which oestrogen does 
this has not been fully explored and explained, but as noted above oestrogen has 
the ability to affect gene expression of various transcription factors through the ER, 
including several genes that play a role in cell proliferation, like c-Myc (deNardo et al, 
2005). It is therefore likely that oestrogens ability to induce telomerase activity is in 
some part responsible for these effects. Other oestrogen-responsive cancers include 
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breast cancer, with mutations in the two breast cancer susceptibility genes BRCA1 
and BRCA2 responsible for tumorigenesis in most families with hereditary breast and 
ovarian cancers (Thompson et al, 2002, Wooster et al, 1995). The BRCA1 gene is 
expressed in high concentrations in differentiating mammary epithelial cells both in 
vivo and in vitro in mice, acting as a tumour suppressor (Marquis et al, 1995, Rajan 
et al, 1997).  Women who inherit certain mutations of this gene are more susceptible 
to develop both breast and ovarian cancer (Hakem et al, 1996, Somasundaram et al, 
1997). Interestingly BRCA1 has been shown to inhibit telomerase activity in human 
cell lines by blocking the hTERT promoter as well as inhibiting c-Myc-dependent 
transcriptional processes (Xiong et al, 2003).  
Stepping away from humans and mammals, one should note that some work 
has been performed on telomerase expression in fish. In most of the species 
studied, telomerase activity seems to be ubiquitously expressed in somatic tissues of 
fish (Elmore et al, 2008). In Japanese medaka and the marine medaka (Oryzias 
melastigma) the TERT protein is localized to the nucleus in all tissues, similar to that 
of human cells (Kong et al, 2008). In the latter of the two, telomerase activity exists in 
regenerative, reproductive as well as somatic tissues of adult fish, with much higher 
activity detected in testes than ovaries (Au et al, 2009).  In zebrafish telomerase is 
ubiquitously expressed in somatic tissues (Kishi et al, 2003) and in rainbow trout, 
telomerase activity can be detected in liver, skin, heart, muscle and brain, 
irrespective of the age or size of the fish tested, except in brain where gradual 
reduction was observed with age (Klapper et al, 1998). It is worth noting that a 
relationship between oestrogen metabolism and telomerase regulation has been 
established in fish. In marine medaka a positive correlation exists between oestrogen 
concentrations, the expression of esr1 mRNA and telomerase activity in the liver. 
Furthermore a clear difference existed between females and males, with females 
showing a greater correlation. It has been suggested that this difference is 
connected with the longevity gender gap females living longer than males reflected 
in this species of fish (Piu, 2011). 
Another endocrine-disrupting chemical which is most topical in the modern 
scientific discussion is BPA, a chemical used in the production of polycarbonate 
plastics and epoxy resins which are then used to make a range of products from 
food and drinks packaging to dental sealants. BPA has been detected in surface-
water and freshwater streams of up to a concentration of about 2000 ng/l, with 
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occasional one off measurements of up to 21 μg/l (Belfroid et al, 2002, Quednow and 
Püttmann, 2008). It has been shown to be oestrogenic and most of its effects on test 
species are believed to be due to its ability to act as an ER antagonist. But it is also 
capable of exerting effects through alternative molecular mechanisms not involving 
ER binding. One example is that in humans it seems to have a high affinity for ERR γ 
(Matsushima et al, 2007) and is able to alter expression of ERR alpha (ERRα) 
(Melzer et al., 2011). BPA has been shown to affect a range of physiological 
processes in vertebrate species. High exposure to BPA has been shown to 
negatively affect foetal survival and growth in rodents without inducing 
dysmorphogenesis (Kim et al, 2001). In fish, BPA has been shown to induce 
vitellogenin synthesis (Van den Belt et al, 2003), interfere with spermatogenesis 
(Haubruge et al, 2000) and induce feminization of the gonads in fish, reptiles and 
birds, although these take place at concentrations higher than those found in the 
environment (Crain et al, 2007). What is also worth noting is that BPA has been 
shown to up-regulate TERT transcription in human cell lines (Takahashi et al, 2004).  
  
5.2 Aims and Objectives 
 
The primary objectives of this study were firstly to examine the effect of 
oestrogenic exposure on telomerase activity in rainbow trout hepatocytes, and 
secondly to examine the effect of oestrogenic exposure on mRNA expression of 
TERT in rainbow trout embryos and larvae. The means by which this was done was 
to expose rainbow trout embryos to the oestrogen E2 and the manufactured 
compound BPA in order to establish whether and to what extent these can influence 
the modulation of the mRNA expression of the omTertLong and omTertShort splice 
variants during the embryonic development of rainbow trout. During the embryonic 
exposure growth and mortality of the animals was also monitored. A hepatocyte 
exposure was also performed, with the aim of evaluating the effects E2 has on the 
activity of the telomerase TERT protein itself. The concentrations chosen where of 
environmental relevance; E2 being one of the principal components responsible for 
oestrogenic activity in sewage treatment works effluents (it has been found in 
sewage effluents up to 50 ng/l, in: Desbrow et al., 1998) and BPA being a widely 
used component in the manufacturing of polycarbonate polymers and epoxy resins 
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(Belfroid et al, 2002, Quednow and Püttmann, 2008). We furthermore examined the 
effects of a known anti-oestrogen, TAM, in order to determine whether the effect 
observed from oestrogen exposure was mediated via ER binding mechanism. 
Furthermore we hope to establish whether the two distinct splice variants previously 
isolated and characterized in this study respond differently to these chemicals, which 
may provide us with further understanding of whether these play different roles in 
telomerase modulation. In order to accomplish the latter, the following hypotheses 
were addressed: 
 
A. The natural steroid hormone E2 and the ER agonist BPA can disrupt the 
embryonic development of the rainbow trout. 
B. The natural steroid hormone E2 and the ER agonist BPA inhibit growth and 
reduce survival of early life-stages of rainbow trout.  
C. The natural steroid hormone E2 induces telomerase activity in hepatocyte 
cell cultures of rainbow trout. 
D. The natural steroid hormone E2 and the ER agonist BPA induce the mRNA 
expression of the two splice variants of the main catalytic subunit of 
telomerase, TERT, in early life-stages rainbow trout. 
E. The two model species are affected by exposures to the two oestrogenic 
chemicals, E2 and the ER agonist BPA, reflected both in their 
developmental success as well as transcriptional efficiency. 
 
Overall, these results may provide us with a better understanding of the scope of 
environmental risk E2 and BPA pose, as well as further our understanding of the role 
oestrogens play in the modulation of the of the enzyme telomerase and its wider 
function in telomere maintenance. 
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5.3 Materials and Methods 
 
5.3.1 Telomerase activity in in primary cultures of rainbow trout hepatocytes 
exposed to E2 – preliminary study 
 
Primary cultures of rainbow trout hepatocyte cells were exposed to two 
concentrations of E2; 20 and 2 ng E2/ml, to quantify the degree to which telomerase 
activity is modulated by exposure. They were also exposed to a telomerase inhibitor, 
AZT. Ethanol was used as a solvent at a concentration of 0.05% when preparing the 
E2. Cells were cultured at 12ºC and the exposed cell cultures were monitored 
throughout the entire experiment during which samples taken at several time-points: 
12, 24, 36, 48 hours after time of exposure. At the end of the experiment the sample 
extracts analysed for telomerase activity using a variation of the TRAP assay 
(method in chapter 2.2).  
 
5.3.2 Rainbow trout embryos – early life-stages chemical exposures 
 
In preparation for rainbow trout embryonic exposure to the two oestrogenic 
chemicals, E2 and BPA, female and male gametes were collected from adult rainbow 
trout were collected from a trout farm in Dorset, South West England (Hooke Springs 
Trout Farm, Hooke, Beaminster, Dorset, DT8 3NZ). These were fertilized and then 
rinsed and allowed to harden in clean freshwater until 2 hpf when they were 
transferred to ten different experimental exposure wells, 130 embryos in each. These 
pyrex glass pots contained the following experimental chemicals, these being: the 
sex steroid E2, the major oestrogen in humans; the antioestrogen TAM, an 
antagonist of the ER; BPA, an oestrogen mimic; and AZT, an inhibitor of retroviral 
reverse transcriptase. The exposure concentrations were made up in dechlorinated, 
filtered freshwater and were as follows: 0.1 ng, 20 ng and 500 ng E2 / ml; a 
combination exposure of 500 ng E2 and 0.019 ng TAM / ml; 150 ng and 600 ng BPA 
/ ml; and 100 M AZT. The E2, TAM and BPA stock solutions were made up with 
dimethyl sulfoxide (DMSO) for a final solvent concentration in exposure wells of 
0.05%. The AZT stock solution was made up with ethanol (EtOH) for a final solvent 
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concentration in exposure wells of 0.01%. The controls were as follows: a freshwater 
control; a 0.01% EtOH control; and a 0.05% DMSO control. 
Throughout the exposure, water changes were performed every other day, with 
the same exposure concentrations. The fish were kept under a constant photo-
period of 16 hours light/8 hours dark and once old enough to feed they were fed to 
satiation twice a day firstly with powdered feed, Liquifry No. 1 (Interpet, Dorking, 
U.K.) and live Artemia (ZM Ltd., Hampshire, U.K.), and then later with live and frozen 
Daphnia (Tropical Marine Center, Chorleywood, U.K.). The animals were monitored 
for mortalities twice daily. The water temperature and quality was examined at 
regular intervals, testing for both nitrite (NO2
-) and nitrate (NO3
-). In preparation for 
the detection of the mRNA expression of the telomerase catalytic subunit TERT, 
whole embryos and larvae were sampled at several time points throughout their 
development: 12, 14, and 37 dpf by immediate immersion in liquid nitrogen. At 167 
dpf fry were killed by terminal anesthesia using benzocaine (Sigma, Missouri, USA) 
at a 0.5g/l concentration (ethyl-p-aminobenzoate, C9H11NO2), once killed whole body 
weight was measured and tissue samples taken from brain, muscle and liver. All 
protocols involving animal use were carried out ethically in accordance with U.K. 
Home Office guidelines.  
The fish embryos and larvae in the control exposures were imaged throughout 
their development and the physical growth (fork length) of fish in all exposures was 
measured at 49 dpf with the use of photo-imaging and then fork length at point of 
death was measured at 167 dpf. The development of the trout embryos was plotted 
and their growth and mortality rate evaluated during the 167 day exposure.  
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5.3.3 Quantitative PCR for the amplification of rainbow trout TERT mRNA 
expression 
 
Two quantitative PCR assays have been previously designed (chapter 4) for 
the detection of the two splice variants of rainbow trout TERT, omTertShort which is 
a short variant and omTertLong which is a long variant, these are as follows. 
 
For the qPCR amplification of the rainbow trout TERT long splice variant, a 
previously optimized qPCR assay was used (chapter 5), utilizing oligonucleotide 
primers omQLONG-FW1 (5´- CGGGTGTGTGGTGAAC-3´) and omQLONG-RV1 (5´-
GGCGTAGTTGTTGTAGAC -3´) at annealing temperature T=59ºC with 88.5% PCR 
efficiency. 
For the qPCR amplification of the rainbow trout TERT short splice variant a 
previously optimized qPCR assay was used (chapter 5), utilizing oligonucleotide 
primers omQSHORT-FW3 (5´-GCACAGACCTTCCTCAAG -3´) and omQSHORT-
RV3 (5´-GCCAGCGTAGCCAAAG -3´) at annealing temperature at T=59ºC with 
94.1% PCR efficiency. 
For normalization purposes, to allow for relative quantification, to confirm the 
integrity of cDNA and to control for any pipetting errors, each of the samples were 
also amplified for a chosen housekeeping gene (non-responsive to the exposures), 
the ribosomal protein L8 (rpl8). The assay used was performed according to a 
previously optimized quantitative PCR assay for use in rainbow trout (Tyler et al, 
2009). The primers used were an rpl8 sense primer (5´-
ACAACCCAGACACCAAGAAG-3´) and an rpl8 anti-sense primer (5´-
CAGCAACCACACCAACAAC-3´) which yields a product size of 96 bp, with 
optimized annealing temperature at T=60ºC and a 110% PCR efficiency. 
Total RNA was extracted using Tri reagent (Sigma-Aldrich, Missouri, USA) 
following manufacturer’s instructions. To further clean the RNA samples from poly-
mucosaccharides (known to interfere with downstream processes, e.g. PCR) the 
samples were purified with RNeasy Mini kit RNA extraction columns (Quiagen, 
Crawley, West Sussex, UK) which incorporate a DNase step. Complementary DNA 
was synthesized from each of the exposure using 2μg total RNA, random hexamers 
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synthesized by Eurofins MWG Operon (Acton, London) and M-MLV reverse 
transcriptase (Promega, Fitchburg, Winsconsin) as per manufacturer’s instructions.  
Target mRNA was amplified in the Quantica Real Time qPCR Thermal Cycler 
(Techne, Bibby Scientific Ltd., Beacon Road, Stone, Staffordshire, UK), with a 
triplicate amplification for each of the sample biological replicates. Before beginning 
the procedure the ROX dye is diluted to 1.25% concentration. The total PCR reaction 
for each replicate was 15 μl using the bsolute qPCR master mix (Thermo-Scientific, 
Waltham, Massachusetts, USA) which includes a ROX passive reference dye. Each 
PCR reaction was made up of the following: 7.5 μl Absolute blue reaction mix, 0.06 
μl ROX dye dilution, 5.94 μl H20, 0.375 μl forward primer, 0.375 μl reverse primer, 
0.75 μl sample cDNA. For each plate two negative controls were included, without a 
cDNA template and the other without reverse transcriptase. 
The PCR reaction was as follows: 1) denaturation at 95ºC for 15 minutes, 2) 
amplification through 40 cycles of a) 95ºC for 15 seconds, b) annealing at 59ºC (60 
ºC for rpl8) for 60 seconds, c) extension at 72ºC for 30 seconds, 3) followed by a 
dissociation curve analysis.  
 
5.3.4 Data analysis  
 
The statistical analysis for the rainbow trout fry length measurement and 
mortality data was performed using Minitab® Statistical Software (Minitab Inc). 
Statistical differences in length data were analysed with Kruskal-Wallis one-way 
analysis of variance by ranks, with Dunn’s multiple pairwise comparison test for post-
hoc analysis for non-normally distributed data and with one-way ANOVA with a 
Fishers LSD post-hoc test for normally distributed data. The statistical analysis for 
mortality data were analysed with Friedman’s method for randomized blocks. 
Differences were considered statistically signiﬁcant at p<0.05. 
 
For the analysis of rainbow trout TERT mRNA expression, a mathematical 
model proposed by Pfaffl (Pfaffl, 2001) was used to calculate its relative expression 
levels in the samples examined. The method compares the relative expression of the 
 203 
gene of interest to that of a housekeeping gene, yielding a relative expression ratio 
between exposure samples and controls (Equation 1). This method has been shown 
to provide higher reproducibility than many of the previously recognised methods. It 
simultaneously provides comparative results between a control and a test sample, as 
well as correcting for PCR efficiency differences between the gene of interest and 
the housekeeping gene, and the results are expressed as a ratio between the two 
relative expressions. 
 
Equation 1: An equation for the calculation of the relative expression ratio (R) 
according to the Pfaffl method. Etarget is the PCR efficiency of the gene of 
interest, Eteference is the PCR efficiency of the reference gene, CP is crossing 
point, ΔCP is the deviation of crossing point of the control subtracted by an 
exposed sample; ΔCPtarget for the gene of interest and ΔCPreference for the 
reference gene. 
 
 
 
Statistical differences in relative mRNA expression between experimental 
exposures were analysed with Kruskal-Wallis one-way analysis of variance by ranks, 
with Mann-Whitney U test post-hoc analysis for non-normally distributed data and 
with one-way analysis of variance (ANOVA) for normally distributed data, followed by 
Bonferroni correction. Normality of data was analysed with Lillefors test. The 
statistical analysis for the qPCR data was performed using the freeware program 
Open Stat version 08.11.12 (http://www.statpages.org/miller/openstat). Differences 
were considered statistically signiﬁcant at p<0.05. 
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5.4 Results 
 
5.4.1 Telomerase activity in in primary cultures of rainbow trout hepatocytes 
exposed to E2 – preliminary study 
 
Primary cultures of rainbow trout hepatocyte cells were exposed to two 
concentrations of E2; 20 and 2 ng E2/ml (method in chapter 2.1.2). The TRAPeze 
assay yielded varied results. In many of the samples the supposedly heat-inactivated 
extracts showed similar activity to that in the other samples. The only sample that 
yielded acceptable results was that taken at 36 hours. When examining the results 
(Figure 61) it is clear that telomerase activity has been significantly induced at 20 
ng/ml E2 exposure (two-way ANOVA: F=4.30, 23 d.f., p<0.05). This induction was 
subsequently reversed when exposed to AZT. There was, however, no significant 
difference between the control, the AZT exposure and the 2ng/ml E2 exposure which 
may suggest that the telomerase activity in the controls is well below the detection 
level of this assay, for one would expect significant reduction in the AZT exposures 
when compared to the controls. One point that must be mentioned is that the 
concentration of telomeric repeats AG(GGTTAG)7) extensions (amole/Rx) in these 
samples is high when compared to that in the sea urchin exposure documented in 
chapter 0 (Figure 22), which would suggest that these results should reflect actual 
telomerase. But seeing as the TRAPeze analysis of most of the exposure samples 
failed, just as it did with the purple sea urchin samples (chapter 0), the efficacy and 
reproducibility of this assay must be called into question. 
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Figure 61. The concentration of telomeric repeats AG(GGTTAG)7) extensions 
in primary cultures of rainbow trout hepatocytes after 36 hours of exposure to 
two concentrations of E2, 2 and 20 ng/ml, and a telomerase inhibitor AZT at 100 
M. Statistically significant differences are denoted by stars (*), p<0.05. 
 
 
5.4.2 Rainbow trout embryo exposure 
 
5.4.2.1 Exposure effect endpoints: growth and mortality 
  
Rainbow trout embryos/larvae and fry were exposed to E2 and BPA and their 
growth / length was imaged (Figure 62, Figure 63 and Figure 64) and measured, 
and their mortality recorded throughout the exposure (Figure 66 to Figure 69).  
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Figure 62. Normal embryonic development of rainbow trout in a freshwater 
control exposure, incubated at 12ºC. a) Fertilized rainbow trout egg at 4 hpf, b) 
rainbow trout embryo at 7 dpf (days post fertilization), c) rainbow trout embryo 
at 9 dpf, d) rainbow trout embryo at 12 dpf, e) rainbow trout embryo at 14 dpf, 
f) rainbow trout embryo at 19 dpf, g) rainbow trout embryo at 23 dpf, h) 
rainbow trout larvae at 37 dpf, i) rainbow trout fry at 49 dpf.
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Of the two length measurements made during the exposure, at 48 and 167 
dpf, the former of these were non-normally distributed (Levene’s test; W=2.74, 
p=0.04), whereas the data from the measurements taken at 167 dpf were normally 
distributed (Levene’s test; W=2.46, p=0.073). When examined, the results show that 
the growth of the fish is significantly influenced by some of the test exposures 
(Figure 63 and Figure 64).  
Significant reduction in length was observed between the controls and the test 
exposures (Kruskal-Wallis; H=231.27, 9 d.f., p<0.001). It revealed that after 48 days 
of exposure, rainbow trout fry are significantly shorter in the test exposures E220 
(Z=7.30, p<0.001), E2500 (Z=7.60, p<0.001) and BPA600 (Z=8.47, p<0.001) than in 
the controls. Furthermore, a clear response can also be seen in the two chemical 
controls, the combined TAM/E2500 (Z=6.80, p<0.001) and AZT (Z=8.60, p<0.001) 
exposures. 
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Figure 63. The measured lengths of rainbow trout fry at 48 dpf. Data is 
expressed as the mean of length ± standard error. Each experimental group 
contained between 10 and 46 individuals. Statistically significant differences 
as revealed by Kruskal-Wallis one-way analysis of variance by ranks (Minitab) 
are denoted by stars (*), p<0.001. 
 
 The length measurement dataset collected on day 167 dpf was normally 
distributed (Levene’s test; W=2.46, p=0.073) and so a one-way ANOVA with a 
Fishers LSD post-hoc test was performed in Minitab showing that the length 
measurements at this timepoint differed significantly. It revealed that the fish in the 
E2 0.1 test exposure differed significantly from the controls (one-way ANOVA; 
F=3.98, 4 d.f., p<0.05). Neither of the BPA exposures differed from the controls. At 
this point all the animals in the two higher E2 exposures, E220 and E2500, were 
dead. 
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Figure 64. The measured lengths of rainbow trout fry at 167 dpf. Data is 
expressed as the mean of length ± standard error. Each experimental group 
contained between 4 and 8 individuals. Statistically significant differences as 
revealed by one-way ANOVA (Minitab) are denoted by stars (*), p<0.05. 
 
The weight of the animals sampled at 167 dpf was measured and at this point 
and significant increase was observed in fish exposed to 0.1 ng E2/ml, but not in 
either of the two BPA exposures (one-way ANOVA; F=4.02, 55 d.f., p<0.05) (Figure 
65). 
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Figure 65. The measured weights of rainbow trout fry at 167 dpf. Data is 
expressed as the mean of weight ± standard error. Each experimental group 
contained between 4 and 8 individuals. Statistically significant differences as 
revealed by one-way ANOVA (Minitab) are denoted by stars (*), p<0.05 
 
The mortality rate of the test animals was recorded throughout the 167 day 
exposure. A graphical analysis of the data indicates that the mortality rate in all 
exposure tanks increased after hatching which took place between days 28 and 36 
dpf, with much greater mortality in the E220 and E2500 exposures, as well as the 
combined 0.019 g/l TAM and 500 ng/ml E2 exposure (Figure 66). 
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Figure 66. Interaction graph for Mortality rates (%) of embryos, larvae and fry 
throughout the exposure. Exposures: 1=Control, 2=EtOH, 3=DMSO, 4= E20.1, 
5= E220, 6= E2500, 7=TAM, 8=AZT, 9=BPA150, 10=BPA600. 
 
Statistical differences in mortality between exposures throughout the 167 days 
was analysed using Friedman’s method for randomized blocks. A significant 
difference was observed both between exposures (blocking for time-point, S=113.21, 
9 d.f., p<0.001) as well as over the time-period observed (blocking for exposure, 
S=114.80, 13 d.f., p<0.001). In the E2 exposures the mortality rate did not start to 
increase above that of the controls until after hatching which took place between 
days 28 and 33 in these relevant exposures. In the lowest E2 exposure, E2 0.1 
ng/ml, no significant increase in mortality was observed. Significant increase in 
mortality was however observed in the two higher concentrations, E2 20 and E2 500 
ng/ml, as well as the combined 0.019 g/l TAM and 500 ng/ml E2 exposure (Figure 
67). 
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Figure 67. Mortality rates (%) of developing rainbow trout young, tracked over 
167 day exposure of to E2 at three concentrations E20.1 E2/ml, E220 (20ng 
E2/ml) and E2500 (500ng E2/ml) as well as combined exposure to the 
antioestrogen TAM and E2 (0.019ng TAM/ml + 500ng E2/ml. Data is expressed 
as the proportion of dead animals out of original number exposed (%). Each 
experimental group originally contained 130 individuals. Statistically 
significant differences as revealed by Friedman’s method of randomized 
blocks (Minitab) are denoted by stars (*), p<0.001. 
 
As opposed to that which was observed in the E2 exposures, no significant 
difference was observed between either of the BPA concentrations, 150 and 600 
ng/ml BPA, or the controls Figure 68). In the 100 M AZT exposure, the mortality 
rate gradually increases throughout the later stages of the exposure. No immediate 
increase is observed after hatching (Figure 69). 
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Figure 68. Mortality rates (%) of developing rainbow trout young, tracked over 
167 day exposure of to BPA at two concentrations BPA150 (150ng BPA/ml) 
and BPA600 (600ng BPA/ml). Data is expressed as the proportion of dead 
animals out of original number exposed (%). Each experimental group 
originally contained 130 individuals. Statistically significant differences as 
revealed by Friedman’s method of randomized blocks (Minitab) are denoted by 
stars (*), p<0.001. 
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Figure 69. Mortality rates (%) of developing rainbow trout young, tracked over 
167 day exposure of to 100 M AZT. Data is expressed as the proportion of 
dead animals out of original number exposed (%). Each experimental group 
originally contained 130 individuals. Statistically significant differences as 
revealed by Friedman’s method of randomized blocks (Minitab) are denoted by 
stars (*), p<0.001. 
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5.4.2.2 Exposure effect endpoints: TERT mRNA expression 
 
Out of the two qPCR assays for the amplification and detection of the two 
splice variants of trout TERT mRNA, the omTertLong and omTertShort (chapter 
4.4.2 above), only the former of the two was successful in amplifying TERT mRNA. 
The assay designed to amplify omTertShort failed to do so in any of the 
samples/exposures examined. Expression of omTertLong was clearly detectable in 
all life stages and tissues examined, these include; whole embryos at 12 and 14 dpf, 
alevins larvae at 37 dpf and brain, liver and muscle tissue from 167 day old fry. No 
significant difference in amplification was observed between the three controls; 
freshwater, EtOH and DMSO. Since RNA extraction from the two whole embryo 
extracts from the two BPA exposures, BPA150 and BPA600, failed these were not 
available for use. 
In whole 12 day old rainbow trout embryos it is clear that the overall 
omTertLong mRNA expression is significantly induced when exposed to the highest 
E2 concentration, E2500 (500 ng E2/ml) (Mann-Whitney U-test: U=0, z=2.18, p<0.05), 
this induction is reversed in the combined exposure of the antioestrogen TAM  and 
E2500. At this time point neither of the other two E2 exposures has an effect on 
omTertLong mRNA expression (Figure 70). In whole 14 day old rainbow trout 
embryos, however, omTertong mRNA expression also was significantly induced 
(one-way Anova: F(6,11) = 5.36, p<0.05) but this time in both of the two higher E2 
exposures, E220 and E2500, when compared to the controls (Figure 71) 
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Figure 70. Expression of omTertLong mRNA in unhatched rainbow trout 
embryos at 12 dpf as determined by qPCR. The results are espressed as the 
ratio of omTertLong mRNA/ RPL8 mRNA and represented as median ± 
standard error. Each experimental group contained 3-6 individuals and each 
individual was analysed in triplicate. Statistically significant differences are 
denoted by stars (*), p<0.05. 
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Figure 71. Expression of omTertLong mRNA in unhatched rainbow trout 
embryos at 14 dpf as determined by qPCR. The results are espressed as the 
ratio of omTertLong mRNA/ RPL8 mRNA and represented as mean ± standard 
error. Each experimental group contained 3-6 individuals and each individual 
was analysed in triplicate. Statistically significant differences are denoted by 
stars (*), p<0.05. 
 
Once hatched, the fish were yet again sampled, this time alevins larvae at 37 
dpf. The results reveal that BPA significantly induces omTertLong mRNA expression 
at the higher concentration of BPA600 (600 ngBPA/ml) (Mann-Whitney U-test: 
U=8.0, z=1.75, p<0.05). Furthermore, omTertLong mRNA expression seemed to be 
significantly inhibited in the highest of the E2 exposures, E2500 (Mann-Whitney U-
test: U=8, z=1.75, p<0.05) when compared to the controls. This effect is reversed in 
the combined TAM/E2500 exposure (Mann-Whitney U-test: U=6, z=1.73, p<0.05) 
(Figure 72). 
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Figure 72. Expression of omTertLong mRNA in rainbow trout hatched alevins 
larvae at 37 dpf as determined by qPCR. The results are espressed as the ratio 
of omTertLong mRNA/ RPL8 mRNA and represented as median ± standard 
error. Each experimental group contained 3-6 individuals and each individual 
was analysed in triplicate. Statistically significant differences are denoted by 
stars (*), p<0.05. 
 
Having noted that overall omTertLong mRNA expression is significantly 
induced in two of the higher E2 exposures E220 and E2500 in whole embryo and 
larvae samples, the expression in these exposures were compared between the 
three sampling timepoints; 12, 14 and 37 dpf. There is no significant difference in 
omTertLong mRNA expession between the E220 exposures at the three timepoints, 
with great variation in relative expression rates. A significant difference is, however, 
observed when comparing expression in the controls as well as the E2500 
exposures. E2500 exposure show a significant drop in expression in hatched alevins 
larvae at 37 dpf (Kruskal-Wallis; H=6.49, 2 d.f., p<0.05) and in the controls 
expression is significantly greater in embryos at 14 dpf than before and after 
(Kruskal-Wallis; H=6.49, 2 d.f., p<0.05) (Figure 73). 
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Figure 73. Expression of omTertLong mRNA in rainbow trout embryos and 
hatched alevins larvae at 12, 14 and 37 dpf in controls as well as E220 (20 ng 
E2/ml) and E2500 (500ng E2/ml) exposures as determined by qPCR. The results 
are espressed as the ratio of omTertLong mRNA/ RPL8 mRNA and represented 
as median ± standard error. Each experimental group contained 3-6 individuals 
and each individual was analysed in triplicate. Statistically significant 
differences are denoted by stars (*), p<0.05. 
 
 At the end of the exposure, at 167 dpf, the remaining fry were killed and brain, 
liver and muscle tissues harvested. Results indicated mRNA expression of 
omTertLong is differentially responsive to the exposure chemicals between tissue 
types. In the brain, no significant induction of omTertLong mRNA expression was 
observed in any of the exposures (one-way Anova: F(4,18) = 1.89, p>0.16) (Figure 
74). Significant induction of omTertLong mRNA expression was, however, observed 
in both liver (Mann-Whitney U-test: U=26, z=2.01, Prob=0.022) and muscle (Mann-
Whitney U-test: U=2.0, z=1.73, prob=0.0416) tissues, whereas the two BPA 
exposures, BPA150 and BPA600, do yet again fail to effect of omTertLong mRNA 
expression (Figure 75 and Figure 76).  
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Figure 74. Expression of omTertLong mRNA in rainbow trout fry brain tissues 
at 167 dpf as determined by qPCR. The results are espressed as the ratio of 
omTertLong mRNA/ RPL8 mRNA and represented as mean ± standard error. 
Each experimental group contained 3-6 individuals and each individual was 
analysed in triplicate. 
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Figure 75. Expression of omTertLong mRNA in rainbow trout fry liver tissues 
at 167 dpf as determined by qPCR. The results are espressed as the ratio of 
Tert mRNA/ RPL8 mRNA and represented as median ± standard error. Each 
experimental group contained 3-6 individuals and each individual was 
analysed in triplicate. Statistically significant differences are denoted by stars 
(*), p<0.05. 
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Figure 76. Expression of omTertLong mRNA in rainbow trout fry muscle 
tissues at 167 dpf as determined by qPCR. The results are espressed as the 
ratio of omTertLong mRNA/ RPL8 mRNA and represented as median ± 
standard error. Each experimental group contained 3-6 individuals and each 
individual was analysed in triplicate. Statistically significant differences are 
denoted by stars (*), p<0.05. 
 
 In order to establish whether omTertLong mRNA expression differs between 
tissues in both normal/unexposed tissues as well as exposed tissues, significance 
tests were conducted on data from the control, the two BPA exposures BPA150 and 
BPA600 as well as the E2 exposure E20.1, and a comparison conducted between 
tissues. The relative mRNA expression of omTertLong showed no significant 
difference between liver, muscle and brain tissues in unexposed animals (control), 
whereas the lower of the two BPA exposures, BPA150 (Kruskal-Wallis: H=6.35, 2 
d.f.,  P=0.042), as well as the E2 exposure E20.1 (Kruskal-Wallis: H=6.06, 2 d.f.,  
P=0.048) cause omTertLong to be differentially expressed between tissues, with 
least mRNA expression in the brain (Figure 77). 
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Figure 77. Expression of omTertLong mRNA in rainbow trout fry tissue 
extracts from liver, muscle and brain harvested at 167 dpf from controls as 
well as E20.1 (0.1ng E2/ml) and BPA 150 (150ng BPA/ml) and BPA600 (600ng 
BPA/ml) exposures as determined by qPCR. The results are espressed as the 
ratio of omTertLong mRNA/ RPL8 mRNA and represented as median ± 
standard error. Each experimental group contained 3-6 individuals and each 
individual was analysed in triplicate. Statistically significant differences are 
denoted by stars (*), p<0.05. 
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5.5 Discussion 
 
The sheer volume of chemicals of both natural and anthropogenic origin 
released into the environment is a great concern (EEA, 2005, Roy et al., 1996). 
Many of these are naturally-produced steroid hormones or artificial homologues of 
them, which are absorbed by the fauna inhabiting the exposed habitats and often 
disrupt their normal hormonal functions (Gadd et al, 2005, Roy et al., 1996). Studies 
have shown that the majority of sewage effluents from sewage treatment works in 
the UK have detectable oestrogenic activity and that this can be detected several 
kilometres downstream from the outlet (Harries et al, 1997). Some of the main 
culprits responsible for the environmentally hazardous oestrogenic activity of these 
effluents are EE2, estrone and E2 (Desbrow et al, 1998). Another topical chemical 
pollutant is BPA, a chemical used in polycarbonate plastic and epoxy resin 
production which has also been shown to mimic oestrogenic activity (Matsushima et 
al, 2007). It is frequently detected in freshwater streams and surface waters (Belfroid 
et al, 2002, Quednow and Püttmann, 2008). Due to these chemicals being widely 
detected in environmental samples and their frequently observed teratogenicity, they 
are a popular target for the study of the mechanisms of environmental oestrogen 
action (Desbrow et al., 1998).  
One of the worrying aspects of the increased release of substances of both 
natural and anthropogenic origin into the environment every year (EEA, 2005, Roy et 
al., 1996) is the accumulating evidence of the occurrence of teratogenicity (Pagano 
et al., 1983, Seki et al, 2005), an example of which is the induction of telomerase 
activity and mRNA expression by oestrogens. It has been shown that telomerase 
activity can be regulated by human hormones, including oestrogens like E2 (Cong et 
al, 2002, Kawagoe et al, 2003, Kyo et al., 1999, Liu, 1999). In esr1-positive human 
cell lines, oestrogens have been shown to trans-activate the telomerase catalytic 
subunit, hTERT, and thus induce telomerase activity (Kyo, Takakura et al., 1999, 
Misiti et al, 2000). In various human normal and cancerous cell lines, the natural 
oestrogen E2 can induce the mRNA production of hTERT as well as increase 
telomerase activity in a dose-dependent manner (Nanni et al., 2002; Gao et al., 
2003, Benvenuti et al, 2005). 
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In this study, rainbow trout were exposed to two endocrine disrupting 
chemicals, E2 and BPA, in order to establish whether and to what extent these can 
influence the modulation of TERTt mRNA expression during the embryonic 
development of rainbow trout, as well as to attempt to further throw a light upon the 
mechanism by which oestrogenic chemicals affect telomerase. The results clearly 
show that the mRNA expression of the telomerase reverse transcriptase subunit 
TERT in rainbow trout embryos and fry tissue samples is effected by both E2 and 
BPA. Furthermore, telomerase activity is induced in hepatocyte cultures exposed to 
high concentration of E2, although the activity detected is extremely low in all 
samples so the exposure would need to be repeated in order for the results to be 
validated. 
This study has established that mRNA expression of the TERT long splice 
variant, omTertLong, is ubiquitously present in whole embryos and larvae, as well as 
in fry liver, brain and muscle tissues. This supports that which has been previously 
documented; that telomerase activity is ubiquitously present in eyed embryos of 
rainbow trout (Yoda et al., 2002) as well as several adult tissues; kidney, liver, skin, 
heart, muscle and brain (Klapper et al., 1998). This has also been observed in other 
fish species such as the zebrafish, where TERT mRNA is ubiquitously expressed in 
all tissues that have been examined (Lau et al, 2008). This ubiquitous expression of 
telomerase, combined with great cellular potency and capacity for tissue 
regeneration, suggests that fish tissues and embryos might make an excellent 
source for stem cells, although the role of telomerase in cellular proliferation in fish, 
as well as other aquatic animals, would first need to be further examined (Elmore et 
al. 2008). The present study failed to detect the short TERT splice variant, 
omTertShort, in any of the embryos, larvae or tissues examined, despite it having 
been first discovered in cDNA pool created with similar samples. In Japanese 
medaka, five TERT isoforms have been identified (Rao et al, 2011). The longest 
TERT mRNA splice variant olTERTa is ubiquitously expressed in embryos as well as 
several adult tissues; brain, liver, heart, ovaries, testis, and skin. Two of the other 
splice variants in medaka, olTERTb and olTERTc, which are truncated versions of 
the long one, are, however, differentially expressed. These are usually absent in 
early embryogenesis but become expressed as embryogenesis progresses with 
increased differentiation. Once expressed, these are usually tissue specific, with 
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olTERTb restricted to testis and olTERTc only detectable in differentiated cells (Rao 
et al, 2011). It seems that the four altered isoforms of TERT are expressed mainly 
where high levels of differentiation take place. It is highly likely that omTertShort is 
differentially expressed in rainbow trout, similar to that of the Medaka variants, and it 
is possible that the timepoints where this variant is expressed were not included in 
this study. A comprehensive analysis incorporating a wide range of sample 
timepoints, throughout embryogenesis and past hatching, as well as juvenile and 
adult tissues, would need to be performed in order to establish when this short 
variant is expressed and what role it plays. Another reason for why the present study 
failed to detect the short splice variant of rainbow trout TERT may be because it is 
expressed in such low concentrations that the qPCR assay was unable to detect it. It 
would be worth repeating this study, using alternative methods more suitable for the 
detection of extremely low concentrations of RNA (Hanley et al., 2013). 
The main conclusion of this work is that telomerase mRNA expression is 
significantly increased (p<0.05) in the presence of the two endocrine disruptors; E2 
and BPA, with the ER antagonist TAM reversing this effect, suggesting that the 
mechanism of this induction is through interaction with the ER. Furthermore, E2 
seems to affect embryonic growth in a dose-dependent manner, with significant 
increase in growth (length and weight) when exposed to 1.5 ng E2/ml (167 dpf) but 
stunted growth when exposed to higher concentrations of E2 (E2500 and E220; 500 
ng E2/ml and 20 ng E2/ml) (48 dpf). This correlates well with that seen in human 
breast cancer cells which response to oestrogen in ER-mediated and dose-
dependent manner, with concentrations higher than 10nM inducing cellular apoptosis 
(Song et al., 2002), but lower concentrations inducing cellular proliferation 
(Katzenellenbogen et al., 1987; Inoue et al., 2002). Furthermore, an alternatively 
sliced variant of TERT has been shown to stimulate cell proliferation in human 
somatic cells, without inducing telomerase activity (Hrdlikova, 2002b). In the rainbow 
trout exposures, these higher concentrations also lead to increased mortality in 
larvae after hatching, with TAM failing to reverse this effect, suggesting that this is a 
result of mechanisms not involving the ER. This is not surprising, for E2 is classified 
as a toxic chemical which can have acute as well as sub-lethal effects when exposed 
at high concentrations. In pregnant rats exposed to E2, it leads to reduced litter sizes, 
increased mortality post-partum and reduced success in carrying full term (WHO 
IARC, 1979) and a similar effect has been observed in zebrafish with increased 
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embryo and larval mortality following maternal exposure to E2 (Olsson et al, 1999). 
Although oestrogens have been shown to induce growth in certain tissues such as 
the human endometrium (Tanaka et al, 1998), in tissues such as the brain as well as 
the bone marrow oestrogen induces cell differentiation and growth only at normal 
concentrations (Curry and Heim, 1966, Jung-Testas et al, 1992, Tiftikcioglu et al, 
2012), At high exposure concentrations it suppresses growth in the bone marrow 
where high concentrations lead to myelotoxicity (Luster et al, 1984). Another 
example is in human prostate cancer cells, where E2 has long been known to 
suppress growth (Huggins and Hodges, 1941). The process by which E2 does this is 
potentially due to receptor dependent inhibition via esr2 (Ho et al., 2006; Pravettoni 
et al., 2007) or due to a receptor independent mechanisms. An example would be 
the metabolism of E2 into cytotoxic oestrogens like 2-methoxyoestradiol (Quadan et 
al., 2001). Cytotoxic oestrogens, which are naturally occurring metabolites of E2, 
have been shown to inhibit differentiation and induce apoptosis in non-carcinogenic 
cell model systems, such as in osteoclast bone marrow cells, a process which is not 
ER-dependent (Maran et al., 2006).  
When exploring the results of this study it is clear that the effects of these 
chemical exposures differ depending on what developmental stage the fish are at. 
Whole embryo extracts were analysed for mRNA activity at two time points when the 
trout were at embryonic level (12 and 14 dpf) and thus not hatched. At these time-
points E2 significantly induced omTertLong mRNA expression (p<0.05). On day 12 
TERT expression was increased in the highest of the E2 exposures, E2500 (500 ng 
E2/ml) and two days later, at day 14, an increase could also be detected in the E220 
(20 ng E2/ml) exposure as well as the E2500 (500 ng E2/ml) exposure. During this 
time the embryos go through high levels of cell differentiation and growth, with 
normal omTertLong expression significantly higher at 14 dpf than at 12 dpf and at 37 
dpf when the larvae have hatched. Similar patterns can be observed in mouse 
embryos where TERT is abundantly expressed in areas where high levels of cellular 
differentiation and division such as the limbs and tail in eleven day old embryos 
(Martin-Rivera et al., 1998). The results from this study indicate that the effect of the 
chemical is delayed in the E220 exposure when compared to the higher exposure. 
This may be because lesser concentrations take longer to produce a detectable 
effect. It is also worth noting that no effect is detected at the lowest E2 concentration, 
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E21.5 (1.5 ng E2/ml), which may suggest that the chorion membrane offers some sort 
of protection from the exposure as it has been shown to do with many types of 
environmental pollutants (Johnson et al, 2007), resulting in less concentrations of the 
chemical being absorbed into the embryos.  
Once hatched the pattern of effects seems to change, at 37 dpf whole alevins 
larvae were sampled, at which point no significant effect is seen in the two lower E2 
exposures, E21.5 and E220, whereas omTertLong mRNA expression in the highest 
E2 exposure E2500 seems to be inhibited. This may well be a sign of toxicity, 
although it is worth noting that TAM reversed this effect indicating that the 
mechanisms by which this takes place are through interaction with the ER. One 
might speculate that a negative feedback loop might play a role in this, for E2-bound 
ER’s have been shown to mediate negative feedback loops in androgen synthesis in 
human granulosa cells (Taniguchi et al., 2007). Further research is required in order 
to explain the mechanism by which E2 regulates telomerase in such a manner. 
Taking this notable inhibition into account it is interesting to note that after the trout 
have hatched, a significant increase in mortality is observed in the two higher E2 
exposures, E220 and E2500, as well as stunted growth. These effects are symptomic 
of toxicity and in this case not reversed by TAM. This indicates that at these 
concentrations E2 is toxic to the larvae through a mechanism that does not require 
ER binding. It is possible that this is due to high occurrence of DNA damage caused 
by high levels of E2 metabolites and free radicals released through E2 metabolism 
(Miller et al., 2003). As a result one would expect an increase in telomerase activity 
to counteract this with DNA repair (Chico et al., 2011; Terraadas et al., 2012), but 
this is not observed. 
As for the BPA exposures, the higher of the two BPA600 (600 ng BPA/ml) 
significantly induced omTertLong mRNA expression and led to stunted growth, 
whereas no significant difference was detected in the lower concentration BPA150 
(150 ng BPA/ml). Mortality was not significantly increased in either of the BPA 
exposures. It is clear that at high concentrations, BPA can modulate TERT 
expression, although the inhibition of growth is likely induced via a different pathway. 
BPA, as well as its methylated congeners, have been shown to inhibit growth in 
human fibroblasts (Lehmann and Metzler, 2004). This chemical is genotixic and 
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induces micronucleus formation at relatively low concentrations in mammalian cell 
lines (Johnson and Parry, 2008) and this may well explain the stunted growth in the 
exposed rainbow trout. As for BPA, it has been shown to be oestrogenic and cause 
transient embryonic deformities in medaka at sub-lethal concentrations (200 ng/ml) 
(Pastva et al, 2001). In rainbow trout, BPA has been shown to induce vitellogenin 
production in juveniles at concentrations of 1000ng BPA/ml (Van den Belt et al, 
2003). Furthermore, metabolites of this chemical have been shown to also have 
significant effect. The BPA active metabolite 4-methyl-2,4-bis(4-hydroxyphenyl)pent-
1-ene (MBP) is both more oestrogenic and toxic than BPA itself, inducing vitellogenin 
production in adult males and mortality in early life stages of the Japanese Medaka 
at much lower concentration than BPA (Ishibashi et al, 2005). MBP has also been 
shown to cause transcriptional inhibition of ER mRNA to a similar level of E2 in rats, 
when BPA exhibits none such effects (Okuda et al, 2010). It is therefore clear that 
further examination of the metabolism of BPA induction of TERT in rainbow trout and 
the and the potential effects of its metabolites, is in order.  
A time-related difference in omTertLong mRNA expression is observed in 
unexposed rainbow trout embryos and larvae, with expression significantly greater at 
14 dpf than before and after (p<0.05). The significance in this natural fluctuation is 
lost in E220 exposures, with great variability in the data. This suggests interruption of 
the natural fluctuations in omTertLong transcription due to the oestrogenic exposure, 
although no significant induction or inhibition is observed. This natural trend towards 
increased expression at 14 dpf is also lost in the E2500 exposures, although the 
mRNA expression inhibition exhibited in at 37 dpf is most significant (p<0.05) when 
compared to expression at previous time-points (12 and 14 dpf). This may well be 
due to protection offered by the chorion membrane, protecting unhatched embryos 
from absorbing the full concentration of E2 throughout the pre-hatching 
developmental stages. 
In order to try and establish whether any tissue dependent variability in 
transcriptional induction or inhibition occurs in early life-stages of rainbow trout 
exposed to E2 and BPA, the fish were continuously exposed for a prolonged period 
of time until the fry were large enough for tissue extraction. At 167 dpf, rainbow trout 
fry having been continuously exposed from time of fertilization were killed and three 
tissue types harvested: liver, muscle and brain. By this time mortality in the highest 
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E2 concentrations, E220 and E2500 had reached 100% and so these were not 
sampled at this time point. When the results are examined it is clear that different 
tissues respond differently to these exposures. The BPA exposures BPA150 and 
BPA600 had no significant effect on omTertLong mRNA expression in any of the 
tissues examined when compared to controls, whereas the E2 exposure E20.1 did. 
Significant induction (p<0.05) of omTertLong mRNA expression was observed in 
both rainbow trout fry muscle and liver tissues, whereas none were observed in brain 
tissue. This corresponds well with previously published data on the pattern of 
telomerase activity in rainbow trout tissues, where telomerase activity has been 
detected in kidney, liver, skin, heart, muscle and brain, with the highest activity in the 
kidney and liver, and the lowest in the brain (Klapper et al., 1998). Telomerase 
activity has also been examined in tissue samples from other fish species, with 
telomerase activity high in liver but low in brain in samples from little skate and 
dogfish shark. In mackarel, activity is higher in muscles than liver, but greatest in 
heart. In killifish, activity is present in liver, heart, gills, testes and eggs (Elmore et al., 
2008). The liver is a central station of metabolism, including that of steroid 
metabolism. It is therefore not surprising to see an increase in TERT expression in 
the exposed rainbow trout liver tissues. The liver has a remarkable capacity for 
regeneration, a process which is associated with telomerase activation, due to 
increased proliferation and consequentially an increased need for telomere 
maintenance (Wege and Brummendorf, 2007). The tissue analysis results from this 
study clearly show that the mechanisms of interaction between this splice variant of 
TERT, omTertLong, and oestrogen, differs between tissue types, suggesting a 
differential role played by telomerase. The above results are confirmed when relative 
mRNA expression is compared across tissues, with omTertLong mRNA expression 
similar across tissues in non-exposed fry (controls), but when the animals are 
exposed to E2, omTertLong mRNA expression is significantly less (p<0.05) in brain 
tissues than the other tissues examined. Cross-tissue comparisons of mRNA 
expression reveal another interesting point, where although exposure to BPA150 
does not induce mRNA expression in any of the tissues examined when compared 
to controls, it does cause omTertLong to be differentially expressed across tissue 
types (p<0.05). Exposed brain tissue samples express significantly less TERT 
mRNA than do liver and muscle samples, which is a trend not reflected in normal, 
unexposed fry (controls). This differential expression of TERT between tissues in 
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response to both BPA and E2 is a most interesting finding. Previous publications 
have suggested that oestrogen, which has been shown to be synthesized de novo in 
mammalian brains (Amateau et al., 2003), might be neuroprotective, an effect 
mediated via ERs. Although the exact mechanism of how this takes place is not fully 
understood (Yamazaki et al., 2013).  This biosynthesis of oestrogen has been 
observed at exceptionally high levels in teleost fish (Vallard et al., 1995) which has 
been suggested to be related to the neuroplasticity and regenerative potential in fish 
central nervous system cells (Callard et al., 2001). 
It is no surprise that TERT mRNA expression should be induced in rainbow 
trout exposed to E2, for the TERT promoter region in humans has been shown to 
contain a degenerate ERE which specifically binds to the ER. Studies have shown 
that when oestrogen-activated ER binds to this element it leads directly to 
transcriptional activation (Kyo, Takakura et al, 1999). But this is not the only means 
by which oestrogen can induce TERT mRNA expression, for oestrogen-activated ER 
also induces the expression of c-Myc which then binds to E-boxes in the promoter 
region of hTERT, resulting in indirect upregulation of hTERT. Furthermore, hTERT 
also contains a sp1/ER motif that weakly functions as an ERE site, with much less 
binding between oestrogen-activated ER and the site, but none the less leading to 
some transcriptional induction albeit less than that of the degenerate ERE (Kyo, 
Takakura et al, 1999). Where oestrogens have been shown to lead to transcriptional 
induction in human cell-lines, it is now clear that it also does so in vivo in the teleost 
fish species rainbow trout at environmentally relevant (Belfroid et al, 2002, Quednow 
and Püttmann, 2008) and sub-lethal concentrations. Although the lower range of 
these chemical exposure concentrations have been detected in sewage effluents, 
these concentrations are still relatively high compared to what is frequently detected 
in nature. But it must be considered that in nature organisms get exposed to a range 
of chemical pollutants, many of which have opposing effects. Combined effect of 
these chemicals may well lead to inductions such as are observed in this study. 
Combination exposure studies would need to be conducted, using a range of 
chemicals found in effluents, including a range of agonists and antagonists of ER, 
and anti-oestrogenic chemicals like dioxin, which affect how oestrogen acts via ER 
and AhR (Safe et al., 1998; Rogers and Denison, 2002). One example of these AhR 
agonists is β-naphthoflavone (BNF) which has been shown to inhibit oestrogen-
induced VTG synthesis in rainbow trout, via AhR mechanism (Anderson et al., 1996; 
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Grans et al., 2010). When considering chemical pollution in the enviroment one must 
also take into account other environmental stressors. One of the most topical issues 
of environmental science today is that of climate change; increased temperatures of 
aquatic environments leads to reduced dissolved oxygen and acidification, as well as 
potential reduced availability of food and hence increased competition (Bates et al., 
2008).  
It is worth considering that all of the above are results are from qPCR runs 
where cDNA made from whole embryo/larvae RNA samples was used and are 
therefore an indication of the overall effect of these pollutants on omTertLong mRNA 
expression in the animals. As has been previously shown, telomerase activity and 
mRNA expression can differ between tissue and even cell types (Au et al, 2009, 
Klapper et al, 1998), but by using whole animal extracts any small tissue or cell 
dependent variability in transcriptional induction or inhibition is not detectable. 
. Further studies would need to be performed in order to examine the long-term 
effects of TERT mRNA induction on the life cycle of these animals and relevance to 
other established oestrogenic effects previously recorded. In fish species such as the 
zebrafish, E2 exposures lead to increased vitellogenin production in males and 
females as well as reduced ovary weight (Rose et al, 2002, Van den Belt et al, 
2004). Similar responses have been observed in rainbow trout, where trout shows 
similar sensitivity to E2 as do zebrafish, with vitellogenin induction observed at very 
low concentrations of 0.02 and 0.1 ng E2/ml (Van der Belt et al, 2003). Furthermore, 
taking into account the role telomerase plays in carcinogenesis and the direct 
correlation between TERT expression and telomerase activity (Chang et al., 2002), it 
is worth noting that increased telomerase activity due to an environmental 
contaminant might have unforeseen effect on cancer development. 
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Conclusion 
 
This study has demonstrated that there exists a link between environmental 
oestrogens and telomerase. It has furthermore shown that the expression of the 
telomere reverse transcriptase component, TERT, is directly influenced by the two 
oestrogenic chemicals, E2 and BPA in early life-stages of the model test species 
rainbow trout, with the previous of the two chemicals inducing transcriptional 
response at sub-lethal concentrations.  
It is clear that rainbow trout is a suitable test model for the examination of the 
mode of action and extent to which oestrogenic chemicals affect telomerase. In vivo 
models are an important part of such examination, for studies have shown that 
relative oestrogenic potency of oestrogens is often far more potent in vivo than could 
be expected based on in vitro results (Van den Belt et al, 2004). The knowledge 
acquired from this study is a valuable addition to the previously published evidence 
of oestrogenic effects on telomerase, and the effect environmental oestrogens have 
on vertebrates. These results are important to the continuous quest to understand 
the extent of oestrogens toxicity, including their teratogenicity which can lead to a 
detrimental effect on organizational level. 
It is furthermore important to try and understand how a vital enzyme like 
telomerase can be seriously affected by relatively low concentrations of oestrogenic 
compounds. Telomerase is an enzyme involved in cell division, and is important to 
maintain genomic stability. Overly expressed telomerase may lead to increased rate 
of tumour development, and more importantly there is a possibility of long term 
effects on the germ line of the relevant species, leading to alterations in the species 
gene pool which can have irreversible consequences. An extensive knowledge of the 
aforementioned issues is therefore important in order for environmental institutions 
and agencies to establish guidelines and limitations to the release of oestrogens and 
oestrogenic chemicals into the environment.  
Further research is recommended in order to gain an extensive understanding 
of the link between environmental oestrogens and TERT transcription. This study 
demonstrates that there is a causal link between oestrogens and TERT transcription, 
and that this is mediated in part via ER interaction, although further study is needed 
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in order to further explain the mechanisms behind this process. Many alternative 
pathways exist for oestrogens to influence various cascades and pathways, as some 
recent studies have cast a light on (Canesi et al, 2005). It would furthermore be 
valuable to map the time-dependent effects of E2 to more detail, as well as 
examining more tissues to further explore the tissue specific differences already 
evident. This may also allow us to understand what role the short splice variant 
omTertShort plays in embryo development, cell growth and differentiation, if any.  
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6. General conclusion 
 
The objectives of this study were to firstly identify and characterize the main 
catalytic subunit of telomerase, TERT, in two model species, the teleost fish species 
rainbow trout and the deuterostome invertebrate the European purple sea urchin. 
Secondly, the aim was to explore and define any links between the activity of the 
telomerase protein itself, expression of TERT, cell-cycle controls, embryonic 
development and environmental oestrogens in these two animal models. Previous 
studies have mainly focused on telomerase activity in yeast, ciliates (Tetrahymena), 
mice and human cell lines (Blackburn et al., 2006). Information on telomerase and its 
modulation and activity in other vertebrate animal models available is small in 
comparison. Several researchers have suggested animal models for use as 
bioassays in telomerase study (Nakajima et al., 2009; Morgan, 2013). One of these 
is the laboratory mouse model of telomerase overexpression which is designed to 
examine the effects of increased telomerase expression/activity on tissue survival 
and lifespan (Geserick and Blasco, 2006) and another is the laboratory mouse model 
of telomerase deficiency which is designed to examine the role telomerase plays in 
normal tissue development, tissue function, and disease, utilising transgenic mice 
deficient in telomerase (Zuan et al., 1999; Erdmann et al., 2004; Blasco et al., 1997). 
Mice do however have exceptionally long telomeres (Manning et al., 2002), and are 
therefore not a good model for the study of the mechanisms of telomerase regulation 
in animals with shorter telomeres, like humans. Teleost fish do, however, have 
telomerase length equivalent to that observed in humans (Elmore et al., 2008). A 
mutant zebrafish model has been designed, utilizing adult fish for examination of 
telomerase activity (Henriques et al., 2013) but there is a need for a wider range of 
animal models designed for study of telomerase which is a highly conserved protein. 
The design of an assay intended for the examination of TERT expression in rainbow 
trout would provide a novel bioassay for the study of telomerase modulation in a fish 
species which has environmental relevance across the world due to its distribution. 
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This study has been partly successful in concluding the first goal of identifying 
and characterisizing the main catalytic subunits of telomerase reverse transcriptase, 
with two separate splice variants of rainbow trout TERT identified and characterized. 
This study did however fail to do the same for the European purple sea urchin. 
Alternative splicing has been shown to regulate hTERT expression in several human 
cell lines and tissues (Kilian et al., 1997; Ulaner et al.,1998) although the function of 
these isoforms is not fully explained. Most are missing vital RT motifs which indicates 
that alternative splicing may play a role in telomerase activity regulation. This seems 
to be the case in human foetal kidney tissues where telomerase activity is 
suppressed via alternative splicing (Ulaner et al., 1998). It is possible that alternative 
splicing plays a similar role in rainbow trout, with the two splice variants 
characterized in this study, being differentially expressed across tissues and 
embryogenesis. In Japanese medaka, splice variants resulting in truncated TERT 
are expressed in embryos and tissues going through cellular differentiation (Rao et 
al, 2011). Interestingly E2 is a known mediator of cellular differentiation in various cell 
types through ER’s, examples are: neuronal differentiation in humans (Merot et al., 
2005) and the epithelial cells in mammalian oviduct (Okada et al., 2004). It is 
therefore likely that oestrogenic regulation of TERT, hand in hand with alternative 
splicing, plays a significant role in cellular differentiation in fish. Other mechanisms of 
regulation of telomerase are phosphorylation of hTERT and hTEP1 by protein kinase 
Cα, inhibition of telomerase activity by protein phosphatase and protein kinase C 
inhibitors in cancer cells (Li et al., 1997, 1998; Bodnar et al.1996; Ku et al., 1997). 
Furthermore, c-Myc has been shown to induce mRNA transcription of hTERT and by 
doing so induce telomerase activity (Wang et al., 1998; Takakura et al., 1999; 
Greenberg et al.,1999; Falchetti et al.,1999; Wu et al.,1999).  
Having characterized two different splice variants of rainbow trout TERT, 
quantitative PCR assays were developed which then allowed for some of the 
hypotheses outlined in the thesis aims to be tackled. This optimized bioassay can be 
used as a part of a larger environmental testing strategy for screening of 
environmental effects of a range of other chemicals and used concurrently with other 
bioassays for the assessment of chemical toxicity. By using early embryonic stages, 
one allows for minimal use of older animals and therefore allowing for fulfilment of 
the three R’s of animal testing (Flecknell, 2002). Also, by including in vivo models in 
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chemical screening, significantly improves the reliability of a testing strategy. 
Overreliance in in vitro tests can lead to false-positive and false-negative results, the 
latter of which need to be minimized in order for accurate prioritisation of chemicals 
(Navas and Segner, 2006). Furthermore, combining embryonic studies with 
examination of adults, as can be done with this assay, allows for examination of 
potential ecological significance of any effects observed.  
By using these optimized assays, this study has demonstrated that there 
exists a link between environmental oestrogens and telomerase. It has furthermore 
shown that the expression of the telomere reverse transcriptase component, TERT, 
is directly influenced by the two oestrogenic chemicals, E2 and BPA in early life-
stages of the model test species rainbow trout, with the previous of the two 
chemicals inducing transcriptional response at sub-lethal concentrations. This 
corresponds well with previously published literature where telomerase has been 
shown to be regulated by hormones. Androgens regulate telomerase expression in 
prostate cancer cells, hematopoietic cells as well as normal reproductive tissues 
(Guo et al., 2003; Bayne and Liu, 2005; Calado et al., 2009). Oestrogen is also 
known to regulate telomerase activity through direct transcriptional regulation of 
TERT. This only takes place in tissues sensitive to oestrogen (Kyo et al., 1999; Misiti 
et al., 2000). In ovary epithelial cells hTERT activation is modulated via esr1 and not 
esr2 (Misiti et al., 2000). The nonsteroid antioestrogen TAM, inhibits telomerase 
activity by inhibiting oestrogen from binding with hTERT promoter (Nakayama et al., 
2000; Misiti et al., 2000). This study provides novel information on telomerase 
regulation by showing there exists a causal link between exposure to oestrogenic 
and TERT expression, during embryogenesis in a vertebrate model. Similar results 
were observed by using a deuterostome invertebrate model for the examination of 
telomerase-oestrogen interaction, when experiments showed that throughout the 
embryonic development of sea urchin embryos, telomerase activity was significantly 
increased in the presence of E2. 
It is clear from data cproduced from this study that the early life-stages of both 
sea urchins and rainbow trout are sensitive to oestrogens, exhibiting similar 
transcriptional relationship between telomerase and oestrogenic chemials as have 
been demonstrated in humans (Kyo, Takakura et al, 1999). This study demonstrates 
that there exists a causal link between environmental oestrogens and TERT 
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transcription and that this is mediated, at least in part, by ER mediated action.  The 
knowledge acquired from this study is a valuable addition to the previously published 
evidence of oestrogenic effects on telomerase, and the effect environmental 
oestrogens have on vertebrates and embryogenesis. These results are important to 
the continuous quest to understand the extent of oestrogen’s toxicity, including their 
teratogenicity, as teratogenicity can lead to a detrimental effect on organizational 
level. Further research is recommended in order to gain an extensive understanding 
of the link between environmental oestrogens and TERT transcription. It would, 
furthermore, be valuable to map the time-dependent effects of E2 to more detail, as 
well as examining more tissues to further explore the tissue specific differences 
already evident. This may also allow us to understand what role the short splice 
variant omTertShort plays in embryo development, cell growth and differentiation, if 
any.  
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Appendices 
 
 
Figure A.4.4. Nucleotide sequence aligment between the predicted American purple sea urchin TERT nucleotide sequence 
(XM_001181282.1) and those of other deuterostome species: zebrafish (Danio rerio) (NM_001083866.1), Japanese medaka 
(Oryzias latipes) (NM_001104816.1), chicken (Gallus gallus)  (NM_001031007.1), brown rat (Rattus norvegicus) (NM_053423.1), 
and human transcript variant 1 (NM_198253.2). The black shading represents 100% similarity. 
 
 
 
Rat                 ------------------------------------------------------------ 
Human               ---------------------CAGGCAGCGCTGCGTCCTGCTGCGCACGTGGGAAG---- 35 
Chicken             ----------------------ATGGAGCGCGGGGCTCAGCCGG------GAGTCG---- 28 
Zebra               ----------------------AAATAGAACTCCCCAAGCACGCGCACAGATG------- 31 
Medaka              TCCTTGAATCACCCATACTGCAATGTAGAAGTCACCGAAGTTGCTAAAAAAAAGTCCGTT 60 
XM_001181282.1      -----ATGGATATCCTGGAGAGATTCTTCCCTAGAGTCTCGTGTCTTGAAGACTTCCTTA 55 
                                                                                 
 
Rat                 -------------------------ATGCCCCGCG-------------CTCCTCGTTGCC 22 
Human               --CCCTGGCCCCGGCCACCCCCGCGATGCCGCGCG-------------CTCCCCGCTGCC 80 
Chicken             --GCGTG-----CGGCGGCTCCGCAATGTAGCGCGG-----------GAGGAGCCCTTCG 70 
Zebra               --------------TCTGGAC------AGTACTCG---------ACAGATGGCGGATTTA 62 
Medaka              TGTAACGTTGACGTTCAGAACGTCCACAGTACTCAGACGTCATGACATCCGGGGATTTGT 120 
XM_001181282.1      GAGATCTGAATGGATGTCCACCTCTCTGCATCCCCAAAG------ACAAGGCTGGCTACC 109 
                                               .   * *              .       *    
 
Rat                 CCGCCGTGCG-----CTCTCTACTGCGCAGCCGATATCGGGAGGTGTGGCCGCTGGCGAC 77 
Human               GAGCCGTGCG-----CTCCCTGCTGCGCAGCCACTACCGCGAGGTGCTGCCGCTGGCCAC 135 
Chicken             CCGCGGTCCT-----GGGCGCGCTGCGGGGCTGCTACGCCGAGGCCACGCCGCTGGAGGC 125 
Zebra               GGCCGGTTTT-----GGAGATTCTGCGCTCCTTATATCCGGTCGTGCAGACTTTGGAGGA 117 
Medaka              CGAGCGTCCT-----GAACATCCTCCGGTCGCTCTACAAACGCACGCGGACGCTGGAGGA 175 
XM_001181282.1      GAGCCTTCCTGCAGTCGACTCTCATAGGAATCCCATCATGTCATATTAGCTATCAAGGGC 169 
                          *               *: .*      .::            *.    ..  .. 
 
 304 
Rat                 CTTTG-----TGCGGCGCCT--------GGGGCTTGAGGGCAGTCGG-CTTGTGCAACCC 123 
Human               GTTCG-----TGCGGCGCCT--------GGGGCCCCAGGGCTGGCGG-CTGGTGCAGCGC 181 
Chicken             CTTCG-----TCCGGCGGCTGCAGGAGGGTGGCACCGGGGAGGTCGAGGTGCTGCGAGGC 180 
Zebra               GTTCA-----CCGACGGACT--------GCAATTCCCTGACGGCCGAAAGCCGGTTCTGC 164 
Medaka              GTTCG-----CTGACGGCGT--------TGTGTTCAGGGAGGGACGGAGAGCTGCGCTGC 222 
XM_001181282.1      CATTGGATTATACACAGCATTCTGATCATATGGAAGTTATCAACCGAGTGTTGTTGAGAC 229 
                     :* .        .  *  *           .      .   . **.            * 
 
Rat                 GGGGACCCGAAGGTCTTCCGCACGTTGGTTGCCCAGTGCCTAG----TGTG--CGTGCCC 177 
Human               GGGGACCCGGCGGCTTTCCGCGCGCTGGTGGCCCAGTGCCTGG----TGTG--CGTGCCC 235 
Chicken             GACGACGCTCAGTGCTACCGGACCTTCGTGTCGCAGTGCGTGG----TGTG--CGTCCCC 234 
Zebra               TGGAGGAAACAGACGGCGCGCGCTTTAAAAAGCTCCTCAGTGG----ACTTATTGTATGT 220 
Medaka              TTCAACCTTCGGACACACACAGCTTTAAGTCTTTCGTTCGGGG----AGTGTTTGTGTGT 278 
XM_001181282.1      TGCAACACCAAGGAAAAGGAGGAAAGAATGTCCTACTGAACGGTTTTACTTCTTGGAGAT 289 
                       ..      *         ..    .      . * .  .*    : *    *      
 
Rat                 TGGGGCTCACAGCCGCCACCTGCTGACCTTTC--CTTCCACCAGGTGTCATCCCTGAAAG 235 
Human               TGGGACGCACGGCCGCCCCCCGCCGCCCCCTC--CTTCCGCCAGGTGTCCTGCCTGAAGG 293 
Chicken             CGCGGTGCTCG--CGCCATCCCCCGGCCCATCTGCTTCCAGCAGTTATCCAGTCAGAGCG 292 
Zebra               GCGTACACGCCGCCGCAGCTGCGCGTCCCCG--------CCCAGCTCAGCACCCTGCCGG 272 
Medaka              TCTGATGAGGAGCTGCAGG---ACGTCCCAAG--CTGTAATCAGACCTGCACGTTTCCAG 333 
XM_001181282.1      CAGAAGGTGATTATGCAGGGATCCTTCCTTCGATAAATGTTCCGAACAACAACAGTAACC 349 
                        .         **.         **             *.*   : .:     .    
 
Rat                 AGCTGG---TGTCCAGGG---------TTGTGCAGAAACTTTGCGAGCGCGGTGAGAGGA 283 
Human               AGCTGG---TGGCCCGAG---------TGCTGCAGAGGCTGTGCGAGCGCGGCGCGAAGA 341 
Chicken             AAGTCA---TCACAAGAA---------TCGTTCAGAGGCTGTGTGAAAAGAAAAAGAAGA 340 
Zebra               AGGTCT---TGGCGTTCA---------CTCTGAACCACATTAAACGTAAGAAACTGAGGA 320 
Medaka              AGCTCC---TGGCTTTCA---------TCCTCAACAGCCTGAAAAGGAAAAGGAGGAGAA 381 
XM_001181282.1      AACTCAGGATACCATTCTGGAGCAAGCTGCTAAGCAGAATTGGAGATGAGTTGATGATGC 409 
                    *. *     *  *                 * .. .. .*  .  .  .      ** .. 
 
Rat                 ATGTGCTGGC------------TTTTGG--------CTTTGCACTGCTTAACGGGGCCAG 323 
Human               ACGTGCTGGC------------CTTCGG--------CTTCGCGCTGCTGGACGGGGCCCG 381 
Chicken             ACATCCTTGC------------GTATGG--------ATACTCCTTGCTGGATGAGAACAG 380 
Zebra               ACGTCCTGGG------------CTTCGG--------TTATCAATGCAGCG-------ACG 353 
Medaka              ATGTTTTGGC------------CCACGG--------CTACAACTTCCTGGGTGTGGCACA 421 
XM_001181282.1      ACATTCTGGAGAATCTGTCTATTTTTGGTGCAGCTCCACCATCCTGCTATATTCAACTTA 469 
                    * .*  * *               : **         :        .            . 
 
Rat                 AGGTGGGCCTCCCATGGCCTTCACGACCAGCGTG----CATAGCTACTTGC------CCA 373 
Human               CGGGGGCCCCCCCGAGGCCTTCACCACCAGCGTG----CGCAGCTACCTGC------CCA 431 
Chicken             TTG--TCACTTCAGAG--TTTTGCCATCTTCGTGTATATACAGCTATCTGT------CCA 430 
 305 
Zebra               TGACGACCAG--TTCGGATCCCTTCCGTTTCCAT-------GGCGACGTTT------CGC 398 
Medaka              GGAGGACCGGGATGCAGACCACTTCCGCTTCCAG-------GGAGATCTGT------CTC 468 
XM_001181282.1      CAGGTACCCCACTGAGTATGTTGATATCCTCCTTACCAACCAACACACCAAGTCCTGCCA 529 
                      .    .       .         .    * :        ... .           * . 
 
Rat                 ACTCGGTTACTGAGTCCCTGTG----TGTCAGTGGTGCATGG------ATGCTACTGTTG 423 
Human               ACACGGTGACCGACGCACTGCG----GGGGAGCGGGGCGTGG------GGGCTGCTGCTG 481 
Chicken             ATACTGTAACAGAAACGATTCG----CATCAGTGGCCTCTGG------GAGATACTGCTG 480 
Zebra               AGACGG---CTGCCTCCATCAG----CACCAGCGAGGTCTGG------AAGCGTATCAAC 445 
Medaka              AAAGCG---CCGCCTACATCCA----CAGCAGCGACCTGTGG------AAGAAGGTCACG 515 
XM_001181282.1      AAACATCCACAGTTGAACAAAGGTTCAAACAGCGGAGAAAGAGTTTCCAAGTTAAGGATG 589 
                    * :      * *   . .:  .     .  ** *.    :*.      . *          
 
Rat                 AGCCGAGTGGGCGACGACCTGCTGGTCTACCTG----CTGTCGCACTGTGCGCTCTACCT 479 
Human               CGCCGCGTGGGCGACGACGTGCTGGTTCACCTG----CTGGCACGCTGCGCGCTCTTTGT 537 
Chicken             AGTAGGATAGGGGACGACGTGATGATGTACCTG----CTGGAGCACTGTGCACTCTTCAT 536 
Zebra               CAGCGTCTGGGCACGGAGGTAACGCGGTACCTG----CTGCAGGACTGTGCCGTTTTCAC 501 
Medaka              GCGCGCCTCGGCACAGACGTCACCCGCTACCTG----TTGGGGAGCTGCTCCGTCTTCGT 571 
XM_001181282.1      CTGCCAAAGGAGGGAAGGTTGATCGATGCGATGGTGACGGAAGGAAAGTTCACGGAAAGA 649 
                       .   : *. .  ..  * .      . .**      *  . ..:*  *    ::    
 
Rat                 GCTGGTGCCCCCCAGCTGTG----CCTACCAGG----TGTGCGGGTCACCCCTGTACCAA 531 
Human               GCTGGTGGCTCCCAGCTGCG----CCTACCAGG----TGTGCGGGCCGCCGCTGTACCAG 589 
Chicken             GCTGGTTCCCCCAAGTAACT----GTTACCAGG----TCTGCGGGCAACCAATTTATGAA 588 
Zebra               CACCGTCCCGCCATCGTGTG----TTCTGCAGG----TGTGCGGAGAACCTGTTTACGAC 553 
Medaka              GCTGGCACCTCCTTCCTGCA----TCTTCCAGA----TCTGCGGCGTTCCAGCGTATGAC 623 
XM_001181282.1      GGAAGAGAGATGAGGATGCAGGATGCAACCAGGGAGATGCCAATGTTGCCAAATTCCGAA 709 
                        *           :.         : ***.    *   ..     **    *.  *  
 
Rat                 ATTT----------------GTGCCACCACGGATACCTG---GTCCTCTGTGCCCGCTGG 572 
Human               CTCG----------------GCGCTGCCACTCAGGCCCG---GCCCCCGCCACACGCTAG 630 
Chicken             CTTATTT--CGCGTAACGTAGGGCCATCCCCAGGGTTTGTTAGACGACGGTACTCAAGGT 646 
Zebra               TTGCTG--------------ATGCCGCGCTCATGGTCTGG-----CTTTTTCCTCAGTAA 594 
Medaka              AGAGTG--------------TCCATGACCACCGCCTCCAG-----CGGGTTTCT------ 658 
XM_001181282.1      GAGGAGAGCAAGGGATGAGGCAGCCTACACATAGGAAAGAG-GCTGAGAATCGTGAAGAA 768 
                                           .    .         .                      
 
Rat                 TTACAGGCCCACTCGA-----CCCGTGGGCGG---------GAATTTCACTAACCTTGGG 618 
Human               TGGAC----------------CCCGAAGGCG----------------------TCTGGGA 652 
Chicken             TTAAACATAATAGCTTGCTTGACTATGTGCGA---------AAAAGGCTTGTGTTTCACA 697 
Zebra               CTCAGATAATGAACGA-ATCAGCGGCGCGATG---------CGGAAATTCCCTGCTGTCC 644 
Medaka              ------------------TCTCCGGCCTCCGT---------CGAGGAAACACAAAAGTTT 691 
XM_001181282.1      TTTAAGAAAGATCCCAAGGTTCTTGAGAGCATGATCACAGGACTGGAGAGAAATCTCATT 828 
 306 
                                            .    .                         :     
 
Rat                 TCCGCACACCAGATCAAAAACAGTGGTCACCAGGAAGCACCAAAACCCCAGGCCTTGCCA 678 
Human               TGCGAACG---GGCCTGGAACCATAGCGTCAGGGAGGCCGGGGTCCCCCTGGGCCTGCCA 709 
Chicken             GGCACTATCTTTCCAAGTCACAGTGGTGGAAGTGCAGGCCGAGACGTCGAGGTCGTGTCT 757 
Zebra               AGAAGACAGTCGCAATTTCCAAAAAGAGAACAAGAGATAACGAAAAATATATTTCGGTAA 704 
Medaka              TCAGGTCGGAAAGAAGAGACGCTCAGCGAACCTGACAAAGAGAG------GCTCCGTTGG 745 
XM_001181282.1      TCCAAGCTACCTGCCTCAAACAGCGGTGCCCAAATGCTGACGCAACACATCTTCAACTCT 888 
                      ..  .       .   .. .  .*   ..  .       .                   
 
Rat                 TCACGAGG-TACGAAG--AGGCTTCTGAGTCTCACCAG---------------------- 713 
Human               GCCCCGGG-TGCGAGG--AGGCGCGGGGGCAGTGCCAG---------------------- 744 
Chicken             CCAGCAGG-AGAAAAAGAAGGAGCCATAGGATACAAAG---------------------- 794 
Zebra               AGCGGCGG-AGGGTAAAGGAAACTGTGAATAATAATAA---------------------- 741 
Medaka              AGATGTGG-AGGAAAGCAGGAAGAGG-----AGGAGAG---------------------- 777 
XM_001181282.1      CCTCACAGTAGTGCAATGGCCCCTGGGAAATATGACAAGACTCTCCAGCGCACCTGTCGC 948 
                          .* :. . ..  .  .            . *.                       
 
Rat                 TACAAA---------CGTGCCTTCAGCTAAG---------------------AAGGCCAG 743 
Human               CCGAAG---------TCTGCCGTTGCCCAAG---------------------AGGCCCAG 774 
Chicken             CCTAAGGTCTGGTTATCAGCCTTCTGCAAAAGTGAACTTTCAAGCAGGTAGGCAGATCAG 854 
Zebra               CGGAAATTACAGATCTCTGTGTTTTGCAATT------------------TCTAAAAAGAG 783 
Medaka              TGGAAAGTGGAG---TCAGCG-----------------------------CGAGGAAAAG 805 
XM_001181282.1      CGTCTGATCAAGGTTCAAGCTTTACTCAAGGCTTTCCTCACTCAACATAGGAAACTCAAG 1008 
                       .:.           :*                                 ..    ** 
 
Rat                 GTTTGAACCTGCCC---------------------------------------------- 757 
Human               GCGTGGCGCTGCCC---------------------------------------------- 788 
Chicken             CACTGTTACTGCACGTCTGGAAAAACAGAGCTGCTCCAGTTTATGTTTGCCAGCTAGAGC 914 
Zebra               AGCGATAGATAATG---------------------------------------------- 797 
Medaka              AAAAAGAGAACCTG---------------------------------------------- 819 
XM_001181282.1      CTCAATAGCATCCTAAACCACCAG------------------------------------ 1032 
                        .   .: .                                                 
 
Rat                 -------------TGAGAGTGGATAAGGGACCCC-------------------------- 778 
Human               -------------CTGAGCCGGAGCGGACGCCCG-------------------------- 809 
Chicken             ACCATCTTTAAAAAGGAAGCGTGATGGAGAACAGGTTGAAATCACAGCTAAGAGAGTGAA 974 
Zebra               ------------AAGAAAATATTTCGTTAAAGCG-------------------------- 819 
Medaka              ------------AGGAGGAGGAATCAAGAGAAAG-------------------------- 841 
XM_001181282.1      ------TGTCCTCTGAATCTGCCTCAAGACAGCCCACCCTTAG----------------- 1069 
                                   ..   .    .    . .                            
 
Rat                 ------------------------ACAGGCAGGTGGTACC-------------------- 794 
 307 
Human               ------------------------TTGGGCAGGGGTCCTG-------------------- 825 
Chicken             AGTAATGGAGAAAGAGATAGAGGAACAGGCTTGTAGTATCGTTCCTGATGTAAACCAAAG 1034 
Zebra               -------------------------ACGGAGGATGGAGGA-------------------- 834 
Medaka              -------------------------GAGGCG--CGGCG---------------------- 852 
XM_001181282.1      ---------CCCATACCAACAACAATTATCAGGAGGGGTCCACAGGAACACAAGGTCAAG 1120 
                                               . .    .                          
 
Rat                 -AACCCCATCAGGCAAA-----ACATG------GGCGCCAAGTCCTGCTG---------- 832 
Human               -GGCCCACCCGGGCAGG-----ACGCG------TGGACCGAGTGACCGTG---------- 863 
Chicken             TAGCTCCCAGAGGCATGGAACCTCCTGGCATGTAGCACCACGTGCTGTAGGTCTTATTAA 1094 
Zebra               -AACTGACCAAGTAGCG-----------------AAAATACGTAATGAAAATC------- 869 
Medaka              ---TTCATCATGAAGAG-----------------AGACGGCAGCATGAAG---------- 882 
XM_001181282.1      GGTCACACACCAAGAAG-----ACATCACTACCTCCACCATCTTATGGTGAATATG---- 1171 
                          .    .  . .                   .. .    .   :.           
 
Rat                 -----------------------CGTCCCCCAA--GGTGCCT---CCTGCAG-------C 857 
Human               -----------------------GTTTCTGTGT--GGTGTCA---CCTGCCAGACCCGCC 895 
Chicken             AGAACATTACATTTCTGAAAGAAGTAACAGTGA--GATGTCTGGTCCTTCTGTAG--TTC 1150 
Zebra               ----------------------ACGAATCTCAG--AGTTTCG-CAATTTCTA-------A 897 
Medaka              -----------------------CCGTTCTTGA--TGAGTCAACACTTTCAG-------G 910 
XM_001181282.1      -----------------------CGTCTCGTGAGAAAAGCCTGGCAGAGCTACGGG-AAG 1207 
                                                   .    .:  *    . : * .         
 
Rat                 GAAAAA--CTTGTC------------------TTTGAAAGG---------------AAAG 882 
Human               GAAGAAGCCACCTC------------------TTTGGAGGG---------------TGCG 922 
Chicken             GCAGAT--CTCACC------------------CTGGGAAGAGGCCTGTGGCAGACAAAAG 1190 
Zebra               AAAGAGAGCGAGAG------------------ATAATGAAG----------------AAA 923 
Medaka              AAAGT---CTGGAG------------------AAAACGATG----------------CAG 933 
XM_001181282.1      AAAGTATGCTGGAGGGTTATTCACCGAAGGTGTTTCAAAGGAAGAGGCCCAAACAGAGCG 1267 
                    ..*.:   *                        :   .. .                 .. 
 
Rat                 GCATCTGACCCGAG--------------TCTCTCTGG---GTCGGT----------GTGC 915 
Human               CTCTCTGGCACGCG--------------CCACTCCCACCCATCCGT----------GGGC 958 
Chicken             CTCTTTTCCACAAGGAGTTCAGGGTAACAAACGCATAAAGACCGGTGCAGAAAAACGAGC 1250 
Zebra               ATATTTCGTTAAAG--------------CGACAAAGGATGGAGGAA-------ATTGACC 962 
Medaka              CTGCT--GTCAAGC--------------CGCCTCCTGAAACG-----------------T 960 
XM_001181282.1      TTCTAAACAACTCACAGATTCTATCAG-CAGAGCAGTTTGATGGAACAAGAATGGAAGAG 1326 
                              .                    . .                           
 
Rat                 TGTAAACACAAGCCCAG-----------------CTCCTCGTCCCTG---CTGTCA---- 951 
Human               CGCCAGCACCACGCGGG-----------------CCCCCCATCCACATCGCGGCCA---- 997 
Chicken             AGAATCCAATAGAAGGGGCATAGAGATGTATATAAACCCAATCCATAAACCCAATAGAAG 1310 
Zebra               AAGTAGCGAAAATACGT-----------------AACGAAAATCATGGATCTCAGAG--- 1002 
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Medaka              CAGCAGCTCCTCCGCCT-----------------TTGGAG------GGAGGTCCCAG--- 994 
XM_001181282.1      AGATTGATAATTGATGAGAAGAATGGAGACTCCAAAAGCCATCCAGGTTCCACAAAGGAC 1386 
                     .  : . . :                                   .        *     
 
Rat                 ---------------------------TCACCACCCCAAG-------------ATGCT-- 969 
Human               ---------------------------CCACGTCCCTGGG-------------ACACG-- 1015 
Chicken             GGGCATAGAGAGGCGTATAAATCCAACCCACAAACCTGAGTTGAATTCTGTACAAACTGA 1370 
Zebra               ---------------------------TTGGAAACCAGCA-------------------- 1015 
Medaka              ---------------------------CTGGAGATCGGGG-------------------- 1007 
XM_001181282.1      AGTGATG-----------------TGTCCCAGTCTCTAAGTGTTAGGATGGAGATGGATG 1429 
                                                     . * . .                     
 
Rat                 -------------------------------------GAAAAGCTCAGG----------- 981 
Human               -------------------------------------CCTTGTCCCCCG----------- 1027 
Chicken             ACCAATGGAAGGTGCTTCTTCAGGGGACAGAAAGCAGGAAAATCCCCCAGCTCATTTGGC 1430 
Zebra               -------------------------------------GATCAGCGTCCT----------- 1027 
Medaka              -------------------------------------GCGTTCCCGCCT----------- 1019 
XM_001181282.1      -------------------------------------AAAATGCTACCAGCTCCACTGCA 1452 
                                                          .    *  .              
 
Rat                 ----------------------------------CCATTCACTGAGACCAG------ACA 1001 
Human               ----------------------------------GTGTACGCCGAGACCAA------GCA 1047 
Chicken             AAAGCAGTTACCAAATACATTGTCGCGCTCTACAGTGTACTTTGAGAAGAA------ATT 1484 
Zebra               ----------------------------------CCTCGACCCTCGCAATG------TTC 1047 
Medaka              ----------------------------------TTGCCGTCCTCCCAGTG------TTT 1039 
XM_001181282.1      GATG------------------------------ATGCCCTCCGAGAGACAGACAGTATT 1482 
                                                                . .   .          
 
Rat                 TTTCCTTTACTCCAGGGGAGGTGGCCAAGAGGAGCTAAATCCCTCATTCCTACTCAACAG 1061 
Human               CTTCCTCTACTCCTCAGGCG---ACAAGGAGCAGCTGCGGCCCTCCTTCCTACTCAGCTC 1104 
Chicken             TCTTCTGTATTCCCGCAGTT---ACCAAGAATATTTTCCTAAATCGTTCATACTGAGCCG 1541 
Zebra               AATACGCGTTCTGAGCATGCTCTACAATGGGCGGGGCATGAAGAACTTCCTGCTCAACAG 1107 
Medaka              TATCCGCACGTTGGGGTTCCTTTACGGCGGCCGTGGCATGCACGGCTTCTGTCTCAACAG 1099 
XM_001181282.1      CCATCTCAACCTCACATGAGGTTAAGAAGGAAAACTAACACAGAAAGTGAGAGTGAGACA 1542 
                      : *                  .. . *.  .    .  ..     *     * *..   
 
Rat                 CCTCCCGCCTAGCTTGACCGG------------------------------GGCCAGGAG 1091 
Human               TCTGAGGCCCAGCCTGACTGG------------------------------CGCTCGGAG 1134 
Chicken             CCTGCAGGGTTGTCAGGCAGG------------------------------TGGAAGGCG 1571 
Zebra               GAAGTTGAAAGGAGTGGGCGG------------------------------GGCCAGGCG 1137 
Medaka              GAAGAGGAGAACCGCTGCTGG------------------------------ACCCAGGCG 1129 
XM_001181282.1      GGGGCAGGGCTGCCTGGTGGTGAAGTCACTGTAGACAATGATGATGATGATACCTTGACC 1602 
                          *         .  *                                    *..  
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Rat                 ACTGGTGGAGATCATCTTTCTGGGCTCAAGGCCTA-------GGACATCAGGACCATT-- 1142 
Human               GCTCGTGGAGACCATCTTTCTGGGTTCCAGGCCCT-------GGATGCCAGGGACTCC-- 1185 
Chicken             GCTTATAGAAACTATATTCTTAAGCCAAAACCCATTAAAG--GAACAGCAGAACCAAAGC 1629 
Zebra               CATGCAAGGGGAGGATCTTGTCCGCATGATTTTCCTC--------CAATCAGAATCCAAC 1189 
Medaka              CTTACAGGGGCAGGATTTGGTGAGACTGGTCTTCTTTGAG--GGTCTGCCGTATTTAAAC 1187 
XM_001181282.1      GTTTCAGGCAAAATCCTGTCTCAACCTGATAAGAGGTTAAGAGGAAAGACCAACATGAGG 1662 
                      *  :.* .          *  .    .                    .  .        
 
Rat                 ---CTGCAGGACCCGCCGC-----------------------CTGCCCCGTCGATACTGG 1176 
Human               ---CCGCAGGTTGCCCCGC-----------------------CTGCCCCAGCGCTACTGG 1219 
Chicken             CTACCACAGCAAAAGTGGCGAAAG------------AAGAGGTTGCCCAAACGCTACTGG 1677 
Zebra               G-ACAG-----CAAACCGAAA------------------AAACTTCCCAAACGATTCTTC 1225 
Medaka              GGACAGGAGAGGAAGCCGAAG------------------AAACTCCCCCTGCGCTACTTT 1229 
XM_001181282.1      GCTAAGAGAAATACACTGCTGATTGGTGATGGTGTCCAGAGAGAATCCCAACGTGACAGG 1722 
                       . .       .   *.                        :  **.  **  :*:   
 
Rat                 CAGATGCGAC------------CCCTATTCCAGCAGCTGCT-------------CATGAA 1211 
Human               CAAATGCGGC------------CCCTGTTTCTGGAGCTGCT-------------TGGGAA 1254 
Chicken             CAAATGAGAG------------AGATATTTCAGAAGCTGGT-------------AAAGAA 1712 
Zebra               GCAATGGTGC------------CGCTATTCAGTCGGCTGTT-------------GCGGCA 1260 
Medaka              AACATGGTCC------------CGGTGTTTGGCCGGCTGCT-------------GCAGAG 1264 
XM_001181282.1      AAGATACAACGCAAGTCTAAAACTAAAACAGGGAGGCAGTTGCCTAGCGATACAGCTGCT 1782 
                     . **.                .  :.:      .**:* *                *.  
 
Rat                 CCACGCAAAGTGCCAATATGTCAGATTCCTCCGGTCGCACTGCAGA-------------- 1257 
Human               CCACGCGCAGTGCCCCTACGGGGTGCTCCTCAAGACGCACTGCCCG-------------- 1300 
Chicken             CCATGAGAAGTGCCCTTATTTAGTTTTCTTGAGGAAAAATTGCCCTGTTTTGCTTTCTGA 1772 
Zebra               GCACAGGAAGTGTCCGTATCGGCTGTTCCTGCAGAGGAAGT------------------- 1301 
Medaka              GCACAGAAAGTGTCGCTACAGCAGCGTTTTGCACCGGATGT------------------- 1305 
XM_001181282.1      CCAAGTGACCATCCCAAGAGGAATGAGACTCCAGATAGCATGCAAT-------------- 1828 
                     ** . ... :  *  :.           * ..   .   *                    
 
Rat                 ----------------------------TTTCGAACAGC--------------------- 1268 
Human               ----------------------------CTGCGAGCTGCGGT-----------------C 1315 
Chicken             AGCATGTTTGAAAAAGACGGAGCTGACCTTGCAGGCGGCTCTGCCTGGGGAAGCAAAGGT 1832 
Zebra               --------------------------------GTGCAGG--------------------- 1308 
Medaka              --------------------------------GTCCAGTGGT------------------ 1315 
XM_001181282.1      ------------------------------TCCAACTGAAGAG----------------- 1841 
                                                       * *                       
 
Rat                 AAACCAGCG---GGTG------------------------------------------CC 1283 
Human               ACCCCAGCAGCCGGTGTCTG-----------------------------------TGCCC 1340 
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Chicken             TCACAAGCACACAGAACATGGGAAAGAGTCCACTGAGGGTACTGCACCGAACAGCTTCCT 1892 
Zebra               ------------------------------------------------------------ 
Medaka              ------------------------------------------------------------ 
XM_001181282.1      GAAGATGAAAAAGACGACTG----------------------------------ATACCA 1867 
                                                                                 
 
Rat                 GG---ATGCCATGG----------------------------ACACCAGCCCATCCCA-- 1310 
Human               GGGAGAAGCCCCAGGGCTCTGTGGCGGCCCCCGAGGAGGAGGACACAGACCCCCGTCG-- 1398 
Chicken             CGCTCCTCCCTCAGTGCTAGCGTGTGGGCAGCCAGAGAGAGGGGAACAGCACCCTGCAGA 1952 
Zebra               ------AAATCCA-------------------------------GACG----TGAAGG-- 1325 
Medaka              -TGAGCTGAGCCG-------------------------------TGCGGCTCAGGGGG-- 1341 
XM_001181282.1      AGGACAAGCCAAGG----------------------------ATGCGATTGCCTAACG-- 1897 
                          : .   .                                  .         .   
 
Rat                 ---------------CCTCACGAGTTTGCTCCGGTTACACAGCAGCCCCTGGCAGGTATA 1355 
Human               ---------------CCTGGTGCAGCTGCTCCGCCAGCACAGCAGCCCCTGGCAGGTGTA 1443 
Chicken             GGGGAGTGATCCGCTCCTCAGGGAGCTGCTCAGGCAGCACAGCAGCCACTGGCAGGTGTA 2012 
Zebra               --------------ATATGGAGTCTCTGCTGAAGTCACACTCGTCTCCATATAGAGTTTA 1371 
Medaka              --------------AGCTGAGCTCGCTCATCCCTCAGCACTGCGCGCCGCATCGGGTCTA 1387 
XM_001181282.1      --------------ATGCAGCAACTCTGATCAAGATGAAGACAGATCCATGGCAGGTCTG 1943 
                                       .      * .* .    ..* :     *.  . ...** *. 
 
Rat                 CGGCTTTCTTCGGGCCTGCCTCCGCGAGC-TGGTGCCTGCCGGTCTCTGGGGCACCAGGC 1414 
Human               CGGCTTCGTGCGGGCCTGCCTGCGCCGGC-TGGTGCCCCCAGGCCTCTGGGGCTCCAGGC 1502 
Chicken             TGGCTTTGTGAGGGAGTGCCTGGAGCGGG-TGATCCCTGCTGAGCTGTGGGGTTCAAGCC 2071 
Zebra               TCTGTTCGTCAGGGAGTGTCTGCGCCATATTATTCCCCACG-AGCTCTGGGGCTGCCAGG 1430 
Medaka              CCTGTTTGTCAGAGAATGCCT-CACCGCCGTCGTCCCTGAGGAGCTGTGGGGCTCCGACC 1446 
XM_001181282.1      TCTTTTTCTGCGGCAGGTTCTTCTCAAGG-TTGTCCCAGATGAGCTTTGGGGAAGTGTGC 2002 
                        **  * .*. .    **     .   *  * **  .  . ** ***** :       
 
Rat                 ACAATGAGCGCCGCTTCTTAAAGAACGTGAAGAAGTTCATCTCGTTGGGGAAGTACGCCA 1474 
Human               ACAACGAACGCCGCTTCCTCAGGAACACCAAGAAGTTCATCTCCCTGGGGAAGCATGCCA 1562 
Chicken             ATAACAAATGCCGGTTCTTTAAAAACGTGAAAGCATTCATTTCCATGGGGAAGTATGCTA 2131 
Zebra               AAAACCAGCTCCACTTCCTGTCTAATGTAAAGAACTTCCTGCTTCTGGGGAAGTTTGAGC 1490 
Medaka              ACAACCGACTCCAATTCTTCAGCAGAGTCAGAGGCTTCCTGAAGAGCGGCAAGTTTGAGA 1506 
XM_001181282.1      ACAACAGGAATGTCTTCCTCAAAGGTGTGAAGAAGTTTGTACAACTTGGTCGTTTTGAAA 2062 
                    * **  ..      *** * :  .. .  *...  **  *       ** ..  : *. . 
 
Rat                 AGCTATCCCTGCAGGAACTGATGTGGAGGGTGAAAGTGGAGGACTGCCACTGGCTCCGCA 1534 
Human               AGCTCTCGCTGCAGGAGCTGACGTGGAAGATGAGCGTGCGGGACTGCGCTTGGCTGCGCA 1622 
Chicken             AGCTTTCATTGCAGCAGCTGATGTGGAAGATGAGAGTGAATGACTGCGTATGGCTTCGTC 2191 
Zebra               GCCTCACGCTGGTCCAGCTGATGTGGAGGATGAAGGTTCAGGCCTGCCATTGGCTGGGGC 1550 
Medaka              GAATCTCGGTGGCGGAACTCATGTGGAAGATAAAGGTGATGGACTGTGATTGGTTGAAGC 1566 
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XM_001181282.1      GACTGTCTCTCAGGGAACTCACTGAAGAAATCAGGGCGGAAGATTGCGATTGGTGCCAGC 2122 
                    . .* :*  *     *.** *   ......* *. *     *. **    ***    . . 
 
Rat                 GCAGCCCAGAGAAGGACACTGTCCCTGCCGCAGAGCACCG---TCTGAGGGAGAGGATCC 1591 
Human               GGAGCCCAGGGGTTGGCTGTGTTCCGGCCGCAGAGCACCG---TCTGCGTGAGGAGATCC 1679 
Chicken             TGGCCAAAGGTAATCACTCTGTTCCTGCCTATGAACATTG---TTACCGTGAAGAAATTC 2248 
Zebra               -CCAAGAAACGTCAGTGTGCG--------AGCGAGCACCG---CTACCGTGAGTGGATGT 1598 
Medaka              TCCGCAGGACAGCAGGCCGCTTCCCCCCCAGTGAGCTGGC---CTACCGGACGCGGATCC 1623 
XM_001181282.1      TTGAAAAGTTCAGAGGTCGCGATCCACCCTTCACATCCGTGGTCAAACAGCGCCAGCTAG 2182 
                        .  .                        ...          : ..     ...*   
 
Rat                 TTGCCATGTTCCTGTTCTGGCTAATGGACACATATGTGGTACAGCTGCTGAGGTCATTCT 1651 
Human               TGGCCAAGTTCCTGCACTGGCTGATGAGTGTGTACGTCGTCGAGCTGCTCAGGTCTTTCT 1739 
Chicken             TGGCAAAATTCCTATACTGGCTGATGGATTCCTATGTTATCGAGTTGCTCAAATCATTTT 2308 
Zebra               TGGGTCAGTGTATGGGCTGGATGTTGAGTGGTTTTGTGGTCGGTCTGGTCAGAGCTCAGT 1658 
Medaka              TGAGTCAGTTTCTGACCTGGCTTCTGGATGGCTTTGTCGTGGGCCTGGTCCGGGCCTGCT 1683 
XM_001181282.1      TGACAGACTTCTTTCACTGGCTGATGATTGGTTACACCGTTCCTCTTATCATGATGTGCT 2242 
                    * .   : *   *   ****.*  **.     *: .  .*     *  * . .      * 
 
Rat                 TCTACATCACAGAGACCACGTTCCAGAAGAACCGCCTTTTCTTCTACCGTAAGAGTGTGT 1711 
Human               TTTATGTCACGGAGACCACGTTTCAAAAGAACAGGCTCTTTTTCTACCGGAAGAGTGTCT 1799 
Chicken             TCTATATCACCGAGACCATGTTCCAGAAAAACATGCTTTTCTACTACCGAAAGTTTATCT 2368 
Zebra               TCTACATCACGGAGAGTATGGGCCACAAACACACACTGCGCTTCTACAGGGGAGATGTCT 1718 
Medaka              TCTACGCCACAGAAAGCGTGGGACAGAAGAACGCCATCAGGTTCTACAGGCAGGAGGTCT 1743 
XM_001181282.1      TCTATGTGACAGAGAATTCTAGTTCCAGGAACCAGCTCGTATTCTACCGGAAGCCTGTCT 2302 
                    * ** .  ** **.*         . *...**   .*    *:****.*  ..   .* * 
 
Rat                 GGAGCAAGCTGCAGAGCATTGGAATCAGGCAACAGCTTGAGAGAGTTCAGCTACGGGAAC 1771 
Human               GGAGCAAGTTGCAAAGCATTGGAATCAGACAGCACTTGAAGAGGGTGCAGCTGCGGGAGC 1859 
Chicken             GGGGCAAGTTACAGAACATTGGAATTAGAGACCATTTTGCCAAAGTACATCTACGTGCCT 2428 
Zebra               GGAGCAGACTGCAGGACCAGGCCTTCAGGGCTCATCTGTGTAAGGGCCAGTGGAGGCCCC 1778 
Medaka              GGAGCAAACTCCAGGATTTGGCTTTCAGAAGGCACATCGCTAAAGGCGAGATGGAGGAGC 1803 
XM_001181282.1      GGCTCCTGCTGGAGAAGATAGGCATTCAGTATTATGTGTCTCATGGAGTCATGAAGCCTA 2362 
                    **  *. . *  *...  : *  :* ...    *  *    .. *   :   . .  .   
 
Rat                 TGTCACAAGAGGAGGTCAAGCATCACCAGGACACTTGGCTGGCCATGCCTATCTGCAGAT 1831 
Human               TGTCGGAAGCAGAGGTCAGGCAGCATCGGGAAGCCAGGCCCGCCCTGCTGACGTCCAGAC 1919 
Chicken             TGTCTTCAGAGGAGATGGAAGTGATCCGTCAAAAAAAGTATTTTCCTATTGCATCAAGGC 2488 
Zebra               TGTCTCCATCCCAGGCGCTGAAGGTCCCCAATAGTG---------CAGTGACATCCCGCA 1829 
Medaka              TGAGCCCAGCTCAGGTGGCGTCCCTCCCCAAAGGCA---------CGGTCATCTCCCAAC 1854 
XM_001181282.1      TGAAAGAGAATGATGTGAAGAAGCTTGTATCGGCCGGTCTAACTCTTGGCTTCTCTAGAC 2422 
                    **:   .. .  * .    .    :     . .                    *  ..   
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Rat                 TGCGCTTCATCCCCAAGCTCAATGGTCTCCGGCCCATTGTGAACATGAGTTATGGCATGG 1891 
Human               TCCGCTTCATCCCCAAGCCTGACGGGCTGCGGCCGATTGTGAACATGGACTACGTCGTGG 1979 
Chicken             TCCGGTTCATTCCTAAAATGAATGGTTTAAGACCCGTAGTAAGACTAAGCCGTGTTGTTG 2548 
Zebra               TCCGCTTTATTCCCAAAACCAGCAGCATGAGGCCCATCACACGCCTCAGCGGC------- 1882 
Medaka              TCCGCTTCATTCCCAAGACGGACGGGATGAGGCCCATCACACGGGTCATCGG-------- 1906 
XM_001181282.1      TGCGCTTTGTTCCTAAGACTAAAGGTCTTAGACCCATTACAAGGATGGGCAAG------- 2475 
                    * ** ** .* ** **..  .. .*  * .*.** .* . ...  * .   .         
 
Rat                 ACA---------CCAGAGCTTTTGGCAAAAAGAAGCAGACCCAGTGTTTCACTCAGAGTC 1942 
Human               GAG---------CCAGAACGTTCCGCAGAGAAAAGAGGGCCGAGCGTCTCACCTCGAGGG 2030 
Chicken             AAGGACAGAAACTCAGCAAGGAAAGCAGAGAAAAGAAGATACAGCGCTATAACACTCAGC 2608 
Zebra               -----------------------AGCAGAGACACACTG---CAGTATTTTCAGAGCTGTG 1916 
Medaka              -----------------------GGCAGACTCAAACACA--CGGCTTCACCACAAGCGCA 1941 
XM_001181282.1      -----------------TCTGTCATTGAGGAGAAGAAGGGCCTGAGTGTGAGACTTCTTC 2518 
                                              ... : *...       *    : .          
 
Rat                 TCAAGACTTTGTTCAGCGTGCTCAACTACGAGCGGACCAAACATCCTAA-CCTTATGGGT 2001 
Human               TGAAGGCACTGTTCAGCGTGCTCAACTACGAGCGGGCGCGGCGCCCCGG-CCTCCTGGGC 2089 
Chicken             TAAAAAATCTATTTAGTGTTTTAAACTATGAACGAACTGTAAACACCAG-TATCATTGGC 2667 
Zebra               TGCGTGTGCTGCAGAATGTGTTGAGT-GTGTGTGTGCGTGAGGCCCCGGGGCCCATGGGC 1975 
Medaka              TCCGTGACCTGATGAGCATGCTGCAG-GCGCGTGTGCGCTCCGCTCCGGCGCTCCTGGGC 2000 
XM_001181282.1      TTCAGGATCTGTTTGATGTGTTGACATACCACAAAGT-CAACCAGCCATCTGTGATGGGC 2577 
                    * .. .   *. : .. .*  * .   .     . .         * .      .* **  
 
Rat                 GCTTCAGTACTGGGTACGAGTGACAGC---TACAGGATCTGGCGGACCTTCG-TGCTGCG 2057 
Human               GCCTCTGTGCTGGGCCTGGACGATATC---CACAGGGCCTGGCGCACCTTCG-TGCTGCG 2145 
Chicken             TCTTCAGTATTCGGGAGAGATGATATC---TACAGGAAGTGGAAGGAGTTTGTTACAAAG 2724 
Zebra               TCCACCGTCTGGGGTTGGCAGGACATT---CACAGACGCCTGCAAGACTTCAGCCCTCAG 2032 
Medaka              TCCACCGTCTGGGGCATGACGGACATC---CACAAAGTGCTGCGCTCTCTGGCACCAGCC 2057 
XM_001181282.1      TCATCCCTGCTTGGAATAGACGGTATCTATCACAAAGTATTGAAGTTCATAAAGGATAGG 2637 
                     * :*  *    **   .   *. *      ***..     *..     * .   .:    
 
Rat                 TGTGCGTGCTCTG--GACCAGACACCCAGGATGTACTTTGTTAAGGCAGATGTGACAGGG 2115 
Human               TGTGCGGGCCCAG--GACCCGCCGCCTGAGCTGTACTTTGTCAAGGTGGATGTGACGGGC 2203 
Chicken             GTTTTTGAATCAGGTGGTGAAATGCCTCATTTCTACTTTGTAAAGGGTGATGTATCCAGA 2784 
Zebra               CAGAAG---------AGCTCGCCACGACCGCTCTACTTCGTCAAGGTGGATGTGAGCGGA 2083 
Medaka              CAGAAG---------GACAAACCACAGCCGCTCTACTTTGTAAAGGTGGATGTGAGCGGC 2108 
XM_001181282.1      AAAGAAAG------AAAGGATACCAGACCGCTGTACTTTGTGAAGATTGACATTGAGAAG 2691 
                                   ..  . .  .      * ***** ** ***.  ** .*    ..  
 
Rat                 GCCTATGATGCCATCCCCCAGGACAAGCTCGTGGAAATTGTCGCCAATATAATC---AGG 2172 
Human               GCGTACGACACCATCCCCCAGGACAGGCTCACGGAGGTCATCGCCAGCATCATC---AAA 2260 
Chicken             GCTTTTGATACCATTCCTCACAAGAAACTTGTGGAAGTGATATCACAGGTCTTG---AAA 2841 
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Zebra               GCGTATGACAGTCTCCCGCACCTGAAGCTGGTGGAGGTGCTGAAGGAAGTGTTG---GGT 2140 
Medaka              GCCTACGACAGTCTGCCGCACGACAAACTCAAGGAGGTGATCACCGAGGCTTTG---TCA 2165 
XM_001181282.1      TGTTATGACTCTATCAAACATTCAAAGCTGCTTCAGATCATCTCAATGCTTCTCCAAGGG 2751 
                       *: **    .* .. **    *..**     *..*  *  .        *        
 
Rat                 CGC---TCAGAGAGCATGTACTGTATCCGCCAGTATGCAGTGGTTCAGAAAGATAGCCAA 2229 
Human               C------CCCAGAACACGTACTGCGTGCGTCGGTATGCCGTGGTCCAGAAGGCCGCCCAT 2314 
Chicken             CCTGAGAGCCAAACTGTCTATGGAATAAGGTGGTATGCAGTGATTATGATTACCCCAACT 2901 
Zebra               CCGTTTGCAGAGCAGAGCTTCTTCCTGCGTCAGTACAGCAGTGTGTGGAGCGACCCGACC 2200 
Medaka              CCCGTCCAAGAGGAAGTCTTCACCGTCCGCCACTACGCTAAGATCTGGGCTGATTCCCAC 2225 
XM_001181282.1      CATGACAAACCGGACGAGTATCAGCTCCAGCGTTATGTTACCGTGACGAGAG-CAGCATC 2810 
                    *       . ..   .  *:     * ..  . ** .  .  .*   *.  .     .   
 
Rat                 GGCCAAGTCCACAAGTCCTTCAGGAGACAGGTCTCCACCCTCTCTG------ACCTCCAG 2283 
Human               GGGCACGTCCGCAAGGCCTTCAAGAGCCACGTCTCTACCTTGACAG------ACCTCCAG 2368 
Chicken             GGAAAAGCCAGGAAACTCTATAAGAGACATGTTTCTACTTTCGAGG------ATTTTATT 2955 
Zebra               CGCGGCCTGCGCAAACGCTTCTGCACCAAAGCTGAGATGTCAGAG------------CCG 2248 
Medaka              GAAGGCCTGAAGAAAGCCTTCGCCAGACAGGTGGATTTCTCTGACGGTAGCATGGGATCC 2285 
XM_001181282.1      GGCATCGACTGGTCTGCAGAAGAGAAGCCATCGTCATGTGACTACG-----------GAG 2859 
                     .   .    . :.   . :    *  ..     . :      .                 
 
Rat                 CCATACATGGGCCAGTTCACCAAGCATCTGCAGGACTCAGATGCCAGTGCACTGAGGAAC 2343 
Human               CCGTACATGCGACAGTTCGTGGCTCACCTGCAG------GAGACCAGCCCGCTGAGGGAT 2422 
Chicken             CCAGACATGAAGCAGTTTGTGTCCAAGCTTCAA------GAGAGAACTTCATTACGAAAT 3009 
Zebra               CTCAACATGAAGGGGTTTGTTGTGGATGAACAG------GTCAGCGGGCGCCTGCATGAC 2302 
Medaka              ACCAGCATGAAGGGCTTTGTGATGTCCCTGCAG------AAGAGCAGCAAAGTGCATCAC 2339 
XM_001181282.1      TTGAGCAGTTTTCATCGTCAGTTGATTCAGATGG---CACACCATGGAAAGATCAAGAAT 2916 
                        .**      .              : .:.       :    .      * ..  *  
 
Rat                 TCTGTTGTCATCGAGCAGAGCATCTCCATGAATGAGACTGGCAGTAGCCTGCTCCACTTC 2403 
Human               GCCGTCGTCATCGAGCAGAGCTCCTCCCTGAATGAGGCCAGCAGTGGCCTCTTCGACGTC 2482 
Chicken             GCAATAGTAGTTGAACAGTGCTTAACTTTTAATGAGAACAGTTCCACCCTGTTTACTTTC 3069 
Zebra               GCTATATTAGTGGAGCGG-CACTCGTCTGAGGTCA--GAGGTGGAGACGTCTTCCAGTTC 2359 
Medaka              GCCGTCCTGGTGGAGCAGGCTTTCGGCTCAAATCTTCGAGGCAAAGACGCCTTGCAGTTC 2399 
XM_001181282.1      GCTATCATCATCAATCAGGTTCACACAGTAAAGGTGACACCAAAGGACTTGTTGCAGAGA 2976 
                     * .*  * .* .* *.*     .      ..  :          . *    *  .   . 
 
Rat                 TTCCTGCGCTTTGTCCGTCACAGTGTCGTGAAGATCGATGGCAGGTTCTATGTGCAATGC 2463 
Human               TTCCTACGCTTCATGTGCCACCACGCCGTGCGCATCAGGGGCAAGTCCTACGTCCAGTGC 2542 
Chicken             TTTCTTCAAATGTTACATAATAACATCCTGGAGATTGGGCACAGGTACTATATACAGTGC 3129 
Zebra               TTCCAGAAGATGCTCTGCAGTTACGTCATCCATTACGACCAGCAGATGTTCCGGCAGGTG 2419 
Medaka              TTCACGCAGATGCTCACAGGAAGTGTCGTTCAGCATGGAAAGAAGACGTACCGTCAGTGC 2459 
XM_001181282.1      CTGAAGCAACATGTCATGGCTGATGTAGTGAAGAGTGGTAGAAAGTACTATTGGCGTCAG 3036 
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                     * .  ..  :  *        . . . *  .    ..  . ..*:  *:    *.     
 
Rat                 CAGGGCATCCCCCAGGGCTCCAGCCTGTCCACCCTGCTCTGCAGTCTGTGTTTCGGAGAC 2523 
Human               CAGGGGATCCCGCAGGGCTCCATCCTCTCCACGCTGCTCTGCAGCCTGTGCTACGGCGAC 2602 
Chicken             TCTGGAATCCCACAGGGCTCCATTTTGTCAACCTTACTTTGCAGCTTATGCTACGGAGAC 3189 
Zebra               TGTGGGATCCCGCAGGGCTCTTCAGTGTCTTCTCTGCTGTGTAATCTGTGTTACGGACAC 2479 
Medaka              CGAGGGATTCCTCAGGGCTCGGTGGTGTCCTCTCTGCTGTGCTGTCTGTGCTATGGCCAC 2519 
XM_001181282.1      GATGGCATCAGCCAGGGCTCCATTCTCTCGTCCCTACTCTGTAGTTTCTTCTATGCTCAC 3096 
                       ** ** .  ********     * ** :*  *.** ** :.  * *  *: *   ** 
 
Rat                 ATGGAGAACAAGCTGTTTGCCGAGGTGCAGCAGGACGGCTTGCTTTTACGTTTTGTCGAT 2583 
Human               ATGGAGAACAAGCTGTTTGCGGGGATTCGGCGGGACGGGCTGCTCCTGCGTTTGGTGGAT 2662 
Chicken             ATGGAAAACAAATTACTCTGTGGGATCCAGAAGGATGGAGTCCTAATACGTCTTATTGAT 3249 
Zebra               ATGGAGAAAGCCCTGCTGAAGGACATCGCTAAAGGAGGGTGTCTGATGAGGCTGATTGAT 2539 
Medaka              ATGGAGAACGTCCTCTTCAGAGACATCAAAAACAAAGGGTGTCTGATGAGGCTGGTGGAT 2579 
XM_001181282.1      CTGGAGAGATGCTACCTCTCAGATATAGACCAAGAAGGGCTGATGATGAGATTGATTGAT 3156 
                    .****.*..    :  *    *. .*    .. .. **    .*  *..*  * .* *** 
 
Rat                 GACTTTCTGTTGGTGACACCTCACCTGGCCCATGCAAAAGCCTTTCTCAGCACCCTGGTC 2643 
Human               GATTTCTTGTTGGTGACACCTCACCTCACCCACGCGAAAACCTTCCTCAGGACCCTGGTC 2722 
Chicken             GACTTTTTGCTGGTTACGCCACATTTAATGCAGGCAAGAACTTTTCTAAGGACTATAGCA 3309 
Zebra               GATTTTTTGCTCATTACTCCTCATCTGAGTAAAGCCACAGAGTTCCTGACCACTCTTCTG 2599 
Medaka              GACTTCCTCCTCATCACCCCAGACCGCAACCAAGCACAGTCCTTCCTCAGTATCTTGCTG 2639 
XM_001181282.1      GATTTCCTGCTCATCACCCCTCATCATGACAAAGCTCAACGATTCCTCCAGCTACTTCTT 3216 
                    ** **  *  * .* ** **: *    .  .* ** . .   ** ** .  .   *     
 
Rat                 CATGGCGTGCCCGAGTATGGCTGCATGATAAACTTGCAGAAGACAGTGGTGAACTTCCCT 2703 
Human               CGAGGTGTCCCTGAGTATGGCTGCGTGGTGAACTTGCGGAAGACAGTGGTGAACTTCCCT 2782 
Chicken             GCAGGTATTCCTGAGTATGGCTTTTTAATAAATGCCAAGAAGACTGTGGTGAATTTTCCT 3369 
Zebra               TCTGGAGTTCCAGATTACGGTTGCCAGATTAACCCTCAGAAGGTGGCGGTGAACTTCCCC 2659 
Medaka              GCTGGAGTTCCTCAATACGGCGTGGTGGCCAACCCGCAAAAGGTGGTGGTCAACTTTCAG 2699 
XM_001181282.1      TCAGGTGTGAAGCAGTACGGATGCAGTGCCAATCCCAGCAAGACATTGGCTAACTTTGAT 3276 
                      :** .* ..  * ** **       .  **    .. ***.    **  ** **  .  
 
Rat                 GTGGAGACCGGCGCCCTGGGAGGTGCAGCCCCGCACCAGCTGCCTG--CTCACTGCCTGT 2761 
Human               GTAGAAGACGAGGCCCTGGGTGGCACGGCTTTTGTTCAGATGCCGG--CCCACGGCCTAT 2840 
Chicken             GTTGATGAT---ATCCCGGGATGTTCCAAGTTCAAACATCTGCCAG--ATTGTCGTTTGA 3424 
Zebra               GTGTGTGTGTCCTGGG---TAAACTCGGGCGTCTCTGTGCTGCCGT--CCAGCTGCCTGT 2714 
Medaka              GGGTCAGAGGGCGGCGGCGCTTTCCCCGACATCCGCGTGCTGCCTC--CTCACTGCCTCT 2757 
XM_001181282.1      TT-----------------CATGCATGATGGTCAGTTAGTACCCAGGTCAAAAGAACTGT 3319 
                                        :      .         :  : **    .  .  .  * : 
 
Rat                 TTCCCTGGTGTGGCTTACTGCTGGACACTCGGACTTTGGAAGTATTCTGTGACTACTCAG 2821 
 315 
Human               TCCCCTGGTGCGGCCTGCTGCTGGATACCCGGACCCTGGAGGTGCAGAGCGACTACTCCA 2900 
Chicken             TCTCATGGTGTGGTTTATTATTGGATGTGCAGACACTTGAGGTTTATTGTGATTACTCCA 3484 
Zebra               TCCCCTGGTGCGGCTTGATGATACACACACACACGCTGGACGTCTATAAAGACTACTCAC 2774 
Medaka              TCCCGTGGTGCGGCCTTCTGCTGGACACCCGCTCGCTGGATGTGTGCAAAGACTATTCCA 2817 
XM_001181282.1      TTCCCTGGTGTGGTATAGTCTTCAAGACGCAGACCCTGAACATCAGCAATGATTACACAA 3379 
                    *  * ***** **  *  *  *  * .  *. :*  * .* .*    :. ** ** :*.  
 
Rat                 GTTACGGACGGACCTCAATTAAGATGAGCCTCACCTTCCAGGGTGTCT---CCAGGGCCG 2878 
Human               GCTATGCCCGGACCTCCATCAGAGCCAGTCTCACCTTCAACCGCGGCT---TCAAGGCTG 2957 
Chicken             GTTATGCCTTTACTTCTATCAGATCAAGTCTTTCCTTCAATTCAAGTA---GAATAGCTG 3541 
Zebra               GGTATGACGGCCTATCACTGCGCTACAGCCTGACTCTTGGCTCCGCCC---ACTCTCCAT 2831 
Medaka              GCTATGCAGGCCTCTCTCTGCGCTACAGCCTCACGCTAGGCTCCGCCC---ACTCCGCAG 2874 
XM_001181282.1      AATACAACAATGTCAGTATCCGCTACACTCTTACCATCTGTACAGACAGAGATACATCTC 3439 
                    . ** . .      :  .* ..    *  ** :*  *  .    .        :   *   
 
Rat                 GGAAGACCATGCGGTACAAGCTCTTGTCAGTCTTGCGGTTGAAGTGTCATGGTCTGTTTC 2938 
Human               GGAGGAACATGCGTCGCAAACTCTTTGGGGTCTTGCGGCTGAAGTGTCACAGCCTGTTTC 3017 
Chicken             GAAAAAACATGAAATGCAAATTGACTGCAGTCCTCAAACTGAAATGCCATCCTTTACTTC 3601 
Zebra               --CTACAGTCATGAAG-AAGCTGCTGTCGGTGCTCAGCATCAAAAGCACGGACATCTTCT 2888 
Medaka              GACAGCAGATGAGGAGGAAGCTGATGTCCATTCTCAGAATCAAATGTCACCCTCTGTTTT 2934 
XM_001181282.1      TACATCTTATGAGAATCAAACTCACCTGGTCTCTGAAAGCCAAGAATGTCAGCATATTCA 3499 
                      .  .  : . .    **. *           * ..    **.:.        *  *   
 
Rat                 TAGACTTGCAGGTGAACAGCCTGCAGACAGTCTGCATCAATATATACAAGATCTTCCTGC 2998 
Human               TGGATTTGCAGGTGAACAGCCTCCAGACGGTGTGCACCAACATCTACAAGATCCTCCTGC 3077 
Chicken             TTGACTTAAAGATCAACAGCCTTCAGACAGTTCTAATTAACATCTACAAGATATTTTTAC 3661 
Zebra               TAGACCTCAGGCTGAACTCTGTGGAGGCCGTTTACAGGAGTCTGTATAAGCTGATTCTGC 2948 
Medaka              TGGACTTGAAGACTAATTCCCTCGAGTCTGCTTACAAGAACATCCACAAGCTGGTGCTGC 2994 
XM_001181282.1      TGGACCCACTAATCAACTCATTTCTGACGATTGTCATCAATGTGTACCATCTCCTTCTAC 3559 
                    * **    . .   ** :   *  :* * .    .*  *.  *  * .* .*  *  *.* 
 
Rat                 TTCAGGCCTACAGGTTCCATGCATGTGTGATTCGGCTTCCCTTTGGCCAGCATGTTAGGA 3058 
Human               TGCAGGCGTACAGGTTTCACGCATGTGTGCTGCAGCTCCCATTTCATCAGCAAGTTTGGA 3137 
Chicken             TTCAGGCTTACAGGTTCCATGCCTGTGTTCTTCAGCTTCCATTCAACCAGAAAGTTAGGA 3721 
Zebra               TGCAGGCGCTCAGGTTTCATGCGTGCGTGAGGAGTCTGCCGTTGGGTCAGAGTGTGAACA 3008 
Medaka              TGCAGGCGTGCAGGTTCCATGTCTGTGTTCAGAGTTTACCCTTCGCCCAGACGGTCGCAA 3054 
XM_001181282.1      TGCTAGCGCATCGTTTCCACTCCTAC-TACTACTGCCTTGCTAGCTACATCAAACAGAAC 3618 
                    * *:.**    .* ** **    *.  * .  .        *:    ** .  .     . 
 
Rat                 AGAACCATGCATTCTTTCTGGGCATCATCTCCAACCTAG--CATCCTGCTGCTACGCCAT 3116 
Human               AGAACCCCACATTTTTCCTGCGCGTCATCTCTGACACGG--CCTCCCTCTGCTACTCCAT 3195 
Chicken             ATAATCCTGATTTCTTCCTAAGGATCATCTCTGATACTG--CTTCATGCTGCTATTTTAT 3779 
Zebra               GAAACCCGTCGTTCTTCCTGAAGATGATCTGGAGAATGA--CTCGAGTCACCAATAAACT 3066 
 316 
Medaka              AGAACCCAACGTACTTCCAGCAGATGATCTGGGACATGG--CGCACTATGCCAACGCTCT 3112 
XM_001181282.1      ACACCCCCTCTACAGTTCTACAATATCTGGGCATCATGTGTAAGGATATTCCATGCGTGT 3678 
                    . *. *.  . :   * *:. .  : .*    .  .     .   .     *::     * 
 
Rat                 CCTGAAGGTCAAGAATCCAGGAGTGTCACTAAGGGCCA-AGGGTGCCCCTGGCTCCTTTC 3175 
Human               CCTGAAAGCCAAGAACGCAGGGATGTCGCTGGGGGCCA-AGGGCGCCGCCGGCCCTCTGC 3254 
Chicken             CCTGAAAGCTAAAAATCCAGGAGTTTCTTTAGGTAGCA-AAGATGCATCTGGCATGTTCC 3838 
Zebra               CCTCACACACATTAACAAAGGTCTGCCTGTGTGTTCTG-TGGACAGTGGTGGTGTTCTGC 3125 
Medaka              CATCAGGCGCAGCAACACAGGGTTGGTTTTGGGGGATGGAGCTCAGAAGGGCAGCGTT-C 3171 
XM_001181282.1      ACTGTCTCCAAGCTGCGCAAGGATGACCAGGGTGAGAG--GGAGACCACCTTCCCTCTCA 3736 
                    ..* :     *  :.  .*.*  *      .      .  .   .            * . 
 
Rat                 CGCCCGAGGCCACACGTTGGCTCTGCTACCAAGCCTTCCTGCTCAAGCTGGCTGCTCATT 3235 
Human               CCTCCGAGGCCGTGCAGTGGCTGTGCCACCAAGCATTCCTGCTCAAGCTGACTCGACACC 3314 
Chicken             CTTTTGAGGCAGCAGAATGGCTGTGCTACCATGCCTTCATTGTCAAACTGTCCAACCACA 3898 
Zebra               AGTCTGAGGCGGTTCAGCTTTTATTCTGTTTGGCCTTCGAGACGCTTTTCAGACGGTTTC 3185 
Medaka              AGTACGAGGCCGTGGAGCTGCTCTTCTGTCTGGCCTTCCTGCGGGTTCTGTCTAAACACC 3231 
XM_001181282.1      CGATCAATACTGTCAACTGGATTGGACTGAAAGCTTTTGACACCAAGCTGGGCAAGCACA 3796 
                    .    .* .* .   .     *   .    : ** **  :     :  *        :   
 
Rat                 CTGTCACCTACAAGTGTCTCCTGGGACCTCTTAGGACAGCCCAAAAACAG-CTGTGCCGG 3294 
Human               GTGTCACCTACGTGCCACTCCTGGGGTCACTCAGGACAGCCCAGACGCAG-CTGAGTCGG 3373 
Chicken             AAGTTATTTACAAATGCTTACTTAAGCCCCTTAAAGTCTATAAGATGCAT-CTGTTTGGG 3957 
Zebra               GCTCGGTTTACCACTGCCTGAT---CCCTGCACTGCACAAACGGAAGCGTGCTCTTCAGC 3242 
Medaka              GACCCGTCTACAAAGACCTGCT---GCCACGCCTGCACAAATGGAAGCG--CCGGTTGGA 3286 
XM_001181282.1      AAGGGCTGTACCACCCCCTCATCAAACTGGTCAGGAAACACAGACAGAAAGCAGCTCT-C 3855 
                            *** :     * .*          . .  . .  ... ...  *         
 
Rat                 AAGCTCCCAGAGGCAACAATGACCCTCCTTAAGACTGCAGCTGACCCAGCCCTAAGCACA 3354 
Human               AAGCTCCCGGGGACGACGCTGACTGCCCTGGAGGCCGCAGCCAACCCGGCACTGCCCTCA 3433 
Chicken             AAGATCCCAAGGGATACTATGGAACTGCTGAAGACGGTGACGGAACCATCGCTTTGTCAA 4017 
Zebra               GTGAGCTCTGCGGGATCACT--CTGGCTCGGGTCCGTCAAGCTTCCTCTCCCAGAATCCC 3300 
Medaka              GAGGCTTCTGGGAGACCTGAGGCTGGCTAGGGTCCGGCAGGCCGCCAACCCCCGGGCTCT 3346 
XM_001181282.1      AAAATGGGGAAAGCCATGTTGGAGGTTCTTGAAGAGATGACCAATCCTGCCCTTCCGGAC 3915 
                    .:.      . ..      :  .       ..  .   ..     *   * *      .  
 
Rat                 GATTTTCAGACCATTTTGGACTAA------------------------------------ 3378 
Human               GACTTCAAGACCATCCTGGACTGATGGCCACCCGCCCA----------CAGCCAGGCCGA 3483 
Chicken             GATTTCAAAACTATACTGGACTAAGGGATGAAGGTCTATTTCATAATCCTTCCAGGCTTA 4077 
Zebra               CCTGGATTTCAGCATGCGGGTGTAAAAAAAAC----------------CTGTCACGC--- 3341 
Medaka              GCTGGACTTCC-----TGGCTATGCAGATGTG----------------AGTCCACAG--- 3382 
XM_001181282.1      GACTTCGTGAA-------GATGAGAAGATGA----------------------------- 3939 
                     .     : ..       *    .                                     
 317 
 
Rat                 ------------------------------------------------------------ 
Human               GAGCAGACACCAGCAGCCCTGTCACGCCGGGCTCTACG---TCCCAGGGAGGGAGGGGCG 3540 
Chicken             AAAATAAATCTTAAATTTTTAGATTAATTTTCTCTGTAGATAATTTTGGTAGACTGAACT 4137 
Zebra               ------------------------------------------------------------ 
Medaka              ------------------------------------------------------------ 
XM_001181282.1      ------------------------------------------------------------ 
                                                                                 
 
Rat                 ------------------------------------------------------------ 
Human               GCCCACACCCAGGCCC-------------------------GCACCGCTGGGAGTCTGAG 3575 
Chicken             GAAAGCATCTCTACTTGAAAGTTTTCTTTTTTTTTTTATGGGTACCACCCAATGACCTTT 4197 
Zebra               -----------------------------------------GACACAACAGTAAACACTG 3360 
Medaka              -----------------------------------------GTAAAAGCAG---CCACAG 3398 
XM_001181282.1      ------------------------------------------------------------ 
                                                                                 
 
Rat                 ------------------------------------------------------------ 
Human               GCCTGAGTG-AGTGTTTGGCCGAGGCCTGCATGTCCGG------CTGAAGGCTGAGTGTC 3628 
Chicken             AAAAGAGTAGACTGTTTTGTTAACATCTTCATGTTTGTGTTTTTCTGTAAGTTCGAAGGC 4257 
Zebra               ATCTGGGAACAGTTTCCT-----------------------------TTTACTGTCTGAC 3391 
Medaka              GAACGG-AAATGTG---------------------------------TGGGCAGTTTGAC 3424 
XM_001181282.1      ------------------------------------------------------------ 
                                                                                 
 
Rat                 ------------------------------------------------------------ 
Human               CGGCTGAGGCCTGAGCGAGTGTCCAGCCAAGGG------CTGAGTGTCCAGCACACCTGC 3682 
Chicken             TGTTTGAAGTACAACCTGTGAACTTGACTCGATTTCCTTCAGTAATTCCTTTCTTCTTGG 4317 
Zebra               AG-CTGACTAAACACATCTGCACTG--------------------CTCATAAACACTTGA 3430 
Medaka              AG-CATGGCTTTCACATGAGGATTT--------------------ATTTTGTTAAAGTGA 3463 
XM_001181282.1      ------------------------------------------------------------ 
                                                                                 
 
Rat                 ------------------------------------------------------------ 
Human               CGTCTTCACTTCCCCACAGGCTG-GCGCTCGGCTCCACCCCAGGGCCAGCTTTTCCTCAC 3741 
Chicken             TGAAGACATATTTAACCTATCTGTATAAACAGATCAATATTTTTGCCAGTATTGTTTCTG 4377 
Zebra               TGGCTGACTGTAAAACACACACACACACTCGTAAACACAGCATTTCTGTTCAGGTCGCTT 3490 
Medaka              T------------TAAAAGAAAAGAAAATGGAAAAAAAA--------------------- 3490 
XM_001181282.1      ------------------------------------------------------------ 
                                                                                 
 
Rat                 ------------------------------------------------------------ 
Human               CAGGAGC----------CCGGCTTCCACTCCCCACATAGGAATAGTCCATCCCCAGATTC 3791 
 318 
Chicken             AAGAACTGTTCTTTGATTTTTCTATTGCAGACAATTTTACAATAAATTGTCTACATAGTT 4437 
Zebra               GA---------------TATTCTGTCTGAAAATAAACCAAAATCACAGATCGATG----- 3530 
Medaka              ----------------------------AAAAAAAAAAAAAAAAAAAAA----------- 3511 
XM_001181282.1      ------------------------------------------------------------ 
                                                                                 
 
Rat                 ------------------------------------------------------------ 
Human               GCCATTGTTCACCCCT--CGCCCTGCCCTCCTTTG------------CCTTCCACCCCCA 3837 
Chicken             GCAATAATGCATACTTGCCTCCAATACCTTTATTTTGTAGTAAGCTTCAACCCAATCCCA 4497 
Zebra               ------------------------------------------------------------ 
Medaka              ------------------------------------------------------------ 
XM_001181282.1      ------------------------------------------------------------ 
                                                                                 
 
Rat                 ------------------------------------------------------------ 
Human               CCATCCAGG---------TGGAGACCCTGAGAAGGACCCTGGGAGCT------------- 3875 
Chicken             CCCAACTTGGCATTGTCTTGAAATGCACTTATTGGTACAGGGAAAGTGCATTTCATGGCT 4557 
Zebra               ------------------------------------------------------------ 
Medaka              ------------------------------------------------------------ 
XM_001181282.1      ------------------------------------------------------------ 
                                                                                 
 
Rat                 ------------------------------------------------------------ 
Human               --------CTGGGAATTTGGAGTGACCAAAGGTGTGCCCTG---TACACAGGCGAGG--- 3921 
Chicken             GCGCCTAGCAAGATATGTGGGGTAAAGATTCTTTCACTTTGGAGAACACAGTCAAAATTT 4617 
Zebra               ------------------------------------------------------------ 
Medaka              ------------------------------------------------------------ 
XM_001181282.1      ------------------------------------------------------------ 
                                                                                 
 
Rat                 ------------------------------------------------------------ 
Human               ---ACCCTGCACCTGGATGGGGGTCCCTGTGGGTCAAATTGGGGGGAGGTGCTGTGGGAG 3978 
Chicken             GTATGCCAAATCTGGGTATGTTCAACATGTTTAATATATTCTGAGAGTTTACAGAG-ATG 4676 
Zebra               ------------------------------------------------------------ 
Medaka              ------------------------------------------------------------ 
XM_001181282.1      ------------------------------------------------------------ 
                                                                                 
 
Rat                 ------------------------------------------------------------ 
Human               TAAAATACTGAATATATGAGTTTTTCAGTTTTGAAAAAAA-------------------- 4018 
Chicken             TACAGAACAATGGTGATGTATTTATAACTACAAAAACAAGGGGAACCAGAGTTATTGATT 4736 
Zebra               ------------------------------------------------------------ 
Medaka              ------------------------------------------------------------ 
 319 
XM_001181282.1      ------------------------------------------------------------ 
                                                                                 
 
Rat                 ---------------------------- 
Human               ---------------------------- 
Chicken             AGATAATAGAAAAGTAATCTGCTTGGTA 4764 
Zebra               ---------------------------- 
Medaka              ---------------------------- 
XM_001181282.1      ---------------------------- 
                                                 
 
 
 
 
Figure A.4.5. An alignment of the predicted protein sequences for American purple sea urchin TERT (XP001181282.1) and those 
of other deuterostome species: zebrafish (Danio rerio) (NP_001077335.1), Japanese medaka (Oryzias latipes) (NP_001098286.1), 
chicken (Gallus gallus) (NP_001026178.1), brown rat (Rattus norvegicus) (NP_445875.1), and human isoform 1 (NP_937983.2). 
The black shading represents 100% similarity. 
 
 
gi|55741827|ref|NP_445875.1|        ----------------MPRAPRCPAVRSLLRSRYREVWPLATFVRRLGLE 34 
gi|109633031|ref|NP_937983.2|       ----------------MPRAPRCRAVRSLLRSHYREVLPLATFVRRLGPQ 34 
gi|71896531|ref|NP_001026178.1      MERGAQPGVGVRRLRNVAREEPFAAVLGALRGCYAEATPLEAFVRRLQEG 50 
gi|139947514|ref|NP_001077335.      ------------MSGQYSTDGGFRPVLEILRSLYPVVQTLEEFTDGLQFP 38 
gi|157278369|ref|NP_001098286.      -----------------MTSGDLSSVLNILRSLYKRTRTLEEFADGVVFR 33 
                                                            .*   **. *  . .*  *.  :    
 
gi|55741827|ref|NP_445875.1|        GS---RLVQPGDPKVFRTLVAQCLVCVPWGSQPPPADLSFHQVSSLKELV 81 
gi|109633031|ref|NP_937983.2|       GW---RLVQRGDPAAFRALVAQCLVCVPWDARPPPAAPSFRQVSCLKELV 81 
gi|71896531|ref|NP_001026178.1      GTGEVEVLRGDDAQCYRTFVSQCVVCVPRGARAIPRPICFQQLSSQSEVI 100 
gi|139947514|ref|NP_001077335.      DGRKPVLLEETDGARFKKLLSGLIVCA---YTPPQLRVPA-QLSTLPEVL 84 
gi|157278369|ref|NP_001098286.      EGRRAALLQPSDTHSFKSFVRGVFVCS---DEELQDVPSCNQTCTFPELL 80 
                                          ::.  *   :: ::   .**               * .   *:: 
 
gi|55741827|ref|NP_445875.1|        SRVVQKLCERGERNVLAFGFALLNGARGGPPMAFTTSVHSYLPNSVTESL 131 
 320 
gi|109633031|ref|NP_937983.2|       ARVLQRLCERGAKNVLAFGFALLDGARGGPPEAFTTSVRSYLPNTVTDAL 131 
gi|71896531|ref|NP_001026178.1      TRIVQRLCEKKKKNILAYGYSLLDENSCHFRVLPSSCIYSYLSNTVTETI 150 
gi|139947514|ref|NP_001077335.      AFTLNHIKRKKLRNVLGFGYQCSDVTTS-----SDPFRFHGDVSQTAASI 129 
gi|157278369|ref|NP_001098286.      AFILNSLKRKRRRNVLAHGYNFLGVAQEDRD--ADHFRFQGDLSQSAAYI 128 
                                    :  :: : .:  :*:*..*:   .                   .  :  : 
 
gi|55741827|ref|NP_445875.1|        CVSGAWMLLLSRVGDDLLVYLLSHCALYLLVPPSCAYQVCGSPLYQICAT 181 
gi|109633031|ref|NP_937983.2|       RGSGAWGLLLRRVGDDVLVHLLARCALFVLVAPSCAYQVCGPPLYQLGAA 181 
gi|71896531|ref|NP_001026178.1      RISGLWEILLSRIGDDVMMYLLEHCALFMLVPPSNCYQVCGQPIYELISR 200 
gi|139947514|ref|NP_001077335.      STSEVWKRINQRLGTEVTRYLLQDCAVFTTVPPSCVLQVCGEPVYD-LLM 178 
gi|157278369|ref|NP_001098286.      HSSDLWKKVTARLGTDVTRYLLGSCSVFVLAPPSCIFQICGVPAYDRVSM 178 
                                      *  *  :  *:* ::  :**  *:::  ..**   *:** * *:     
 
gi|55741827|ref|NP_445875.1|        TDTWSSVPAGYRPTRPVGGNFTNLG-----------SAHQIKNSGHQEAP 220 
gi|109633031|ref|NP_937983.2|       TQARP-PPHASGPRRRLG-------------------CERAWNHSVREAG 211 
gi|71896531|ref|NP_001026178.1      NVGPSPGFVRRRYSRFKHNSLLDYVRKRLVFHRHYLSKSQWWKCRPRRRG 250 
gi|139947514|ref|NP_001077335.      PRSWSGFFLSNSDNERISGAMRKFP-----------AVQKTVAISKKRTR 217 
gi|157278369|ref|NP_001098286.      TTASSGFLLRPPSRKHKSFQVGKK--------------RRSANLTKRGSV 214 
                                        .         .                        :      :    
 
gi|55741827|ref|NP_445875.1|        KPQALPSRGTKRLLSLTSTNVPSAKK------------------------ 246 
gi|109633031|ref|NP_937983.2|       VPLGLPAPGARRRGGSASRSLPLPKR------------------------ 237 
gi|71896531|ref|NP_001026178.1      RVSSRRKRRSHRIQSLRSGYQPSAKVNFQAGRQISTVTARLEKQSCSSLC 300 
gi|139947514|ref|NP_001077335.      DNEKYISVKRRRVKETVNNNNGNYRSLCFA-------------------I 248 
gi|157278369|ref|NP_001098286.      G-DVEESRKRRRVESGVS-------------------------------- 231 
                                              :*     .                                 
 
gi|55741827|ref|NP_445875.1|        -ARFEPALRVDKG---------------------------PHRQVVPTPS 268 
gi|109633031|ref|NP_937983.2|       -PRRGAAPEPERT---------------------------PVGQGSWAHP 259 
gi|71896531|ref|NP_001026178.1      LPARAPSLKRKRDGEQVEITAKRVKVMEKEIEEQACSIVPDVNQSSSQRH 350 
gi|139947514|ref|NP_001077335.      SKKRAIDNEENISLK-------------------------RRRMEETDQV 273 
gi|157278369|ref|NP_001098286.      ARKRKREPEEEESRE-------------------------RRRGVHHEER 256 
                                            . .                                        
 
gi|55741827|ref|NP_445875.1|        GKTWAPSP--------------------------AASPKVPPAAKNLSLK 292 
gi|109633031|ref|NP_937983.2|       GRTRGPSDRGF-----------------------CVVSPARPAEEATSLE 286 
gi|71896531|ref|NP_001026178.1      GTSWHVAPRAVGLIKEHYISERSNSEMSGPSVVRRSHPGKRPVADKSSFP 400 
gi|139947514|ref|NP_001077335.      AKIRNENHESQS----------------------FAISKKRARDNEENIS 301 
gi|157278369|ref|NP_001098286.      RQHEAVLDES-------------------------TLSGKSGENDAAAVK 281 
                                                                         .      .   .  
 
gi|55741827|ref|NP_445875.1|        GKASDPS------------------------------------------- 299 
gi|109633031|ref|NP_937983.2|       GALSGTR------------------------------------------- 293 
 321 
gi|71896531|ref|NP_001026178.1      QGVQGNKRIKTGAEKRAESNRRGIEMYINPIHKPNRRGIERRINPTHKPE 450 
gi|139947514|ref|NP_001077335.      LKRQRME------------------------------------------- 308 
gi|157278369|ref|NP_001098286.      PP------------------------------------------------ 283 
                                                                                       
 
gi|55741827|ref|NP_445875.1|        --------LSGSVCCKHKPSSSSLLSSPPQDAEKLRP--FTETRHFLYSR 339 
gi|109633031|ref|NP_937983.2|       --------HSHPSVGRQHHAGPPSTSRPPRPWDTPCPPVYAETKHFLYS- 334 
gi|71896531|ref|NP_001026178.1      LNSVQTEPMEGASSGDRKQENPPAHLAKQLPNTLSRSTVYFEKKFLLYS- 499 
gi|139947514|ref|NP_001077335.      --------EIDQVAKIRNENHGSQSWKPADQRPPRPSQCSIRVLSMLYNG 350 
gi|157278369|ref|NP_001098286.      ----------PETSAAPPPLEGGPSWRSGAFPPLPSSQCFIRTLGFLYGG 323 
                                                                        .    .   :**.  
 
gi|55741827|ref|NP_445875.1|        GGGQEELNPSFLLNSLPPSLTGARRLVEIIFLGSRPR-------TSGPFC 382 
gi|109633031|ref|NP_937983.2|       SGDKEQLRPSFLLSSLRPSLTGARRLVETIFLGSRPW-------MPGTPR 377 
gi|71896531|ref|NP_001026178.1      RSYQEYFPKSFILSRLQGCQAGGRRLIETIFLSQNPLKEQQNQSLPQQKW 549 
gi|139947514|ref|NP_001077335.      RGMKNFLLNRKLKGVGGARRMQGEDLVRMIFLQ-----------SESNDS 389 
gi|157278369|ref|NP_001098286.      RGMHGFCLNRKRRTAAGPRRLQGQDLVRLVFFEGLPY-------LNGQER 366 
                                     . :                  .. *:. :*:                   
 
gi|55741827|ref|NP_445875.1|        RTRRLPRRYWQMRPLFQQLLMNHAKCQYVRFLRSHCR------------- 419 
gi|109633031|ref|NP_937983.2|       RLPRLPQRYWQMRPLFLELLGNHAQCPYGVLLKTHCP------------- 414 
gi|71896531|ref|NP_001026178.1      RKKRLPKRYWQMREIFQKLVKNHEKCPYLVFLRKNCPVLLSEACLKKTEL 599 
gi|139947514|ref|NP_001077335.      KPKKLPKRFFAMVPLFSRLLRQHRKCPYRLFLQRKC-------------- 425 
gi|157278369|ref|NP_001098286.      KPKKLPLRYFNMVPVFGRLLQRHRKCRYSSVLHRMCP------------- 403 
                                    :  :** *:: *  :* .*: .* :* *  .*:  *               
 
gi|55741827|ref|NP_445875.1|        -FRTAN---------------------------------QRVPDAMDTSP 435 
gi|109633031|ref|NP_937983.2|       -LRAAVTPAAGVCAREKPQG------------------SVAAPEEEDTDP 445 
gi|71896531|ref|NP_001026178.1      TLQAALPGEAKVHKHTEHGKESTEGTAPNSFLAPPSVLACGQPERGEQHP 649 
gi|139947514|ref|NP_001077335.      ---------------------------------------AGNPDVKD--- 433 
gi|157278369|ref|NP_001098286.      ------------------------------------VVELSRAAQGE--- 414 
                                                                              .   :    
 
gi|55741827|ref|NP_445875.1|        SH-----LTSLLRLHSSPWQVYGFLRACLRELVPAGLWGTRHNERRFLKN 480 
gi|109633031|ref|NP_937983.2|       RR-----LVQLLRQHSSPWQVYGFVRACLRRLVPPGLWGSRHNERRFLRN 490 
gi|71896531|ref|NP_001026178.1      AEGSDPLLRELLRQHSSHWQVYGFVRECLERVIPAELWGSSHNKCRFFKN 699 
gi|139947514|ref|NP_001077335.      -------MESLLKSHSSPYRVYLFVRECLRHIIPHELWGCQENQLHFLSN 476 
gi|157278369|ref|NP_001098286.      -------LSSLIPQHCAPHRVYLFVRECLTAVVPEELWGSDHNRLQFFSR 457 
                                           : .*:  *.:  :** *:* **  ::*  ***  .*. :*: . 
 
gi|55741827|ref|NP_445875.1|        VKKFISLGKYAKLSLQELMWRVKVEDCHWLRSSPEKDTVPAAEHRLRERI 530 
gi|109633031|ref|NP_937983.2|       TKKFISLGKHAKLSLQELTWKMSVRDCAWLRRSPGVGCVPAAEHRLREEI 540 
gi|71896531|ref|NP_001026178.1      VKAFISMGKYAKLSLQQLMWKMRVNDCVWLRLAKGNHSVPAYEHCYREEI 749 
 322 
gi|139947514|ref|NP_001077335.      VKNFLLLGKFERLTLVQLMWRMKVQACHWLGPKK---RQCASEHRYREWM 523 
gi|157278369|ref|NP_001098286.      VRGFLKSGKFERISVAELMWKIKVMDCDWLKLRRTAGRFPPSELAYRTRI 507 
                                    .: *:  **. :::: :* *:: *  * **          . *   *  : 
 
gi|55741827|ref|NP_445875.1|        LAMFLFWLMDTYVVQLLRSFFYITETTFQKNRLFFYRKSVWSKLQSIGIR 580 
gi|109633031|ref|NP_937983.2|       LAKFLHWLMSVYVVELLRSFFYVTETTFQKNRLFFYRKSVWSKLQSIGIR 590 
gi|71896531|ref|NP_001026178.1      LAKFLYWLMDSYVIELLKSFFYITETMFQKNMLFYYRKFIWGKLQNIGIR 799 
gi|139947514|ref|NP_001077335.      LGQCMGWMLSGFVVGLVRAQFYITESMGHKHTLRFYRGDVWSRLQDQAFR 573 
gi|157278369|ref|NP_001098286.      LSQFLTWLLDGFVVGLVRACFYATESVGQKNAIRFYRQEVWSKLQDLAFR 557 
                                    *.  : *::. :*: *::: ** **:  :*: : :**  :*.:**. .:* 
 
gi|55741827|ref|NP_445875.1|        QQLERVQLRELSQEEVKHHQDTWLAMPICRLRFIPKLNGLRPIVNMSYGM 630 
gi|109633031|ref|NP_937983.2|       QHLKRVQLRELSEAEVRQHREARPALLTSRLRFIPKPDGLRPIVNMDYVV 640 
gi|71896531|ref|NP_001026178.1      DHFAKVHLRALSSEEMEVIRQKKYFPIASRLRFIPKMNGLRPVVRLSRVV 849 
gi|139947514|ref|NP_001077335.      AHLCKGQWRPLSPSQALKVPNS---AVTSRIRFIPKTSSMRPITRLSGSR 620 
gi|157278369|ref|NP_001098286.      RHIAKGEMEELSPAQVASLPKG---TVISQLRFIPKTDGMRPITRVIGAD 604 
                                     :: : . . **  :     .       .::***** ..:**:..:     
 
gi|55741827|ref|NP_445875.1|        DTRAFG---KKKQTQCFTQSLKTLFSVLNYERTKHPNLMGASVLGTSDSY 677 
gi|109633031|ref|NP_937983.2|       GARTFR---REKRAERLTSRVKALFSVLNYERARRPGLLGASVLGLDDIH 687 
gi|71896531|ref|NP_001026178.1      EGQKLSKESREKKIQRYNTQLKNLFSVLNYERTVNTSIIGSSVFGRDDIY 899 
gi|139947514|ref|NP_001077335.      D-----------TLQYFQSCVRVLQNVLSVCVREAPGPMGSTVWGWQDIH 659 
gi|157278369|ref|NP_001098286.      S-----------NTRLHHKRIRDLMSMLQARVRSAPALLGSTVWGMTDIH 643 
                                                  .     :: * .:*.      .  :*::* *  * : 
 
gi|55741827|ref|NP_445875.1|        RIWRTFVLRVRALD-QTPRMYFVKADVTGAYDAIPQDKLVEIVANIIRR- 725 
gi|109633031|ref|NP_937983.2|       RAWRTFVLRVRAQD-PPPELYFVKVDVTGAYDTIPQDRLTEVIASIIK-- 734 
gi|71896531|ref|NP_001026178.1      RKWKEFVTKVFESGGEMPHFYFVKGDVSRAFDTIPHKKLVEVISQVLKPE 949 
gi|139947514|ref|NP_001077335.      RRLQDFSPQQKSSP---RPLYFVKVDVSGAYDSLPHLKLVEVLKEVLGPF 706 
gi|157278369|ref|NP_001098286.      KVLRSLAPAQKDKP---QPLYFVKVDVSGAYDSLPHDKLKEVITEALSPV 690 
                                    :  : :             :**** **: *:*::*: :* *:: . :    
 
gi|55741827|ref|NP_445875.1|        SESMYCIRQYAVVQKDSQGQVHKSFRRQVSTLSDLQP--YMGQFTKHLQD 773 
gi|109633031|ref|NP_937983.2|       PQNTYCVRRYAVVQKAAHGHVRKAFKSHVSTLTDLQP--YMRQFVAHLQE 782 
gi|71896531|ref|NP_001026178.1      SQTVYGIRWYAVIMITPTGKARKLYKRHVSTFEDFIP--DMKQFVSKLQE 997 
gi|139947514|ref|NP_001077335.      AEQSFFLRQYSSVWSDPTRGLRKRFCTKAEMSEP----LNMKGFVVDEQV 752 
gi|157278369|ref|NP_001098286.      QEEVFTVRHYAKIWADSHEGLKKAFARQVDFSDGSMGSTSMKGFVMSLQK 740 
                                     :  : :* *: :   .    :* :  :..          *  *.   *  
 
gi|55741827|ref|NP_445875.1|        SDASALRNSVVIEQSISMNETGSSLLHFFLRFVRHSVVKIDGRFYVQCQG 823 
gi|109633031|ref|NP_937983.2|       T--SPLRDAVVIEQSSSLNEASSGLFDVFLRFMCHHAVRIRGKSYVQCQG 830 
gi|71896531|ref|NP_001026178.1      R--TSLRNAIVVEQCLTFNENSSTLFTFFLQMLHNNILEIGHRYYIQCSG 1045 
gi|139947514|ref|NP_001077335.      S--GRLHDAILVERHS-SEVRGGDVFQFFQKMLCSYVIHYDQQMFRQVCG 799 
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gi|157278369|ref|NP_001098286.      S--SKVHHAVLVEQAFGSNLRGKDALQFFTQMLTGSVVQHGKKTYRQCRG 788 
                                         ::.::::*:    :  .   : .* :::    :.   : : *  * 
 
gi|55741827|ref|NP_445875.1|        IPQGSSLSTLLCSLCFGDMENKLFAEVQQDGLLLRFVDDFLLVTPHLAHA 873 
gi|109633031|ref|NP_937983.2|       IPQGSILSTLLCSLCYGDMENKLFAGIRRDGLLLRLVDDFLLVTPHLTHA 880 
gi|71896531|ref|NP_001026178.1      IPQGSILSTLLCSLCYGDMENKLLCGIQKDGVLIRLIDDFLLVTPHLMQA 1095 
gi|139947514|ref|NP_001077335.      IPQGSSVSSLLCNLCYGHMEKALLKDIAKGGCLMRLIDDFLLITPHLSKA 849 
gi|157278369|ref|NP_001098286.      IPQGSVVSSLLCCLCYGHMENVLFRDIKNKGCLMRLVDDFLLITPDRNQA 838 
                                    ***** :*:*** **:*.**: *:  : . * *:*::*****:**.  :* 
 
gi|55741827|ref|NP_445875.1|        KAFLSTLVHGVPEYGCMINLQKTVVNFPVETGALGGAAPHQLPAHCLFPW 923 
gi|109633031|ref|NP_937983.2|       KTFLRTLVRGVPEYGCVVNLRKTVVNFPVEDEALGGTAFVQMPAHGLFPW 930 
gi|71896531|ref|NP_001026178.1      RTFLRTIAAGIPEYGFLINAKKTVVNFPVDD-IPGCSKFKHLPDCRLISW 1144 
gi|139947514|ref|NP_001077335.      TEFLTTLLSGVPDYGCQINPQKVAVNFPVCVS-WVNSGVSVLPSSCLFPW 898 
gi|157278369|ref|NP_001098286.      QSFLSILLAGVPQYGVVANPQKVVVNFQGSEGGGAFPDIRVLPPHCLFPW 888 
                                      **  :  *:*:**   * :*..***         .    :*   *:.* 
 
gi|55741827|ref|NP_445875.1|        CGLLLDTRTLEVFCDYSGYGRTSIKMSLTFQGVSRAGKTMRYKLLSVLRL 973 
gi|109633031|ref|NP_937983.2|       CGLLLDTRTLEVQSDYSSYARTSIRASLTFNRGFKAGRNMRRKLFGVLRL 980 
gi|71896531|ref|NP_001026178.1      CGLLLDVQTLEVYCDYSSYAFTSIRSSLSFNSSRIAGKNMKCKLTAVLKL 1194 
gi|139947514|ref|NP_001077335.      CGLMIHTHTLDVYKDYSRYDGLSLRYSLTLGSAHSPSTVMK-KLLSVLSI 947 
gi|157278369|ref|NP_001098286.      CGLLLDTRSLDVCKDYSSYAGLSLRYSLTLGSAHSAGQQMRRKLMSILRI 938 
                                    ***::..::*:*  *** *   *:: **::     ..  *: ** .:* : 
 
gi|55741827|ref|NP_445875.1|        KCHGLFLDLQVNSLQTVCINIYKIFLLQAYRFHACVIRLPFGQHVRKNHA 1023 
gi|109633031|ref|NP_937983.2|       KCHSLFLDLQVNSLQTVCTNIYKILLLQAYRFHACVLQLPFHQQVWKNPT 1030 
gi|71896531|ref|NP_001026178.1      KCHPLLLDLKINSLQTVLINIYKIFLLQAYRFHACVLQLPFNQKVRNNPD 1244 
gi|139947514|ref|NP_001077335.      KSTDIFLDLRLNSVEAVYRSLYKLILLQALRFHACVRSLPLGQSVNRNPS 997 
gi|157278369|ref|NP_001098286.      KCHPLFLDLKTNSLESAYKNIHKLVLLQACRFHVCVQSLPFAQTVAKNPT 988 
                                    *.  ::***: **:::.  .::*:.**** ***.**  **: * * .*   
 
gi|55741827|ref|NP_445875.1|        FFLGIISNLASCCYAILKVKNPGVSLRAKGAPGSFPPEATRWLCYQAFLL 1073 
gi|109633031|ref|NP_937983.2|       FFLRVISDTASLCYSILKAKNAGMSLGAKGAAGPLPSEAVQWLCHQAFLL 1080 
gi|71896531|ref|NP_001026178.1      FFLRIISDTASCCYFILKAKNPGVSLGSKDASGMFPFEAAEWLCYHAFIV 1294 
gi|139947514|ref|NP_001077335.      FFLKMIWRMTRVTNKLLTHINKGLPVCSVDSGGVLQSEAVQLLFCLAFET 1047 
gi|157278369|ref|NP_001098286.      YFQQMIWDMAHYANALIRRSNTGLVLGDGAQKGSVQYEAVELLFCLAFLR 1038 
                                    :*  :*   :     ::   * *: :      * .  **.. *   **   
 
gi|55741827|ref|NP_445875.1|        KLAAHSVTYKCLLGPLRTAQKQLCRKLPEATMTLLKTAADPALSTDFQTI 1123 
gi|109633031|ref|NP_937983.2|       KLTRHRVTYVPLLGSLRTAQTQLSRKLPGTTLTALEAAANPALPSDFKTI 1130 
gi|71896531|ref|NP_001026178.1      KLSNHKVIYKCLLKPLKVYKMHLFGKIPRDTMELLKTVTEPSLCQDFKTI 1344 
gi|139947514|ref|NP_001077335.      LFRRFRSVYHCLIPALHKRKRALQRELCGITLARVRQASSPRIPLDFSMR 1097 
gi|157278369|ref|NP_001098286.      VLSKHRPVYKDLLPRLHKWKRRLERLLGDLRLARVRQAANPRALLDFLAM 1088 
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                                     :  .   *  *:  *:  :  *   :    :  :. .:.*    **    
 
gi|55741827|ref|NP_445875.1|        LD 1125 
gi|109633031|ref|NP_937983.2|       LD 1132 
gi|71896531|ref|NP_001026178.1      LD 1346 
gi|139947514|ref|NP_001077335.      V- 1098 
gi|157278369|ref|NP_001098286.      QM 1090 
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Figure A.4.6. Nucleotide sequence aligment between the predicted American purple sea urchin -actin nucleotide sequence 
(XM_001188812.1) and those of other deuterostome species: zebrafish (Danio rerio) (NM_131031.1),grey wolf (Canis lupus)  
(NM_001003349.1) and rainbow trout (NM_001124235.1). The black shading represents 100% similarity. 
 
 
 
Danio             ---GGCACGAGAG-----ATCTTCACTCCCCTTGTTCACAATAACCTACTAATACACAGC 52 
Oncorhynchus      CGCAGTTCGTGCGGGATTATATCATTTACCCTTG-AAACACCCCCCTCCCAAAACCAAAA 59 
Canis             ------------------------------------------------------------ 
Predicted_        ------------------------ATGGCATATGTTGACG-------------------- 16 
                                                                               
 
Danio             ------CATGGATGAGGAAATCGCTGCCCTGGTCGTTGACAACGGCTCCGG-TATGTGCA 105 
Oncorhynchus      GTTCAAAATGGAAGATGAAATCGCCGCACTGGTTGTTGACAACGGATCCGG-TATGTGCA 118 
Canis             -------ATGGACGATGAAATTGCGGCGCTAGTTGTAGATAACGGCTCCGG-TATGTGCA 52 
Predicted_        --------AGGATGACGATTGGCCTGCTCTCGTCTTTGACAGCGGCTCGGGATCTATTCA 68 
                          :*** ** **::   * ** ** **  *:** *.***.** ** *.*.* ** 
 
Danio             AAGCCGGTTTTGCTGGAGATGATGCCCCTCGTGCTGTTTTCCCCTCCATTGTTGGACGAC 165 
Oncorhynchus      AAGCCGGATTCGCCGGAGATGACGCGCCTCGGGCTGTCTTCCCCTCCATCGTCGGGCGTC 178 
Canis             AGGCGGGCTTCGCCGGGGATGACGCCCCTCGAGCCGTGTTCCCGTCCATCGTCGGGCGAC 112 
Predicted_        GTACGGGCAT-GCCGGCGATGACGAGCCAAAGGCAATCATTCCAAATGCAGTTGGCCGAT 127 
                  . .* ** :* ** ** ***** *. **:.. ** .* :* ** :. .  ** ** **:  
 
Danio             CCAGACATCAGG----------------GAGTGATGG---------------TTGGCATG 194 
Oncorhynchus      CCAGGCATCAGG----------------GAGTGATGG---------------TTGGGATG 207 
Canis             CCCGGCACCAGG----------------GCGTGATGG---------------TGCGCATG 141 
Predicted_        ATTTGGATCAGGTAGAATATAAATTAAAAAGAAATGTGGATTACTCTTTGCAGTCGCACG 187 
                  .   . * ****                ..*:.***                   * * * 
 
Danio             -----GGACAGAAAGACTCCTATGTGGGAGATGAGGCTCAGAGCAAGAGAGGTATCCTGA 249 
Oncorhynchus      -----GGCCAGAAAGACAGCTACGTGGGAGACGAGGCTCAGAGCAAGAGGGGTATCCTGA 262 
Canis             -----GGCCAGAAGGACTCCTACGTGGGCGACGAGGCCCAGAGCAAGCGGGGCATCCTGA 196 
Predicted_        TTGACGGGAAGAGGGAGACCTTTATCGGAGAAGCAATCTACAAACACCGAGAAGTCTTGG 247 
                       ** .***..** : **: .* **.** *...   * *...* .*.*. .** **. 
 
Danio             CCCTCAAATACCCCATTGAGCACGGTATTGTGACCAACTGGGATGACATGGAGAAGATCT 309 
Oncorhynchus      CTCTGAAGTACCCCATCGAGCACGGCATCGTCACCAACTGGGACGACATGGAGAAGATCT 322 
Canis             CCCTCAAGTACCCCATCGAGCACGGCATCGTCACCAACTGGGACGACATGGAGAAGATCT 256 
Predicted_        GTATCAACTACCCCATCGAGCACGGTATCGTCAAAGACTGGGAAGACATGGAGAAGATCT 307 
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                    .* ** ******** ******** ** ** *...******* **************** 
 
Danio             GGCATCACACCTTCTACAATGAGCTCCGTGTTGCCCCTGAGGAGCACCCTGTCGTGCTCA 369 
Oncorhynchus      GGCATCACACCTTCTACAACGAGCTGCGAGTGGCTCCAGAGGAGCACCCCGTCCTGCTCA 382 
Canis             GGCACCACACCTTCTACAACGAGCTGCGCGTGGCCCCCGAGGAAGCACCCGTGCTGCTGA 316 
Predicted_        GGCATTATCTTTTCGACGTTGATCTGATGGTCGACACCACAGAGCACCCAGTGCTGATGA 367 
                  ****  * .  *** **.: ** ** .  ** *. .* ...**. ..** **  **.* * 
 
Danio             CTGAGGCTCCCCTGAATCCCAAAGCCAACAGAGAGAAGATGACACAGATCATGTTCGAGA 429 
Oncorhynchus      CAGAGGCCCCCCTCAACCCCAAAGCCAACAGGGAGAAGATGACCCAGATTATGTTTGAGA 442 
Canis             CCGAGGCCCCCCTGAATCCCAAAGCCAACCGTGAGAAGATGACTCAGATCATGTTCGAGA 376 
Predicted_        CAGAGCCACCAGGGAACCCTATGTATAATAGACAGAAGATGGCACAGATAATGTTTGAGA 427 
                  * *** * **.   ** ** *:. . ** .*  ********.* ***** ***** **** 
 
Danio             CCTTCAACACCCCTGCCATGTATGTGGCCATCCAGGCTGTGCTCTCTCTGTACGCTTCTG 489 
Oncorhynchus      CCTTCAACACCCCTGCCATGTACGTGGCCATCCAGGCCGTGTTGTCCCTGTACGCCTCTG 502 
Canis             CGTTCAACACCCCAGCCATGTATGTGGCCATCCAGGCTGTGCTGTCCCTGTACGCCTCTG 436 
Predicted_        CGTTTCAGATACCTGCATTTTACGTGGCCAATCCAGCACTGCTCTCATTGTACTCCAGCG 487 
                  * ** .* * .**:**.:* ** *******: *..**  ** * **  ***** * :  * 
 
Danio             GTCGTACTACTGGTATTGTGATGGACTCTGGTGATGGTGTGACCCACACCGTGCCCATCT 549 
Oncorhynchus      GCCGTACCACCGGTATCGTCATGGACTCCGGTGACGGCGTGACCCACACAGTACCCATCT 562 
Canis             GCCGCACCACTGGTATTGTCATGGACTCTGGGGATGGCGTCACCCACACTGTGCCCATCT 496 
Predicted_        GTCGCGTCAGTGGATTCGTGATCGAGACGGGGGCTGGAGTGACGCAGACATTGGCAATAT 547 
                  * ** .  *  **::* ** ** ** :* ** *. ** ** ** ** **  *. *.**.* 
 
Danio             ATGAGGGTTACGCTCTTCCCCATGCCATCCTGCGTCTGGATCTAGCTGGTCGTGACCTGA 609 
Oncorhynchus      ACGAGGGCTACGCTCTGCCCCACGCCATCCTGCGTCTGGATCTGGCCGGCCGCGACCTCA 622 
Canis             ACGAGGGGTACGCCTTGCCCCACGCCATCCTGCGTCTGGACCTGGCTGGCCGGGACCTGA 556 
Predicted_        ATGAAGGATACTGCCTCGAAGCAGCGACGCATCGAACCGGGTTAGCAGGCAGGGAGATGA 607 
                  * **.** ***    *  .. . ** *  *: **:.  *.  *.** ** .* ** .* * 
 
Danio             CAGACTACCTGATGAAGATCCTGACCGAGCGTGGCTACAGCTTCACCACCACAGCCGAAA 669 
Oncorhynchus      CAGACTACCTGATGAAGATCCTGACGGAGCGCGGTTACAGCTTCACCACCACGGCCGAGA 682 
Canis             CTGACTACCTCATGAAGATCCTCACGGAGCGTGGCTACAGCTTCACCACCACTGCTGAGC 616 
Predicted_        CGCATTATTTGATGAGATTACTCAACAAGAAAGGATATTCTTTCTCCACCACTGGT---- 663 
                  *  * **  * ****..:*.** *. .**.. ** ** :  ***:******* *       
 
Danio             GAGAAATTGTCCGTGACATCAAGGAG-AAGCTGTGCTATGTGGCCCTGGACTTCGAGCAG 728 
Oncorhynchus      GGGAAATCGTACGAGACATCAAGGAG-AAGCTGTGCTACGTGGCGCTGGACTTTGAGCAG 741 
Canis             GGGAGATCGTGCGTGACATCAAGGAAGAAGCTCTGCTACGTCGCCCTGGACTTCGAGCAG 676 
Predicted_        ---------------------------AAGATATGA------------------------ 672 
                                             ***.* **.                         
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Danio             GAGATGGGAACCGCTGCCTCTTCTTCCTCCCTGGAGAAGAGCTATGAGCTGCCTGACGGT 788 
Oncorhynchus      GAGATGGGCACCGCGGCCTCCTCTTCCTCTCTGGAGAAGAGCTACGAGCTGCCTGACGGA 801 
Canis             GAGATGGCCACGGCG-CGTCCTCGTCCTCCCTGGAGAAGAGCTACGAACTACCCGACGGG 735 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             CAGGTCATCACCATCGGCAATGAGCGTTTCCGTTGCCCCGAGGCTCTCTTCCAGCCTTCC 848 
Oncorhynchus      CAGGTCATCACCATCGGCAACGAGAGGTTCCGCTGCCCAGAGGCCCTCTTCCAGCCCTCC 861 
Canis             CAGGTGATCACCATTGGCAACGAGCGGTTCCGCTGCCCAAAAGCACTCTTCCAACCTTCT 795 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             TTCCTGGGTATGGAATCTTGCGGTATCCACGAGACCACCTTCAACTCCATCATGAAGTGC 908 
Oncorhynchus      TTCCTCGGTATGGAGTCTTGCGGTATCCACGAGACCACCTACAACTCCATCATGAAGTGT 921 
Canis             TTCCTGGGGATGGAATCATGCGGTATCCACGAGACCACCTTCAACTCCATCATGAAGTGC 855 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             GACGTGGACATCCGTAAGGACCTGTATGCCAACACAGTGCTGTCTGGAGGTACCACCATG 968 
Oncorhynchus      GACGTGGACATCCGTAAGGACCTGTACGCCAACACGGTGCTGTCCGGAGGAACCACCATG 981 
Canis             GACGTGGACATCCGTAAGGACCTGTATGCCAACACAGTGCTGTCTGGAGGTACCACCATG 915 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             TACCCTGGCATTGCTGACCGTATGCAGAAGGAAATCACCTCTCTTGCTCCTTCCACCATG 1028 
Oncorhynchus      TACCCCGGCATCGCTGACCGGATGCAGAAGGAGATCACCTCTCTGGCCCCCTCCACCATG 1041 
Canis             TACCCTGGCATTGCTGACAGGATGCAGAAGGAAATCACAGCCCTGGCCCCAGCAAGGATG 975 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             AAGATCAAGATCATTGCTCCCCCTGAGCGCAAATACTCCGTCTGGATCGGTGGCTCCATC 1088 
Oncorhynchus      AAGATCAAGATCATCGCCCCCCCAGAGCGTAAATACTCCGTCTGGATCGGAGGCTCCATC 1101 
Canis             AAGATCAAGATCATCGCCCCTCCGGAACGCAAGTATTCTGTGTGGATCGGAGGCTCCATC 1035 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             TTGGCCTCCCTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAGGAGTACGATGAGTCT 1148 
Oncorhynchus      TTGGCTTCTCTCTCCACCTTCCAACAGATGTGGATCAGCAAGCAGGAGTACGACGAGTCT 1161 
Canis             CTGGCCTCGCTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAGGAGTACGACGAGTCG 1095 
Predicted_        ------------------------------------------------------------ 
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Danio             GGCCCATCCATCGTTCACAGGAAGTGCTTCTAAACAGAACTGTTGCCACCTTAAATGGCC 1208 
Oncorhynchus      GGTCCCTCCATCGTCCACCGTAAATGCTTCTAAACAG-ACTGTACCCATCCCAAACGACC 1220 
Canis             GGCCCCTCCATCGTCCATCGCAAATGCTTCTAGATCG-ACTGCGAGCAGATGCGTAGCAT 1154 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             TAGCAA---------------------TGAGATTCAAACGAACGACCAACCTAAA----- 1242 
Oncorhynchus      GACCCAGCCACACCCGACTACCACTTCAGCTCTGCCACCAGACACACCACCCAGAGGGAG 1280 
Canis             TTGCTG---------------CATGAGTGAATTCCGAAGTATAAATTGGCCCTGG----- 1194 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             ------------CTCTCG-------AACAGAACAAGATG-------ACATCAGCATGGCT 1276 
Oncorhynchus      AGAGAGAGGGGGCCCGCGGAGTGAGCCCAAACCCAGCTTCTCAGTCTCATTGGCATGGCT 1340 
Canis             -----CAAATGGCTAGCCT------CATGAAACTGGAATAAG---CGCTTTGAAAAGAAA 1240 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             TCTGCTCTGTATGGCGCATT-----GACTCAGGATGCG-GAAACTGGCAAAGGGAGGTAG 1330 
Oncorhynchus      TCTGTTAT-TTTGGCGCTTTTTTTTGACTCAGGATCTGTGAAAAACAAAAAAATATATAC 1399 
Canis             TTTGTCCTTGAAGCTNGTATCTGATATATCAGCANTGGATTGTAGAACTTGTTGCTGATC 1300 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             TTGTCT----------AACAGGGGAG---AGCTTT------------------------- 1352 
Oncorhynchus      ACAACTGGAACGGTGAAACAGCGGATTAAAGATTTTTAAGAGTTAAAAAAATAATGTAAG 1459 
Canis             TTGACN---------TTGTATCCAAGTTAACTGTT------------------------- 1326 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             ---CCCCGAGAG--------------------------GACAACAA--TGTACAT----- 1376 
Oncorhynchus      GACCCCTGAGATTCTATCATGCAGCTGAGGACTTTAAAAACAACAACATGTACATTCTGT 1519 
Canis             ---CCCTTGGTATATG--------------------TTTAATACCGCCTATTCCAG--GA 1361 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             TTCTTTT---AGTCATTCCAG-----------------------AAGCGTTTACCACTTT 1410 
Oncorhynchus      TTCTTTTTCGAGTCATTCCAATTGTTTTGTTAACTTTTCAGAACAGGTATTTGCCTCTGT 1579 
Canis             TTCTCTAG--AGGCTGGCAAGAG--------------TCTGAACCAGTTGTCATTTCTGT 1405 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             G------CCCTCCTCACAATGGGCGTCCATGACCTTTT-TGTTATAGTGTTTTATGTAAA 1463 
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Oncorhynchus      GAAGGCTGCCGGCTTCCGGCTCTCTGCCACAGCGTTCTGTAACATGGGGCAGTATGGCTT 1639 
Canis             CTTG---CCGGTCTAACAGGGTTGG-----GAAGGTCCGAGCCTTAGGACCCACTTTCCT 1457 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             TTATGTACTCGAT---ACATTGTTT--TTCTTTTTG--TACTT-CAGCCTTAA-ACTTGG 1514 
Oncorhynchus      GTATGTAAATTATGTCACAATGTCTGGGTTTTTTTG--TACTTGCAGCCTTAAGTCTTGG 1697 
Canis             GTCT-TACCCAATGTTTTCCTGCCAGAACACCGTGGGTGGTTAATTGCCTTGAAGTTGGA 1516 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             CCCAG-----------TTTGTTATTGTT---GCAATGAGGGGAAAGCTTTACCTTT---- 1556 
Oncorhynchus      TCCTGTTTAATTTTTTTTTGTTTTTGTTTATGCAAATGAACCCGAGTGTGACCTCTGCTG 1757 
Canis             AAACG----------GTTTGCATTTACAACTGTAAATTTATTCATCCTTTTAATTT---- 1562 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             -------TAAAAAGTGAAGATCTTGCAGGACTTCCCTAGGGTATGTGAATAAGGGATGTC 1609 
Oncorhynchus      GGGGGGGTCAGAGGTGATTAGGGTGCCAGAGGGACCAGTGGGGGGGGGGGCCAACTTGTA 1817 
Canis             ------ATGTAAGGTTTTTTGTACACAATTCTCAATTCTTTTAAGAGATGACAACAAATT 1616 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             CCTTG---AAAATGTAAGCCAGGGTGTCTCTGTACACTGACAAGTCAACCCAAATAAAAC 1666 
Oncorhynchus      CACTGACTAAACTCCCAATAAAAGTGCACATGTGTTCCGACATCAAAAAAAAAAAAAAAA 1877 
Canis             TTGGTTTTCTACTGTCATGTGAG--AACATTAGGCCCCAGCAACGCGTCATTGTGTGAGG 1674 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             GTGCACATGTAAAACCAAAAAAAAAAAAAAAAAA-------------------------- 1700 
Oncorhynchus      AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 1937 
Canis             AAAATAAAGTGCTGCAGTAAAAAAAAAAAAAAAAAAAAAA-------------------- 1714 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             --------------------- 
Oncorhynchus      AAAAAAAAAAAAAAAAAAAAA 1958 
Canis             --------------------- 
Predicted_        --------------------- 
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Figure A.4.7 An alignment of the predicted American purple sea urchin -actin protein sequence (XP001188812.1) and those of 
other deuterostome species: zebrafish (Danio rerio) (NP_571106.1), grey wolf (Canis lupus) (NP001003349.1) and rainbow trout 
(NP_001117707.1). The black shading represents 100% similarity. 
 
 
 
Danio             -----MDEEIAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGR---------PRHQGVMVG 46 
Oncorhynchus      -----MEDEIAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGR---------PRHQGVMVG 46 
Canis             -----MDDEIAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGR---------PRHQGVMVR 46 
Predicted_        MAYVDEDDDWPALVFDSGSGSIQYGHAGDDEPKAIIPNAVGRYLDQVEYKLKRNVDYSLQ 60 
                        ::: .***.*.***  : *.**** *:*::*. ***          *: .  :  
 
Danio             ---MGQKDSYVGDEAQSKRGILTLKYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHPV 103 
Oncorhynchus      ---MGQKDSYVGDEAQSKRGILTLKYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHPV 103 
Canis             ---MGQKDSYVGDEAQSKRGILTLKYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEAPV 103 
Predicted_        SHVDGKRETFIGEAIYKHREVLGINYPIEHGIVKDWEDMEKIWHYLFDVDLMVDTTEHPV 120 
                      *::::::*:   .:* :* ::********.:*:*******: *  :* * . * ** 
 
Danio             VLTEAPLNPKANREKMTQIMFETFNTPAMYVAIQAVLSLYASGRTTGIVMDSGDGVTHTV 163 
Oncorhynchus      LLTEAPLNPKANREKMTQIMFETFNTPAMYVAIQAVLSLYASGRTTGIVMDSGDGVTHTV 163 
Canis             LLTEAPLNPKANREKMTQIMFETFNTPAMYVAIQAVLSLYASGRTTGIVMDSGDGVTHTV 163 
Predicted_        LMTEPPGNPMYNRQKMAQIMFETFQIPAFYVANPALLSLYSSGRVSGFVIETGAGVTQTL 180 
                  ::**.* **  **:**:*******: **:***  *:****:***.:*:*:::* ***:*: 
 
Danio             PIYEGYALPHAILRLDLAGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEKLCYVALDF 223 
Oncorhynchus      PIYEGYALPHAILRLDLAGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEKLCYVALDF 223 
Canis             PIYEGYALPHAILRLDLAGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEEALLRRPGL 223 
Predicted_        AIYEGYCLEAATHRTGLAGREMTHYLMRLLNKKGYSFSTTGKI----------------- 223 
                  .*****.*  *  * .****::*.***::*.::****:**.:                   
 
Danio             EQEMGTAASSSSLEKSYELPDGQVITIGNERFRCPEALFQPSFLGMESCGIHETTFNSIM 283 
Oncorhynchus      EQEMGTAASSSSLEKSYELPDGQVITIGNERFRCPEALFQPSFLGMESCGIHETTYNSIM 283 
Canis             RAGDGHGASSSSLEKSYELPDGQVITIGNERFRCPKALFQPSFLGMESCGIHETTFNSIM 283 
Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             KCDVDIRKDLYANTVLSGGTTMYPGIADRMQKEITSLAPSTMKIKIIAPPERKYSVWIGG 343 
Oncorhynchus      KCDVDIRKDLYANTVLSGGTTMYPGIADRMQKEITSLAPSTMKIKIIAPPERKYSVWIGG 343 
Canis             KCDVDIRKDLYANTVLSGGTTMYPGIADRMQKEITALAPARMKIKIIAPPERKYSVWIGG 343 
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Predicted_        ------------------------------------------------------------ 
                                                                               
 
Danio             SILASLSTFQQMWISKQEYDESGPSIVHRKCF 375 
Oncorhynchus      SILASLSTFQQMWISKQEYDESGPSIVHRKCF 375 
Canis             SILASLSTFQQMWISKQEYDESGPSIVHRKCF 375 
Predicted_        -------------------------------- 
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Figure A.4.8 A nucleotide alignment between the predicted American purple sea urchin Hsp90 nucleotide sequence 
(XM_001188258.1) and those of other deuterostome species: zebrafish (Danio rerio) (NM_131328.1), laboratory mouse (Mus 
musculus) (NM_010480.5), and human Hsp90 β (NM_007355.2). The black shading represents 100% similarity.  
 
 
Danio           --------------------------------------------------GCCGCAGG-- 8 
Homo            ----------------------------------------------CTCCGGCGCAGTGT 14 
Mus             GGAAGGTTCCGGAGGCTTCTGGAAAGAAGCGCCGCGCGCTGGGCGGGCCCGCCTCTATAT 60 
Predicted_      ------TCTCACACACATCATAAAGGGGAACAAGAGTGCT--ACCTCACCGGTGAAGATT 52 
                                                                  *   .:.    
 
Danio           -TGG---------AGAAGAGGAAAT-ACAG---CGAATAA-------TTCAACAAAGAAA 47 
Homo            -TGGGACTGTCTGGGTATCGGAAAG-CAAG---CCTACGT-------TGCTCACTATTAC 62 
Mus             -AAGGCCGGCGCAGGGGGCGGCGCG-CCAGTTGCTTCAGTGTCCTGGTGCGGAGCGTCAC 118 
Predicted_      GTCGAACATTCCTGTACTCGAATCATCTAGAATCAAGAGAG------AGCTTACTGAAAC 106 
                 : *         .    .*.. .  . **   * :  .:       : *  .  .  *. 
 
Danio           CTCTCAGAATAAACCACTCG----AGATGCCTGAGGCTCACGAGCAGCAG------ATGA 97 
Homo            GTATAATCCTTTTCTTTTCA----AGATGCCTGAGG---AAGTGCACCA----------- 104 
Mus             GTCTCGTGCGTGTTCATTCAGCCACGATGCCTGAGGAAACCCAGACCCAAGACCAACCAA 178 
Predicted_      AATAAATAACCATGTCGACT-----GACACCAAGCGTCCCGAAGAACCCA---------- 151 
                 : :..  .   :    :*      ** .**:.. *   .  :*.. *.            
 
Danio           TGGAGGATGAGGAGGTGGAGACGTTTGCGTTTCAGGCTGAGATCGCTCAGCTCATGTCTC 157 
Homo            TGGAG-AGGAGGAGGTGGAGACTTTTGCCTTTCAGGCAGAAATTGCCCAACTCATGTCCC 163 
Mus             TGGAGGAGGAGGAGGTCGAGACCTTTGCCTTTCAGGCAGAAATTGCCCAGTTAATGTCCT 238 
Predicted_      TGGAAGCTGAGGAGGCAGAGACCTTTGCCTTCCAGGCAGAGATTGCTCAGTTGATGAGTC 211 
                ****. . *******  ***** ***** ** *****:**.** ** **. * ***:    
 
Danio           TGATCATCAACACCTTCTACTCCAACAAGGAGATCTTCCTCCGAGAGCTCATCTCCAACT 217 
Homo            TCATCATCAATACCTTCTATTCCAACAAGGAGATTTTCCTTCGGGAGTTGATCTCTAATG 223 
Mus             TGATCATCAATACCTTCTACTCGAACAAAGAGATCTTTCTGAGGGAGCTCATCTCCAATT 298 
Predicted_      TCATCATCAACACATTCTACTCTAACAAGGAGATCTTCCTCAGAGAACTCATCTCTAACT 271 
                * ******** **.***** ** *****.***** ** ** .*.**. * ***** **   
 
Danio           CCTCTGATGCATTGGACAAGATCAGATATGAGAGCTTGACAGATCCGAGCAAACTGGATT 277 
Homo            CTTCTGATGCCTTGGACAAGATTCGCTATGAGAGCCTGACAGACCCTTCGAAGTTGGACA 283 
Mus             CATCGGACGCTCTGGATAAAATCCGTTACGAGAGCCTGACGGACCCCAGTAAACTGGACT 358 
Predicted_      CCTCTGATGCTTTGGACAAGATCCGCTACAAGTCTCTGACTGACCCTAGTGAGATTGAAG 331 
                * ** ** **  **** **.** .* ** .**:   **** ** ** :  .*. * **   
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Danio           CATGCAAGGACCTGAAGATTGAACTGATCCCAGACCAGAAAGAGCGCACGCTGACCATCA 337 
Homo            GTGGTAAAGAGCTGAAAATTGACATCATCCCCAACCCTCAGGAACGTACCCTGACTTTGG 343 
Mus             CGGGGAAGGAGCTGCACATCAATCTCATTCCCAGCAAACAGGACCGAACCCTGACCATTG 418 
Predicted_      CTGAAAAGGATTTCCATATCAGGATTATCCCCAACAAAGATGAGAAGACTCTCACCCTCA 391 
                   . **.**  * .* ** .. .* ** **...*..  * ** .. ** ** **  * . 
 
Danio           TCGACACCGGCATTGGCATGACCAAAGCTGACCTGATCAACAATCTGGGCACCATCGCTA 397 
Homo            TAGACACAGGCATTGGCATGACCAAAGCTGATCTCATAAATAATTTGGGAACCATTGCCA 403 
Mus             TGGATACCGGGATTGGAATGACCAAGGCCGACTTGATCAATAACCTTGGCACCATTGCCA 478 
Predicted_      TTGACACCGGAATTGGTATGACCAAGGCTGACATGATCAACAACCTAGGAACCATTGCCA 451 
                * ** **.** ***** ********.** **  * **.** **  * **.***** ** * 
 
Danio           AATCTGGCACAAAGGCTTTCATGGAGGCTCTGCAGGCCGGAGCGGACATTTCTATGATCG 457 
Homo            AGTCTGGTACTAAAGCATTCATGGAGGCTCTTCAGGCTGGTGCAGACATCTCCATGATTG 463 
Mus             AGTCGGGCACCAAAGCCTTCATGGAGGCTTTGCAGGCTGGTGCAGATATCTCTATGATTG 538 
Predicted_      GGTCTGGCACCAAGAACTTCATGGAAGCCCTGCAGGCAGGAGCTGATATCTCCATGATTG 511 
                ..** ** ** **... ********.**  * ***** **:** ** ** ** ***** * 
 
Danio           GTCAGTTCGGTGTGGGCTTTTATTCTGCGTATCTGGTGGCTGAGAAAGTGACGGTCATCA 517 
Homo            GGCAGTTTGGTGTTGGCTTTTATTCTGCCTACTTGGTGGCAGAGAAAGTGGTTGTGATCA 523 
Mus             GCCAGTTTGGTGTTGGTTTTTACTCTGCCTATTTGGTTGCTGAGAAAGTGACTGTCATCA 598 
Predicted_      GTCAATTTGGTGTTGGATTCTACTCTGCCTACCTAGTAGCAGAGACGGTCACTGTCTACT 571 
                * **.** ***** ** ** ** ***** **  *.** **:****..** .  ** ::*: 
 
Danio           CCAAACACAACGATGATGAGCAGTACATTTGGGAATCTGCAGCTGGCGGATCGTTCACTG 577 
Homo            CAAAGCACAACGATGATGAACAGTATGCTTGGGAGTCTTCTGCTGGAGGTTCCTTCACTG 583 
Mus             CGAAGCATAACGACGATGAGCAGTATGCCTGGGAGTCCTCAGCTGGGGGATCCTTCACAG 658 
Predicted_      CAAAGCACAACGATGATGAGACCTACATGTGGCAATCCAGTGCCGGTGGTTCCTTCACTG 631 
                * **.** ***** *****... ** .  *** *.**   :** ** **:** *****:* 
 
Danio           ---TCAAGCCAGACTTCGGTGAATCAATTGGACGTGGTACCAAAGTCATTCTCCACCTTA 634 
Homo            ---TGCGTGCTGACCATGGTGAGCCCATTGGCAGGGGTACCAAAGTGATCCTCCATCTTA 640 
Mus             ---TGAGGACTGACACAGGTGAACCAATGGGTCGTGGAACAAAGGTTATCTTGCATCTGA 715 
Predicted_      TCCACAGAATTCCTAATAGCGATGACCTGAAGAGAGGAACCAAGATCATTCTAACCATGA 691 
                   : ..   : .    .* **  ...* .. .* **:**.**..* **  * .. .* * 
 
Danio           AAGAGGATCAGTCTGAATATGTGGAGGAAAAGCGCATTAAGGAAGTCGTGAAGAAGCACT 694 
Homo            AAGAAGATCAGACAGAGTACCTAGAAGAGAGGCGGGTCAAAGAAGTAGTGAAGAAGCATT 700 
Mus             AAGAAGACCAAACAGAGTATTTGGAGGAAAGGAGAATAAAGGAGATCGTGAAGAAGCATT 775 
Predicted_      AAGAGGACCAGACAGAATATCTCGATGAGAAGAAAATCAAAGAGGTCATCAAGAAGCACA 751 
                ****.** **.:*:**.**  * ** **.*.*.. .* **.**..*..* ******** : 
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Danio           CTCAGTTCATCGGTTACCCAATTACGCTTTACATTGAGAAACAGAGAGAAAAAGAGGTGG 754 
Homo            CTCAGTTCATAGGCTATCCCATCACCCTTTATTTGGAGAAGGAACGAGAGAAGGAAATTA 760 
Mus             CTCAGTTCATTGGCTATCCCATTACTCTCTTTGTGGAGAAGGAACGAGATAAGGAAGTCA 835 
Predicted_      GTCAGTTCATTGGCTACCCCATTGGTCTTCAGGTGGAGAAGGAACGTGAAAAGGAGGTCA 811 
                 ********* ** ** **.** .  **  :  * *****. *..*:** **.**..* . 
 
Danio           ATCTTGAGGAAGGCGAGAAACAGGAGG---AGGAGGAGGTTGCAGCAGGCGAAGACAA-- 809 
Homo            GTGATGATGAGGCAGAGGAAGAGAAAGGTGAGAAAGAAGAGGAAGATAAAGATGATGA-- 818 
Mus             GTGATGATGAGGCTGAAGAAAAGGAAGAGAAAGAGGAAGAGAAAGAAAAAGAAGAAAAGG 895 
Predicted_      GTGATGATGAAGATGAAGAGGAGAAGAAGGAAGAGGAGGATGAAGAGAATAAGGAAGATG 871 
                .* :*** **.*  **..*. **.*..   *..*.**.*: ..**. .. .* ** .*   
 
Danio           -------AGACAAACCCAAAATTGAAGATCTGGGAGCTGATGAA---GATGAAGACTCTA 859 
Homo            -------AGAAAAACCCAAGATCGAAGATGTGGGTTCAGATGAG---GAGGATGACAGCG 868 
Mus             AGTCTGATGATAAACCTGAAATAGAAGATGTTGGCTCTGATGAAGAAGAGGAGGAGAAGA 955 
Predicted_      ------AAGATAAGCCCAAGATTGAAGATCTGG------ATGAG---GATGAGGAAAAGA 916 
                       :** **.** .*.** ****** * *      ****.   ** ** ** :  . 
 
Danio           AGGATGGCAAGAATAAGAGGAAGAAGAAGGTGAAGGAAAAGTACATTGATGCCCAGGAGC 919 
Homo            GTAAGGATAAGAAGAAGAAAACTAAGAAGATCAAAGAGAAATACATTGATCAGGAAGAAC 928 
Mus             AGGATGGTGACAAGAAGAAAAAGAAGAAGATAAAGGAAAAGTACATTGATCAAGAAGAAC 1015 
Predicted_      AGAAAGAGGAGAAGAAGATCAAGAAGAAGATCAAGGAGAAGTACACTGAAGATGAGGTGC 976 
                . .* *. .* ** ****  *. ******.* **.**.**.**** ***: .  *.*:.* 
 
Danio           TGAATAAGACCAAGCCGATCTGGACCCGTAACCCCGATGACATCACCAATGAGGAGTACG 979 
Homo            TAAACAAGACCAAGCCTATTTGGACCAGAAACCCTGATGACATCACCCAAGAGGAGTATG 988 
Mus             TCAACAAAACAAAGCCGATTTGGACGAGAAATCCTGATGACATCACTAATGAGGAATATG 1075 
Predicted_      TGAACAAGACCAAACCAATCTGGACTAGGAATCCCGATGACATTAGCCAGGACGAGTATG 1036 
                * ** **.**.**.** ** ***** .* ** ** ******** *  .* ** **.** * 
 
Danio           GCGAGTTTTACAAGAGTTTAAGCAATGACTGGGAGGATCACTTGGCTGTCAAGCATTTCT 1039 
Homo            GAGAATTCTACAAGAGCCTCACTAATGACTGGGAAGACCACTTGGCAGTCAAGCACTTTT 1048 
Mus             GAGAGTTCTACAAGAGCTTAACTAACGATTGGGAAGAACACTTGGCAGTAAAGCATTTTT 1135 
Predicted_      GAGAATTCTACAAATCACTCACCAATGATTGGGAAGATCATTTGGCCGTCAAGCACTTCT 1096 
                *.**.** *****.:   *.*  ** ** *****.** ** ***** **.***** ** * 
 
Danio           CAGTTGAGGGCCAACTGGAGTTTCGCGCTCTACTTTTTGTACCCAGAAGAGCTGCTTTTG 1099 
Homo            CTGTAGAAGGTCAGTTGGAATTCAGGGCATTGCTATTTATTCCTCGTCGGGCTCCCTTTG 1108 
Mus             CTGTTGAAGGACAATTAGAATTCCGGGCCCTTCTTTTTGTCCCAAGACGCGCTCCTTTTG 1195 
Predicted_      CTGTGGAAGGGCAGCTTGAGTTCAGAGCTCTTCTCTTCATTCCCAAGCGAGCTCCATTCG 1156 
                *:** **.** **. * **.** .* **  * ** ** .* ** .. .* *** * ** * 
 
Danio           ACCTTTTTGAGAACAAGAAGAAGAGAAACAACATTAAGTTATACGTGCGCAGGGTTTTCA 1159 
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Homo            ACCTTTTTGAGAACAAGAAGAAAAAGAACAACATCAAACTCTATGTCCGCCGTGTGTTCA 1168 
Mus             ATCTGTTTGAAAACAGAAAGAAAAAGAACAACATCAAGTTGTATGTTCGCAGAGTTTTTA 1255 
Predicted_      ACATGTTTGAAAACAAGAAGAAAAAGAACAACATCAAGCTGTACGTGAGGAGAGTCTTCA 1216 
                * .* *****.****..*****.*..******** **. * ** ** .* .* ** ** * 
 
Danio           TCATGGACAATTGCGAGGAACTCATTCCAGAATATCTCAACTTTATTAAGGGTGTGGTGG 1219 
Homo            TCATGGACAGCTGTGATGAGTTGATACCAGAGTATCTCAATTTTATCCGTGGTGTGGTTG 1228 
Mus             TCATGGATAACTGTGAGGAATTAATCCCTGAGTATCTGAATTTCATTAGAGGGGTAGTGG 1315 
Predicted_      TCATGGACAACTGTGAAGATATCATCCCTGAATACCTCAATTTCATCAAGGGTGTTGTAG 1276 
                ******* *. ** ** **  * ** **:**.** ** ** ** ** .. ** ** ** * 
 
Danio           ACTCTGAGGATCTGCCTCTGAACATCTCCAGAGAAATGCTTCAACAGAGTAAAATCCTGA 1279 
Homo            ACTCTGAGGATCTGCCCCTGAACATCTCCCGAGAAATGCTCCAGCAGAGCAAAATCTTGA 1288 
Mus             ATTCTGAGGATCTCCCTCTAAATATTTCCCGTGAAATGCTGCAACAAAGTAAAATTCTGA 1375 
Predicted_      ATTCTGAGGATCTGCCTCTGAATATCTCTCGTGAGATGCTCCAGCAGAGTAAGATCTTGA 1336 
                * *********** ** **.** ** ** .*:**.***** **.**.** **.**  *** 
 
Danio           AGGTGATCCGCAAAAACCTGGTCAAGAAGTGTCTCGATCTCTTCACCGAACTGGCAGAGG 1339 
Homo            AAGTCATTCGCAAAAACATTGTTAAGAAGTGCCTTGAGCTCTTCTCTGAGCTGGCAGAAG 1348 
Mus             AAGTTATCAGAAAGAATTTGGTCAAGAAATGCTTAGAACTATTTACTGAACTAGCAGAAG 1435 
Predicted_      AGGTGATCAGGAAGAACATTGTCAAGAAGTGTATGGAACTCTTCCAAGAACTCTGCGAGG 1396 
                *.** ** .* **.**  * ** *****.**  * ** **.**  . **.**   .**.* 
 
Danio           ATAAAGACAACTACAAGAAATACTACGAGCAGTTCTCCAAAAACATCAAGCTTGGCATCC 1399 
Homo            ACAAGGAGAATTACAAGAAATTCTATGAGGCATTCTCTAAAAATCTCAAGCTTGGAATCC 1408 
Mus             ATAAAGAGAACTACAAAAAGTTTTATGAGCAGTTCTCAAAAAATATAAAGCTTGGAATTC 1495 
Predicted_      ACAGGGAAAACTACAAGAAGTTGTACGAACAATTCTCAAAGAACCTCAAGCTTGGAATCC 1456 
                * *..** ** *****.**.*: ** **. ..***** **.** .*.********.** * 
 
Danio           ATGAGGACTCTCAGAATCGCAAGAAACTTTCTGATCTTTTGCGCTACTACACTTCAGCTT 1459 
Homo            ACGAAGACTCCACTAACCGCCGCCGCCTGTCTGAGCTGCTGCGCTATCATACCTCCCAGT 1468 
Mus             ACGAGGACTCTCAGAATCGGAAGAAGCTTTCAGAGCTGTTGCGGTACTACACATCTGCTT 1555 
Predicted_      ATGAAGACTCCCAGAATCGCAGCAAGATTGCCGACTTCCTCAGGTACTACACTTCACATT 1516 
                * **.***** .. ** ** .. .. .*  * **  *  * .* **  * ** **  . * 
 
Danio           CAGGAGATGAGATGGTGTCACTTAAAGACTATGTGTCTCGCATGAAGGACACACAGAAGC 1519 
Homo            CTGGAGATGAGATGACATCTCTGTCAGAGTATGTTTCTCGCATGAAGGAGACACAGAAGT 1528 
Mus             CTGGGGACGAGATGGTTTCTCTGAAGGACTACTGTACCAGAATGAAGGAAAACCAGAAGC 1615 
Predicted_      CTGGTGATGACCTGACAACACTCAAGGACTACGTCTCAAGAATGAAGGAGAACCAGACAC 1576 
                *:** ** ** .**.  :*:** :..** **    :* .*.******** *..****..  
 
Danio           ACATCTACTACATCACCGGTGAGACCAAAGATCAGGTGGCGAACTCAGCGTTTGTGGAGC 1579 
Homo            CCATCTATTACATCACTGGTGAGAGCAAAGAGCAGGTGGCCAACTCAGCTTTTGTGGAGC 1588 
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Mus             ACATCTATTTTATCACAGGTGAGACCAAGGACCAGGTTGCTAACTCCGCCTTTGTGGAAC 1675 
Predicted_      AGATTTACTACATCACAG------------------------------------------ 1594 
                . ** ** *: ***** *                                           
 
Danio           GCCTCCGTAAAGCTGGTCTGGAGGTGATCTACATGATCGAGCCCATCGATGAATACTGTG 1639 
Homo            GAGTGCGGAAACGGGGCTTCGAGGTGGTATATATGACCGAGCCCATTGACGAGTACTGTG 1648 
Mus             GTCTCCGAAAGCATGGCTTAGAAGTAATTTATATGATTGAGCCCATTGATGAGTATTGTG 1735 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           TTCAGCAGCTGAAGGAATATGATGGCAAGAATCTGGTGTCGGTCACTAAAGAAGGCCTGG 1699 
Homo            TGCAGCAGCTCAAGGAATTTGATGGGAAGAGCCTGGTCTCAGTTACCAAGGAGGGTCTGG 1708 
Mus             TGCAACAGCTGAAGGAATTTGAGGGCAAGACCTTGGTGTCTGTTACCAAAGAAGGACTGG 1795 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           AGCTGCCCGAGGATGAAGAGGAGAAGAAGAAGCAGGATGAGCTGAAGGCCAAATATGAGA 1759 
Homo            AGCTGCCTGAGGATGAGGAGGAGAAGAAGAAGATGGAAGAGAGCAAGGCAAAGTTTGAGA 1768 
Mus             AACTTCCAGAAGATGAAGAGGAAAAGAAGAAACAGGAAGAGAAAAAGACAAAATTTGAGA 1855 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           ACTTGTGCAAGATCATGAAGGATATCCTCGACAAAAAGATTGAGAAGGTCACAGTCTCCA 1819 
Homo            ACCTCTGCAAGCTCATGAAAGAAATCTTAGATAAGAAGGTTGAGAAGGTGACAATCTCCA 1828 
Mus             ACCTCTGCAAAATTATGAAAGATATTTTGGAGAAGAAGGTTGAAAAGGTGGTTGTGTCAA 1915 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           ACCGTCTGGTGTCTTCGCCCTGCTGTATCGTCACCAGCACATACGGTTGGACGGCGAACA 1879 
Homo            ATAGACTTGTGTCTTCACCTTGCTGCATTGTGACCAGCACCTACGGCTGGACAGCCAATA 1888 
Mus             ACCGACTGGTGACATCCCCGTGCTGTATTGTCACAAGCACATATGGGTGGACAGCAAACA 1975 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           TGGAGAGGATCATGAAGTCTCAGGCTCTGAGGGATAACTCTACCATGGGCTACATGACCG 1939 
Homo            TGGAGCGGATCATGAAAGCCCAGGCACTTCGGGACAACTCCACCATGGGCTATATGATGG 1948 
Mus             TGGAGAGAATCATGAAAGCTCAAGCCCTCAGAGACAACTCAACAATGGGTTACATGGCAG 2035 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           CTAAAAAGCACCTGGAAATCAACCCAGCACACCCCATTGTGGAGACCCTCAGAGAGAAAG 1999 
Homo            CCAAAAAGCACCTGGAGATCAACCCTGACCACCCCATTGTGGAGACGCTGCGGCAGAAGG 2008 
Mus             CAAAGAAACACCTGGAGATAAATCCTGATCACTCCATTATTGAAACCTTAAGGCAAAAGG 2095 
 337 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           CGGAAGCCGAGAAAAACGACAAGGCGGTGAAGGATCTGGTGATCCTGCTGTTCGAGACGG 2059 
Homo            CTGAGGCCGACAAGAATGATAAGGCAGTTAAGGACCTGGTGGTGCTGCTGTTTGAAACCG 2068 
Mus             CAGAGGCTGACAAGAATGACAAATCTGTGAAGGATCTGGTCATCTTGCTGTATGAAACTG 2155 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           CGCTCTTATCCTCAGGCTTCACACTGGACGACCCACAGACTCATGCAAACCGCATCTACA 2119 
Homo            CCCTGCTATCTTCTGGCTTTTCCCTTGAGGATCCCCAGACCCACTCCAACCGCATCTATC 2128 
Mus             CACTCCTATCTTCTGGCTTCAGTCTGGAAGATCCCCAGACCCATGCTAACAGGATCTACA 2215 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           GGATGATCAAACTCGGACTTGGCATCGATGACGATGACTCTGTGGTCGAGGAAATCTCTC 2179 
Homo            GCATGATCAAGCTAGGTCTAGGTATTGATGAAGATGAAGTGGCAGCAGAGGAACCCAATG 2188 
Mus             GGATGATCAAGCTTGGTCTAGGTATTGATGAGGATGATCCTACTGTGGATGACACCAGTG 2275 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           AACCCGCTGAAGAAGATATGCCCGTTCTGGAGGGAGACGACGACACTTCGAGAATGGAGG 2239 
Homo            CTGCAGTTCCTGATGAGATCCCCCCTCTCGAGGGCGATGAGGATGCGTCTCGCATGGAAG 2248 
Mus             CTGCTGTAACTGAAGAAATGCCTCCCCTGGAAGGAGATGACGACACATCACGCATGGAAG 2335 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           AAGTCGACTA----AAGAGTT-TTAGTG----------------------TACAAATAAA 2272 
Homo            AAGTCGATTAGGTTAGGAGTTCATAGTT----------------------GGAAAACTTG 2286 
Mus             AAGTAGACTAAGTCACCAGAACTATGTGTTTGCTTACCTTCATTCCTTCTGATAATATAT 2395 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           ATCCGTAATGTAATGTAATTTATTGTTT-----------TTGTATAAAACAATCCAGACA 2321 
Homo            TGCCCTTGTATAGTGTCCCCATGGGCTCCCACTGCAGCCTCGAGTGCCCCTGTCCCACCT 2346 
Mus             TTTCCATGATTTTTGTTTATTTTTGTTAACATTTAAAACATCTGTGTGGCATGAAAACTA 2455 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           ------------------TCCCACAGTGAATGT-TAGCT---------ACTTTAAAG--T 2351 
Homo            GG---------------CTCCCCCTGCTGGTGT-CTAGTGTTTTTTTCCCTCTCCTG--T 2388 
Mus             AGGGGAAGATAAAATTTCTACATGTGATACTGTGATACTATAGGTTTAACTCAAGAGGTT 2515 
Predicted_      ------------------------------------------------------------ 
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Danio           CCTTGTAAT----------TGCCTTGTGTG-----------------TCTGCTCTT---- 2380 
Homo            CCTTGTGTTGAAGGCAGTAAACTAAGGGTGTCAAGCCCCATTCCCTCTCTACTCTTGACA 2448 
Mus             GATAGAGCGTTTGTTATAAGACGTAACGTAACCTACTG---TTCATGTTTGCTCTGGTCT 2572 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           GCA---------------------TTTTATAAT--------TCAAACTTTCTTTTTGTAA 2411 
Homo            GCAGGATTGG-----------ATGTTGTGTATTGTGGTTTATTTTATTTTCTTCATTTTG 2497 
Mus             GAAGTGTTTAGCTGTTGAGCTGGATTCCTTAGGAGACCAAATTAAGATGGCTTAAATTAC 2632 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           ACCT-AAGCTGAACGTTTTTAATAAATGACTCCTTATAAATAAAAAAAAAAAAAAAAAAA 2470 
Homo            TTCT-GAAATTAAAGTATGCAAAATAAAGAATATGCCGTTTTAAAAAAAAAAAAAAAAAA 2556 
Mus             ATCTTAAAATTTTCATTTCCTGTAGTTAATTCTGCATGTATTAGTCTTAGAAGTAAACAC 2692 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           AAAAAAAAAAAA------------------------------------------------ 2482 
Homo            AAAAAAAAAAA------------------------------------------------- 2567 
Mus             AAGTTAAAACAACCTGACAGGAATTCCCCAAGTGGCTTGTTTTCCAAAGTCCCGAGAACA 2752 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           ------------------------------------------------------------ 
Homo            ------------------------------------------------------------ 
Mus             ACCCTAAGTTTCCTAGGTCTTGTAACTCAGCAAGGCTTGTGAATGGAAATAACAGTGCCC 2812 
Predicted_      ------------------------------------------------------------ 
                                                                             
 
Danio           -------------------------------------- 
Homo            -------------------------------------- 
Mus             AATCACATTCTGCTTTAAAAGATAAATACAGAGGAGAT 2850 
Predicted_      -------------------------------------- 
                                                       
 
 
  
 339 
Figure A.4.9. An alignment of the predicted American purple sea urchin Hsp90 protein sequence (XP_001188258.1) and those of 
other deuterostome species: zebrafish (Danio rerio) (NP_571403.1), laboratory mouse (Mus musculus) (NP_034610.1), and human 
Hsp90 β (NP_031381.2). The black shading represents 100% similarity. 
 
 
 
 
gi|18858873|ref|NP_571403.1|        MPEAHEQQ--MMEDEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELIS 48 
gi|6754254|ref|NP_034610.1|         MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELIS 50 
gi|20149594|ref|NP_031381.2|        MPEEVHHG-----EEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELIS 45 
gi|115726886|ref|XP_001188258.      MSTDTKRPEEPMEAEEAETFAFQAEIAQLMSLIINTFYSNKEIFLRELIS 50 
                                    *.   .        **.********************************* 
 
gi|18858873|ref|NP_571403.1|        NSSDALDKIRYESLTDPSKLDSCKDLKIELIPDQKERTLTIIDTGIGMTK 98 
gi|6754254|ref|NP_034610.1|         NSSDALDKIRYESLTDPSKLDSGKELHINLIPSKQDRTLTIVDTGIGMTK 100 
gi|20149594|ref|NP_031381.2|        NASDALDKIRYESLTDPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTK 95 
gi|115726886|ref|XP_001188258.      NSSDALDKIRYKSLTDPSEIEAEKDFHIRIIPNKDEKTLTLIDTGIGMTK 100 
                                    *:*********:******:::: *:::* :**. .::***::******** 
 
gi|18858873|ref|NP_571403.1|        ADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTV 148 
gi|6754254|ref|NP_034610.1|         ADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTV 150 
gi|20149594|ref|NP_031381.2|        ADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVVV 145 
gi|115726886|ref|XP_001188258.      ADMINNLGTIARSGTKNFMEALQAGADISMIGQFGVGFYSAYLVAETVTV 150 
                                    **:********:**** *****************************.*.* 
 
gi|18858873|ref|NP_571403.1|        ITKHNDDEQYIWESAAGGSFTVK-PDFGESIGRGTKVILHLKEDQSEYVE 197 
gi|6754254|ref|NP_034610.1|         ITKHNDDEQYAWESSAGGSFTVR-TDTGEPMGRGTKVILHLKEDQTEYLE 199 
gi|20149594|ref|NP_031381.2|        ITKHNDDEQYAWESSAGGSFTVR-ADHGEPIGRGTKVILHLKEDQTEYLE 194 
gi|115726886|ref|XP_001188258.      YSKHNDDETYMWQSSAGGSFTVHRIPNSDDLKRGTKIILTMKEDQTEYLD 200 
                                     :****** * *:*:*******:    .: : ****:** :****:**:: 
 
gi|18858873|ref|NP_571403.1|        EKRIKEVVKKHSQFIGYPITLYIEKQREKEVDLEEGE----KQEEEEVAA 243 
gi|6754254|ref|NP_034610.1|         ERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAEEKEEKEEEKEKEE 249 
gi|20149594|ref|NP_031381.2|        ERRVKEVVKKHSQFIGYPITLYLEKEREKEISDDEAE---EEKGEKEEED 241 
gi|115726886|ref|XP_001188258.      EKKIKEVIKKHSQFIGYPIGLQVEKEREKEVSDDEDEE--EKKEEEDEEN 248 
                                    *:::**::*********** * :**:*:**:. :* *    :: *::    
 
gi|18858873|ref|NP_571403.1|        GEDKDKPKIEDLGADEDEDSK-DGKNKRKKKVKEKYIDAQELNKTKPIWT 292 
gi|6754254|ref|NP_034610.1|         KESDDKPEIEDVGSDEEEEEKKDGDKKKKKKIKEKYIDQEELNKTKPIWT 299 
gi|20149594|ref|NP_031381.2|        KDDEEKPKIEDVGSDEEDDSG-KDKKKKTKKIKEKYIDQEELNKTKPIWT 290 
gi|115726886|ref|XP_001188258.      KEDEDKPKIEDLDEDEEKKKE---EKKIKKKIKEKYTEDEVLNKTKPIWT 295 
                                     :..:**:***:. **:...    .:* .**:**** : : ********* 
 
gi|18858873|ref|NP_571403.1|        RNPDDITNEEYGEFYKSLSNDWEDHLAVKHFSVEGQLEFRALLFVPRRAA 342 
gi|6754254|ref|NP_034610.1|         RNPDDITNEEYGEFYKSLTNDWEEHLAVKHFSVEGQLEFRALLFVPRRAP 349 
gi|20149594|ref|NP_031381.2|        RNPDDITQEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFIPRRAP 340 
 340 
gi|115726886|ref|XP_001188258.      RNPDDISQDEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFIPKRAP 345 
                                    ******:::*********:****:********************:*:**. 
 
gi|18858873|ref|NP_571403.1|        FDLFENKKKRNNIKLYVRRVFIMDNCEELIPEYLNFIKGVVDSEDLPLNI 392 
gi|6754254|ref|NP_034610.1|         FDLFENRKKKNNIKLYVRRVFIMDNCEELIPEYLNFIRGVVDSEDLPLNI 399 
gi|20149594|ref|NP_031381.2|        FDLFENKKKKNNIKLYVRRVFIMDSCDELIPEYLNFIRGVVDSEDLPLNI 390 
gi|115726886|ref|XP_001188258.      FDMFENKKKKNNIKLYVRRVFIMDNCEDIIPEYLNFIKGVVDSEDLPLNI 395 
                                    **:***:**:**************.*:::********:************ 
 
gi|18858873|ref|NP_571403.1|        SREMLQQSKILKVIRKNLVKKCLDLFTELAEDKDNYKKYYEQFSKNIKLG 442 
gi|6754254|ref|NP_034610.1|         SREMLQQSKILKVIRKNLVKKCLELFTELAEDKENYKKFYEQFSKNIKLG 449 
gi|20149594|ref|NP_031381.2|        SREMLQQSKILKVIRKNIVKKCLELFSELAEDKENYKKFYEAFSKNLKLG 440 
gi|115726886|ref|XP_001188258.      SREMLQQSKILKVIRKNIVKKCMELFQELCEDRENYKKLYEQFSKNLKLG 445 
                                    *****************:****::** **.**::**** ** ****:*** 
 
gi|18858873|ref|NP_571403.1|        IHEDSQNRKKLSDLLRYYTSASGDEMVSLKDYVSRMKDTQKHIYYITGET 492 
gi|6754254|ref|NP_034610.1|         IHEDSQNRKKLSELLRYYTSASGDEMVSLKDYCTRMKENQKHIYFITGET 499 
gi|20149594|ref|NP_031381.2|        IHEDSTNRRRLSELLRYHTSQSGDEMTSLSEYVSRMKETQKSIYYITGES 490 
gi|115726886|ref|XP_001188258.      IHEDSQNRSKIADFLRYYTSHSGDDLTTLKDYVSRMKENQTQIYYIT--- 492 
                                    ***** ** :::::***:** ***::.:*.:* :***:.*. **:**    
 
gi|18858873|ref|NP_571403.1|        KDQVANSAFVERLRKAGLEVIYMIEPIDEYCVQQLKEYDGKNLVSVTKEG 542 
gi|6754254|ref|NP_034610.1|         KDQVANSAFVERLRKHGLEVIYMIEPIDEYCVQQLKEFEGKTLVSVTKEG 549 
gi|20149594|ref|NP_031381.2|        KEQVANSAFVERVRKRGFEVVYMTEPIDEYCVQQLKEFDGKSLVSVTKEG 540 
gi|115726886|ref|XP_001188258.      -------------------------------------------------- 
                                                                                       
 
gi|18858873|ref|NP_571403.1|        LELPEDEEEKKKQDELKAKYENLCKIMKDILDKKIEKVTVSNRLVSSPCC 592 
gi|6754254|ref|NP_034610.1|         LELPEDEEEKKKQEEKKTKFENLCKIMKDILEKKVEKVVVSNRLVTSPCC 599 
gi|20149594|ref|NP_031381.2|        LELPEDEEEKKKMEESKAKFENLCKLMKEILDKKVEKVTISNRLVSSPCC 590 
gi|115726886|ref|XP_001188258.      -------------------------------------------------- 
                                                                                       
 
gi|18858873|ref|NP_571403.1|        IVTSTYGWTANMERIMKSQALRDNSTMGYMTAKKHLEINPAHPIVETLRE 642 
gi|6754254|ref|NP_034610.1|         IVTSTYGWTANMERIMKAQALRDNSTMGYMAAKKHLEINPDHSIIETLRQ 649 
gi|20149594|ref|NP_031381.2|        IVTSTYGWTANMERIMKAQALRDNSTMGYMMAKKHLEINPDHPIVETLRQ 640 
gi|115726886|ref|XP_001188258.      -------------------------------------------------- 
                                                                                       
 
gi|18858873|ref|NP_571403.1|        KAEAEKNDKAVKDLVILLFETALLSSGFTLDDPQTHANRIYRMIKLGLGI 692 
gi|6754254|ref|NP_034610.1|         KAEADKNDKSVKDLVILLYETALLSSGFSLEDPQTHANRIYRMIKLGLGI 699 
gi|20149594|ref|NP_031381.2|        KAEADKNDKAVKDLVVLLFETALLSSGFSLEDPQTHSNRIYRMIKLGLGI 690 
gi|115726886|ref|XP_001188258.      -------------------------------------------------- 
                                                                                       
 
gi|18858873|ref|NP_571403.1|        DDDDSVVEEISQPAEEDMPVLEGDDDTSRMEEVD 726 
gi|6754254|ref|NP_034610.1|         DEDDPTVDDTSAAVTEEMPPLEGDDDTSRMEEVD 733 
gi|20149594|ref|NP_031381.2|        DEDEVAAEEPNAAVPDEIPPLEGDEDASRMEEVD 724 
gi|115726886|ref|XP_001188258.      ---------------------------------- 
 341 
                                                                       
 
 
 
Figure A.5.2. Nucleotide sequence aligment of the two published rainbow trout EST sequences that are possibly TERT, 
CX246542.1 and CA353864.1, showing a 115 bp gap indicating that these may possibly be two separate splice variants. The black 
shading represents 100% similarity. 
 
 
 
CA353864.1      -----------TGAGTCGCCCACCAGCATGAAAGGCTTTGAGATGTCGCTGCAAAGAGAG 49 
CX246542.1      ACGGAAGACACTGTGTCGTCCACCAACATGAAAGGCTTTGTGATGTCACTGCAGAGAGAG 60 
                           ** **** ****** ************** ****** ***** ****** 
 
CA353864.1      GGCAAAGTTCACGATGCCATACTGGGGGAGCAGCATTTCTCCACAGATATTCATGGCAAA 109 
CX246542.1      GGCAAAGTTCACGATGCCATACTGGTGGAGCAGCATTTCTCCACAGATATTCATGGCAAA 120 
                ************************* ********************************** 
 
CA353864.1      GACGTCTTGGAGGTCTTGACCCAGATGCTCTCTAGCTGAGTTGACCAGCTTGGGAAGAAA 169 
CX246542.1      GACGTCTTGGAGTTCTTCACCCAGATGCTCTCTAGCTGTGTTGTCCAGTTTGGGAAGAAA 180 
                ************ **** ******************** **** **** *********** 
 
CA353864.1      TCGTTCCGTCAGGGTCAGGGGATTCCTCAGGGGTCCGCGGAGTCGTCTCTGCTGGGCTGC 229 
CX246542.1      TCGTTCCGTCAGTGTCAGGGGATTCCTCAGGGTTCCGCGGTGTCTTCTCTGCTGTGCTGC 240 
                ************ ******************* ******* *** ********* ***** 
 
CA353864.1      CTCTGTTACGGGCACATGGAGAACCTTCTGTTTCCTAACGTCAGACGGCGAGGAGGGTGT 289 
CX246542.1      CTCTGTTACGGCCACATGGAGAACCTTCTGTTTCCTAACGTCAGTCGGCGAGGAGGGTGT 300 
                *********** ******************************** *************** 
 
CA353864.1      CTGATGAGACTGGATGACGATTTCCTCCTCATCACTCCTGACCTGAGCCAGGCACAGACC 349 
CX246542.1      CTGATGAGACTGGTTGACGATTTCCTCCTCATCACTCCTGACCTGAGCCAGGCACAGACC 360 
                ************* ********************************************** 
 
CA353864.1      TTCCTCAAGACCCTGATGGCGGGGGTACCACGGTACGGGTGTGTGGAGAACCCCCAGAAG 409 
CX246542.1      TTCCTCAAGACCCTGATGGCGGGGGTACCACGGTACGGGTGTGTGGTGAACCCCCAGAAG 420 
                ********************************************** ************* 
 
CA353864.1      GTGGCTGTTAACTTCCCTTTGA-------------------------------------- 431 
 342 
CX246542.1      GTGGCTGTTAACTTCCCTTTGGGTGAGTGGGGGTCCTGTCCTGCTGGGGTACGCCTGCTG 480 
                *********************                                        
 
CA353864.1      ------------------------------------------------------------ 
CX246542.1      CCTTTACACTGTCTGTTCCCCTGGTGTGGACTACTGCTGAATACACACACCCTGGACGTC 540 
                                                                             
 
CA353864.1      -----------------CTACGCTGGCCTATCCCTGCGCTACAGCCTGACGCTAGGCTCC 474 
CX246542.1      TACAACAACTACGCCAGCTACGCTGGCCTATCCCTGCGCTACAGCCTGACGCTAGGCTCC 600 
                                 ******************************************* 
 
CA353864.1      GTCCACTGCGCGGGGCAGCAAACGAAGAGGAAGCTCATGTCCATTCTTAGATTCAAGTGC 534 
CX246542.1      GCCCACTGCGCGGGGCAGCAAATGAAGAGGAAGCTCATGTCCATTCTTAGATTCAAGTGC 660 
                * ******************** ************************************* 
 
CA353864.1      CACGCCCTCTTCCTGGACCTCAGAACCAACTCCCTGAAGGCTGTCTATAGCAACGTCTAC 594 
CX246542.1      CACGCCCTCTTCCTGGACCTCAAAACCAACTCCCTGGAGGCTGTCTATAGCAACTTC--- 717 
                ********************** ************* ***************** **    
 
CA353864.1      AAGTTAGTGTTGCTGCAGGCGTTCAGGTTCCATGCCTG 632 
CX246542.1      -------------------------------------- 
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Figure A.5.3. Nucleotide sequence aligment of Group 1 of the newly published rainbow trout TERT sequences: BX889962.3, 
CA380121.1 and BX088059.3. The black shading represents 100% similarity.  
 
 
 
BX088059        ------------------------------------------------------------ 
BX889962        AAATTCCTGTCCGCAGTCAGGAACTTCCTGTCCATGGGCAAGTTTGAGAGGATGTCATTG 60 
CA380121        ------------------------------------------------------------ 
                                                                             
 
BX088059        ------------------------------------------------------------ 
BX889962        GCTGAGCTGATGTGGAAGATGAAGGTGAATGACTGTGATTGGCTGAAGATCAGCAAGACA 120 
CA380121        ------------------------------------------------------------ 
                                                                             
 
BX088059        ------------------------------------------------------------ 
BX889962        GGCCGCTGCCCGCCCAGTGAGCTGTCGTATCGGACGCGGGTGCTAGGCCAGCTCCTGGCT 180 
CA380121        ------------------------------------------------------------ 
                                                                             
 
BX088059        ------------------------------------------------------------ 
BX889962        TGGCTGCTGGATGGCTATGTGCTAGGCCTGGTGAGAGCTATGTTCTACGTCACAGAGAGC 240 
CA380121        ------------------------------------------------------------ 
                                                                             
 
BX088059        ------------------------------------------------------------ 
BX889962        ATGGGACAGAAGAACGCACTGCGCTTCTACAGATACCAGGTCTGGGCCAAGCTGCAGGAG 300 
CA380121        ------------------------------------------------------------ 
                                                                             
 
BX088059        --------------------------------------AGAGTTGACCCTGGCCCAG--- 19 
BX889962        CTGGCTTTCAGTGGTCACCTCTCTAAAGGTCAGATGTCAGAGTTGACCCTGGCCCAG--- 357 
CA380121        ---------------------------------------GCCTCCCTCCTGCCCCAGCAC 21 
                                                       *  *    **** *****    
 
BX088059        -GTG-ACGTCGCT-------------------------CCCCAAAACCACTGTCCCCTC- 51 
BX889962        -GTG-ACGTCGCT-------------------------CCCCAAAACCACTGTCCCCTC- 389 
CA380121        AGTGCACCTCACCGGGTGTACCTCTTTGTCAGAGAGTGCCTCAACGCGGTGGTCCCCTCG 81 
                 *** ** ** *                          ** ***  *    ********  
 344 
 
BX088059        -----------------CCGCCTCCGCTTCA--TCCC----------------------- 69 
BX889962        -----------------CCGCCTCCGCTTCA--TCCC----------------------- 407 
CA380121        GAGTTCTGGGGGTCGGACCATAACCGATTCAAATTCCTGTCCGCAGTCAGGAACTTCCTG 141 
                                 **    *** ****  * **                        
 
BX088059        --------CAAGACCGAAGGGATGA----GACCCATC--ACACGGGTCAT--AGG----- 108 
BX889962        --------CAAGACCGAAGGGATGA----GACCCATC--ACACGGGTCAT--AGG----- 446 
CA380121        TCCATGGGCAAGTTTGAGAGGATGTCATTGGCTGAGCTGATGTGGAAGATGAAGGTGAAT 201 
                        ****   **  *****     * *  * *  *   **   **  ***      
 
BX088059        ----------GGCTGA----CGCCAAAACAAG---------------------GTTGTTC 133 
BX889962        ----------GGCTGA----CGCCAAAACAAG---------------------GTTGTTC 471 
CA380121        GACTGTGATTGGCTGAAGATCAGCAAGACGGGCCGCTGCCCGCCCAGTGAGCTGTCGTAT 261 
                          ******    *  *** **  *                     ** **   
 
BX088059        CAGACCCGTGTGA-AGG--AGCTGTTAGATG---TGCTAGGTGTCTGTGTAC--GGTCC- 184 
BX889962        CAGACCCGTGTGA-AGG--AGCTGTTAGATG---TGCTAGGTGTCTGTGTAC--GGTCC- 522 
CA380121        CGGACGCGGGTGCTAGGCCAGCTCCTGGCTTGGCTGCTGGATGGCTATGTGCTAGGCCTG 321 
                * *** ** ***  ***  ****  * * *    **** * ** ** *** *  ** *   
 
BX088059        -------------TCTCCCTCTCT-----CCTGGG-------------------CTCTAC 207 
BX889962        -------------TCTCCCTCTCT-----CCTGGG-------------------CTCTAC 545 
CA380121        GTGAGAGCTATGTTCTACGTCACAGAGAGCATGGGACAGAAGAACGCACTGCGCTTCTAC 381 
                             *** * ** *      * ****                    ***** 
 
BX088059        AG--------TGTGGG---GGTTG-----ACCGACATCCACAGAGTCCTCTCTTCAA--- 248 
BX889962        AG--------TGTGGG---GGTTG-----ACCGACATCCACAGAGTCCTCTCTTCCA--- 586 
CA380121        AGATACCAGGTCTGGGCCAAGCTGCAGGAGCTGGCTTTCA-GTGGTCACCTCTCTAAAGG 440 
                **        * ****    * **      * * * * **    ***  ****   *    
 
BX088059        --------------TCACCCCTGCTCAGA--AAGAC--------AAACCACAG------- 277 
BX889962        --------------TCACCCCTGCTCAGA--AAGAC--------AAACCACAG------- 615 
CA380121        TCAGATGTCAGAGTTGACCCTGGCCCAGGTGACGTCGCTCCCCAAAACCACTGTCCCCTC 500 
                              * ****  ** ***   * * *        ******* *        
 
BX088059        -CGGCTCTACTTTGTC---AAGGTGGATGTGAGTGGGGCCTATGACA---GTC------- 323 
BX889962        -CGGCTCTACTTTGTC---AAGGTGGATGTGAGTGGGGCCTATGACA---GTC------- 661 
CA380121        CCGCCTCCGCTTCATCCCCAAGACCGAAG-GGATGAGACCCATCACACGGGTCATAGGGG 559 
                 ** ***  ***  **   ***   ** * *  ** * ** ** ***   ***        
 
BX088059        ------------------TACCCCACACTC---------AGCTCTTGGAGGTGATTGGT- 355 
BX889962        ------------------TACCC-ACACTC---------AGCTCTTGGAGGTGATTGGT- 692 
 345 
CA380121        CTGACGCCAAAACAAGGTTGTTCCAGACCCGTGTGAAGGAGCTGTTAGATGTGCTAGGTG 619 
                                  *   * * ** *         **** ** ** *** * ***  
 
BX088059        ------CA-GGTCCTGTCACA-----------TGTGCAGCAAGAGCTTTTC--------- 388 
BX889962        ------CA-NGTCCTGTCACA-----------TGTGCAGCAAGAGCTTTTCTNCGTGCGA 734 
CA380121        TCTGTGTACGGTCCTCTCCCTCTCTCCTGGGCTCTACAGTGTGGGGGGT----------- 668 
                       *  ***** ** *            * * ***   * *   *            
 
BX088059        ------------------------------------------------------------ 
BX889962        CGCTATGCCCAGGTGTGGGCCCGACACCACGAGGGCCCCTCAGAGACCTTTGTCAGACAA 794 
CA380121        ------------------------------------------------------------ 
                                                                             
 
BX088059        ------------------------------------------------------------ 
BX889962        GCAGACTTCACGGNAGACACTGTGTCGTCACCCACATGAAAGGCTTTGTGATGCACTGCA 854 
CA380121        ------------------------------------------------------------ 
                                                                             
 
BX088059        --------------- 
BX889962        AAGAGAGGGCAAGTT 869 
CA380121        --------------- 
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Figure A.5.4 Nucleotide sequence aligment of Group 3 of the newly published rainbow trout TERT sequences: BX315053.3, 
BX882610.3, BX886589.3, BX315052.3, CU074054.1, BX088058.3 and CX246541.1. The black shading represents 100% 
similarity. 
 
 
 
BX315052        ------------------------------------------------------------ 
BX088058        ------------------------------------------------------------ 
BX882610        ------------------------------------------------------------ 
CU074054        ------------------------------------------------------------ 
BX315053        ------------------------------------------------------------ 
BX886589        CTGAATACACACACCCTGGACGTCTACACAACTACGCCAGCTACGCTGGCCTATCCCTGC 60 
CX246541        ------------------------------------------------------------ 
                                                                             
 
BX315052        ------------------------------------------------------------ 
BX088058        ------------------------------------------------------------ 
BX882610        ------------------------------------------------------------ 
CU074054        ------------------------------------------------------------ 
BX315053        ------------------------------------------------------------ 
BX886589        GCTACAGCCTGACGCTAGGCTCCGCCCACTGCGCGGGGCAGCAAATGAAGAGGAAGCTCA 120 
CX246541        ------------------------------------------------------------ 
                                                                             
 
BX315052        ------------------------------------------------------------ 
BX088058        ------------------------------------------------------------ 
BX882610        ------------------------------------------------------------ 
CU074054        ------------------------------------------------------------ 
BX315053        ------------------------------------------------------------ 
BX886589        TGTCCATCCTTAGATTCAAGTGCCACGCCCTCTTCCTGGACCTCAAAACCAACTCCCTGG 180 
CX246541        ------------------------------------------------------------ 
                                                                             
 
BX315052        -------------CAACATCTATAAGTTAGTGT-GCTGCACGCGTTCAGGTTCCATGCCT 46 
BX088058        ------------------------------------------------------------ 
BX882610        -------------CAACATCTATAAGTTAGTGTTGCTGCACGCGTTCAGGTTCCATGCCT 47 
CU074054        -------------CAACATCTATAAGTTAGTGTTGCTGCACGCGTTCAGGTTCCATGCCT 47 
BX315053        -------------CAACATCTATAAGTTAGTGTTGCTGCACGCGTTCAGGTTCCATGCCT 47 
BX886589        AGGCTGTCTATAGCAACGTCTATAAGTTAGTGTTGCTGCAGGCGTTCAGGTTCCATGCCT 240 
 347 
CX246541        ------------GAAAGATGGGTCTGTTGATCTTACAGAAATCTTT---ATTACATGTAT 45 
                                                                             
 
BX315052        GTGCACAGAGTTTGCCGTTTG-TCAGAAAGTGGGCGGAAACCACTCGTACTTCCTCAATC 105 
BX088058        ------------------------------------------------------------ 
BX882610        GTGCACAGAGTTTGCCGTTTGGTCAGAAAGTGGGCGGAAACCACTCGTACTTCCTCAATC 107 
CU074054        GTGCACAGAGTTTGCCGTTTGGTCAGAAAGTGGGCGGAAACCACTCGTACTTCCTCAATC 107 
BX315053        GTGCACAGAGTTTGCCGTTTGGTCAGAAAGTGGGCGGAAACCACTCGTACTTCCTCAATC 107 
BX886589        GTGCACAGAGTTTGCCGTTTGGTCAGAAAGTGGGCGGAAACCACTCGTACTTCCTCAATC 300 
CX246541        TT--------TTT----TTTAA-CAGACAGTCTTTTATGATTCATCCTTGTCACTCA--C 90 
                                                                             
 
BX315052        TGATCTGGGACTTGGCGGAGTACACCAACCATCTAGTCAGACTTTGCAACAAAGGTGTGT 165 
BX088058        ------------------------------------------------------------ 
BX882610        TGATCTGGGACTTGGCGGAGTACACCAACCATCTAGTCAGACTCTGCAACAAAGGTGTGT 167 
CU074054        TGATCTGGGACTTGGCGGAGTACACCAACCATCTAGTCAGACTCTGCAACAAAGGTGTGT 167 
BX315053        TGATCTGGGACTTGGCGGAGTACACCAACCATCTAGTCAGACTCTGCAACAAAGGTGTGT 167 
BX886589        TGATCTGGGACTTGGCGGAGTACACCAACCATCTAGTCAGACTCTGCAACAAAGGTGTGT 360 
CX246541        TGACCTACAACCT--CGGTCTGC--------TTTAAAAAG----TACAACAGAA------ 130 
                                                                             
 
BX315052        CTCTAGGCTGTAAGGCTTTA-ACAGGTAGCCTTCAGTATGAGGCAGTAGAACTGATATAC 224 
BX088058        ------------------------------------------------------------ 
BX882610        CTCTAGGCTGTAAGGCTTTA-ACAGGTAGCCTTCAGTATGAGGCAGTAGAACTGATATAC 226 
CU074054        CTCTAGGCTGTAAGGCTTTA-ACAGGTAGCCTTCAGTATGAGGCAGTAGAACTGATATAC 226 
BX315053        CTCTAGGCTGTAAGGCTTTA-ACAGGTAGCCTTCAGTATGAGGCAGTAGAACTGATATAC 226 
BX886589        CTCTAGGCTGTAAGGCTTTA-ACAGGTAGCCTTCAGTATGAGGCAGTAGAACTGATATAC 419 
CX246541        -TCAAAAC-ATGAGCTAGTATACAACCAAACCAAAATATT-GACACCGGGAC-AATTTAC 186 
                                                                             
 
BX315052        TGTCTGGCCTTCCTGTTGGTTCTGTCCCGTCATCGCCCCCTCTACTACCATCTCCTCGCT 284 
BX088058        ------------------------------------------------GATCTCCTCGCT 12 
BX882610        TGTCTGGCCTTCCTGTTGGTTCTGTCCCGTCATCGCCCCCTCTACTACCATCTCCTCGCT 286 
CU074054        TGTCTGGCCTTCCTGTTGGTTCTGTCCCGTCATCGCCCCCTCTACTACCATCTCCTCGCT 286 
BX315053        TGTCTGGCCTTCCTGTTGGTTCTGTCCCGTCATCGCCCCCTCTACTACCATCTCCTCGCT 286 
BX886589        TGTCTGGCCTTCCTGTTGGTTCTGTCCCGTCATCGCCCCCTCTACTACCATCTCCTCGCT 479 
CX246541        AAT-TGTCCACACCGT--ATTCTGACCCA--ACTG-----TTTA--AGCCCCCCCCCTAC 234 
                                                                   * ** *    
 
BX315052        CCGCTACGCACACGTAAGAGGAAGCTGGAGGGGAAGCTGGAGGGTTTGAGATTGGCCCGA 344 
BX088058        CCGTTACGCACACGTGAGAGGATGCTGGAGGGGAAGCTGGAGGGTTTGAGATTGGCCCGA 72 
BX882610        CCGCTACGCACACGTAAGAGGAAGCTGGAGGGGAAGCTGGAGGGTTTGAGATTGGCCCGA 346 
CU074054        CCGCTACGCACACGTAAGAGGAAGCTGGAGGGGAAGCTGGAGGGTTTGAGATTGGCCCGA 346 
 348 
BX315053        CCGCTACGCACACGTAAGAGGAAGCTGGAGGGGAAGCTGGAGGGTTTGAGATTGGCCCGA 346 
BX886589        CCGCTACGCACACGTAAGAGGAAGCTGGAGGGGAAGCTGGAGGGTTTGAGATTGGCCCGA 539 
CX246541        CTGCTGTGCACA-GTTATAGG--GTT----AAGAGGTTATAGGGTTAAGAGGTGACAAGG 287 
                * * *  ***** ** * ***  * *      ** * *  ******      ** *  *  
 
BX315052        ATCAGA---CAGGCTGCCACACCCA---AAATGC--CTGAAGACTTCAAGGCCATCCAGG 396 
BX088058        ATCAGA---CAGGCTGCCACACCCT---AAATGC--CTGAAGACTTCAAGGCCATCCAGG 124 
BX882610        ATCAGA---CAGGCTGCCACACCCA---AAATGC--CTGAAGACTTCAAGGCCATCCAGG 398 
CU074054        ATCAGA---CAGGCTGCCACACCCA---AAATGC--CTGAAGACTTCAAGGCCATCCAGG 398 
BX315053        ATCAGA---CAGGCTGCCACACCCA---AAATGC--CTGAAGACTTCAAGGCCATCCAGG 398 
BX886589        ATCAGA---CAGGCTGCCACACCCA---AAATGC--CTGAAGACTTCAAGGCCATCCAGG 591 
CX246541        AGCAGAGGGCAAGAGGTCACAGTAGTGGAAATTCTCCTCTAGGCCTGGATGGCCTTGAAG 347 
                * ****   ** *  * ****       **** *  **  ** * *  * * * *  * * 
 
BX315052        CCTAGAGGAGAATTTCCACTACTGTGACCTCTTGCCCTTTGCGCCTTGTCACCTCTTAAC 456 
BX088058        CGTAGAGGAGAATTGCCACTACTGTGACCTCTTGCCCTGTGCGCGTTGTCACCTGTTAAC 184 
BX882610        CCTAGAGGAGAATTTCCACTACTGTGACCTCTTGCCCTCTGCGCCTTGTCACCTCTTAAC 458 
CU074054        CCTAGAGGAGAATTTCCACTACTGTGACCTCTTGCCCTCTGCGCCTTGTCACCTCTTAAC 458 
BX315053        CCTAGAGGAGAATTTCCACTACTGTGACCTCTTGCCCTCTGCGCCTTGTCACCTCTTAAC 458 
BX886589        CCTAGAGGAGAATTTCCACTACTGTGACCTCTTGCCCTCTGCGCCTTGTCACCTCTTAAC 651 
CX246541        TCTTCAGG--CATTTTGGGT---GTGGCAGCCTGTCTGATTCGG---GCCAATCTCAAAC 399 
                  *  ***   ***     *   *** *  * ** *   * **    * **      *** 
 
BX315052        CCTATAACCTCTT----AAC--CCTATAAC-TGTGCACAGCAG--GTAGGGGGGGGGGGG 507 
BX088058        CCTATAACCTCTT----AAC--CCTATAAC-TGTGCACAGCAG--GTAGGGGGGGGGGGG 235 
BX882610        CCTATAACCTCTT----AAC--CCTATAAC-TGTGCACAGCAG--GTAGGGGGGGGGGGG 509 
CU074054        CCTATAACCTCTT----AAC--CCTATAAC-TGTGCACAGCAG--GTAGGGGGGGGGGGG 509 
BX315053        CCTATAACCTCTT----AAC--CCTATAAC-TGTGCACAGCAGTAGGGGGGGGGGGGGGG 511 
BX886589        CCTATAACCTCTT----AAC--CCTATAAC-TGTGCACAGCAG--GTAGGGGGGGGGGGG 702 
CX246541        CCTCCAGCTTCCCCTCCAGCTTCCTCTTACGTGTGCGTAGCGG-AGCGAGGAGATGGTAG 458 
                ***  * * **      * *  *** * ** *****  *** *  *   ** *  **  * 
 
BX315052        ----CTTAAA-----CAGT--TGGGTCAGAAT--ACTGTGTGGACA-ATTGTAAATT-GT 552 
BX088058        ----CTTAAA-----CAGT--TGGGTCAGAAT--ACTGTGTGGACA-ATTGTAAATT-GT 280 
BX882610        ----CTTAAA-----CAGT--TGGGTCAGAAT--ACTGTGTGGACA-ATTGTAAATT-GT 554 
CU074054        ----CTTAAA-----CAGT--TGGGTCAGAAT--ACTGTGTGGACA-ATTGTAAATT-GT 554 
BX315053        ----CTTAAA-----CAGT--TGGGTCAGAAT--ACTGTGTGGACA-ATTGTAAATT-GT 556 
BX886589        GGGCTTTAAA-----CAGT--TGGGTCAGAAT--ACTGTGTGGACA-ATTGTAAATT-GT 751 
CX246541        ------TAGAGGGGGCGATGACGGGACAGAACCAACAGGAAGGCCAGACAGTATATCAGT 512 
                      ** *     *  *   *** *****   ** *   ** ** *  *** **  ** 
 
BX315052        CCCGGTGTCA-ATATTTTGG-TT--TGGTTGTATACT---AGCTCA------------TG 593 
BX088058        CCCGGTGTCA-ATATTTTGG-TT--TGGTTGTATACT---AGCTCA------------TG 321 
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BX882610        CCCGGTGTCA-ATATTTTGGGTT--TGGTTGTATACT---AGCTCA------------TG 596 
CU074054        CCCGGTGTCA-ATATTTTGG-TT--TGGTTGTATACT---AGCTCA------------TG 595 
BX315053        CCCGGTGTCA-ATATTTTTGGTT--TGGTTGTATACT---AGCTCA------------TG 598 
BX886589        CCCGGTGTCA-ATAATTTTGGTT--TGGTTGGAAACT---AGCTCA------------TG 793 
CX246541        TCTACTGCCTCATACTGAAGGCTACCTGTTAAAGCCTTACAGCCTAGAGACACACCTTTG 572 
                 *   ** *  *** *   *  *    ***  *  **   ***  *            ** 
 
BX315052        TTTTGA-TTCTGTTGTACTTTTTAAAGCAGACCG--AGGTTGTAGGTCAGTGAGTGACAA 650 
BX088058        TTTTGA-TTCTGTTGTACTTTTTAAAGCAGACCG--AGGTTGTAGGTCAGTGAGTGACAA 378 
BX882610        TTTTGA-TTCTGTTGTACTTTTTAAAGCAGACCG--AGGTTGTAGGTCAGTGAGTGACAA 653 
CU074054        TTTTGA-TTCTGTTGTACTTTTTAAAGCAGACCG--AGGTTGTAGGTCAGTGAGTGACAA 652 
BX315053        TTTTGA-TTCTGTTGTACTTTTTAAAGCAGACCG--AGGTTGTAGGTCAGTGAGTGACAA 655 
BX886589        TTTTGAATTCTGT----------------------------------------------- 806 
CX246541        TTGCAGAGTCTGACTAGATGGTTGGTGTACTCCGCCAAGTCCCAGATCA--GATTGAGGA 630 
                **      ****                                                 
 
BX315052        GG-ATGA-ATCATAAAAGAC---TGTCTGTTAAAAAAA-AATACATGTAATAAAGATTT- 703 
BX088058        GG-ATGA-ATCATAAAAGAC---TGTCTGTTAAATAT---ATACATGTAATAAAGATTT- 429 
BX882610        GGCATGACATCATAAAAGACC--TGTCTGTTTACAACACAATTCCTGTTATACAGATTT- 710 
CU074054        GG-ATGA-ATCATAAAAGAC---TGTCTGTTAAAAAAA-AATACATGTAATAAAGATTT- 705 
BX315053        GG-ATGA-ATCATAAAAGAC---TGTCTGTTAAAAAAA--ATACATGTAATAAAGATTTT 708 
BX886589        ------------------------------------------------------------ 
CX246541        AGTACGA-GTGGTTTCCGCCCACTTTCTGACCAAACGGCAAACTCTGT-GCACAGGCAT- 687 
                                                                             
 
BX315052        CTGTAAGATC------------------------ 713 
BX088058        CTGTAAGATC------------------------ 439 
BX882610        CTGTAAGATTCCATAAAACACACAAACGTATAAC 744 
CU074054        CTGTAAGATC------------------------ 715 
BX315053        CTGGTAGATC------------------------ 718 
BX886589        ---------------------------------- 
CX246541        --GGAA---------------------------- 691 
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Figure A.5.5.A Nucleotide alignment of the twelve possible rainbow trout TERT sequences with TERT from two other fish species, 
Japanese medaka (NM_001104816.1) and zebrafish (NM_001083866.1). The rainbow trout sequences are; Group 1: BX889962.3, 
CA380121.1, BX088059.3, Group 2: CX246542.1 and CA 363864.1, Group 3: BX315053.3, BX882610.3, BX886589.3, 
BX315052.3, CU074054.1, BX088058.3 and CX246541.1. The black shading represents 100% similarity. 
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Figure A.5.10. Nucleotide sequence aligment of the cloned rainbow trout cDNA encoding the two rainbow trout TERT splice variant 
sequences, omTertLong and omTertShort, with the two published TERT sequences: The longer sequence CX246542.1 and the 
shorter sequence CA353864. The black shading represents 100% similarity. 
 
 
 
9               ------------------------------------------------------------ 
Trout1          -----ACGGAAGACACTGTGTCGTCCACCAACATGAAAGGCTTTGTGATGTCACTGCAGA 55 
2               ------------------------------------------------------------ 
5_T7            ------------------------------------------------------------ 
13_T7           ------------------------------------------------------------ 
10_T7           ------------------------------------------------------------ 
Trout2          GCCTCCCTCCTGCCCCAGCACAGTGCACCTCACCGGGTGTACCTCTTTGTCAGAGAGTGC 60 
                                                                             
 
9               ------------------------------------------------------------ 
Trout1          GAGAGGGCAAAGTTCACGATGCCATACTGGTGGAGCAGCATTTCTCCACAGATATTCATG 115 
2               ------------------------------------------------------------ 
5_T7            ------------------------------------------------------------ 
13_T7           ------------------------------------------------------------ 
10_T7           ------------------------------------------------------------ 
Trout2          CTCAACGCGGTGGTCCCCTCGGAGTTCTGGGGGTCGGACCATAACCGATTCAAATTCCTG 120 
                                                                             
 
9               ------------------------------------------------------------ 
Trout1          GCAAAGACGTCTTGGAGTTCTTCACCCAG---ATGCTCTCTAG------CTGTGTTGTCC 166 
2               ------------------------------------------------------------ 
5_T7            ------------------------------------------------------------ 
13_T7           ------------------------------------------------------------ 
10_T7           ------------------------------------------------------------ 
Trout2          --TCCGCAGTCAGGAACTTCCTGTCCATGGGCAAGTTTGAGAGGATGTCATTGGCTGAGC 178 
                                                                             
 
9               ------------------------------------------------------------ 
Trout1          AGTTTGGGAAGAAATCGTT--CCGTCAGTGTCAGGGGATTCCTCAGGGTTCCGCGGTGTC 224 
2               ------------------------------------------------------------ 
5_T7            ------------------------------------------------------------ 
13_T7           ------------------------------------------------------------ 
10_T7           ------------------------------------------------------------ 
Trout2          TGATGTGGAAGATGAAGGTGAATGACTGTGATTGGCTGAAGATCAGCAAGACGGGCCG-C 237 
 361 
                                                                             
 
9               ------------------------------------------------------------ 
Trout1          TTCTCTGCTGTGCTGCCTCTGTTACGGCCACATGGAGAACCTTCTGTTTCCTAACGTCAG 284 
2               ------------------------------------------------------------ 
5_T7            ------------------------------------------------------------ 
13_T7           ------------------------------------------------------------ 
10_T7           ------------------------------------------------------------ 
Trout2          TGCCCGCCCAGTGAGCTGTCGTATCGGACGCG-GGTGCTAGGCCAG-CTCCTGGCTTGG- 294 
                                                                             
 
9               ---------------------------------------CCTCCTCATCACTCCTGACCT 21 
Trout1          TCGGCGAGGAGGGTGTCTGATGAGACTGGTTGACGATTTCCTCCTCATCACTCCTGACCT 344 
2               ---------------------------------------CCTCCTCATCACTCCTGACCT 21 
5_T7            ---------------------------------------CCTCCTCATCACTCCTGACCT 21 
13_T7           ---------------------------------------CCTCCTCATCACTCCTGACCT 21 
10_T7           ---------------------------------------CCTCCTCATCACTCCTGACCT 21 
Trout2          -CTGCTGGATGGCTATGTGCTAGGCCTGGTGAGAGCTATGTTCTACGTCACAGAGAGCAT 353 
                                                         ** :*.****: . ..*.* 
 
9               GAGCCAG------GCACAGACCTTCCTCAAGACCCTGATGGCGGGGGTACCACGG-TACG 74 
Trout1          GAGCCAG------GCACAGACCTTCCTCAAGACCCTGATGGCGGGGGTACCACGG-TACG 397 
2               GAGCCAG------GCACAGACCTTCCTCAAGACCCTGATGGCGGGGGTACCACGG-TACG 74 
5_T7            GAGCCAG------GCACAGACCTTCCTCAAGACCCTGATGGCGGGGGTACCACGG-TACG 74 
13_T7           GAGCCAG------GCACAGACCTTCCTCAAGACCCTGATGGCGGGGGTACCACGG-TACG 74 
10_T7           GAGCCAG------GCACAGACCTTCCTCAAGACCCTGATGGCGGGGGTACCACGG-TACG 74 
Trout2          GGGACAGAAGAACGCACTGCGCTTCTACAGATACCAGGTCTGGGCCAAGCTGCAGGAGCT 413 
                *.*.***      ****:*. **** :**..:.**:*.*   **  .:.* .*.* :.*  
 
9               GG---TGTGTGGTGAACCCCCAGAAGGT-GGCTGTTA-ACTTCCCTTTGGGTGAGTGGGG 129 
Trout1          GG---TGTGTGGTGAACCCCCAGAAGGT-GGCTGTTA-ACTTCCCTTTGGGTGAGTGGGG 452 
2               GG---TGTGTGGTGAACCCCCAGAAGGT-GGCTGTTA-ACTTCCCTTTGGGTGAGTGGGG 129 
5_T7            GG---TGTGTGGTGAACTCCCAGAAGGT-GGCTGTTA-ACTTCCCTTTGG---------- 119 
13_T7           GG---TGTGTGGTGAACTCCCAGAAGGT-GGCTGTTA-ACTTCCCTTTGG---------- 119 
10_T7           GG---TGTGTGGTGAACTCCCAGAAGGT-GGCTGTTA-ACTTCCCTTTGG---------- 119 
Trout2          GGCTTTCAGTGGTCACCTCTCTAAAGGTCAGATGTCAGAGTTGACCCTGGCCCAGGTGAC 473 
                **   * :***** *.* * *:.***** .*.*** * * ** .*  ***           
 
9               GTCCTGTCCTGCTGGGGTACGCCTGCTGCCTTTACACTGTCTGTTCCCCTGGTGTGGACT 189 
Trout1          GTCCTGTCCTGCTGGGGTACGCCTGCTGCCTTTACACTGTCTGTTCCCCTGGTGTGGACT 512 
2               GTCCTGTCCTGCTGGGGTACGCCTGCTGCCTTTACACTGTCTGTTCCCCTGGTGTGGACT 189 
5_T7            ------------------------------------------------------------ 
13_T7           ------------------------------------------------------------ 
 362 
10_T7           ------------------------------------------------------------ 
Trout2          GTCG-CTCCCCAAAACCACTGTCCCCTCCCG--CCTCCGCTTCATCCCCAAGACCG---A 527 
                                                                             
 
9               ACTGCTGAATACACACACCCTGGACGTCTACAACAACTACGCCAGCTACGCTGG-CCTAT 248 
Trout1          ACTGCTGAATACACACACCCTGGACGTCTACAACAACTACGCCAGCTACGCTGG-CCTAT 571 
2               ACTGCTGAATACACACACCCTGGACGTCTACAACAACTACGCCAGCTACGCTGG-CCTAT 248 
5_T7            ---------------------------------------------CTACGCTGG-CCTAT 133 
13_T7           ---------------------------------------------CTACGCTGG-CCTAT 133 
10_T7           ---------------------------------------------CTACGCTGG-CCTAT 133 
Trout2          AGGGATGAGACCCATCACACGGGTCATAGGGGCTGACG-CCAAAACAAGGTTGTTCCAGA 586 
                                                             *:* * **  **:.: 
 
9               CCC-TGCGCTACAGCCTGACGCTAGGCT-------------------------------- 275 
Trout1          CCC-TGCGCTACAGCCTGACGCTAGGCTCCGCCCACTGCGCGGGGCAGCAAATGAAGAGG 630 
2               CCC-TGCGCTACAGCCTGACGCTAGGCT-------------------------------- 275 
5_T7            CCC-TGCGCTACAGCCTGACGCTAGGCT-------------------------------- 160 
13_T7           CCC-TGCGCTACAGCCTGACGCTAGGCT-------------------------------- 160 
10_T7           CCC-TGCGCTACAGCCTGACGCTAGGCT-------------------------------- 160 
Trout2          CCCGTGTGAAGGAGCTGTTAGATGTGCTAGG----------------------------- 617 
                *** ** *.:. ***   :.*.*. ***                                 
 
9               ------------------------------------------------------------ 
Trout1          AAGCTCATGTCCATTCTTAGATTCAAGTGCCACGCCCTCTTCCTGGACCTCAAAACCAAC 690 
2               ------------------------------------------------------------ 
5_T7            ------------------------------------------------------------ 
13_T7           ------------------------------------------------------------ 
10_T7           ------------------------------------------------------------ 
Trout2          -------TGTCTG--------TGTACGGTCCTCTCCCTCTCTCCTGGGCTCTACAGTG-- 660 
                                                                             
 
9               --------------------------- 
Trout1          TCCCTGGAGGCTGTCTATAGCAACTTC 717 
2               --------------------------- 
5_T7            --------------------------- 
13_T7           --------------------------- 
10_T7           --------------------------- 
Trout2          ----TGGGGGGT--------------- 668 
                                            
 
 
 
